Term,NES,FDR q-val,Perturbation
RRNA_PROCESSING,4.271659556,0,rosiglitazone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.998686802,0,rosiglitazone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.012970991,0,rosiglitazone
METABOLISM_OF_RNA,3.261508065,0,rosiglitazone
SIGNALING_BY_ROBO_RECEPTORS,3.508691994,0,rosiglitazone
CELLULAR_RESPONSE_TO_STARVATION,3.564526519,0,rosiglitazone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.746476903,0,rosiglitazone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.879443177,0,rosiglitazone
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.994034992,0,rosiglitazone
TRANSLATION,3.926575847,0,rosiglitazone
GPCR_LIGAND_BINDING,-3.158513278,0,flutamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.057140834,0,flutamide
RRNA_PROCESSING,2.999062733,0,flutamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.922223588,0,flutamide
SIGNALING_BY_GPCR,-2.914280949,0,flutamide
EUKARYOTIC_TRANSLATION_ELONGATION,2.876294175,0,flutamide
EUKARYOTIC_TRANSLATION_INITIATION,2.777295779,0,flutamide
NONSENSE_MEDIATED_DECAY_NMD,2.772003408,0,flutamide
SELENOAMINO_ACID_METABOLISM,2.768009229,0,flutamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.727018625,0,flutamide
EUKARYOTIC_TRANSLATION_ELONGATION,4.719229378,0,progesterone
SARS_COV_2_INFECTION,2.755587853,0,progesterone
SARS_COV_2_HOST_INTERACTIONS,3.088501822,0,progesterone
INFECTIOUS_DISEASE,3.227724508,0,progesterone
VIRAL_INFECTION_PATHWAYS,3.22969993,0,progesterone
METABOLISM_OF_RNA,3.408315823,0,progesterone
CELLULAR_RESPONSES_TO_STIMULI,3.510692712,0,progesterone
SARS_COV_1_INFECTION,3.650893399,0,progesterone
NERVOUS_SYSTEM_DEVELOPMENT,3.681043489,0,progesterone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.699355844,0,progesterone
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.3497458,0.043495782,resveratrol
COLLAGEN_FORMATION,2.313667873,0.035180412,resveratrol
SIGNALING_BY_MET,2.248824534,0.044775069,resveratrol
DEVELOPMENTAL_CELL_LINEAGES,2.243990853,0.035500233,resveratrol
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.213343516,0.034796625,resveratrol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.113119878,0.065030458,resveratrol
BIOLOGICAL_OXIDATIONS,-2.125095719,0.120527503,resveratrol
SIGNALING_BY_HEDGEHOG,2.099562209,0.061954075,resveratrol
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.035547474,0.083313611,resveratrol
GPCR_LIGAND_BINDING,1.975460696,0.111298029,resveratrol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.702649518,0,fluorouracil
RRNA_PROCESSING,-2.507660369,0.003513643,fluorouracil
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.268409217,0.014906364,fluorouracil
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.143030578,0.097697804,fluorouracil
SIGNALING_BY_ALK_IN_CANCER,2.117047762,0.06513187,fluorouracil
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,2.040110715,0.090862979,fluorouracil
BIOLOGICAL_OXIDATIONS,-2.040818327,0.060370775,fluorouracil
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.035089498,0.049191002,fluorouracil
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.985305398,0.055153548,fluorouracil
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.942174827,0.05996009,fluorouracil
MITOTIC_METAPHASE_AND_ANAPHASE,2.878147729,0,batimastat
M_PHASE,2.836578253,0,batimastat
CELL_CYCLE_CHECKPOINTS,2.692107824,0.00097792,batimastat
CELL_CYCLE_MITOTIC,2.687392152,0.00073344,batimastat
CELL_CYCLE,2.682002635,0.000586752,batimastat
SEPARATION_OF_SISTER_CHROMATIDS,2.675516425,0.00048896,batimastat
RHO_GTPASES_ACTIVATE_FORMINS,2.645691019,0.000419109,batimastat
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.564544926,0.00036672,batimastat
MITOTIC_PROMETAPHASE,2.542634746,0.000325973,batimastat
MITOTIC_SPINDLE_CHECKPOINT,2.413957288,0.000880128,batimastat
MUSCLE_CONTRACTION,3.221819468,0,carbamazepine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.939145909,0.000326838,carbamazepine
CARDIAC_CONDUCTION,2.751393771,0.000217892,carbamazepine
FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX,-2.249415208,0.035828885,carbamazepine
EUKARYOTIC_TRANSLATION_INITIATION,2.367173842,0.007680691,carbamazepine
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.087835726,0.096506836,carbamazepine
TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES,-2.068312703,0.076280852,carbamazepine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.182242681,0.027192913,carbamazepine
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-2.053283752,0.064723147,carbamazepine
DNA_REPAIR,-2.004242248,0.082984321,carbamazepine
SEPARATION_OF_SISTER_CHROMATIDS,2.989987773,0,BRD-K76188144
MITOTIC_SPINDLE_CHECKPOINT,2.961480585,0,BRD-K76188144
M_PHASE,2.939914802,0,BRD-K76188144
CELL_CYCLE_CHECKPOINTS,2.895097629,0,BRD-K76188144
MITOTIC_METAPHASE_AND_ANAPHASE,2.831144341,0,BRD-K76188144
MITOTIC_PROMETAPHASE,2.741854663,0.000379111,BRD-K76188144
CELL_CYCLE_MITOTIC,2.696113354,0.000324952,BRD-K76188144
RHO_GTPASES_ACTIVATE_FORMINS,2.636252112,0.001137333,BRD-K76188144
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.572944542,0.001263703,BRD-K76188144
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.50393277,0.001592266,BRD-K76188144
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.534411092,0,gossypol
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.709881178,0,gossypol
UNFOLDED_PROTEIN_RESPONSE_UPR,2.743580412,0,gossypol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.854026364,0,gossypol
SIGNALING_BY_ROBO_RECEPTORS,2.938161491,0,gossypol
RESPIRATORY_ELECTRON_TRANSPORT,2.994626148,0,gossypol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.013893486,0,gossypol
CELLULAR_RESPONSES_TO_STIMULI,3.136426288,0,gossypol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.440113697,0,gossypol
SIGNALING_BY_GPCR,-2.578761316,0,gossypol
METABOLISM_OF_RNA,3.126676695,0,enzalutamide
TCR_SIGNALING,2.852259519,0,enzalutamide
RRNA_PROCESSING,2.732841721,0.00055941,enzalutamide
ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS,2.678311963,0.000419558,enzalutamide
DOWNSTREAM_TCR_SIGNALING,2.610775784,0.000671292,enzalutamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.608082959,0.00055941,enzalutamide
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,2.567839125,0.000479495,enzalutamide
EUKARYOTIC_TRANSLATION_INITIATION,2.557650415,0.000419558,enzalutamide
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,2.520796176,0.00037294,enzalutamide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.465446201,0.000503469,enzalutamide
MITOTIC_METAPHASE_AND_ANAPHASE,-3.13512895,0,enzastaurin
SEPARATION_OF_SISTER_CHROMATIDS,-2.897235276,0.001320471,enzastaurin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.686160079,0.000880314,enzastaurin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.561613302,0.001980707,enzastaurin
M_PHASE,-2.520028994,0.002640943,enzastaurin
RESPIRATORY_ELECTRON_TRANSPORT,-2.399286725,0.004841729,enzastaurin
MITOTIC_PROMETAPHASE,-2.363584386,0.005659163,enzastaurin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.362511236,0.004951768,enzastaurin
CELL_CYCLE_MITOTIC,-2.217136278,0.012617839,enzastaurin
CELLULAR_RESPONSES_TO_STIMULI,-2.173944134,0.014261092,enzastaurin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.384884602,0,AZD-7545
EUKARYOTIC_TRANSLATION_ELONGATION,3.228861908,0,AZD-7545
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.004693308,0,AZD-7545
INFLUENZA_INFECTION,2.911965181,0,AZD-7545
EUKARYOTIC_TRANSLATION_INITIATION,2.842338962,0,AZD-7545
NONSENSE_MEDIATED_DECAY_NMD,2.751825152,0.000381682,AZD-7545
TRANSLATION,2.739594269,0.000327156,AZD-7545
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.733302932,0.000286262,AZD-7545
CELLULAR_RESPONSE_TO_STARVATION,2.616009611,0.000254455,AZD-7545
SELENOAMINO_ACID_METABOLISM,2.614442345,0.000229009,AZD-7545
GPCR_LIGAND_BINDING,2.925619886,0,glutamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.862846751,0,glutamine
SIGNALING_BY_GPCR,2.571211131,0.000171828,glutamine
G_ALPHA_I_SIGNALLING_EVENTS,2.392800017,0.000902098,glutamine
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-2.280126643,0.026808879,glutamine
NEUTROPHIL_DEGRANULATION,-2.15423997,0.060319977,glutamine
METABOLISM_OF_NUCLEOTIDES,-2.130893243,0.052128375,glutamine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.229122104,0.008350852,glutamine
REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC,-1.860373101,0.273673969,glutamine
PROTEASOME_ASSEMBLY,-1.855435893,0.220726434,glutamine
G_ALPHA_I_SIGNALLING_EVENTS,2.929992054,0,vorinostat
SIGNALING_BY_GPCR,2.903848362,0,vorinostat
METABOLISM_OF_RNA,-2.743532978,0,vorinostat
CELL_CYCLE,-2.612814191,0,vorinostat
M_PHASE,-2.584543312,0,vorinostat
CELL_CYCLE_MITOTIC,-2.501133907,0,vorinostat
CHROMATIN_ORGANIZATION,-2.501060398,0,vorinostat
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.447539842,0.000320806,vorinostat
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.443341753,0.000274977,vorinostat
SIGNALING_BY_INSULIN_RECEPTOR,2.534250623,0.0021586,vorinostat
METABOLISM_OF_RNA,2.461744592,0.006926846,BRD-K31342827
GPCR_LIGAND_BINDING,-1.990037135,0.063105939,BRD-K31342827
MRNA_SPLICING,1.88181272,0.148927184,BRD-K31342827
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.860742954,0.110829532,BRD-K31342827
METABOLISM_OF_STEROIDS,1.825992162,0.101305119,BRD-K31342827
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.809259396,0.088663626,BRD-K31342827
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.755333934,0.095244129,BRD-K31342827
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.639713169,0.151895832,BRD-K31342827
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.884238979,0.127076342,BRD-K31342827
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.611043015,0.151957679,BRD-K31342827
NEURONAL_SYSTEM,-2.405956405,0,AR-C133057XX
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.704411429,0.00206012,AR-C133057XX
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.268051508,0.004992299,AR-C133057XX
RESPIRATORY_ELECTRON_TRANSPORT,2.228535404,0.037082161,AR-C133057XX
M_PHASE,2.11624478,0.054936535,AR-C133057XX
MITOTIC_SPINDLE_CHECKPOINT,2.100738974,0.046867731,AR-C133057XX
CELL_CYCLE_CHECKPOINTS,2.059457559,0.046970737,AR-C133057XX
PEPTIDE_HORMONE_METABOLISM,-2.059229984,0.036610191,AR-C133057XX
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.002700697,0.052189708,AR-C133057XX
RHO_GTPASES_ACTIVATE_FORMINS,1.980468699,0.052091607,AR-C133057XX
EUKARYOTIC_TRANSLATION_ELONGATION,3.986009742,0,phenacetin
SARS_COV_2_HOST_INTERACTIONS,2.480095993,0,phenacetin
METABOLISM_OF_RNA,2.537692483,0,phenacetin
VIRAL_INFECTION_PATHWAYS,2.561752518,0,phenacetin
CELLULAR_RESPONSES_TO_STIMULI,2.597285671,0,phenacetin
NERVOUS_SYSTEM_DEVELOPMENT,2.836930423,0,phenacetin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.953437866,0,phenacetin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-3.134015909,0,phenacetin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.294187672,0,phenacetin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.303275634,0,phenacetin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.467600944,0.014600131,PX-12
ECM_PROTEOGLYCANS,-1.957447776,0.239312589,PX-12
MITF_M_DEPENDENT_GENE_EXPRESSION,1.855693459,0.279227501,PX-12
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.934225938,0.149776672,PX-12
SIGNALING_BY_ALK_IN_CANCER,1.817861197,0.232385414,PX-12
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.79539081,0.200751798,PX-12
GPCR_LIGAND_BINDING,-1.9075479,0.128183525,PX-12
SIGNALING_BY_PDGF,-1.892473285,0.108722185,PX-12
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,1.758326363,0.192721726,PX-12
SIGNALING_BY_GPCR,-1.839687705,0.135995568,PX-12
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.529708975,0,ASN-05257430
SARS_COV_1_HOST_INTERACTIONS,2.641475279,0,ASN-05257430
VIRAL_INFECTION_PATHWAYS,2.693186621,0,ASN-05257430
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.791572572,0,ASN-05257430
TRANSLATION,2.879155201,0,ASN-05257430
SIGNALING_BY_ROBO_RECEPTORS,2.985621166,0,ASN-05257430
INFLUENZA_INFECTION,3.092056875,0,ASN-05257430
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.518620531,0,ASN-05257430
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.10082179,0,ASN-05257430
CELLULAR_RESPONSE_TO_STARVATION,3.223202863,0,ASN-05257430
G_ALPHA_Q_SIGNALLING_EVENTS,-2.554052361,0.00098119,MLN-8054
DEVELOPMENTAL_CELL_LINEAGES,-2.20764267,0.015699038,MLN-8054
GPCR_LIGAND_BINDING,-2.159630871,0.015044911,MLN-8054
SIGNALING_BY_GPCR,-2.15067463,0.012264873,MLN-8054
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,2.063713688,0.219010985,MLN-8054
RAB_REGULATION_OF_TRAFFICKING,1.887516999,0.44828811,MLN-8054
CELL_CYCLE,1.818662838,0.482736713,MLN-8054
M_PHASE,1.804902958,0.395246387,MLN-8054
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.788852729,0.350143813,MLN-8054
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.783019325,0.303421469,MLN-8054
CELLULAR_RESPONSE_TO_STARVATION,3.565554438,0,carbimazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.413340877,0,carbimazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.235638154,0,carbimazole
EUKARYOTIC_TRANSLATION_ELONGATION,3.217665015,0,carbimazole
INFLUENZA_INFECTION,3.128279662,0,carbimazole
RESPIRATORY_ELECTRON_TRANSPORT,3.122908287,0,carbimazole
SELENOAMINO_ACID_METABOLISM,3.040362031,0,carbimazole
NONSENSE_MEDIATED_DECAY_NMD,3.025173242,0,carbimazole
EUKARYOTIC_TRANSLATION_INITIATION,2.866276041,0,carbimazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.756320411,0,carbimazole
EUKARYOTIC_TRANSLATION_ELONGATION,3.611474803,0,gefitinib
SARS_COV_2_HOST_INTERACTIONS,2.544963865,0,gefitinib
NERVOUS_SYSTEM_DEVELOPMENT,2.660033436,0,gefitinib
SARS_COV_1_INFECTION,2.790544791,0,gefitinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.937844252,0,gefitinib
TRANSLATION,2.966083956,0,gefitinib
SARS_COV_1_HOST_INTERACTIONS,3.075672795,0,gefitinib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.298683388,0,gefitinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.323306661,0,gefitinib
CELLULAR_RESPONSE_TO_STARVATION,3.344157958,0,gefitinib
MITOTIC_PROMETAPHASE,-2.205349792,0.020231038,cabozantinib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.963012078,0.150269589,cabozantinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.905228837,0.104281913,cabozantinib
KINESINS,-2.03326542,0.094893203,cabozantinib
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.031781799,0.063262136,cabozantinib
CELL_CYCLE_MITOTIC,-2.022172691,0.052504361,cabozantinib
MITOTIC_SPINDLE_CHECKPOINT,-2.008874138,0.046820403,cabozantinib
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,-2.008430086,0.03933813,cabozantinib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.809458774,0.115293047,cabozantinib
GLYCOSAMINOGLYCAN_METABOLISM,1.787832875,0.096833205,cabozantinib
EUKARYOTIC_TRANSLATION_ELONGATION,-3.506596126,0,trifluoperazine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.007902232,0,trifluoperazine
INFLUENZA_INFECTION,-3.077537763,0,trifluoperazine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.115572822,0,trifluoperazine
TRANSLATION,-3.125577459,0,trifluoperazine
RRNA_PROCESSING,-3.138648829,0,trifluoperazine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.143945596,0,trifluoperazine
SARS_COV_1_HOST_INTERACTIONS,-3.148510419,0,trifluoperazine
SARS_COV_1_INFECTION,-2.835557112,0,trifluoperazine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.185748152,0,trifluoperazine
GPCR_LIGAND_BINDING,-2.357871712,0.005750667,lonidamine
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.423134314,0.016754046,lonidamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.231896852,0.013555145,lonidamine
PEROXISOMAL_PROTEIN_IMPORT,2.116952752,0.066318099,lonidamine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.076740692,0.045183816,lonidamine
SIGNALING_BY_NTRKS,2.056530149,0.075858597,lonidamine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.046763353,0.062827673,lonidamine
SIGNALING_BY_ALK_IN_CANCER,1.925149398,0.111414406,lonidamine
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,-1.965437142,0.08790306,lonidamine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.885368094,0.115184067,lonidamine
EUKARYOTIC_TRANSLATION_ELONGATION,3.720724349,0,sildenafil
TRANSLATION,2.777514352,0,sildenafil
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.809316922,0,sildenafil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.810328939,0,sildenafil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.901592837,0,sildenafil
SARS_COV_1_HOST_INTERACTIONS,2.976381576,0,sildenafil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.210226864,0,sildenafil
RRNA_PROCESSING,3.33844446,0,sildenafil
SIGNALING_BY_ROBO_RECEPTORS,3.374609285,0,sildenafil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.935907085,0,sildenafil
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.310771611,0.017365729,ruxolitinib
EUKARYOTIC_TRANSLATION_INITIATION,2.144937179,0.039941176,ruxolitinib
KERATINIZATION,2.082378931,0.043607274,ruxolitinib
RRNA_PROCESSING,2.047692473,0.042256606,ruxolitinib
EXTRACELLULAR_MATRIX_ORGANIZATION,2.035150257,0.037509974,ruxolitinib
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.028210413,0.032801932,ruxolitinib
BIOLOGICAL_OXIDATIONS,-2.037757835,0.195306807,ruxolitinib
SIGNALING_BY_PTK6,1.958350057,0.047135549,ruxolitinib
HEMOSTASIS,-1.946040519,0.22553286,ruxolitinib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.91389348,0.194996796,ruxolitinib
GPCR_LIGAND_BINDING,2.853187277,0,BRD-K59058747
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.784702278,0,BRD-K59058747
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.768671022,0,BRD-K59058747
SIGNALING_BY_GPCR,2.435204077,0.000227114,BRD-K59058747
HCMV_EARLY_EVENTS,-2.340498257,0.16930639,BRD-K59058747
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.273981442,0.118917583,BRD-K59058747
NEUTROPHIL_DEGRANULATION,-2.241915939,0.085996896,BRD-K59058747
HCMV_INFECTION,-2.132090761,0.130003121,BRD-K59058747
HIV_INFECTION,-1.956857271,0.332163013,BRD-K59058747
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-1.882707012,0.485748095,BRD-K59058747
EUKARYOTIC_TRANSLATION_INITIATION,4.810874471,0,TG-101348
DNA_STRAND_ELONGATION,-2.446834164,0,TG-101348
G2_M_CHECKPOINTS,-2.525832818,0,TG-101348
DNA_REPAIR,-2.543997965,0,TG-101348
CELL_CYCLE_MITOTIC,-2.582268804,0,TG-101348
CELL_CYCLE,-2.6148787,0,TG-101348
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-2.641144213,0,TG-101348
SARS_COV_INFECTIONS,2.73502037,0,TG-101348
SARS_COV_2_INFECTION,2.790894716,0,TG-101348
HOMOLOGY_DIRECTED_REPAIR,-2.807576235,0,TG-101348
SIGNALING_BY_ALK_IN_CANCER,2.10632836,0.151814396,tosedostat
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.821042516,0.464069007,tosedostat
EPH_EPHRIN_SIGNALING,-1.861161117,0.951008646,tosedostat
OPIOID_SIGNALLING,-1.816248492,0.654922376,tosedostat
BIOLOGICAL_OXIDATIONS,-1.640654863,1,tosedostat
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.611204845,1,tosedostat
ISG15_ANTIVIRAL_MECHANISM,1.466057138,1,tosedostat
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.443620006,1,tosedostat
MITOCHONDRIAL_BIOGENESIS,1.415794126,1,tosedostat
ADAPTIVE_IMMUNE_SYSTEM,1.409070201,1,tosedostat
SEMAPHORIN_INTERACTIONS,-2.238228217,0.018661538,capsaicin
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.069438145,0.074097284,capsaicin
DEVELOPMENTAL_CELL_LINEAGES,1.961668099,0.215655645,capsaicin
S_PHASE,-1.98826282,0.115262441,capsaicin
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-1.945604072,0.124867645,capsaicin
HOST_INTERACTIONS_OF_HIV_FACTORS,-1.909134914,0.141169047,capsaicin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.82361783,0.218389308,capsaicin
AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,-1.90294438,0.123861385,capsaicin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.816010813,0.149845237,capsaicin
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,-1.893069353,0.118085195,capsaicin
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.601306114,0.003385774,dacarbazine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.552825145,0.001692887,dacarbazine
MYD88_INDEPENDENT_TLR4_CASCADE,2.432371141,0.001692887,dacarbazine
GASTRULATION,-2.309900521,0.002603775,dacarbazine
TOLL_LIKE_RECEPTOR_CASCADES,2.200144134,0.013543096,dacarbazine
GPCR_LIGAND_BINDING,-2.157787528,0.014320765,dacarbazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.145171353,0.010993719,dacarbazine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.171573065,0.012865941,dacarbazine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.146903802,0.013825243,dacarbazine
SIGNALING_BY_NOTCH,-2.048395811,0.025603792,dacarbazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.99180655,0.256312982,tamoxifen
SIGNALING_BY_ROBO_RECEPTORS,-1.990410845,0.13030137,tamoxifen
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.903222091,0.209840614,tamoxifen
CELLULAR_RESPONSE_TO_STARVATION,-1.81493368,0.329775071,tamoxifen
ADAPTIVE_IMMUNE_SYSTEM,-1.747051415,0.451282439,tamoxifen
GPCR_LIGAND_BINDING,1.436335018,1,tamoxifen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.431850524,0.538369754,tamoxifen
SIGNALING_BY_HEDGEHOG,-1.692495212,0.570180204,tamoxifen
SENSORY_PERCEPTION,-1.653061945,0.669968124,tamoxifen
NERVOUS_SYSTEM_DEVELOPMENT,-1.639408965,0.646144652,tamoxifen
RESPIRATORY_ELECTRON_TRANSPORT,-2.645788194,0.009053081,olaparib
CELL_CYCLE,-2.596558837,0.007242465,olaparib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.552076754,0.007846004,olaparib
CELL_CYCLE_CHECKPOINTS,-2.492992362,0.009053081,olaparib
CELL_CYCLE_MITOTIC,-2.480822589,0.007966712,olaparib
METABOLISM_OF_RNA,-2.417722797,0.015088469,olaparib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.3824503,0.019140801,olaparib
SIGNALING_BY_WNT,-2.377557861,0.016974528,olaparib
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-2.275407228,0.03399935,olaparib
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.246976667,0.038204004,olaparib
TRANSLATION,2.852156269,0,7-nitroindazole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.164971431,0.06342045,7-nitroindazole
RESPIRATORY_ELECTRON_TRANSPORT,2.038858256,0.101141109,7-nitroindazole
RHOG_GTPASE_CYCLE,-2.046354579,0.209141386,7-nitroindazole
BIOLOGICAL_OXIDATIONS,1.987521115,0.106633403,7-nitroindazole
RHOA_GTPASE_CYCLE,-1.988991772,0.157476024,7-nitroindazole
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.891996711,0.157431939,7-nitroindazole
RHO_GTPASE_CYCLE,-1.879871858,0.248820384,7-nitroindazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.821473555,0.217204677,7-nitroindazole
INFLUENZA_INFECTION,1.82106678,0.186708382,7-nitroindazole
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.890251274,0.603799376,dienestrol
SIGNALING_BY_WNT,1.563430494,1,dienestrol
SIGNALING_BY_NTRKS,1.562748258,0.862147239,dienestrol
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.537681214,0.656605317,dienestrol
CHROMATIN_ORGANIZATION,1.494897839,0.607101227,dienestrol
SIGNALING_BY_MET,1.474608933,0.539018405,dienestrol
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.466603314,0.466349693,dienestrol
CELL_CELL_COMMUNICATION,1.379145952,0.613803681,dienestrol
ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,-1.642194537,1,dienestrol
PI3K_AKT_SIGNALING_IN_CANCER,1.330841565,0.671480061,dienestrol
MRNA_SPLICING,2.130274406,0.03649635,zileuton
EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES,-2.087580545,0.019935069,zileuton
MITOTIC_METAPHASE_AND_ANAPHASE,1.854601441,0.078359811,zileuton
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.974351022,0.038920848,zileuton
G_ALPHA_Q_SIGNALLING_EVENTS,-1.956939214,0.031642966,zileuton
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.77597162,0.085158151,zileuton
GPCR_LIGAND_BINDING,-1.931462715,0.032513148,zileuton
AMINE_LIGAND_BINDING_RECEPTORS,-1.921408265,0.029617816,zileuton
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-1.902926584,0.029111529,zileuton
NUCLEOTIDE_EXCISION_REPAIR,1.661624283,0.107878918,zileuton
EUKARYOTIC_TRANSLATION_ELONGATION,3.930424384,0,synephrine
VIRAL_INFECTION_PATHWAYS,2.755987101,0,synephrine
NERVOUS_SYSTEM_DEVELOPMENT,2.877076311,0,synephrine
SARS_COV_2_HOST_INTERACTIONS,2.886008631,0,synephrine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.057408992,0,synephrine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.186460023,0,synephrine
SARS_COV_1_INFECTION,3.332385102,0,synephrine
SIGNALING_BY_ROBO_RECEPTORS,3.401505666,0,synephrine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.43011561,0,synephrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.52939231,0,synephrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.944028946,0,losartan
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.909395453,0,losartan
CELLULAR_RESPONSES_TO_STIMULI,2.978282566,0,losartan
NERVOUS_SYSTEM_DEVELOPMENT,2.996652042,0,losartan
INFECTIOUS_DISEASE,3.029947931,0,losartan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-3.155512143,0,losartan
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.15815101,0,losartan
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.1843831,0,losartan
SARS_COV_1_INFECTION,3.217073099,0,losartan
VIRAL_INFECTION_PATHWAYS,3.23811656,0,losartan
EUKARYOTIC_TRANSLATION_ELONGATION,5.146991596,0,nabumetone
CELL_CYCLE,2.55895828,0,nabumetone
GPCR_LIGAND_BINDING,-2.600765409,0,nabumetone
MITOTIC_METAPHASE_AND_ANAPHASE,2.648325266,0,nabumetone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.681283412,0,nabumetone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.78339978,0,nabumetone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.001746365,0,nabumetone
SARS_COV_2_HOST_INTERACTIONS,3.022760934,0,nabumetone
SARS_COV_2_INFECTION,3.03760413,0,nabumetone
SARS_COV_INFECTIONS,3.053004146,0,nabumetone
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.270899678,0.020439448,curcumin
INTERFERON_SIGNALING,2.08349384,0.115388706,curcumin
G2_M_CHECKPOINTS,2.073204683,0.062639583,curcumin
CELL_CYCLE_CHECKPOINTS,1.913925222,0.134620157,curcumin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.988050626,0.129024016,curcumin
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,1.836353552,0.15206583,curcumin
ANTIGEN_PROCESSING_CROSS_PRESENTATION,1.768394185,0.183962565,curcumin
GLYCOSAMINOGLYCAN_METABOLISM,1.627903586,0.321439966,curcumin
UB_SPECIFIC_PROCESSING_PROTEASES,1.53124244,0.458258003,curcumin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.473005501,0.525842816,curcumin
GPCR_LIGAND_BINDING,-2.771043554,0,lenalidomide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.609536567,0,lenalidomide
SIGNALING_BY_GPCR,-2.552141472,0,lenalidomide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.520310358,0,lenalidomide
G_ALPHA_Q_SIGNALLING_EVENTS,-2.508977724,0,lenalidomide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.507460947,0,lenalidomide
EUKARYOTIC_TRANSLATION_INITIATION,-2.446087905,0,lenalidomide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.404976732,0.000100556,lenalidomide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.388940707,8.94E-05,lenalidomide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.376244661,8.04E-05,lenalidomide
NEUTROPHIL_DEGRANULATION,-2.804530185,0,myricetin
GPCR_LIGAND_BINDING,2.226750397,0.034495454,myricetin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.915562299,0.274731655,myricetin
INNATE_IMMUNE_SYSTEM,-1.787229628,0.560795147,myricetin
SIGNALING_BY_GPCR,1.85730903,0.289926081,myricetin
NEURONAL_SYSTEM,1.839073421,0.251734685,myricetin
METABOLISM_OF_LIPIDS,-1.685642148,0.639137882,myricetin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.808305301,0.250831233,myricetin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.803133239,0.214090836,myricetin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.642910962,0.606164516,myricetin
EXTRACELLULAR_MATRIX_ORGANIZATION,3.04238171,0,valdecoxib
SIGNALING_BY_TGFB_FAMILY_MEMBERS,2.496760861,0.004139852,valdecoxib
GPCR_LIGAND_BINDING,-2.251586749,0.005089927,valdecoxib
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.375504922,0.006899753,valdecoxib
DEVELOPMENTAL_CELL_LINEAGES,2.23125646,0.011902074,valdecoxib
SIGNALING_BY_GPCR,-2.130002527,0.01357314,valdecoxib
AUTOPHAGY,2.130478666,0.017387377,valdecoxib
HCMV_INFECTION,2.044176667,0.02345916,valdecoxib
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.815910368,0.073038812,valdecoxib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.752926619,0.087713108,valdecoxib
KERATINIZATION,-2.881001724,0,iniparib
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.587512411,0.002637117,iniparib
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.203348991,0.069449014,iniparib
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,2.105083543,0.079990382,iniparib
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.081654323,0.063248209,iniparib
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.077166015,0.049916479,iniparib
HATS_ACETYLATE_HISTONES,2.057908146,0.047126117,iniparib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.029362754,0.049193052,iniparib
CHROMATIN_ORGANIZATION,2.027577103,0.04269697,iniparib
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.006779043,0.042940574,iniparib
RRNA_PROCESSING,3.93612009,0,BRD-K97118047
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.148702098,0,BRD-K97118047
CELL_CYCLE_CHECKPOINTS,2.917840155,0,BRD-K97118047
MRNA_SPLICING,2.859838395,0,BRD-K97118047
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.816852588,0,BRD-K97118047
G2_M_CHECKPOINTS,2.357691049,0.000791178,BRD-K97118047
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.203439349,0.000748402,BRD-K97118047
CELL_CYCLE,2.405751561,0.000923041,BRD-K97118047
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.184121641,0.000748402,BRD-K97118047
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.284846029,0.002076843,BRD-K97118047
EUKARYOTIC_TRANSLATION_INITIATION,5.171293727,0,selumetinib
VIRAL_INFECTION_PATHWAYS,3.946073603,0,selumetinib
SARS_COV_1_INFECTION,3.924685435,0,selumetinib
CELLULAR_RESPONSES_TO_STIMULI,3.637296754,0,selumetinib
INFECTIOUS_DISEASE,3.601216859,0,selumetinib
SARS_COV_2_HOST_INTERACTIONS,3.445614869,0,selumetinib
SARS_COV_INFECTIONS,3.306229196,0,selumetinib
NERVOUS_SYSTEM_DEVELOPMENT,4.002880067,0,selumetinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.294785914,0,selumetinib
SIGNALING_BY_GPCR,-3.186055378,0,selumetinib
EUKARYOTIC_TRANSLATION_ELONGATION,3.261655171,0,enalapril
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.614099116,0,enalapril
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.616002422,0,enalapril
TRANSLATION,2.688470399,0,enalapril
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.763594123,0,enalapril
INFLUENZA_INFECTION,2.853446516,0,enalapril
SIGNALING_BY_ROBO_RECEPTORS,2.865426464,0,enalapril
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.497090413,0,enalapril
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.926336772,0,enalapril
NONSENSE_MEDIATED_DECAY_NMD,3.021600583,0,enalapril
EUKARYOTIC_TRANSLATION_ELONGATION,3.483874303,0,melatonin
SARS_COV_1_INFECTION,2.520012675,0,melatonin
SARS_COV_1_HOST_INTERACTIONS,2.629262554,0,melatonin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.793516228,0,melatonin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.905428571,0,melatonin
INFLUENZA_INFECTION,3.010605254,0,melatonin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.048930751,0,melatonin
SIGNALING_BY_ROBO_RECEPTORS,3.069022003,0,melatonin
TRANSLATION,3.127220282,0,melatonin
CELLULAR_RESPONSE_TO_STARVATION,3.119584688,0,melatonin
SELENOAMINO_ACID_METABOLISM,3.415647935,0,gemcitabine
SARS_COV_1_HOST_INTERACTIONS,2.434161058,0,gemcitabine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.49987692,0,gemcitabine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.718554901,0,gemcitabine
TRANSLATION,2.739511865,0,gemcitabine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.780567092,0,gemcitabine
INFLUENZA_INFECTION,2.791133778,0,gemcitabine
NEURONAL_SYSTEM,-2.80527464,0,gemcitabine
SARS_COV_2_HOST_INTERACTIONS,2.426311374,0,gemcitabine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.10852176,0,gemcitabine
RESPIRATORY_ELECTRON_TRANSPORT,2.767696868,0,promethazine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.743883707,0,promethazine
CELL_CYCLE_MITOTIC,2.53079491,0.001565476,promethazine
M_PHASE,2.481106417,0.002348213,promethazine
MITOTIC_METAPHASE_AND_ANAPHASE,2.478961141,0.001878571,promethazine
CELL_CYCLE,2.438499533,0.002739582,promethazine
METABOLISM_OF_RNA,2.410827587,0.003019132,promethazine
CELL_CYCLE_CHECKPOINTS,2.400654138,0.002935267,promethazine
MRNA_SPLICING,2.375348376,0.003391864,promethazine
TRANSLATION,2.308736828,0.006105355,promethazine
GPCR_LIGAND_BINDING,-2.422438743,0.000858278,swainsonine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.279646919,0.001287417,swainsonine
SIGNALING_BY_GPCR,-2.145789704,0.008010593,swainsonine
G_ALPHA_I_SIGNALLING_EVENTS,-2.086566588,0.012445028,swainsonine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.081144733,0.010642644,swainsonine
SELENOAMINO_ACID_METABOLISM,-2.014697918,0.022887407,swainsonine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.007627782,0.021702166,swainsonine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.977878129,0.026713896,swainsonine
CELLULAR_RESPONSE_TO_STARVATION,-1.972468273,0.025366876,swainsonine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.94381749,0.031412966,swainsonine
METABOLISM_OF_RNA,-3.142509731,0,sirolimus
GPCR_LIGAND_BINDING,3.136062264,0,sirolimus
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.851855052,0,sirolimus
SIGNALING_BY_GPCR,2.606899846,0,sirolimus
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.474721996,0.00089933,sirolimus
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.470268063,0.00279852,sirolimus
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.448784738,0.00186568,sirolimus
RRNA_PROCESSING,-2.42236629,0.001958964,sirolimus
G_ALPHA_Q_SIGNALLING_EVENTS,2.420224221,0.001618795,sirolimus
G_ALPHA_S_SIGNALLING_EVENTS,2.41141319,0.001348996,sirolimus
EUKARYOTIC_TRANSLATION_ELONGATION,-2.710001598,0,LY-294002
EUKARYOTIC_TRANSLATION_INITIATION,-2.669296354,0,LY-294002
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.619216668,0,LY-294002
NONSENSE_MEDIATED_DECAY_NMD,-2.60590861,0,LY-294002
SELENOAMINO_ACID_METABOLISM,-2.542762959,0,LY-294002
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.528560043,0.000348901,LY-294002
SIGNALING_BY_ROBO_RECEPTORS,-2.452597608,0.000299058,LY-294002
INFLUENZA_INFECTION,-2.428920606,0.000261676,LY-294002
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.422949084,0.000232601,LY-294002
CELLULAR_RESPONSE_TO_STARVATION,-2.334070363,0.000628022,LY-294002
EUKARYOTIC_TRANSLATION_ELONGATION,3.847089229,0,pentoxifylline
INFECTIOUS_DISEASE,2.68163771,0,pentoxifylline
SARS_COV_2_HOST_INTERACTIONS,2.70907874,0,pentoxifylline
CELLULAR_RESPONSES_TO_STIMULI,2.766732027,0,pentoxifylline
VIRAL_INFECTION_PATHWAYS,2.814381295,0,pentoxifylline
METABOLISM_OF_RNA,2.858289005,0,pentoxifylline
SARS_COV_1_INFECTION,2.996156549,0,pentoxifylline
NERVOUS_SYSTEM_DEVELOPMENT,3.018650159,0,pentoxifylline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.224500723,0,pentoxifylline
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.271924315,0,pentoxifylline
CELL_CYCLE_CHECKPOINTS,-3.415765107,0,alisertib
NEURONAL_SYSTEM,2.653424777,0,alisertib
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.729810568,0,alisertib
DNA_REPAIR,-2.802743873,0,alisertib
TRANSLATION,-2.857019652,0,alisertib
HOMOLOGY_DIRECTED_REPAIR,-2.871675032,0,alisertib
S_PHASE,-2.877676566,0,alisertib
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.944288351,0,alisertib
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-3.036784316,0,alisertib
MITOCHONDRIAL_TRANSLATION,-2.900192582,0,alisertib
KERATINIZATION,4.244950476,0,troglitazone
FORMATION_OF_THE_CORNIFIED_ENVELOPE,4.182241199,0,troglitazone
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.855858653,0,troglitazone
DEVELOPMENTAL_CELL_LINEAGES,2.616315894,0.000661858,troglitazone
SIGNALING_BY_INTERLEUKINS,2.326824627,0.004765376,troglitazone
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.303846276,0.004853624,troglitazone
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.021845154,0.029121743,troglitazone
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,1.964576356,0.03458207,troglitazone
CHROMATIN_ORGANIZATION,-2.00356993,0.210475384,troglitazone
FATTY_ACID_METABOLISM,1.91937009,0.042800138,troglitazone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.217029365,0,alvocidib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.979355808,0,alvocidib
RESPIRATORY_ELECTRON_TRANSPORT,2.978037493,0,alvocidib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.905275881,0,alvocidib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.819315432,0,alvocidib
METABOLISM_OF_RNA,-2.723065927,0,alvocidib
MRNA_SPLICING,-2.555059118,0,alvocidib
CHROMATIN_ORGANIZATION,-2.501421918,0,alvocidib
CELL_CYCLE,-2.408616667,0.000180176,alvocidib
CELL_CYCLE_MITOTIC,-2.406781498,0.000300293,alvocidib
EXTRACELLULAR_MATRIX_ORGANIZATION,3.550916222,0,mitoxantrone
GPCR_LIGAND_BINDING,3.32509851,0,mitoxantrone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,3.128771831,0,mitoxantrone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.298345911,0.000487828,mitoxantrone
COLLAGEN_FORMATION,2.687344121,0.000158782,mitoxantrone
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.30662928,0.000975656,mitoxantrone
DEVELOPMENTAL_CELL_LINEAGES,2.80232757,0.000222295,mitoxantrone
G_ALPHA_S_SIGNALLING_EVENTS,2.818720927,0.000277869,mitoxantrone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.74798662,0.000185246,mitoxantrone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.575393148,0.001111474,mitoxantrone
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.889502927,0,fluspirilene
MUSCLE_CONTRACTION,2.43092687,0.003939865,fluspirilene
BIOLOGICAL_OXIDATIONS,2.287944021,0.009849663,fluspirilene
SELENOAMINO_ACID_METABOLISM,2.247607384,0.010588388,fluspirilene
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.219931757,0.012016589,fluspirilene
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.204019455,0.063810439,fluspirilene
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.115406829,0.025937446,fluspirilene
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.09134663,0.026312671,fluspirilene
NONSENSE_MEDIATED_DECAY_NMD,2.009027376,0.045431571,fluspirilene
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-1.960100324,0.239542363,fluspirilene
SELENOAMINO_ACID_METABOLISM,5.594579051,0,tanespimycin
G_ALPHA_S_SIGNALLING_EVENTS,-2.449025699,0,tanespimycin
SIGNALING_BY_GPCR,-2.52458912,0,tanespimycin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.700088643,0,tanespimycin
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.763817891,0,tanespimycin
GPCR_LIGAND_BINDING,-2.852312943,0,tanespimycin
INFECTIOUS_DISEASE,2.881246555,0,tanespimycin
SARS_COV_INFECTIONS,2.916606944,0,tanespimycin
CELLULAR_RESPONSES_TO_STIMULI,3.049035139,0,tanespimycin
SARS_COV_2_HOST_INTERACTIONS,3.131556098,0,tanespimycin
CELL_CYCLE_CHECKPOINTS,-4.551347772,0,dasatinib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.442996319,0,dasatinib
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-2.786179841,0,dasatinib
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,-2.824096815,0,dasatinib
MITOTIC_SPINDLE_CHECKPOINT,-2.827434058,0,dasatinib
RHO_GTPASES_ACTIVATE_FORMINS,-2.85377783,0,dasatinib
MITOTIC_PROMETAPHASE,-2.959419581,0,dasatinib
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-3.064978224,0,dasatinib
HOST_INTERACTIONS_OF_HIV_FACTORS,-3.14968282,0,dasatinib
HOMOLOGY_DIRECTED_REPAIR,-3.169400784,0,dasatinib
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.20401166,0.039534683,pazopanib
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,2.109143595,0.054854373,pazopanib
MAPK1_MAPK3_SIGNALING,2.012967345,0.083681746,pazopanib
PI3K_AKT_SIGNALING_IN_CANCER,1.997213503,0.073880439,pazopanib
KERATINIZATION,1.969895556,0.073336837,pazopanib
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.942358108,0.076268993,pazopanib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.939288534,0.066785375,pazopanib
G_ALPHA_S_SIGNALLING_EVENTS,1.924110852,0.066591232,pazopanib
EXTRACELLULAR_MATRIX_ORGANIZATION,1.921542627,0.060839484,pazopanib
PROGRAMMED_CELL_DEATH,1.900015751,0.06424386,pazopanib
CELL_CYCLE_MITOTIC,-3.427058745,0,BRD-K59333713
CELL_CYCLE,-3.308010635,0,BRD-K59333713
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-3.091123609,0,BRD-K59333713
DNA_REPLICATION,-2.937428987,0,BRD-K59333713
S_PHASE,-2.858686457,0,BRD-K59333713
SYNTHESIS_OF_DNA,-2.803989086,0,BRD-K59333713
CELL_CYCLE_CHECKPOINTS,-2.767187872,0,BRD-K59333713
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,-2.734622489,0,BRD-K59333713
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.52737302,0,BRD-K59333713
NUCLEOTIDE_EXCISION_REPAIR,-2.504852445,0,BRD-K59333713
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.257730304,0.033195697,etoposide
RESPIRATORY_ELECTRON_TRANSPORT,2.149973735,0.045963273,etoposide
SYNTHESIS_OF_DNA,2.001075073,0.086819515,etoposide
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1.978186048,0.077243834,etoposide
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.976872312,0.06230577,etoposide
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.860228499,0.109801152,etoposide
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1.826916602,0.117096909,etoposide
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.823456111,0.105013311,etoposide
DNA_REPLICATION,1.75876221,0.135620027,etoposide
KEAP1_NFE2L2_PATHWAY,1.75823671,0.122313376,etoposide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.301894346,0.019191227,afatinib
CELLULAR_RESPONSE_TO_STARVATION,1.813850683,0.285848274,afatinib
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.769267748,0.24746582,afatinib
MITF_M_DEPENDENT_GENE_EXPRESSION,1.677629997,0.310594856,afatinib
DNA_REPAIR,-1.79732178,1,afatinib
ASPARAGINE_N_LINKED_GLYCOSYLATION,-1.797189007,0.816025315,afatinib
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,-1.794907713,0.554983619,afatinib
DISEASES_OF_METABOLISM,-1.776642442,0.480542702,afatinib
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.493704454,0.647653404,afatinib
NUCLEOTIDE_EXCISION_REPAIR,-1.672507584,0.78302539,afatinib
METABOLISM_OF_RNA,4.133104594,0,iloprost
RRNA_PROCESSING,3.937251625,0,iloprost
TRANSLATION,3.902258033,0,iloprost
EUKARYOTIC_TRANSLATION_INITIATION,3.483575852,0,iloprost
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.228988287,0,iloprost
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,3.039544722,0,iloprost
INFLUENZA_INFECTION,3.003867414,0,iloprost
EUKARYOTIC_TRANSLATION_ELONGATION,2.915376424,0,iloprost
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.912750077,0,iloprost
SELENOAMINO_ACID_METABOLISM,2.861241842,0,iloprost
GPCR_LIGAND_BINDING,-2.528947792,0,disulfiram
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.447636267,0.000297303,disulfiram
SIGNALING_BY_GPCR,-2.397954539,0.000198202,disulfiram
CELL_CYCLE_MITOTIC,2.659766061,0.010335917,disulfiram
CELL_CYCLE_CHECKPOINTS,2.648975755,0.005167959,disulfiram
CELL_CYCLE,2.627003215,0.003445306,disulfiram
M_PHASE,2.514052477,0.002583979,disulfiram
MYD88_INDEPENDENT_TLR4_CASCADE,2.428525618,0.003100775,disulfiram
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.27358393,0.000594607,disulfiram
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.289613805,0.007751938,disulfiram
NEUTROPHIL_DEGRANULATION,-2.915803486,0,xylazine
SIGNALING_BY_NUCLEAR_RECEPTORS,-2.03007403,0.128964108,xylazine
ESR_MEDIATED_SIGNALING,-1.902985049,0.209980022,xylazine
INNATE_IMMUNE_SYSTEM,-1.824622753,0.244701128,xylazine
TRNA_PROCESSING,-1.796632006,0.227175236,xylazine
GPCR_LIGAND_BINDING,1.787912861,1,xylazine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.573465592,0.597974602,xylazine
GASTRULATION,-1.53922947,0.587188227,xylazine
HEMOSTASIS,-1.53822338,0.516476451,xylazine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.53558994,0.465520013,xylazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.288206629,0,doxylamine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.700712691,0,doxylamine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.733785882,0,doxylamine
INFLUENZA_INFECTION,2.753309629,0,doxylamine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.759518819,0,doxylamine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.973069675,0,doxylamine
NONSENSE_MEDIATED_DECAY_NMD,2.978008499,0,doxylamine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.753405957,0,doxylamine
TRANSLATION,3.02419129,0,doxylamine
SELENOAMINO_ACID_METABOLISM,3.160386705,0,doxylamine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.180471038,0.006883531,mibefradil
VIRAL_INFECTION_PATHWAYS,2.095818572,0.093607537,mibefradil
SARS_COV_INFECTIONS,2.031171578,0.060176274,mibefradil
GPCR_LIGAND_BINDING,-2.066234576,0.019885757,mibefradil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.065567488,0.013512117,mibefradil
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.829111104,0.135210887,mibefradil
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.760664472,0.115003546,mibefradil
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.762408201,0.143754432,mibefradil
UB_SPECIFIC_PROCESSING_PROTEASES,1.624125743,0.201330497,mibefradil
ADAPTIVE_IMMUNE_SYSTEM,1.622638904,0.175116141,mibefradil
EUKARYOTIC_TRANSLATION_ELONGATION,3.515908754,0,phenazone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.621224686,0,phenazone
RRNA_PROCESSING,2.745260525,0,phenazone
TRANSLATION,2.776033135,0,phenazone
SIGNALING_BY_ROBO_RECEPTORS,3.013866812,0,phenazone
CELLULAR_RESPONSE_TO_STARVATION,3.051928908,0,phenazone
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.120746394,0,phenazone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-3.013009661,0,phenazone
SELENOAMINO_ACID_METABOLISM,3.205565862,0,phenazone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.255406231,0,phenazone
TRANSLATION,3.341028909,0,cilastatin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.725706571,0,cilastatin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.819084926,0,cilastatin
RRNA_PROCESSING,2.831228546,0,cilastatin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.852563382,0,cilastatin
INFLUENZA_INFECTION,2.677827784,0,cilastatin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.987117932,0,cilastatin
EUKARYOTIC_TRANSLATION_ELONGATION,3.0150624,0,cilastatin
EUKARYOTIC_TRANSLATION_INITIATION,3.272139872,0,cilastatin
SELENOAMINO_ACID_METABOLISM,2.881505759,0,cilastatin
EUKARYOTIC_TRANSLATION_INITIATION,4.840637177,0,benzydamine
CELLULAR_RESPONSES_TO_STIMULI,3.591274607,0,benzydamine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.585188336,0,benzydamine
CELL_CYCLE,3.433650066,0,benzydamine
VIRAL_INFECTION_PATHWAYS,3.403411264,0,benzydamine
MITOTIC_METAPHASE_AND_ANAPHASE,3.32336961,0,benzydamine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.041945925,0,benzydamine
SARS_COV_1_HOST_INTERACTIONS,3.624994172,0,benzydamine
CELL_CYCLE_CHECKPOINTS,3.012948987,0,benzydamine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.990509776,0,benzydamine
TRANSLATION,3.177915079,0,brimonidine
EUKARYOTIC_TRANSLATION_INITIATION,3.077432075,0,brimonidine
RESPIRATORY_ELECTRON_TRANSPORT,2.746667903,0,brimonidine
RRNA_PROCESSING,2.447711156,0.004253803,brimonidine
DNA_REPLICATION,2.37215863,0.005833787,brimonidine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.253977557,0.010533227,brimonidine
SYNTHESIS_OF_DNA,2.252039071,0.00902848,brimonidine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.235882838,0.00881145,brimonidine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.167047946,0.012288765,brimonidine
S_PHASE,2.148917869,0.01276141,brimonidine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.301221246,0.032258643,modafinil
EUKARYOTIC_TRANSLATION_INITIATION,2.190727712,0.065676105,modafinil
GPCR_LIGAND_BINDING,2.138404027,0.051188729,modafinil
EUKARYOTIC_TRANSLATION_ELONGATION,2.098207549,0.051832612,modafinil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.052483976,0.057225135,modafinil
NEUTROPHIL_DEGRANULATION,-1.841118407,0.27141755,modafinil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.921938315,0.13173854,modafinil
SELENOAMINO_ACID_METABOLISM,1.901890011,0.129742501,modafinil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,1.867085098,0.142528185,modafinil
NONSENSE_MEDIATED_DECAY_NMD,1.821071475,0.176504532,modafinil
EUKARYOTIC_TRANSLATION_INITIATION,4.845489448,0,pyrimethamine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.215116386,0,pyrimethamine
SIGNALING_BY_ROBO_RECEPTORS,3.366170632,0,pyrimethamine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.502650767,0,pyrimethamine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.541572129,0,pyrimethamine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.622089987,0,pyrimethamine
NONSENSE_MEDIATED_DECAY_NMD,3.692159645,0,pyrimethamine
RESPIRATORY_ELECTRON_TRANSPORT,3.884387202,0,pyrimethamine
INFLUENZA_INFECTION,3.652534837,0,pyrimethamine
SELENOAMINO_ACID_METABOLISM,4.318850118,0,pyrimethamine
COLLAGEN_FORMATION,-2.383814919,0.008885735,vicriviroc
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.138981793,0.056646561,vicriviroc
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.02285418,0.106999059,vicriviroc
GPCR_LIGAND_BINDING,-1.914546812,0.180213813,vicriviroc
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.820779475,0.892490392,vicriviroc
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.837699832,0.249244867,vicriviroc
RHO_GTPASES_ACTIVATE_FORMINS,-1.807813788,0.250281536,vicriviroc
MITOTIC_METAPHASE_AND_ANAPHASE,-1.760019706,0.304653771,vicriviroc
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.739800761,0.306835537,vicriviroc
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.717305464,0.311864616,vicriviroc
GPCR_LIGAND_BINDING,-3.467570678,0,amiodarone
SELENOAMINO_ACID_METABOLISM,-2.583555132,0,amiodarone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.589693158,0,amiodarone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.59101633,0,amiodarone
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.596532556,0,amiodarone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.606455218,0,amiodarone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.623637768,0,amiodarone
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.662064751,0,amiodarone
CHROMATIN_ORGANIZATION,2.665620956,0,amiodarone
G_ALPHA_S_SIGNALLING_EVENTS,-2.662275945,0,amiodarone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.469412521,0,letrozole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.388458568,0,letrozole
SELENOAMINO_ACID_METABOLISM,-2.387421644,0,letrozole
EUKARYOTIC_TRANSLATION_INITIATION,-2.375616353,0,letrozole
TRANSLATION,-2.354201618,0,letrozole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.295315358,0,letrozole
NONSENSE_MEDIATED_DECAY_NMD,-2.262104111,0.000138265,letrozole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.196659808,0.00084687,letrozole
SIGNALING_BY_ROBO_RECEPTORS,-2.099520315,0.002043242,letrozole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.158798066,0.033610878,letrozole
EUKARYOTIC_TRANSLATION_ELONGATION,-4.095021714,0,warfarin
SARS_COV_2_INFECTION,-2.782242186,0,warfarin
SARS_COV_INFECTIONS,-2.794901631,0,warfarin
SARS_COV_2_HOST_INTERACTIONS,-2.939757654,0,warfarin
INFECTIOUS_DISEASE,-2.943542935,0,warfarin
CELLULAR_RESPONSES_TO_STIMULI,-3.07633526,0,warfarin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.084762757,0,warfarin
VIRAL_INFECTION_PATHWAYS,-3.122457242,0,warfarin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.149067081,0,warfarin
SARS_COV_1_INFECTION,-3.150688508,0,warfarin
EUKARYOTIC_TRANSLATION_INITIATION,3.077918863,0,loxapine
NONSENSE_MEDIATED_DECAY_NMD,2.629724281,0,loxapine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.652583439,0,loxapine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.662589656,0,loxapine
CELLULAR_RESPONSE_TO_STARVATION,2.682681637,0,loxapine
SARS_COV_1_HOST_INTERACTIONS,2.697612164,0,loxapine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.58332603,0,loxapine
SELENOAMINO_ACID_METABOLISM,2.783138338,0,loxapine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.931788628,0,loxapine
EUKARYOTIC_TRANSLATION_ELONGATION,2.988016348,0,loxapine
TRANSLATION,2.830656065,0.001654382,megestrol-acetate
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.732700589,0.000827191,megestrol-acetate
RESPIRATORY_ELECTRON_TRANSPORT,2.404486364,0.007720448,megestrol-acetate
PCP_CE_PATHWAY,2.31383003,0.011167076,megestrol-acetate
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,2.211663118,0.021506962,megestrol-acetate
BIOLOGICAL_OXIDATIONS,2.153716925,0.025918646,megestrol-acetate
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,2.127972316,0.026470106,megestrol-acetate
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.089405018,0.028331286,megestrol-acetate
RRNA_PROCESSING,2.032598109,0.035293475,megestrol-acetate
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.031902571,0.031764128,megestrol-acetate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.491156585,0.001093011,terfenadine
EUKARYOTIC_TRANSLATION_INITIATION,2.489157763,0.000546506,terfenadine
CELLULAR_RESPONSE_TO_STARVATION,2.457955749,0.000364337,terfenadine
EUKARYOTIC_TRANSLATION_ELONGATION,2.447580598,0.000546506,terfenadine
RRNA_PROCESSING,2.316037285,0.002623227,terfenadine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.29966533,0.003461202,terfenadine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.280366567,0.003903611,terfenadine
SELENOAMINO_ACID_METABOLISM,2.209471932,0.00833421,terfenadine
CHOLESTEROL_BIOSYNTHESIS,2.1870157,0.009472763,terfenadine
TRANSLATION,2.138569126,0.012788231,terfenadine
EUKARYOTIC_TRANSLATION_INITIATION,4.448609671,0,BRD-K28761384
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.538623522,0,BRD-K28761384
CELLULAR_RESPONSES_TO_STIMULI,3.057489223,0,BRD-K28761384
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.121926451,0,BRD-K28761384
SARS_COV_1_INFECTION,3.264505132,0,BRD-K28761384
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.332929441,0,BRD-K28761384
CELLULAR_RESPONSE_TO_STARVATION,3.637771854,0,BRD-K28761384
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.750302042,0,BRD-K28761384
SELENOAMINO_ACID_METABOLISM,3.888874818,0,BRD-K28761384
INFLUENZA_INFECTION,3.931316897,0,BRD-K28761384
EUKARYOTIC_TRANSLATION_ELONGATION,-3.464316324,0,ifenprodil
SARS_COV_INFECTIONS,-2.440637436,0,ifenprodil
SARS_COV_2_HOST_INTERACTIONS,-2.475279301,0,ifenprodil
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.488120079,0,ifenprodil
SARS_COV_1_INFECTION,-2.730510414,0,ifenprodil
INFECTIOUS_DISEASE,-2.799694616,0,ifenprodil
NERVOUS_SYSTEM_DEVELOPMENT,-2.84747932,0,ifenprodil
CELLULAR_RESPONSES_TO_STIMULI,-2.852773081,0,ifenprodil
VIRAL_INFECTION_PATHWAYS,-2.932508914,0,ifenprodil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.979077398,0,ifenprodil
RRNA_PROCESSING,-2.565443893,0.001171965,reserpine
M_PHASE,-2.559967441,0.000585983,reserpine
CELL_CYCLE,-2.493492416,0.00156262,reserpine
CELL_CYCLE_MITOTIC,-2.482803873,0.001171965,reserpine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.374758195,0.001875144,reserpine
METABOLISM_OF_RNA,-2.277739579,0.006641135,reserpine
MITOTIC_PROMETAPHASE,-2.250786493,0.00652952,reserpine
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-2.171415157,0.011866146,reserpine
SEPARATION_OF_SISTER_CHROMATIDS,-2.157248413,0.011459214,reserpine
CELLULAR_RESPONSE_TO_HEAT_STRESS,-2.104353979,0.017345083,reserpine
GPCR_LIGAND_BINDING,-2.273360296,0.0128901,rosuvastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.152764432,0.021483499,rosuvastatin
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.163726374,0.134238469,rosuvastatin
SIGNALING_BY_ALK_IN_CANCER,2.055563274,0.146516378,rosuvastatin
REGULATION_OF_TP53_ACTIVITY,2.049063864,0.102588749,rosuvastatin
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.021203053,0.088810207,rosuvastatin
CELLULAR_RESPONSE_TO_STARVATION,2.017654514,0.071375576,rosuvastatin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.943262304,0.112907724,rosuvastatin
S_PHASE,-1.932607136,0.093095163,rosuvastatin
SIGNALING_BY_NTRKS,1.856531539,0.162068396,rosuvastatin
RESPIRATORY_ELECTRON_TRANSPORT,2.051050189,0.187189542,xanthinol
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.097885155,0.200625275,xanthinol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.981027501,0.168888889,xanthinol
TRANSLATION,1.953375234,0.136993464,xanthinol
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.014111193,0.197745487,xanthinol
CILIUM_ASSEMBLY,-1.943645562,0.209904594,xanthinol
REGULATION_OF_TP53_ACTIVITY,-1.836122761,0.310057244,xanthinol
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.78174733,0.322614379,xanthinol
PI_METABOLISM,-1.724616367,0.47497314,xanthinol
SIGNALING_BY_WNT,1.658783139,0.553202614,xanthinol
CELLULAR_RESPONSE_TO_STARVATION,3.082568039,0,mercaptopurine
CELL_CYCLE,-2.481261868,0,mercaptopurine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.850717565,0.000335414,mercaptopurine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.848932811,0.000223609,mercaptopurine
EUKARYOTIC_TRANSLATION_ELONGATION,2.825048837,0.000167707,mercaptopurine
SELENOAMINO_ACID_METABOLISM,2.790397087,0.000134165,mercaptopurine
NONSENSE_MEDIATED_DECAY_NMD,2.716721713,0.000111805,mercaptopurine
EUKARYOTIC_TRANSLATION_INITIATION,2.536995666,9.58E-05,mercaptopurine
CELL_CYCLE_MITOTIC,-2.407298955,0.001654112,mercaptopurine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.411845348,0.002481168,mercaptopurine
TRANSLATION,2.830473203,0,purvalanol-b
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.427437951,0.004814305,purvalanol-b
RESPIRATORY_ELECTRON_TRANSPORT,2.397113796,0.005135259,purvalanol-b
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,2.056011342,0.047180193,purvalanol-b
RRNA_PROCESSING,2.033539318,0.042365887,purvalanol-b
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,-2.039348192,0.100512243,purvalanol-b
MITOTIC_METAPHASE_AND_ANAPHASE,1.908792124,0.071251719,purvalanol-b
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.978530358,0.104565156,purvalanol-b
MRNA_SPLICING,1.865713722,0.080330124,purvalanol-b
METABOLISM_OF_RNA,1.84347245,0.077751032,purvalanol-b
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.230985933,0,nocodazole
NERVOUS_SYSTEM_DEVELOPMENT,2.759963065,0,nocodazole
VIRAL_INFECTION_PATHWAYS,2.859508381,0,nocodazole
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.022703801,0,nocodazole
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.045090413,0,nocodazole
SARS_COV_1_INFECTION,3.070765461,0,nocodazole
METABOLISM_OF_RNA,3.146209893,0,nocodazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.233757628,0,nocodazole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.297863905,0,nocodazole
SIGNALING_BY_ROBO_RECEPTORS,3.343744921,0,nocodazole
NONSENSE_MEDIATED_DECAY_NMD,3.692568957,0,dapsone
EUKARYOTIC_TRANSLATION_ELONGATION,3.670878546,0,dapsone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.551966833,0,dapsone
TRANSLATION,3.51582026,0,dapsone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.448113092,0,dapsone
METABOLISM_OF_RNA,3.44489126,0,dapsone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.399302461,0,dapsone
SELENOAMINO_ACID_METABOLISM,3.388405677,0,dapsone
CELLULAR_RESPONSE_TO_STARVATION,3.386640931,0,dapsone
INFLUENZA_INFECTION,3.346201941,0,dapsone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.906540915,0,tripelennamine
EUKARYOTIC_TRANSLATION_INITIATION,2.904265586,0,tripelennamine
TRANSLATION,2.846802545,0.000402735,tripelennamine
EUKARYOTIC_TRANSLATION_ELONGATION,2.831425714,0.000302051,tripelennamine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.818376733,0.000241641,tripelennamine
RRNA_PROCESSING,2.814971129,0.000201368,tripelennamine
SELENOAMINO_ACID_METABOLISM,2.812747064,0.000172601,tripelennamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.792713468,0.000151026,tripelennamine
NONSENSE_MEDIATED_DECAY_NMD,2.670039712,0.000134245,tripelennamine
SIGNALING_BY_ROBO_RECEPTORS,2.661971987,0.000120821,tripelennamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,5.507222647,0,venlafaxine
INFECTIOUS_DISEASE,3.101026326,0,venlafaxine
NERVOUS_SYSTEM_DEVELOPMENT,3.268167249,0,venlafaxine
RESPIRATORY_ELECTRON_TRANSPORT,3.323056035,0,venlafaxine
VIRAL_INFECTION_PATHWAYS,3.42606226,0,venlafaxine
SARS_COV_1_INFECTION,3.437266842,0,venlafaxine
CELLULAR_RESPONSES_TO_STIMULI,3.580387941,0,venlafaxine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.593083637,0,venlafaxine
SARS_COV_1_HOST_INTERACTIONS,3.66929112,0,venlafaxine
METABOLISM_OF_RNA,3.986818037,0,venlafaxine
CELLULAR_RESPONSE_TO_STARVATION,1.921758576,0.490381169,BRD-K41170226
RAB_REGULATION_OF_TRAFFICKING,1.834504027,0.433385112,BRD-K41170226
SIGNALING_BY_ALK_IN_CANCER,1.833757679,0.290715737,BRD-K41170226
INFLUENZA_INFECTION,1.755449514,0.348428725,BRD-K41170226
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.666874445,0.455968455,BRD-K41170226
S_PHASE,-1.715020206,1,BRD-K41170226
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.603722404,0.530529334,BRD-K41170226
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.700701835,1,BRD-K41170226
CELL_CYCLE_MITOTIC,-1.679741347,1,BRD-K41170226
G_ALPHA_Q_SIGNALLING_EVENTS,-1.674549136,0.830441271,BRD-K41170226
CELL_CYCLE,2.788314439,0,BRD-K20152659
CELL_CYCLE_CHECKPOINTS,2.77181617,0,BRD-K20152659
CELL_CYCLE_MITOTIC,2.674709271,0.000846516,BRD-K20152659
METABOLISM_OF_RNA,2.672526644,0.000634887,BRD-K20152659
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,2.661937122,0.000507909,BRD-K20152659
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.539416381,0.001269773,BRD-K20152659
M_PHASE,2.507732342,0.001451169,BRD-K20152659
MITOTIC_METAPHASE_AND_ANAPHASE,2.483267588,0.00190466,BRD-K20152659
TRANSLATION,2.448601577,0.001777683,BRD-K20152659
MRNA_SPLICING,2.465233828,0.001975203,BRD-K20152659
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.850634236,0,tadalafil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.613847257,0,tadalafil
GPCR_LIGAND_BINDING,-2.762655627,0,tadalafil
SARS_COV_2_HOST_INTERACTIONS,2.898939554,0,tadalafil
SARS_COV_1_INFECTION,3.325068564,0,tadalafil
INFECTIOUS_DISEASE,3.325620162,0,tadalafil
NERVOUS_SYSTEM_DEVELOPMENT,3.335079824,0,tadalafil
SARS_COV_1_HOST_INTERACTIONS,3.422632862,0,tadalafil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.48062795,0,tadalafil
VIRAL_INFECTION_PATHWAYS,3.484042135,0,tadalafil
EUKARYOTIC_TRANSLATION_ELONGATION,-3.455453417,0,raloxifene
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.497396487,0,raloxifene
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.511904908,0,raloxifene
RRNA_PROCESSING,-2.601165981,0,raloxifene
SARS_COV_1_HOST_INTERACTIONS,-2.69671533,0,raloxifene
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.829383513,0,raloxifene
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.903804045,0,raloxifene
TRANSLATION,-2.94096677,0,raloxifene
SARS_COV_1_INFECTION,-2.415972774,0,raloxifene
INFLUENZA_INFECTION,-3.048687955,0,raloxifene
EUKARYOTIC_TRANSLATION_INITIATION,3.156830567,0,meclizine
SELENOAMINO_ACID_METABOLISM,3.088659,0,meclizine
EUKARYOTIC_TRANSLATION_ELONGATION,3.017865903,0,meclizine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.818979281,0,meclizine
RESPIRATORY_ELECTRON_TRANSPORT,2.811049255,0,meclizine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.810765681,0,meclizine
TRANSLATION,2.745694914,0,meclizine
CELLULAR_RESPONSE_TO_STARVATION,2.74095037,0,meclizine
RRNA_PROCESSING,2.720284043,0,meclizine
NONSENSE_MEDIATED_DECAY_NMD,2.694401113,0,meclizine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.752635489,0,amlodipine
GPCR_LIGAND_BINDING,-2.541345706,0,amlodipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.461955697,0,amlodipine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.421502519,0,amlodipine
SIGNALING_BY_GPCR,-2.401810674,0,amlodipine
DNA_REPAIR,2.449578457,0.004459745,amlodipine
CELL_CYCLE,2.122907872,0.02675847,amlodipine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.117344009,0.002593037,amlodipine
G_ALPHA_I_SIGNALLING_EVENTS,-2.109478528,0.002729512,amlodipine
G_ALPHA_S_SIGNALLING_EVENTS,-2.095852788,0.002729512,amlodipine
METABOLISM_OF_RNA,4.596930185,0,lorazepam
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.159133874,0,lorazepam
TRANSLATION,2.968072693,0,lorazepam
RRNA_PROCESSING,2.943828908,0,lorazepam
SIGNALING_BY_ROBO_RECEPTORS,2.676277256,0,lorazepam
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.438970369,0.001091906,lorazepam
GPCR_LIGAND_BINDING,-2.133892793,0.017660609,lorazepam
HIV_INFECTION,2.179154342,0.011698992,lorazepam
SENSORY_PERCEPTION,-2.122310289,0.009982083,lorazepam
MRNA_SPLICING,2.121814563,0.012693407,lorazepam
EXTRACELLULAR_MATRIX_ORGANIZATION,2.249311263,0.01434103,donepezil
CELL_CYCLE_MITOTIC,-2.160585389,0.063863869,donepezil
INTERFERON_ALPHA_BETA_SIGNALING,2.198192479,0.009759867,donepezil
MUSCLE_CONTRACTION,2.166874201,0.00889675,donepezil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.059715407,0.01434103,donepezil
CELL_CYCLE,-2.012512196,0.135710722,donepezil
S_PHASE,-1.944124408,0.157442177,donepezil
OXIDATIVE_STRESS_INDUCED_SENESCENCE,-1.897200692,0.173962518,donepezil
MRNA_SPLICING,-1.892771279,0.144225904,donepezil
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.825016922,0.056009688,donepezil
GPCR_LIGAND_BINDING,-2.031430067,0.050769113,moxonidine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.96135878,0.061020569,moxonidine
GLYCOSAMINOGLYCAN_METABOLISM,1.707598535,0.331477516,moxonidine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.677887732,0.193361884,moxonidine
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.6543887,0.146038544,moxonidine
SIGNALING_BY_GPCR,-1.845535285,0.151331011,moxonidine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-1.811738641,0.161094302,moxonidine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.78347258,0.169881264,moxonidine
REGULATED_NECROSIS,-1.781920682,0.143845821,moxonidine
PROGRAMMED_CELL_DEATH,-1.743012228,0.182155116,moxonidine
GPCR_LIGAND_BINDING,2.528558642,0.000760964,mafenide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.327171161,0.006468197,mafenide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.905721162,0.142553994,mafenide
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.030289459,0.777235581,mafenide
G_ALPHA_Q_SIGNALLING_EVENTS,1.894745018,0.115856827,mafenide
CELL_CELL_JUNCTION_ORGANIZATION,-1.941554265,0.641953197,mafenide
SIGNALING_BY_GPCR,1.782924043,0.199524861,mafenide
CELL_JUNCTION_ORGANIZATION,-1.879694506,0.61174864,mafenide
G_ALPHA_S_SIGNALLING_EVENTS,1.760784058,0.193792263,mafenide
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.75961246,0.166868618,mafenide
CELL_CELL_COMMUNICATION,-1.938255652,1,xylometazoline
RRNA_PROCESSING,1.809912593,1,xylometazoline
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.750523493,1,xylometazoline
DISEASES_OF_METABOLISM,-1.746583923,0.808018954,xylometazoline
REPRODUCTION,-1.710241013,0.688737015,xylometazoline
MEIOSIS,-1.667353763,0.638545653,xylometazoline
INNATE_IMMUNE_SYSTEM,-1.662178497,0.542035721,xylometazoline
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.652661204,0.479739124,xylometazoline
DEVELOPMENTAL_CELL_LINEAGES,-1.608664608,0.487739202,xylometazoline
APOPTOSIS,1.676383554,1,xylometazoline
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.326852317,0,clomipramine
MRNA_SPLICING,2.929213814,0,clomipramine
METABOLISM_OF_RNA,2.420486356,0.003084759,clomipramine
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-1.891121907,0.226457705,clomipramine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.850680666,0.162041291,clomipramine
MITOTIC_SPINDLE_CHECKPOINT,1.519165175,0.461557086,clomipramine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.452629562,0.525642957,clomipramine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.798036063,0.181646286,clomipramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.796863125,0.137835122,clomipramine
HOST_INTERACTIONS_OF_HIV_FACTORS,1.408401419,0.549087127,clomipramine
KERATINIZATION,3.073213179,0,mestinon
FORMATION_OF_THE_CORNIFIED_ENVELOPE,3.073213179,0,mestinon
NONSENSE_MEDIATED_DECAY_NMD,-2.401693343,0.008434329,mestinon
SELENOAMINO_ACID_METABOLISM,-2.399900203,0.004217164,mestinon
METABOLISM_OF_NUCLEOTIDES,2.401224357,0.003136025,mestinon
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.306693903,0.007028607,mestinon
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.286176542,0.006325746,mestinon
EUKARYOTIC_TRANSLATION_INITIATION,-2.246861481,0.006114888,mestinon
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,2.254908972,0.007840063,mestinon
EUKARYOTIC_TRANSLATION_ELONGATION,-2.207211197,0.007555753,mestinon
RRNA_PROCESSING,2.043007511,0.295899619,guaifenesin
NEUTROPHIL_DEGRANULATION,-1.852023148,0.729182377,guaifenesin
RAC3_GTPASE_CYCLE,-1.828274986,0.414308169,guaifenesin
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.827238321,0.797217155,guaifenesin
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,1.815220824,0.571012901,guaifenesin
RAC1_GTPASE_CYCLE,-1.775118155,0.376790263,guaifenesin
METABOLISM_OF_RNA,1.779500494,0.55144929,guaifenesin
INTERLEUKIN_1_SIGNALING,1.778735458,0.444338518,guaifenesin
SYNTHESIS_OF_DNA,1.767100414,0.399423728,guaifenesin
IRE1ALPHA_ACTIVATES_CHAPERONES,1.762389566,0.352669026,guaifenesin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.033276722,0,pindolol
VIRAL_INFECTION_PATHWAYS,2.898328632,0,pindolol
INFECTIOUS_DISEASE,2.916362217,0,pindolol
SARS_COV_1_INFECTION,2.962982249,0,pindolol
SARS_COV_1_HOST_INTERACTIONS,3.078774428,0,pindolol
SIGNALING_BY_ROBO_RECEPTORS,3.336667702,0,pindolol
TRANSLATION,3.501782781,0,pindolol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.525616984,0,pindolol
RRNA_PROCESSING,3.340841266,0,pindolol
SELENOAMINO_ACID_METABOLISM,3.716492786,0,pindolol
NEUTROPHIL_DEGRANULATION,-2.862588194,0.003360597,chlorcyclizine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-1.835910173,0.362104327,chlorcyclizine
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.938489231,0.405654203,chlorcyclizine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.718290879,0.460401789,chlorcyclizine
SIGNALING_BY_NTRKS,-1.644911282,0.509970595,chlorcyclizine
INNATE_IMMUNE_SYSTEM,-1.620613618,0.462754207,chlorcyclizine
HOMOLOGY_DIRECTED_REPAIR,1.770578681,0.704886778,chlorcyclizine
GPCR_LIGAND_BINDING,1.74625072,0.555340047,chlorcyclizine
CARDIAC_CONDUCTION,1.742772933,0.429651236,chlorcyclizine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.500680444,0.697603927,chlorcyclizine
EUKARYOTIC_TRANSLATION_ELONGATION,4.849476205,0,lidocaine
INFECTIOUS_DISEASE,2.832549486,0,lidocaine
NERVOUS_SYSTEM_DEVELOPMENT,2.916423383,0,lidocaine
CELLULAR_RESPONSES_TO_STIMULI,2.995445887,0,lidocaine
VIRAL_INFECTION_PATHWAYS,3.164205437,0,lidocaine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.288110198,0,lidocaine
SARS_COV_1_HOST_INTERACTIONS,3.369870492,0,lidocaine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.408529988,0,lidocaine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.450706359,0,lidocaine
METABOLISM_OF_RNA,3.73681164,0,lidocaine
TRANSLATION,4.255728615,0,midodrine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.681665127,0,midodrine
NONSENSE_MEDIATED_DECAY_NMD,2.75300816,0,midodrine
INFLUENZA_INFECTION,2.88611154,0,midodrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.018697844,0,midodrine
CELLULAR_RESPONSE_TO_STARVATION,3.452371827,0,midodrine
RESPIRATORY_ELECTRON_TRANSPORT,3.369617651,0,midodrine
SELENOAMINO_ACID_METABOLISM,3.647561562,0,midodrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.691333803,0,midodrine
RRNA_PROCESSING,4.012242523,0,midodrine
EUKARYOTIC_TRANSLATION_INITIATION,2.246961432,0.022473878,thiethylperazine
GPCR_LIGAND_BINDING,2.171838687,0.027155936,thiethylperazine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.155106629,0.020601055,thiethylperazine
EUKARYOTIC_TRANSLATION_ELONGATION,2.126332279,0.01943054,thiethylperazine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.095052763,0.021724749,thiethylperazine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.06144605,0.028248416,thiethylperazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.020363129,0.035449867,thiethylperazine
POTENTIAL_THERAPEUTICS_FOR_SARS,2.002850067,0.036285949,thiethylperazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.998590811,0.033294634,thiethylperazine
SELENOAMINO_ACID_METABOLISM,1.945428353,0.04607145,thiethylperazine
ESR_MEDIATED_SIGNALING,-2.426107904,0.002369481,riluzole
CELLULAR_RESPONSES_TO_STIMULI,-2.209210846,0.025471922,riluzole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.202539202,0.017376195,riluzole
OXIDATIVE_STRESS_INDUCED_SENESCENCE,-2.194772262,0.013624516,riluzole
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.191973973,0.010899613,riluzole
TRANSCRIPTIONAL_REGULATION_BY_TP53,-2.172134393,0.010070295,riluzole
MRNA_SPLICING,-2.15168875,0.009816422,riluzole
EUKARYOTIC_TRANSLATION_INITIATION,-2.146191333,0.008885554,riluzole
INFLUENZA_INFECTION,-2.128158409,0.0097412,riluzole
SIGNALING_BY_VEGF,-2.090011651,0.011728931,riluzole
TRANSLATION,3.20115888,0,montelukast
EUKARYOTIC_TRANSLATION_INITIATION,3.09436291,0,montelukast
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.090590556,0,montelukast
EUKARYOTIC_TRANSLATION_ELONGATION,3.090571375,0,montelukast
SELENOAMINO_ACID_METABOLISM,2.924110834,0,montelukast
RRNA_PROCESSING,2.756618599,0,montelukast
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.746747114,0,montelukast
CELLULAR_RESPONSE_TO_STARVATION,2.721541791,0,montelukast
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.652840106,0,montelukast
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.520426267,0.000111534,montelukast
EUKARYOTIC_TRANSLATION_ELONGATION,3.10899833,0,sertraline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.051202889,0,sertraline
EUKARYOTIC_TRANSLATION_INITIATION,2.998576088,0,sertraline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.980474669,0,sertraline
SELENOAMINO_ACID_METABOLISM,2.894803658,0,sertraline
CELLULAR_RESPONSE_TO_STARVATION,2.854952521,0,sertraline
TRANSLATION,2.625069868,0.000187808,sertraline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.621075027,0.000164332,sertraline
INFLUENZA_INFECTION,2.588693698,0.000146073,sertraline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.435122203,0.000920258,sertraline
EUKARYOTIC_TRANSLATION_INITIATION,5.497646757,0,milrinone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.809088732,0,milrinone
SIGNALING_BY_GPCR,-2.836691525,0,milrinone
GPCR_LIGAND_BINDING,-3.001773317,0,milrinone
MRNA_SPLICING,3.002381101,0,milrinone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.022145026,0,milrinone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.024192867,0,milrinone
SARS_COV_INFECTIONS,3.36326637,0,milrinone
SARS_COV_2_INFECTION,3.459681414,0,milrinone
SARS_COV_2_HOST_INTERACTIONS,3.506466538,0,milrinone
TRANSLATION,2.810945266,0,memantine
RRNA_PROCESSING,2.54119763,0.001035528,memantine
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,2.287768804,0.010700461,memantine
MITOCHONDRIAL_TRANSLATION,2.077199176,0.041938904,memantine
KERATINIZATION,2.02972975,0.040558199,memantine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.02972975,0.040558199,memantine
HATS_ACETYLATE_HISTONES,-2.026484427,0.289944776,memantine
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-1.935640647,0.290434548,memantine
DNA_REPLICATION,1.791730121,0.152962351,memantine
SARS_COV_2_HOST_INTERACTIONS,-1.804619122,0.49336324,memantine
TRANSLATION,2.879065817,0.001709347,triprolidine
RESPIRATORY_ELECTRON_TRANSPORT,2.45656146,0.003418693,triprolidine
METABOLISM_OF_RNA,2.434940525,0.003418693,triprolidine
S_PHASE,2.381140641,0.003418693,triprolidine
RRNA_PROCESSING,2.366512547,0.003076824,triprolidine
CELL_CYCLE_MITOTIC,2.342772767,0.00256402,triprolidine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.178579432,0.009523502,triprolidine
CELL_CYCLE,2.164236009,0.009615075,triprolidine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.102744327,0.012345281,triprolidine
DNA_REPLICATION,2.101384271,0.010100684,triprolidine
EUKARYOTIC_TRANSLATION_ELONGATION,4.098202682,0,zafirlukast
CELLULAR_RESPONSES_TO_STIMULI,2.525006124,0,zafirlukast
METABOLISM_OF_RNA,2.539282356,0,zafirlukast
SARS_COV_1_HOST_INTERACTIONS,2.688132505,0,zafirlukast
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.720609932,0,zafirlukast
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.757649389,0,zafirlukast
NERVOUS_SYSTEM_DEVELOPMENT,2.761742369,0,zafirlukast
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.840295362,0,zafirlukast
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.201506321,0,zafirlukast
RRNA_PROCESSING,3.516121945,0,zafirlukast
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.726518086,0,nitrendipine
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.124481148,0.082782853,nitrendipine
GPCR_LIGAND_BINDING,-2.07257901,0.043085536,nitrendipine
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.877103233,0.188802998,nitrendipine
TOLL_LIKE_RECEPTOR_CASCADES,1.871435998,0.145959241,nitrendipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.995250064,0.047171233,nitrendipine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.990206258,0.032685579,nitrendipine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.809793318,0.152494729,nitrendipine
SUMOYLATION,1.79990696,0.13361443,nitrendipine
SIGNALING_BY_GPCR,-1.954320272,0.039371266,nitrendipine
NEUTROPHIL_DEGRANULATION,-2.009536004,0.345801132,molsidomine
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.707682308,0.819398335,molsidomine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-1.680041424,0.639717354,molsidomine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.553426748,0.886833977,molsidomine
DNA_REPAIR,1.624105717,1,molsidomine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.453737784,1,molsidomine
SIGNALING_BY_NTRKS,-1.442075729,0.950437212,molsidomine
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,-1.431720664,0.848899454,molsidomine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.420308439,0.778384198,molsidomine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.392023575,0.778470181,molsidomine
NEUTROPHIL_DEGRANULATION,-2.460151728,0.022529532,oxcarbazepine
GPCR_LIGAND_BINDING,2.160286187,0.045062544,oxcarbazepine
INNATE_IMMUNE_SYSTEM,-2.032847998,0.158511353,oxcarbazepine
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.910747048,0.227977412,oxcarbazepine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.894151015,0.190294086,oxcarbazepine
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.891557955,0.154166372,oxcarbazepine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.882463389,0.326703442,oxcarbazepine
SENSORY_PERCEPTION,1.843852428,0.294201435,oxcarbazepine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.724861621,0.323459716,oxcarbazepine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.634431892,0.450590649,oxcarbazepine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.637283519,0,erythromycin
NONSENSE_MEDIATED_DECAY_NMD,2.661464159,0.001464651,erythromycin
CELLULAR_RESPONSE_TO_STARVATION,2.617797697,0.000732326,erythromycin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.593937692,0.000488217,erythromycin
EUKARYOTIC_TRANSLATION_ELONGATION,2.500383788,0.001098488,erythromycin
EUKARYOTIC_TRANSLATION_INITIATION,2.397621614,0.002050512,erythromycin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.386333311,0.00170876,erythromycin
INFLUENZA_INFECTION,2.377630319,0.001464651,erythromycin
GPCR_LIGAND_BINDING,-2.383858233,0.005272408,erythromycin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.338137493,0.002746221,erythromycin
EUKARYOTIC_TRANSLATION_ELONGATION,2.78359782,0,levetiracetam
EUKARYOTIC_TRANSLATION_INITIATION,2.598298485,0,levetiracetam
INFLUENZA_INFECTION,2.60335132,0,levetiracetam
SELENOAMINO_ACID_METABOLISM,2.639248476,0,levetiracetam
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.575589911,0,levetiracetam
NONSENSE_MEDIATED_DECAY_NMD,2.692724953,0,levetiracetam
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.711457268,0,levetiracetam
CELLULAR_RESPONSE_TO_STARVATION,2.761977157,0,levetiracetam
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.423576643,0.000200274,levetiracetam
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.420274566,0.000180246,levetiracetam
SELENOAMINO_ACID_METABOLISM,2.675479152,0,omeprazole
EUKARYOTIC_TRANSLATION_ELONGATION,2.60856491,0,omeprazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.575392269,0,omeprazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.573995206,0,omeprazole
EUKARYOTIC_TRANSLATION_INITIATION,2.552323801,0,omeprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.522766655,0.000177718,omeprazole
NONSENSE_MEDIATED_DECAY_NMD,2.471456145,0.000456988,omeprazole
INFLUENZA_INFECTION,2.431734474,0.000426522,omeprazole
CELLULAR_RESPONSE_TO_STARVATION,2.436985398,0.000473914,omeprazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.437380744,0.000533153,omeprazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.488409036,0.001787949,nilotinib
MRNA_SPLICING,-2.144801283,0.071604061,nilotinib
GPCR_LIGAND_BINDING,2.082566028,0.03486501,nilotinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.029453728,0.134105911,nilotinib
CELL_CYCLE_MITOTIC,-1.974608086,0.154535319,nilotinib
SYNTHESIS_OF_DNA,-1.946025449,0.152613741,nilotinib
M_PHASE,-1.904509892,0.178646065,nilotinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.804451002,0.152273675,nilotinib
DNA_REPLICATION,-1.87092756,0.200653188,nilotinib
DNA_REPLICATION_PRE_INITIATION,-1.866102844,0.179616967,nilotinib
EUKARYOTIC_TRANSLATION_ELONGATION,-3.548292768,0,estradiol
SARS_COV_INFECTIONS,-2.488096455,0,estradiol
SARS_COV_2_INFECTION,-2.500813093,0,estradiol
INFECTIOUS_DISEASE,-2.521746493,0,estradiol
CELLULAR_RESPONSES_TO_STIMULI,-2.575990698,0,estradiol
VIRAL_INFECTION_PATHWAYS,-2.576529258,0,estradiol
NERVOUS_SYSTEM_DEVELOPMENT,-2.716633297,0,estradiol
SARS_COV_2_HOST_INTERACTIONS,-2.945537226,0,estradiol
RRNA_PROCESSING,-2.948181856,0,estradiol
SARS_COV_1_INFECTION,-2.954282472,0,estradiol
EUKARYOTIC_TRANSLATION_INITIATION,3.719805603,0,BRD-K89997465
EUKARYOTIC_TRANSLATION_ELONGATION,3.659885649,0,BRD-K89997465
SELENOAMINO_ACID_METABOLISM,3.484121593,0,BRD-K89997465
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.449040816,0,BRD-K89997465
TRANSLATION,3.34306743,0,BRD-K89997465
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.207864028,0,BRD-K89997465
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.154053335,0,BRD-K89997465
RESPIRATORY_ELECTRON_TRANSPORT,3.144235638,0,BRD-K89997465
CELLULAR_RESPONSE_TO_STARVATION,2.982896499,0,BRD-K89997465
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.826773296,0,BRD-K89997465
GPCR_LIGAND_BINDING,3.187568647,0,SNS-314
SIGNALING_BY_GPCR,2.985539664,0,SNS-314
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.898409102,0,SNS-314
EXTRACELLULAR_MATRIX_ORGANIZATION,2.512937505,0.000143474,SNS-314
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.53453456,0.00513098,SNS-314
G_ALPHA_Q_SIGNALLING_EVENTS,2.425386165,0.000573897,SNS-314
KERATINIZATION,2.311355141,0.001912989,SNS-314
METABOLISM_OF_RNA,-2.300989254,0.014751568,SNS-314
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.271874699,0.002049631,SNS-314
G_ALPHA_I_SIGNALLING_EVENTS,2.254019001,0.002080376,SNS-314
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.510140532,0.00295403,benazepril
S_PHASE,-2.507713473,0.001477015,benazepril
SIGNALING_BY_INSULIN_RECEPTOR,-2.440409129,0.002461692,benazepril
METABOLISM_OF_RNA,-2.379416364,0.002215523,benazepril
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.294685603,0.007385075,benazepril
SIGNALING_BY_NOTCH,-2.26157901,0.008123583,benazepril
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,-2.247932538,0.008440086,benazepril
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.215220456,0.010339105,benazepril
CELL_CYCLE_MITOTIC,-2.196630082,0.010831444,benazepril
GASTRULATION,-2.178226725,0.011963822,benazepril
MUSCLE_CONTRACTION,3.178273683,0,meclofenamic-acid
EXTRACELLULAR_MATRIX_ORGANIZATION,2.623279124,0.00048695,meclofenamic-acid
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.076378516,0.122699172,meclofenamic-acid
TCR_SIGNALING,-2.065489435,0.065218479,meclofenamic-acid
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-2.064903078,0.043847452,meclofenamic-acid
DEVELOPMENTAL_CELL_LINEAGES,1.98193489,0.027269186,meclofenamic-acid
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.950806323,0.024590962,meclofenamic-acid
APOPTOSIS,-2.009012418,0.056927994,meclofenamic-acid
MRNA_SPLICING,-1.992939557,0.05350126,meclofenamic-acid
CILIUM_ASSEMBLY,-1.951559393,0.063744615,meclofenamic-acid
TRANSLATION,3.445422479,0,BRD-K92073408
RRNA_PROCESSING,2.541892074,0.00443186,BRD-K92073408
RESPIRATORY_ELECTRON_TRANSPORT,2.406178642,0.006894005,BRD-K92073408
MITOCHONDRIAL_TRANSLATION,2.278336343,0.009971685,BRD-K92073408
CILIUM_ASSEMBLY,-2.15402213,0.042411035,BRD-K92073408
SIGNALING_BY_ALK_IN_CANCER,-2.036058856,0.071250538,BRD-K92073408
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.995269642,0.056432353,BRD-K92073408
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.921287728,0.072140835,BRD-K92073408
DISEASES_OF_METABOLISM,1.896938282,0.07259809,BRD-K92073408
HATS_ACETYLATE_HISTONES,-1.901613306,0.168795918,BRD-K92073408
INFLUENZA_INFECTION,-2.325343727,0.032086748,nicotinamide
PROGRAMMED_CELL_DEATH,-2.27548591,0.024065061,nicotinamide
SELENOAMINO_ACID_METABOLISM,-2.270618724,0.016489023,nicotinamide
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,-2.268882412,0.012366767,nicotinamide
NONSENSE_MEDIATED_DECAY_NMD,-2.263376159,0.009893414,nicotinamide
VIRAL_INFECTION_PATHWAYS,-2.25587227,0.008690161,nicotinamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.232643096,0.008021687,nicotinamide
METABOLISM_OF_RNA,-2.203958133,0.008690161,nicotinamide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.188036291,0.008615886,nicotinamide
RHO_GTPASE_CYCLE,-2.174982803,0.008823856,nicotinamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.33238236,0.026223362,pentamidine
SIGNALING_BY_ROBO_RECEPTORS,-2.137753772,0.071079113,pentamidine
NEURONAL_SYSTEM,2.099618638,0.06236869,pentamidine
NEUTROPHIL_DEGRANULATION,-2.032884558,0.127436338,pentamidine
METABOLISM_OF_RNA,-2.017989897,0.105928581,pentamidine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.966118916,0.124491961,pentamidine
TRANSLATION,-1.94536247,0.120305424,pentamidine
SYNTHESIS_OF_DNA,-1.937384609,0.108245307,pentamidine
PROTEIN_LOCALIZATION,-1.933793773,0.096784909,pentamidine
DNA_REPLICATION_PRE_INITIATION,-1.927798325,0.090324914,pentamidine
GLYCOSAMINOGLYCAN_METABOLISM,1.982123216,0.17484528,tolazamide
DISEASES_OF_GLYCOSYLATION,1.972163819,0.091857122,tolazamide
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.837780784,0.133034453,tolazamide
RRNA_PROCESSING,1.760611184,0.167876809,tolazamide
PI_METABOLISM,-1.865960921,0.822373226,tolazamide
DISEASES_OF_METABOLISM,1.672682797,0.228565859,tolazamide
TRANSLATION,1.639274638,0.227847896,tolazamide
EXTRACELLULAR_MATRIX_ORGANIZATION,1.63399487,0.201814169,tolazamide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.594735577,0.215705862,tolazamide
SIGNALING_BY_ALK_IN_CANCER,-1.786017357,0.781395866,tolazamide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.967037369,0,levothyroxine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.959946158,0,levothyroxine
EUKARYOTIC_TRANSLATION_INITIATION,-2.932196464,0,levothyroxine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.898176277,0,levothyroxine
NONSENSE_MEDIATED_DECAY_NMD,-2.841241329,0,levothyroxine
INFLUENZA_INFECTION,-2.825354395,0,levothyroxine
SELENOAMINO_ACID_METABOLISM,-2.754422463,0,levothyroxine
SIGNALING_BY_ROBO_RECEPTORS,-2.74028669,0,levothyroxine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.71692463,0,levothyroxine
TRANSLATION,-2.607523387,0,levothyroxine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.561529641,0,valproic-acid
VIRAL_INFECTION_PATHWAYS,-2.406125453,0,valproic-acid
METABOLISM_OF_RNA,-2.421355267,0,valproic-acid
SARS_COV_INFECTIONS,-2.467672975,0,valproic-acid
SARS_COV_2_INFECTION,-2.639617418,0,valproic-acid
SARS_COV_2_HOST_INTERACTIONS,-2.861620546,0,valproic-acid
SARS_COV_1_INFECTION,-2.909275037,0,valproic-acid
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.017567635,0,valproic-acid
SARS_COV_1_HOST_INTERACTIONS,-3.108910375,0,valproic-acid
RRNA_PROCESSING,-3.135578197,0,valproic-acid
L1CAM_INTERACTIONS,1.899453201,0.685319528,PD-0325901
HOMOLOGY_DIRECTED_REPAIR,-1.695962352,0.646236847,PD-0325901
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.6440064,0.428491579,PD-0325901
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.727877471,1,PD-0325901
NEDDYLATION,-1.438663503,0.78777127,PD-0325901
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1.681826075,1,PD-0325901
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.400483076,0.702811733,PD-0325901
RAC2_GTPASE_CYCLE,1.629993857,1,PD-0325901
PROTEIN_LOCALIZATION,-1.329585039,0.788237867,PD-0325901
EUKARYOTIC_TRANSLATION_ELONGATION,1.579967811,1,PD-0325901
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.803419801,0,geldanamycin
DNA_REPLICATION,-2.781046793,0,geldanamycin
DNA_STRAND_ELONGATION,-2.765925059,0,geldanamycin
SYNTHESIS_OF_DNA,-2.763596726,0,geldanamycin
S_PHASE,-2.649499228,0,geldanamycin
CELL_CYCLE_MITOTIC,-2.567661025,0.000181751,geldanamycin
CELL_CYCLE,-2.554658977,0.000155786,geldanamycin
DNA_REPLICATION_PRE_INITIATION,-2.500567912,0.000272626,geldanamycin
CHROMOSOME_MAINTENANCE,-2.388595889,0.001211673,geldanamycin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.349823463,0.001308606,geldanamycin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.170866274,0,erlotinib
SELENOAMINO_ACID_METABOLISM,2.980374582,0,erlotinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.926949648,0,erlotinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.888153946,0,erlotinib
CELLULAR_RESPONSE_TO_STARVATION,2.658513693,0,erlotinib
EUKARYOTIC_TRANSLATION_INITIATION,2.538127712,0.000112588,erlotinib
NONSENSE_MEDIATED_DECAY_NMD,2.276411148,0.003088141,erlotinib
INFLUENZA_INFECTION,2.210344052,0.005404246,erlotinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.114179094,0.010508256,erlotinib
DISEASES_OF_GLYCOSYLATION,-2.125361462,0.149868536,erlotinib
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.121838961,0.134504802,PD-168393
INFLUENZA_INFECTION,2.094695515,0.075658951,PD-168393
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.074527813,0.059779912,PD-168393
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.038179825,0.056744213,PD-168393
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.877826346,0.119373011,PD-168393
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.940049521,0.271564734,PD-168393
KEAP1_NFE2L2_PATHWAY,1.78334898,0.184477072,PD-168393
RESPIRATORY_ELECTRON_TRANSPORT,1.774500677,0.166529754,PD-168393
GPCR_LIGAND_BINDING,-1.887527192,0.218721597,PD-168393
NONSENSE_MEDIATED_DECAY_NMD,1.716497294,0.198604746,PD-168393
COLLAGEN_FORMATION,2.262739195,0.005986465,glibenclamide
EXTRACELLULAR_MATRIX_ORGANIZATION,2.196024373,0.006319047,glibenclamide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.99525356,0.025276187,glibenclamide
DISEASES_OF_GLYCOSYLATION,1.93442388,0.027105385,glibenclamide
CARDIAC_CONDUCTION,1.674614927,0.10482966,glibenclamide
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.668020838,0.089907841,glibenclamide
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,-1.814033053,1,glibenclamide
RRNA_PROCESSING,1.559359885,0.132272378,glibenclamide
INTERFERON_ALPHA_BETA_SIGNALING,1.551476155,0.119563017,glibenclamide
SARS_COV_1_INFECTION,-1.794045312,0.858081129,glibenclamide
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.574698413,0.007336152,bortezomib
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.255160129,0.031178646,bortezomib
METABOLISM_OF_NUCLEOTIDES,-2.116152279,0.089653191,bortezomib
MITOTIC_PROMETAPHASE,-2.102668315,0.051618504,bortezomib
MITOTIC_SPINDLE_CHECKPOINT,-2.077118945,0.046184977,bortezomib
MRNA_SPLICING,2.080406957,0.067655623,bortezomib
SIGNALING_BY_ALK_IN_CANCER,2.038130515,0.065414021,bortezomib
KEAP1_NFE2L2_PATHWAY,2.037513397,0.052575755,bortezomib
FOXO_MEDIATED_TRANSCRIPTION,2.037197391,0.043813129,bortezomib
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.02234652,0.040698176,bortezomib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.20599954,0.042473197,aclidinium
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.093559492,0.073866429,aclidinium
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.834586196,0.770839932,aclidinium
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.755229239,0.627400731,aclidinium
GPCR_LIGAND_BINDING,-1.824838383,0.399802049,aclidinium
REGULATION_OF_TP53_ACTIVITY,1.720552116,0.508839874,aclidinium
RNA_POLYMERASE_II_TRANSCRIPTION,1.667984572,0.524194477,aclidinium
SIGNALING_BY_ALK_IN_CANCER,1.640654035,0.484194765,aclidinium
PEROXISOMAL_PROTEIN_IMPORT,1.635711384,0.414768637,aclidinium
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.736291133,0.555383215,aclidinium
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.981755142,0.157014781,ofloxacin
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.963369781,0.088320814,ofloxacin
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.958273792,0.061061304,ofloxacin
RESPIRATORY_ELECTRON_TRANSPORT,1.876772816,0.080960746,ofloxacin
TOLL_LIKE_RECEPTOR_CASCADES,1.849041047,0.073273564,ofloxacin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.964518816,0.158522758,ofloxacin
MYD88_INDEPENDENT_TLR4_CASCADE,1.781004456,0.098679428,ofloxacin
MITF_M_DEPENDENT_GENE_EXPRESSION,1.772795182,0.091591955,ofloxacin
EUKARYOTIC_TRANSLATION_ELONGATION,-1.903686897,0.141508535,ofloxacin
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.654962545,0.15537921,ofloxacin
GPCR_LIGAND_BINDING,-2.623006247,0,lapatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.557539045,0,lapatinib
SIGNALING_BY_GPCR,-2.507002397,0,lapatinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.487628254,0,lapatinib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.995365148,0.00372978,lapatinib
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,2.879558256,0.00186489,lapatinib
CHROMATIN_ORGANIZATION,2.672433966,0.00372978,lapatinib
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.52252864,0.00372978,lapatinib
MITF_M_DEPENDENT_GENE_EXPRESSION,2.456902894,0.002983824,lapatinib
G_ALPHA_I_SIGNALLING_EVENTS,-2.293594576,0.000541727,lapatinib
GPCR_LIGAND_BINDING,-2.054216295,0.049095219,latanoprost
NEDDYLATION,1.762036426,0.378461538,latanoprost
SIGNALING_BY_GPCR,-1.959113075,0.066321612,latanoprost
CELL_CYCLE_CHECKPOINTS,1.674274463,0.28,latanoprost
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.896657374,0.085270644,latanoprost
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.582585601,0.302564103,latanoprost
G_ALPHA_S_SIGNALLING_EVENTS,-1.814638597,0.133073884,latanoprost
CELL_CYCLE_MITOTIC,1.446654471,0.456923077,latanoprost
G_ALPHA_I_SIGNALLING_EVENTS,-1.792235603,0.129714737,latanoprost
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.419532353,0.409230769,latanoprost
EUKARYOTIC_TRANSLATION_ELONGATION,-3.114674873,0,disopyramide
NERVOUS_SYSTEM_DEVELOPMENT,-2.489028766,0,disopyramide
SARS_COV_1_INFECTION,-2.526918225,0,disopyramide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.701079438,0,disopyramide
NONSENSE_MEDIATED_DECAY_NMD,-2.773090152,0,disopyramide
SARS_COV_1_HOST_INTERACTIONS,-2.78017767,0,disopyramide
INFLUENZA_INFECTION,-2.795898207,0,disopyramide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.80052778,0,disopyramide
CELLULAR_RESPONSE_TO_STARVATION,-2.813944655,0,disopyramide
RRNA_PROCESSING,-2.795920166,0,disopyramide
PEROXISOMAL_PROTEIN_IMPORT,2.814282504,0.001293898,fenoterol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.204999794,0.053915765,fenoterol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.131000384,0.052079392,fenoterol
GASTRULATION,-1.99980218,0.166435622,fenoterol
INTERLEUKIN_1_SIGNALING,-1.944604159,0.183626155,fenoterol
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.935174311,0.128527194,fenoterol
PROTEIN_LOCALIZATION,1.931778726,0.098983192,fenoterol
CELL_CYCLE_MITOTIC,-1.898673457,0.205700364,fenoterol
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,-1.871678184,0.206051988,fenoterol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.846405812,0.207458486,fenoterol
SELENOAMINO_ACID_METABOLISM,3.679314697,0,dantrolene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.633526771,0,dantrolene
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.619037526,0,dantrolene
EUKARYOTIC_TRANSLATION_ELONGATION,3.608176721,0,dantrolene
CELLULAR_RESPONSE_TO_STARVATION,3.496549605,0,dantrolene
NONSENSE_MEDIATED_DECAY_NMD,3.478908743,0,dantrolene
EUKARYOTIC_TRANSLATION_INITIATION,3.420405343,0,dantrolene
TRANSLATION,3.314212077,0,dantrolene
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.22292101,0,dantrolene
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.141753184,0,dantrolene
GPCR_LIGAND_BINDING,-2.333013414,0.005307759,resorcinol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.314068727,0.003412131,resorcinol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.296853388,0.002527504,resorcinol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.163012646,0.006824261,resorcinol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.131085851,0.008189113,resorcinol
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.09961537,0.010741893,resorcinol
SIGNALING_BY_ALK_IN_CANCER,2.034417368,0.246503748,resorcinol
PEROXISOMAL_PROTEIN_IMPORT,1.960495563,0.211621142,resorcinol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.959846157,0.141597541,resorcinol
DEVELOPMENTAL_CELL_LINEAGES,-1.928443366,0.051127798,resorcinol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,5.363067175,0,levallorphan
SARS_COV_INFECTIONS,2.76572238,0,levallorphan
GPCR_LIGAND_BINDING,-2.776390995,0,levallorphan
SARS_COV_2_INFECTION,3.091519975,0,levallorphan
SARS_COV_2_HOST_INTERACTIONS,3.141208544,0,levallorphan
CELLULAR_RESPONSES_TO_STIMULI,3.167513062,0,levallorphan
INFECTIOUS_DISEASE,3.202026476,0,levallorphan
VIRAL_INFECTION_PATHWAYS,3.528896526,0,levallorphan
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.651799466,0,levallorphan
MRNA_SPLICING,3.749406307,0,levallorphan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.148308766,0.050159441,lisinopril
MUSCLE_CONTRACTION,2.172968644,0.069269463,lisinopril
NEUTROPHIL_DEGRANULATION,2.042046347,0.104511822,lisinopril
INFLUENZA_INFECTION,1.97666797,0.106537245,lisinopril
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.961364545,0.085979202,lisinopril
CELLULAR_RESPONSE_TO_STARVATION,1.948799167,0.072915225,lisinopril
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.925708737,0.244869271,lisinopril
PLATELET_HOMEOSTASIS,1.753786604,0.202137206,lisinopril
CELL_CYCLE_MITOTIC,-1.777159004,0.541417966,lisinopril
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.659451913,0.294785836,lisinopril
EUKARYOTIC_TRANSLATION_INITIATION,5.760214644,0,SKF-91488
CELLULAR_RESPONSES_TO_STIMULI,3.702530285,0,SKF-91488
SARS_COV_2_HOST_INTERACTIONS,3.594038196,0,SKF-91488
NERVOUS_SYSTEM_DEVELOPMENT,3.576583848,0,SKF-91488
SARS_COV_INFECTIONS,3.384771,0,SKF-91488
INFECTIOUS_DISEASE,3.373715855,0,SKF-91488
SARS_COV_2_INFECTION,3.363026229,0,SKF-91488
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,3.008728186,0,SKF-91488
SARS_COV_1_INFECTION,3.875754557,0,SKF-91488
CELL_CYCLE_CHECKPOINTS,2.998524594,0,SKF-91488
SIGNALING_BY_INSULIN_RECEPTOR,2.861493545,0,BMS-387032
IRON_UPTAKE_AND_TRANSPORT,2.822755395,0,BMS-387032
CELL_CYCLE,-2.804932636,0,BMS-387032
CELL_CYCLE_MITOTIC,-2.708578618,0,BMS-387032
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.654447835,0,BMS-387032
CELLULAR_RESPONSE_TO_STARVATION,2.643517196,0.000325183,BMS-387032
CELL_CYCLE_CHECKPOINTS,-2.519464291,0.000296934,BMS-387032
HOMOLOGY_DIRECTED_REPAIR,-2.517077236,0.000222701,BMS-387032
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.5164373,0.00017816,BMS-387032
CHROMOSOME_MAINTENANCE,-2.472619635,0.000445401,BMS-387032
G_ALPHA_Q_SIGNALLING_EVENTS,-2.013294019,0.093850811,enprofylline
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.808597989,0.276726672,enprofylline
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.660467334,0.272501837,enprofylline
RAB_REGULATION_OF_TRAFFICKING,1.576132036,0.286584619,enprofylline
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.547414763,0.240815577,enprofylline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.819887473,0.341022254,enprofylline
ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,1.400122674,0.390374724,enprofylline
GPCR_LIGAND_BINDING,-1.77201606,0.35124363,enprofylline
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.710759813,0.426742426,enprofylline
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.272741556,0.574577517,enprofylline
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.744625778,0.001537242,ciclopirox
CELLULAR_RESPONSES_TO_STIMULI,2.685358254,0.001537242,ciclopirox
KEAP1_NFE2L2_PATHWAY,2.655397438,0.001537242,ciclopirox
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.469787728,0.003074483,ciclopirox
FOXO_MEDIATED_TRANSCRIPTION,2.443631536,0.002767035,ciclopirox
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.184575354,0.044112818,ciclopirox
SIGNALING_BY_NTRKS,2.214795676,0.018959312,ciclopirox
MYD88_INDEPENDENT_TLR4_CASCADE,2.044684509,0.048752516,ciclopirox
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.025843194,0.087886306,ciclopirox
RRNA_PROCESSING,-1.983004573,0.081665268,ciclopirox
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.401956751,0.005058374,doramapimod
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.239260021,0.063640333,doramapimod
SELENOAMINO_ACID_METABOLISM,2.143624811,0.038443645,doramapimod
NONSENSE_MEDIATED_DECAY_NMD,2.122089371,0.032710821,doramapimod
EUKARYOTIC_TRANSLATION_ELONGATION,2.096139146,0.03161484,doramapimod
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.094917428,0.025898877,doramapimod
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.099093657,0.075878858,doramapimod
SIGNALING_BY_NOTCH,-1.967900409,0.120100731,doramapimod
EUKARYOTIC_TRANSLATION_INITIATION,1.929293859,0.088858777,doramapimod
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.885372878,0.155184504,doramapimod
CELL_JUNCTION_ORGANIZATION,-2.150534722,0.822554633,emodin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.138299475,0.441879687,emodin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.043641056,0.437088407,emodin
GLUCOSE_METABOLISM,-1.967043596,0.422869123,emodin
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.804475026,1,emodin
DEVELOPMENTAL_CELL_LINEAGES,-1.935335171,0.374461737,emodin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.805264477,0.431678897,emodin
CELL_CELL_COMMUNICATION,-1.748300352,0.422339212,emodin
GPCR_LIGAND_BINDING,-1.650830966,0.468656762,emodin
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.649781529,0.417408094,emodin
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.471648712,0,marimastat
GPCR_LIGAND_BINDING,-2.29086138,0,marimastat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.268619063,0,marimastat
SIGNALING_BY_GPCR,-2.191214539,0.000772461,marimastat
G_ALPHA_S_SIGNALLING_EVENTS,-2.156910253,0.001158691,marimastat
SUMOYLATION,2.186301403,0.032183017,marimastat
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.155583106,0.025031235,marimastat
REGULATION_OF_TP53_ACTIVITY,2.090668724,0.032183017,marimastat
G_ALPHA_Q_SIGNALLING_EVENTS,-2.105009462,0.003707811,marimastat
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.094118752,0.00357263,marimastat
EUKARYOTIC_TRANSLATION_INITIATION,5.889517841,0,anagrelide
SARS_COV_1_HOST_INTERACTIONS,4.259021355,0,anagrelide
INFECTIOUS_DISEASE,4.155998787,0,anagrelide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,4.095246624,0,anagrelide
SARS_COV_1_INFECTION,4.037564564,0,anagrelide
SARS_COV_INFECTIONS,3.514932057,0,anagrelide
SARS_COV_2_HOST_INTERACTIONS,3.470458425,0,anagrelide
NERVOUS_SYSTEM_DEVELOPMENT,4.342986125,0,anagrelide
GPCR_LIGAND_BINDING,-3.344827103,0,anagrelide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.211307976,0,anagrelide
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.931002809,0,azathioprine
GPCR_LIGAND_BINDING,-2.516261837,0,azathioprine
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.544399561,0.002467559,azathioprine
SIGNALING_BY_GPCR,-2.35613085,0.001270272,azathioprine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.2611323,0.004022528,azathioprine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.243591301,0.02138551,azathioprine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.213071418,0.020357361,azathioprine
REGULATION_OF_TP53_ACTIVITY,2.199987283,0.0167794,azathioprine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.153672955,0.01111488,azathioprine
RNA_POLYMERASE_II_TRANSCRIPTION,2.100209841,0.026731888,azathioprine
TRANSLATION,3.007880771,0,fludarabine
RESPIRATORY_ELECTRON_TRANSPORT,2.993480168,0,fludarabine
EUKARYOTIC_TRANSLATION_INITIATION,2.803546252,0,fludarabine
HATS_ACETYLATE_HISTONES,-2.345442297,0.003813695,fludarabine
DNA_STRAND_ELONGATION,2.423490226,0.00310039,fludarabine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.39470883,0.002705795,fludarabine
CHROMATIN_ORGANIZATION,-2.226595508,0.009534237,fludarabine
METABOLISM_OF_NUCLEOTIDES,2.229840214,0.007516098,fludarabine
CELLULAR_RESPONSE_TO_STARVATION,2.158532562,0.010146732,fludarabine
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-2.112532116,0.022882169,fludarabine
GPCR_LIGAND_BINDING,2.086129864,0.165498071,1-benzylimidazole
GASTRULATION,2.072038631,0.092518019,1-benzylimidazole
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-2.040672435,0.330268794,1-benzylimidazole
DNA_REPLICATION,1.971212616,0.132168598,1-benzylimidazole
DNA_REPLICATION_PRE_INITIATION,1.961331502,0.105447556,1-benzylimidazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.017219992,0.193946909,1-benzylimidazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.892942074,0.153315574,1-benzylimidazole
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-1.891318167,0.290992037,1-benzylimidazole
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.86931559,0.253292083,1-benzylimidazole
TOLL_LIKE_RECEPTOR_CASCADES,-1.853311204,0.220523226,1-benzylimidazole
EUKARYOTIC_TRANSLATION_INITIATION,3.143017645,0,vardenafil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.988094462,0,vardenafil
EUKARYOTIC_TRANSLATION_ELONGATION,2.952533342,0,vardenafil
NONSENSE_MEDIATED_DECAY_NMD,2.917010208,0,vardenafil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.891741737,0,vardenafil
SIGNALING_BY_ROBO_RECEPTORS,2.865286773,0,vardenafil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.821613887,0,vardenafil
CELLULAR_RESPONSE_TO_STARVATION,2.781967751,0,vardenafil
METABOLISM_OF_RNA,2.774707921,0,vardenafil
TRANSLATION,2.637756154,0.000418634,vardenafil
EUKARYOTIC_TRANSLATION_ELONGATION,4.020055135,0,procainamide
CELLULAR_RESPONSES_TO_STIMULI,2.478483876,0,procainamide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.529991668,0,procainamide
SARS_COV_2_HOST_INTERACTIONS,2.541494003,0,procainamide
SARS_COV_1_INFECTION,2.632552549,0,procainamide
INFECTIOUS_DISEASE,2.660260288,0,procainamide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.794529895,0,procainamide
NERVOUS_SYSTEM_DEVELOPMENT,2.812660488,0,procainamide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.860207117,0,procainamide
VIRAL_INFECTION_PATHWAYS,2.868153019,0,procainamide
METABOLISM_OF_RNA,6.173212852,0,flumetasone
DNA_REPLICATION_PRE_INITIATION,2.949845021,0,flumetasone
CELL_CYCLE_CHECKPOINTS,2.882531024,0,flumetasone
SEPARATION_OF_SISTER_CHROMATIDS,2.87054311,0,flumetasone
MRNA_SPLICING,2.840247235,0,flumetasone
CELLULAR_RESPONSES_TO_STIMULI,2.827606479,0,flumetasone
ISG15_ANTIVIRAL_MECHANISM,2.786657042,0,flumetasone
SYNTHESIS_OF_DNA,2.723447221,0,flumetasone
MITOTIC_SPINDLE_CHECKPOINT,2.638511297,0,flumetasone
ORC1_REMOVAL_FROM_CHROMATIN,2.614007725,0,flumetasone
INFLUENZA_INFECTION,3.608921195,0,acalabrutinib
METABOLISM_OF_RNA,3.369327032,0,acalabrutinib
MRNA_SPLICING,2.904173657,0,acalabrutinib
CELLULAR_RESPONSE_TO_STARVATION,2.577814618,0.001957462,acalabrutinib
TRANSLATION,2.556971998,0.001565969,acalabrutinib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.521414211,0.001304974,acalabrutinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.494455558,0.00111855,acalabrutinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.483783532,0.000978731,acalabrutinib
SARS_COV_2_HOST_INTERACTIONS,2.024322205,0.01739966,acalabrutinib
MITOTIC_METAPHASE_AND_ANAPHASE,2.021816671,0.016442679,acalabrutinib
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.281496798,0.028214696,BRD-K30697463
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.083972949,0.079565443,BRD-K30697463
BIOLOGICAL_OXIDATIONS,2.078958037,0.055300804,BRD-K30697463
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.116459028,0.205240453,BRD-K30697463
GASTRULATION,2.032916847,0.058968715,BRD-K30697463
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.099265118,0.116774741,BRD-K30697463
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-1.972348946,0.175456997,BRD-K30697463
GPCR_LIGAND_BINDING,1.907637411,0.126627556,BRD-K30697463
DEVELOPMENTAL_CELL_LINEAGES,1.889183745,0.120006507,BRD-K30697463
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,1.79866684,0.18541086,BRD-K30697463
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,2.030246915,0.054209446,zardaverine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.904112369,0.055338809,zardaverine
GASTRULATION,-1.902329899,0.140253106,zardaverine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.668992749,0.131759069,zardaverine
MITOTIC_PROMETAPHASE,1.576273129,0.170533881,zardaverine
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.502294996,0.217289528,zardaverine
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-1.796516459,0.228956229,zardaverine
BIOLOGICAL_OXIDATIONS,1.474991536,0.205167693,zardaverine
CILIUM_ASSEMBLY,1.430589204,0.218773834,zardaverine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.756090856,0.232826348,zardaverine
NONSENSE_MEDIATED_DECAY_NMD,4.693407982,0,lomerizine
SARS_COV_1_HOST_INTERACTIONS,2.850297878,0,lomerizine
SARS_COV_1_INFECTION,2.981132654,0,lomerizine
VIRAL_INFECTION_PATHWAYS,3.078444018,0,lomerizine
TRANSLATION,3.517592769,0,lomerizine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.620444064,0,lomerizine
RRNA_PROCESSING,3.810051279,0,lomerizine
SIGNALING_BY_ROBO_RECEPTORS,3.866052748,0,lomerizine
METABOLISM_OF_RNA,3.041681067,0,lomerizine
CELLULAR_RESPONSE_TO_STARVATION,4.132168606,0,lomerizine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.0838625,0.21409899,nicergoline
SYNTHESIS_OF_DNA,-2.017132447,0.282835781,nicergoline
DNA_REPLICATION,-1.993948292,0.168789095,nicergoline
NONSENSE_MEDIATED_DECAY_NMD,1.93105153,0.324476449,nicergoline
PEROXISOMAL_PROTEIN_IMPORT,1.922505818,0.223713107,nicergoline
GPCR_LIGAND_BINDING,-1.923733728,0.185820067,nicergoline
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.917243743,0.143698824,nicergoline
S_PHASE,-1.872688144,0.15692824,nicergoline
GASTRULATION,-1.859711245,0.144459135,nicergoline
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.784381097,0.413776805,nicergoline
EUKARYOTIC_TRANSLATION_INITIATION,3.39209238,0,aloisine
TRANSLATION,2.955872134,0,aloisine
EUKARYOTIC_TRANSLATION_ELONGATION,2.921403902,0,aloisine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.851769396,0,aloisine
RRNA_PROCESSING,2.811636737,0,aloisine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.709556394,0,aloisine
METABOLISM_OF_RNA,2.641762162,0,aloisine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.594296846,0,aloisine
SELENOAMINO_ACID_METABOLISM,2.590574435,0,aloisine
CELLULAR_RESPONSE_TO_STARVATION,2.468521343,0.00037621,aloisine
EUKARYOTIC_TRANSLATION_INITIATION,3.435387565,0,coumarin
VIRAL_INFECTION_PATHWAYS,2.677166905,0,coumarin
METABOLISM_OF_RNA,2.715133121,0,coumarin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.737657647,0,coumarin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.792495578,0,coumarin
SARS_COV_1_HOST_INTERACTIONS,2.794786928,0,coumarin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.800855033,0,coumarin
SIGNALING_BY_ROBO_RECEPTORS,2.849999542,0,coumarin
NONSENSE_MEDIATED_DECAY_NMD,3.09861433,0,coumarin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.740807356,0,coumarin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.705786097,0,clonidine
CELLULAR_RESPONSES_TO_STIMULI,2.94584585,0,clonidine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.042702129,0,clonidine
SARS_COV_1_INFECTION,3.243873919,0,clonidine
SARS_COV_1_HOST_INTERACTIONS,3.46852407,0,clonidine
METABOLISM_OF_RNA,3.652910547,0,clonidine
SIGNALING_BY_ROBO_RECEPTORS,3.698834196,0,clonidine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.767903972,0,clonidine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,4.161420082,0,clonidine
VIRAL_INFECTION_PATHWAYS,3.012306344,0,clonidine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.442051156,0.000739533,rimexolone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.425480173,0.000369767,rimexolone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.381988097,0.000246511,rimexolone
SELENOAMINO_ACID_METABOLISM,-2.350143235,0.000184883,rimexolone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.340842325,0.000147907,rimexolone
GPCR_LIGAND_BINDING,-2.33619069,0.000123256,rimexolone
CELLULAR_RESPONSE_TO_STARVATION,-2.309751225,0.000105648,rimexolone
NONSENSE_MEDIATED_DECAY_NMD,-2.305053403,9.24E-05,rimexolone
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.468799579,0.011267606,rimexolone
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.441916304,0.007042254,rimexolone
SELENOAMINO_ACID_METABOLISM,2.584162682,0.007594669,duloxetine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.470967209,0.006509716,duloxetine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.370885327,0.00795632,duloxetine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.339261059,0.007323431,duloxetine
CELLULAR_RESPONSE_TO_STARVATION,2.315465176,0.006943697,duloxetine
PEROXISOMAL_PROTEIN_IMPORT,2.263076613,0.008679621,duloxetine
CHROMATIN_ORGANIZATION,-2.212676777,0.054110881,duloxetine
MITOTIC_PROMETAPHASE,-2.209699555,0.027521914,duloxetine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.162808151,0.013949392,duloxetine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.158464304,0.012883813,duloxetine
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.743171697,0,timolol
SIGNALING_BY_GPCR,2.45937081,0.004661623,timolol
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.426392298,0.006559594,timolol
GPCR_LIGAND_BINDING,2.312505984,0.010255571,timolol
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.352855006,0.009474969,timolol
TRANSLATION,2.118195565,0.041333061,timolol
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.976563099,0.089037007,timolol
G_ALPHA_Q_SIGNALLING_EVENTS,1.934186564,0.098267021,timolol
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.927522673,0.08577387,timolol
G_ALPHA_S_SIGNALLING_EVENTS,1.88979093,0.093365657,timolol
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.362703192,0.003520464,zonisamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.296582255,0.004107208,zonisamide
PROTEASOME_ASSEMBLY,-2.134745083,0.025425574,zonisamide
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,-2.133374075,0.01906918,zonisamide
CARDIAC_CONDUCTION,2.124276993,0.037984757,zonisamide
RAB_REGULATION_OF_TRAFFICKING,-2.083565921,0.026051434,zonisamide
SIGNALING_BY_INSULIN_RECEPTOR,-2.064164154,0.026599062,zonisamide
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-2.051170287,0.026822583,zonisamide
INFLUENZA_INFECTION,-2.007765458,0.034177839,zonisamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.988799427,0.036247741,zonisamide
CELLULAR_RESPONSE_TO_STARVATION,2.88264112,0,amonafide
EUKARYOTIC_TRANSLATION_INITIATION,2.517785945,0,amonafide
NONSENSE_MEDIATED_DECAY_NMD,2.379950503,0.002790919,amonafide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.25432464,0.004884109,amonafide
INFLUENZA_INFECTION,2.182867797,0.005442293,amonafide
TRANSLATION,2.139282697,0.006512145,amonafide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.07994497,0.00946919,amonafide
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.084628851,0.170162729,amonafide
SIGNALING_BY_ROBO_RECEPTORS,1.942686221,0.024682193,amonafide
NEUTROPHIL_DEGRANULATION,1.809831771,0.050624175,amonafide
MUSCLE_CONTRACTION,2.601449596,0.000807946,bosentan
PLATELET_HOMEOSTASIS,2.402646741,0.002019866,bosentan
CARDIAC_CONDUCTION,2.32914104,0.004039732,bosentan
NEURONAL_SYSTEM,2.289733076,0.005857611,bosentan
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.127133632,0.023430445,bosentan
CELL_CYCLE,-2.066423035,0.308312599,bosentan
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.024148735,0.22254564,bosentan
CELL_CYCLE_MITOTIC,-2.022587825,0.150232321,bosentan
M_PHASE,-1.964117861,0.172655056,bosentan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.864695759,0.271763542,bosentan
TRANSLATION,4.360418168,0,dipyridamole
RESPIRATORY_ELECTRON_TRANSPORT,3.04202975,0,dipyridamole
METABOLISM_OF_RNA,3.287658089,0,dipyridamole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.462196006,0,dipyridamole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.515248119,0,dipyridamole
INFLUENZA_INFECTION,3.612750297,0,dipyridamole
RRNA_PROCESSING,3.844296837,0,dipyridamole
NONSENSE_MEDIATED_DECAY_NMD,3.765604978,0,dipyridamole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.984134513,0,dipyridamole
EUKARYOTIC_TRANSLATION_INITIATION,4.06661233,0,dipyridamole
DNA_REPLICATION_PRE_INITIATION,-2.886408412,0,quizartinib
DNA_REPLICATION,-2.740720933,0.001053285,quizartinib
SYNTHESIS_OF_DNA,-2.740720933,0.001053285,quizartinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.716208297,0.000752967,quizartinib
SELENOAMINO_ACID_METABOLISM,2.710735015,0.000376483,quizartinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.694828951,0.000250989,quizartinib
NONSENSE_MEDIATED_DECAY_NMD,2.677551596,0.000188242,quizartinib
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.65716551,0.001184945,quizartinib
CELL_CYCLE_CHECKPOINTS,-2.638248345,0.000947956,quizartinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.510951411,0.000301187,quizartinib
EUKARYOTIC_TRANSLATION_INITIATION,3.606468843,0,olomoucine
TRANSLATION,3.581655375,0,olomoucine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.21674321,0,olomoucine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.195674436,0,olomoucine
EUKARYOTIC_TRANSLATION_ELONGATION,3.185005946,0,olomoucine
NONSENSE_MEDIATED_DECAY_NMD,3.071488828,0,olomoucine
SELENOAMINO_ACID_METABOLISM,3.048392278,0,olomoucine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.874746121,0,olomoucine
RRNA_PROCESSING,2.773352247,0,olomoucine
METABOLISM_OF_RNA,2.692886689,0.000176348,olomoucine
CELL_CYCLE,-2.499893615,0.009157454,levonorgestrel
CELL_CYCLE_MITOTIC,-2.415478253,0.005886935,levonorgestrel
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,-2.388620967,0.004796761,levonorgestrel
MUSCLE_CONTRACTION,2.318716123,0.010929278,levonorgestrel
M_PHASE,-2.340407936,0.005886935,levonorgestrel
MITOTIC_PROMETAPHASE,-2.327069063,0.005494472,levonorgestrel
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.291611227,0.008196958,levonorgestrel
DNA_REPAIR,-2.261148188,0.009811558,levonorgestrel
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.213366822,0.01289519,levonorgestrel
POTASSIUM_CHANNELS,2.158410646,0.016393917,levonorgestrel
METABOLISM_OF_RNA,4.410342636,0,BRD-K76674262
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.56029491,0,BRD-K76674262
NONSENSE_MEDIATED_DECAY_NMD,3.539982243,0,BRD-K76674262
MRNA_SPLICING,3.216414314,0,BRD-K76674262
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.165769144,0,BRD-K76674262
RRNA_PROCESSING,3.102317159,0,BRD-K76674262
CELLULAR_RESPONSE_TO_STARVATION,2.960827359,0,BRD-K76674262
HIV_INFECTION,2.887823657,0,BRD-K76674262
HIV_LIFE_CYCLE,2.708908044,0.00035189,BRD-K76674262
INFLUENZA_INFECTION,2.733587862,0.000378958,BRD-K76674262
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-3.261230394,0,bezafibrate
SARS_COV_1_INFECTION,2.401798378,0,bezafibrate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.498800557,0,bezafibrate
SARS_COV_1_HOST_INTERACTIONS,2.544344511,0,bezafibrate
TRANSLATION,2.586889827,0,bezafibrate
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.619755126,0,bezafibrate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.64178766,0,bezafibrate
INFLUENZA_INFECTION,2.865054524,0,bezafibrate
SELENOAMINO_ACID_METABOLISM,2.950469343,0,bezafibrate
CELLULAR_RESPONSE_TO_STARVATION,2.805772244,0,bezafibrate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.263923481,0.036395656,felbamate
MRNA_SPLICING,2.069286482,0.040945113,felbamate
GPCR_LIGAND_BINDING,-1.892713257,0.228406621,felbamate
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.531156655,0.475165509,felbamate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.766317754,0.405064867,felbamate
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.404112682,0.633132766,felbamate
HOST_INTERACTIONS_OF_HIV_FACTORS,1.387473107,0.54593484,felbamate
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.382498582,0.459495157,felbamate
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.331844504,0.50044027,felbamate
G_ALPHA_Q_SIGNALLING_EVENTS,-1.72004492,0.401198609,felbamate
GPCR_LIGAND_BINDING,2.440224408,0.006370052,pizotifen
MEIOSIS,-2.272934007,0.035067886,pizotifen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.196615978,0.049367899,pizotifen
SIGNALING_BY_GPCR,2.096729729,0.070424459,pizotifen
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.124055087,0.06180715,pizotifen
REPRODUCTION,-2.100306528,0.046757182,pizotifen
RHO_GTPASE_CYCLE,-2.069103875,0.044492381,pizotifen
RAC3_GTPASE_CYCLE,-1.93213431,0.089773789,pizotifen
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.846059155,0.124637113,pizotifen
BIOLOGICAL_OXIDATIONS,1.833048781,0.372648014,pizotifen
EUKARYOTIC_TRANSLATION_ELONGATION,-2.483488396,0,fluphenazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.477341368,0,fluphenazine
NONSENSE_MEDIATED_DECAY_NMD,-2.445782002,0,fluphenazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.415904272,0.00022479,fluphenazine
EUKARYOTIC_TRANSLATION_INITIATION,-2.350079536,0.000179832,fluphenazine
SELENOAMINO_ACID_METABOLISM,-2.340039696,0.00029972,fluphenazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.339970611,0.000256902,fluphenazine
SIGNALING_BY_ROBO_RECEPTORS,-2.324437294,0.00022479,fluphenazine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.213440353,0.001498598,fluphenazine
CELLULAR_RESPONSE_TO_STARVATION,-2.197941087,0.001708401,fluphenazine
GPCR_LIGAND_BINDING,-3.155838946,0,oxymetazoline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.96875429,0,oxymetazoline
SIGNALING_BY_GPCR,-2.910884921,0,oxymetazoline
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.703463248,0,oxymetazoline
G_ALPHA_Q_SIGNALLING_EVENTS,-2.645601125,0,oxymetazoline
G_ALPHA_I_SIGNALLING_EVENTS,-2.520999961,0,oxymetazoline
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.837297894,0.001986395,oxymetazoline
EUKARYOTIC_TRANSLATION_ELONGATION,-2.377539576,0.000109925,oxymetazoline
EUKARYOTIC_TRANSLATION_INITIATION,-2.280513236,0.000192369,oxymetazoline
CHROMATIN_ORGANIZATION,2.597954231,0.002979592,oxymetazoline
CILIUM_ASSEMBLY,-2.134972818,0.100748809,flucytosine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.043955356,0.095477069,flucytosine
GPCR_LIGAND_BINDING,2.052831474,0.169946345,flucytosine
NEUTROPHIL_DEGRANULATION,-1.991473664,0.091767326,flucytosine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.9000895,0.122128643,flucytosine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.946623119,0.229519928,flucytosine
ESR_MEDIATED_SIGNALING,-1.872929934,0.11574398,flucytosine
SENSORY_PERCEPTION,1.921203436,0.182569172,flucytosine
SUMOYLATION,-1.789617508,0.155809204,flucytosine
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.648586028,0.300572858,flucytosine
TRANSLATION,2.309250194,0.015858368,BRD-K82216340
RESPIRATORY_ELECTRON_TRANSPORT,2.02020778,0.042123791,BRD-K82216340
SIGNALING_BY_ALK_IN_CANCER,-2.038992588,0.136186626,BRD-K82216340
EXTRACELLULAR_MATRIX_ORGANIZATION,1.912816247,0.050878932,BRD-K82216340
RRNA_PROCESSING,1.9060648,0.039893708,BRD-K82216340
HATS_ACETYLATE_HISTONES,-1.996345694,0.116659867,BRD-K82216340
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.832354139,0.05035032,BRD-K82216340
LEISHMANIA_INFECTION,-1.856193098,0.301413048,BRD-K82216340
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,1.609693513,0.141568976,BRD-K82216340
CHROMATIN_ORGANIZATION,-1.831476472,0.279382858,BRD-K82216340
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.92209699,0,purvalanol-a
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,2.864532502,0,purvalanol-a
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.833626442,0,purvalanol-a
ASPARAGINE_N_LINKED_GLYCOSYLATION,2.715889548,0.000520209,purvalanol-a
EXTRACELLULAR_MATRIX_ORGANIZATION,2.713072584,0.000416167,purvalanol-a
COLLAGEN_FORMATION,2.542682386,0.002080837,purvalanol-a
CELLULAR_RESPONSE_TO_STARVATION,2.134697396,0.015457649,purvalanol-a
MHC_CLASS_II_ANTIGEN_PRESENTATION,-2.089732839,0.05732188,purvalanol-a
DISEASES_OF_METABOLISM,1.912234278,0.04785926,purvalanol-a
MITOTIC_PROMETAPHASE,-1.986933472,0.093762217,purvalanol-a
MUSCLE_CONTRACTION,2.14393189,0.068035944,BRD-K97440753
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.072284416,0.180390245,BRD-K97440753
BIOLOGICAL_OXIDATIONS,1.703201735,0.506977515,BRD-K97440753
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.688482731,0.363955719,BRD-K97440753
SIGNALING_BY_WNT,1.63570889,0.371179966,BRD-K97440753
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.839161666,0.726436392,BRD-K97440753
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.827147563,0.531744938,BRD-K97440753
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.570063175,0.412385606,BRD-K97440753
GPCR_LIGAND_BINDING,-1.789174109,0.53117614,BRD-K97440753
G2_M_CHECKPOINTS,1.474126813,0.56330835,BRD-K97440753
METABOLISM_OF_RNA,2.996363012,0,eprosartan
RESPIRATORY_ELECTRON_TRANSPORT,2.996197437,0,eprosartan
RRNA_PROCESSING,2.75745644,0,eprosartan
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,2.708832936,0,eprosartan
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.51972758,0.000927614,eprosartan
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.496051217,0.000773012,eprosartan
MRNA_SPLICING,2.369074909,0.002650327,eprosartan
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.165936975,0.074189963,eprosartan
TRANSLATION,2.037277402,0.030533973,eprosartan
MITOCHONDRIAL_PROTEIN_IMPORT,2.000978224,0.035902112,eprosartan
MRNA_SPLICING,2.26485703,0.011063059,nefazodone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.064321471,0.019913507,nefazodone
GPCR_LIGAND_BINDING,-1.948717825,0.11885758,nefazodone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.885090944,0.122133183,nefazodone
ESR_MEDIATED_SIGNALING,-1.868660175,0.095148457,nefazodone
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-1.860306875,0.077210633,nefazodone
METABOLISM_OF_RNA,1.523177411,0.320091186,nefazodone
CLATHRIN_MEDIATED_ENDOCYTOSIS,1.487623186,0.289852157,nefazodone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.795544699,0.120354999,nefazodone
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-1.784074208,0.113710205,nefazodone
EUKARYOTIC_TRANSLATION_ELONGATION,7.67055143,0,spironolactone
SARS_COV_2_HOST_INTERACTIONS,3.960151456,0,spironolactone
NERVOUS_SYSTEM_DEVELOPMENT,3.595712553,0,spironolactone
CELL_CYCLE_MITOTIC,3.418807051,0,spironolactone
S_PHASE,3.236245547,0,spironolactone
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,3.102985052,0,spironolactone
MITOTIC_METAPHASE_AND_ANAPHASE,3.033943256,0,spironolactone
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,2.954561793,0,spironolactone
DNA_REPLICATION,2.94145095,0,spironolactone
CELL_CYCLE_CHECKPOINTS,2.922306421,0,spironolactone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.345222422,0.014099585,mesoridazine
NEUTROPHIL_DEGRANULATION,-2.179216618,0.026084232,mesoridazine
INNATE_IMMUNE_SYSTEM,-2.152394252,0.021854357,mesoridazine
EUKARYOTIC_TRANSLATION_INITIATION,2.088807738,0.19748868,mesoridazine
TRANSLATION,2.043909815,0.144711533,mesoridazine
RRNA_PROCESSING,2.042547436,0.097987678,mesoridazine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.925493669,0.053813415,mesoridazine
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-1.927000018,0.080367634,mesoridazine
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.926847292,0.064294107,mesoridazine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.895817996,0.056599762,mesoridazine
METABOLISM_OF_RNA,3.742586726,0,edrophonium
RRNA_PROCESSING,3.282689597,0,edrophonium
TRANSLATION,3.120519972,0,edrophonium
INFLUENZA_INFECTION,3.027895404,0,edrophonium
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.87316095,0.00049418,edrophonium
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.867082059,0.000411816,edrophonium
EUKARYOTIC_TRANSLATION_INITIATION,2.852662679,0.000352985,edrophonium
EUKARYOTIC_TRANSLATION_ELONGATION,2.792546137,0.000308862,edrophonium
RESPIRATORY_ELECTRON_TRANSPORT,2.695814852,0.000274544,edrophonium
NONSENSE_MEDIATED_DECAY_NMD,2.671745199,0.00049418,edrophonium
NEUTROPHIL_DEGRANULATION,-2.140980805,0.168143239,valsartan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.084604005,0.093866033,valsartan
INNATE_IMMUNE_SYSTEM,-2.060093211,0.187887332,valsartan
SELENOAMINO_ACID_METABOLISM,1.977338457,0.106638943,valsartan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.960086426,0.082380316,valsartan
EUKARYOTIC_TRANSLATION_ELONGATION,1.917316597,0.08153869,valsartan
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.970148372,0.255611692,valsartan
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.90490426,0.310491777,valsartan
APOPTOSIS,-1.87874333,0.291703044,valsartan
TOLL_LIKE_RECEPTOR_CASCADES,-1.860858052,0.275143483,valsartan
GPCR_LIGAND_BINDING,-3.539007059,0,ibudilast
EUKARYOTIC_TRANSLATION_ELONGATION,-2.559674259,0,ibudilast
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2.622159323,0,ibudilast
G2_M_DNA_DAMAGE_CHECKPOINT,2.669674969,0,ibudilast
DNA_DOUBLE_STRAND_BREAK_REPAIR,2.671714488,0,ibudilast
G_ALPHA_I_SIGNALLING_EVENTS,-2.709267427,0,ibudilast
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.75899128,0,ibudilast
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.689099667,0,ibudilast
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,2.860719475,0,ibudilast
G_ALPHA_Q_SIGNALLING_EVENTS,-2.87287272,0,ibudilast
MRNA_SPLICING,2.054701534,0.133004361,sulpiride
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.02574754,0.035863894,sulpiride
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.856180723,0.234507689,sulpiride
EUKARYOTIC_TRANSLATION_ELONGATION,-1.974494141,0.029626695,sulpiride
G_ALPHA_Q_SIGNALLING_EVENTS,-1.966371124,0.021830196,sulpiride
SELENOAMINO_ACID_METABOLISM,-1.93421185,0.023389496,sulpiride
NONSENSE_MEDIATED_DECAY_NMD,-1.929034839,0.019959037,sulpiride
EUKARYOTIC_TRANSLATION_INITIATION,-1.924195046,0.018061889,sulpiride
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.913351713,0.017820569,sulpiride
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.898238987,0.018419228,sulpiride
EUKARYOTIC_TRANSLATION_ELONGATION,-2.867607898,0,fluoxetine
SARS_COV_1_INFECTION,-2.401353725,0,fluoxetine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.416990919,0,fluoxetine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.482242295,0,fluoxetine
SIGNALING_BY_ROBO_RECEPTORS,-2.532570527,0,fluoxetine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.551385649,0,fluoxetine
RRNA_PROCESSING,-2.585939778,0,fluoxetine
INFLUENZA_INFECTION,-2.592948129,0,fluoxetine
SARS_COV_1_HOST_INTERACTIONS,-2.380994733,0,fluoxetine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.631311999,0,fluoxetine
INNATE_IMMUNE_SYSTEM,-2.487458207,0.010074901,felodipine
NEUTROPHIL_DEGRANULATION,-2.192424097,0.063327948,felodipine
TOLL_LIKE_RECEPTOR_CASCADES,-2.078106549,0.103627552,felodipine
PROGRAMMED_CELL_DEATH,-2.043528024,0.107585549,felodipine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.011719379,0.109960347,felodipine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,-1.989103427,0.109144759,felodipine
SIGNALING_BY_INTERLEUKINS,-1.974705217,0.103216331,felodipine
HEMOSTASIS,-1.905747243,0.136191071,felodipine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.870650273,0.153522299,felodipine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.853618446,0.154721692,felodipine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.417543134,0.002785974,trapidil
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.314983845,0.00464329,trapidil
SIGNALING_BY_NTRKS,2.157717357,0.074321105,trapidil
PEROXISOMAL_PROTEIN_IMPORT,2.119736426,0.049934493,trapidil
GASTRULATION,-2.001065704,0.09410401,trapidil
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.968049911,0.090079825,trapidil
NEURONAL_SYSTEM,1.926605048,0.141674607,trapidil
INFLUENZA_INFECTION,1.901893538,0.124545915,trapidil
SIGNALING_BY_ALK_IN_CANCER,1.862631348,0.126345879,trapidil
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.797856761,0.15754526,trapidil
MRNA_SPLICING,2.09159148,0.04418146,eugenol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.685148216,0.196055227,eugenol
METABOLISM_OF_RNA,1.582968895,0.238395792,eugenol
G_ALPHA_Q_SIGNALLING_EVENTS,-1.850902347,0.232072966,eugenol
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.484633531,0.280966469,eugenol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.796006677,0.222863721,eugenol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.762692487,0.202910357,eugenol
SENSORY_PERCEPTION,-1.753078505,0.167838484,eugenol
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.293035039,0.564970414,eugenol
GPCR_LIGAND_BINDING,-1.720807029,0.185474188,eugenol
INFLUENZA_INFECTION,7.989050825,0,hyoscyamine
CELL_CYCLE_MITOTIC,3.349657575,0,hyoscyamine
MITOTIC_METAPHASE_AND_ANAPHASE,3.183692729,0,hyoscyamine
DNA_REPLICATION_PRE_INITIATION,3.173418936,0,hyoscyamine
DNA_REPLICATION,3.138876806,0,hyoscyamine
SARS_COV_INFECTIONS,3.120987948,0,hyoscyamine
SYNTHESIS_OF_DNA,3.1117675,0,hyoscyamine
CELL_CYCLE,3.089212184,0,hyoscyamine
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,3.051915994,0,hyoscyamine
S_PHASE,3.0279812,0,hyoscyamine
NONSENSE_MEDIATED_DECAY_NMD,3.262577033,0,nalbuphine
EUKARYOTIC_TRANSLATION_ELONGATION,3.254946637,0,nalbuphine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.252798328,0,nalbuphine
EUKARYOTIC_TRANSLATION_INITIATION,3.171912355,0,nalbuphine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.001764392,0,nalbuphine
SELENOAMINO_ACID_METABOLISM,2.973742847,0,nalbuphine
TRANSLATION,2.940963447,0,nalbuphine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.924590523,0,nalbuphine
CELLULAR_RESPONSE_TO_STARVATION,2.816810638,0,nalbuphine
SIGNALING_BY_ROBO_RECEPTORS,2.553183888,0.000471237,nalbuphine
DNA_STRAND_ELONGATION,-3.282185396,0,BRD-K47869605
SYNTHESIS_OF_DNA,-3.131753087,0,BRD-K47869605
DNA_REPLICATION,-2.847828618,0.00025011,BRD-K47869605
S_PHASE,-2.79442475,0.000187582,BRD-K47869605
RESOLUTION_OF_ABASIC_SITES_AP_SITES,-2.681217428,0.000150066,BRD-K47869605
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.668992346,0.000125055,BRD-K47869605
TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS,-2.662866009,0.00010719,BRD-K47869605
BASE_EXCISION_REPAIR,-2.658567642,9.38E-05,BRD-K47869605
DNA_REPAIR,-2.647472906,0.00016674,BRD-K47869605
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.589174266,0.002541934,BRD-K47869605
GPCR_LIGAND_BINDING,-2.236646079,0.01154932,celecoxib
SIGNALING_BY_GPCR,-2.086783445,0.032723073,celecoxib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.069094996,0.026306784,celecoxib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.97864087,0.053656215,celecoxib
G_ALPHA_I_SIGNALLING_EVENTS,-1.968075545,0.047929677,celecoxib
G_ALPHA_Q_SIGNALLING_EVENTS,-1.9259521,0.061275558,celecoxib
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.829506119,0.12498014,celecoxib
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,-1.823262307,0.114771366,celecoxib
SIGNALING_BY_WNT,-1.788819585,0.138805715,celecoxib
PI3K_AKT_SIGNALING_IN_CANCER,-1.773184709,0.140997947,celecoxib
EUKARYOTIC_TRANSLATION_ELONGATION,5.333148799,0,ubenimex
GPCR_LIGAND_BINDING,-2.677535403,0,ubenimex
SARS_COV_2_HOST_INTERACTIONS,2.83211322,0,ubenimex
NERVOUS_SYSTEM_DEVELOPMENT,3.079660079,0,ubenimex
SARS_COV_2_INFECTION,3.1426599,0,ubenimex
SARS_COV_INFECTIONS,3.226161851,0,ubenimex
INFECTIOUS_DISEASE,3.554076833,0,ubenimex
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.645209436,0,ubenimex
VIRAL_INFECTION_PATHWAYS,3.69593513,0,ubenimex
METABOLISM_OF_RNA,3.862225086,0,ubenimex
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.666608178,0,primidone
TOLL_LIKE_RECEPTOR_CASCADES,2.602339028,0,primidone
MYD88_INDEPENDENT_TLR4_CASCADE,2.519105456,0.000989893,primidone
CELL_CYCLE_MITOTIC,2.382260712,0.002969678,primidone
SENSORY_PERCEPTION,-2.298878423,0.003512231,primidone
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.34151248,0.003563614,primidone
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.33445624,0.002969678,primidone
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.249160903,0.005090877,primidone
REGULATION_OF_TP53_ACTIVITY,2.229469668,0.004825727,primidone
GPCR_LIGAND_BINDING,-2.17902407,0.006673239,primidone
GLYCOSAMINOGLYCAN_METABOLISM,2.430807933,0.006312882,pimozide
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.21698031,0.012625764,pimozide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.110166804,0.022909165,pimozide
GPCR_LIGAND_BINDING,-2.108944274,0.011454583,pimozide
METABOLISM_OF_STEROIDS,2.060651552,0.023848666,pimozide
SIGNALING_BY_GPCR,-2.06259204,0.012523677,pimozide
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.916091148,0.039981587,pimozide
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.862362596,0.043769317,pimozide
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.852627817,0.038578725,pimozide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.885650005,0.07903662,pimozide
CHOLESTEROL_BIOSYNTHESIS,2.337777869,0.010558441,perphenazine
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-2.015950238,0.31431279,perphenazine
RHO_GTPASE_CYCLE,-1.972093763,0.227065824,perphenazine
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-1.957088728,0.17039258,perphenazine
CILIUM_ASSEMBLY,-1.891788828,0.203296618,perphenazine
HATS_ACETYLATE_HISTONES,-1.849072669,0.221025649,perphenazine
RAC3_GTPASE_CYCLE,-1.798780341,0.266587954,perphenazine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.745481407,0.599800645,perphenazine
G2_M_DNA_DAMAGE_CHECKPOINT,-1.757703555,0.300091215,perphenazine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.755412137,0.266215104,perphenazine
TRANSLATION,3.072250371,0,beclomethasone-dipropionate
RESPIRATORY_ELECTRON_TRANSPORT,2.652720891,0.000585919,beclomethasone-dipropionate
RRNA_PROCESSING,2.600085371,0.001171837,beclomethasone-dipropionate
DISEASES_OF_METABOLISM,2.071924659,0.036912881,beclomethasone-dipropionate
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.919513253,0.076872539,beclomethasone-dipropionate
MITOCHONDRIAL_TRANSLATION,1.845292664,0.097067205,beclomethasone-dipropionate
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.83006507,0.089561865,beclomethasone-dipropionate
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-1.802896189,1,beclomethasone-dipropionate
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-1.794058095,0.61788301,beclomethasone-dipropionate
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.752498622,0.577695497,beclomethasone-dipropionate
EUKARYOTIC_TRANSLATION_ELONGATION,3.841453296,0,BRD-K25836724
METABOLISM_OF_RNA,2.883991779,0,BRD-K25836724
SARS_COV_1_INFECTION,2.925911807,0,BRD-K25836724
SARS_COV_1_HOST_INTERACTIONS,3.022193966,0,BRD-K25836724
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.171764952,0,BRD-K25836724
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.280784261,0,BRD-K25836724
TRANSLATION,3.359914234,0,BRD-K25836724
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.390048597,0,BRD-K25836724
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.398952234,0,BRD-K25836724
SIGNALING_BY_ROBO_RECEPTORS,3.258175963,0,BRD-K25836724
EUKARYOTIC_TRANSLATION_ELONGATION,-3.021603898,0,dopamine
NERVOUS_SYSTEM_DEVELOPMENT,-2.255689341,0,dopamine
SARS_COV_2_INFECTION,-2.329734265,0,dopamine
SARS_COV_2_HOST_INTERACTIONS,-2.509688248,0,dopamine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.528839741,0,dopamine
SIGNALING_BY_ROBO_RECEPTORS,-2.585715555,0,dopamine
SARS_COV_1_INFECTION,-2.666193451,0,dopamine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.671435294,0,dopamine
SARS_COV_1_HOST_INTERACTIONS,-2.705526688,0,dopamine
CELLULAR_RESPONSE_TO_STARVATION,-2.725118519,0,dopamine
TRANSLATION,4.079221848,0,phenoxybenzamine
RRNA_PROCESSING,3.13185404,0,phenoxybenzamine
RESPIRATORY_ELECTRON_TRANSPORT,2.221616186,0.011998331,phenoxybenzamine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.026410566,0.034195242,phenoxybenzamine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.816224673,0.127662238,phenoxybenzamine
INFLUENZA_INFECTION,1.772269513,0.143580024,phenoxybenzamine
DNA_REPLICATION,1.680499643,0.207056906,phenoxybenzamine
S_PHASE,1.568404556,0.322755095,phenoxybenzamine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1.515219866,0.375414435,phenoxybenzamine
CILIUM_ASSEMBLY,-1.750580404,1,phenoxybenzamine
TRANSLATION,3.850185429,0,BRD-K66766661
DISEASES_OF_METABOLISM,2.691625875,0.000378589,BRD-K66766661
RESPIRATORY_ELECTRON_TRANSPORT,2.374153178,0.003281107,BRD-K66766661
RRNA_PROCESSING,2.28689133,0.003785893,BRD-K66766661
CILIUM_ASSEMBLY,-2.133828175,0.078423536,BRD-K66766661
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.004620865,0.019686645,BRD-K66766661
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-1.835940831,0.535371342,BRD-K66766661
UB_SPECIFIC_PROCESSING_PROTEASES,-1.834363387,0.361445365,BRD-K66766661
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.827652754,0.284416025,BRD-K66766661
EXTRACELLULAR_MATRIX_ORGANIZATION,1.600232838,0.14424253,BRD-K66766661
EUKARYOTIC_TRANSLATION_INITIATION,2.716799955,0,clemastine
RRNA_PROCESSING,2.586329875,0,clemastine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.568020098,0,clemastine
SELENOAMINO_ACID_METABOLISM,2.561694745,0,clemastine
EUKARYOTIC_TRANSLATION_ELONGATION,2.534391242,0,clemastine
CELLULAR_RESPONSE_TO_STARVATION,2.496942579,0.000190867,clemastine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.433144018,0.000163601,clemastine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.279450286,0.00286301,clemastine
TRANSLATION,2.262737245,0.003181122,clemastine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.278446906,0.03072835,clemastine
EUKARYOTIC_TRANSLATION_INITIATION,4.2966946,0,mestranol
SARS_COV_1_HOST_INTERACTIONS,2.912631636,0,mestranol
METABOLISM_OF_RNA,3.067917875,0,mestranol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.316450167,0,mestranol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.325491157,0,mestranol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.357055804,0,mestranol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.482709087,0,mestranol
SIGNALING_BY_ROBO_RECEPTORS,3.615019462,0,mestranol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.738247643,0,mestranol
INFLUENZA_INFECTION,3.814743028,0,mestranol
EUKARYOTIC_TRANSLATION_INITIATION,3.381502322,0,PLX-4720
EUKARYOTIC_TRANSLATION_ELONGATION,3.108145102,0,PLX-4720
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.068717537,0,PLX-4720
CELLULAR_RESPONSE_TO_STARVATION,2.994622645,0,PLX-4720
INFLUENZA_INFECTION,2.84098255,0,PLX-4720
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.835947831,0,PLX-4720
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.825985354,0,PLX-4720
TRANSLATION,2.678585248,0,PLX-4720
RRNA_PROCESSING,2.619923747,0,PLX-4720
NONSENSE_MEDIATED_DECAY_NMD,2.59482035,0,PLX-4720
NEUTROPHIL_DEGRANULATION,-2.285917417,0.019010901,phenazopyridine
EUKARYOTIC_TRANSLATION_ELONGATION,1.903121236,0.848866334,phenazopyridine
RAC3_GTPASE_CYCLE,-1.729934018,0.351701675,phenazopyridine
EUKARYOTIC_TRANSLATION_INITIATION,1.864688711,0.575823341,phenazopyridine
SELENOAMINO_ACID_METABOLISM,1.758020614,0.848866334,phenazopyridine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.749267813,0.684499859,phenazopyridine
SIGNALING_BY_NTRKS,-1.551315361,0.626872286,phenazopyridine
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,1.745243182,0.565550437,phenazopyridine
NONSENSE_MEDIATED_DECAY_NMD,1.728615537,0.5318481,phenazopyridine
INNATE_IMMUNE_SYSTEM,-1.414917842,0.922028716,phenazopyridine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.214173335,0,cyproheptadine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.568371967,0,cyproheptadine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.574801578,0,cyproheptadine
METABOLISM_OF_RNA,-2.669041581,0,cyproheptadine
SARS_COV_1_INFECTION,-2.676328203,0,cyproheptadine
INFLUENZA_INFECTION,-2.739450975,0,cyproheptadine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.826412607,0,cyproheptadine
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.858735764,0,cyproheptadine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.865265742,0,cyproheptadine
SARS_COV_1_HOST_INTERACTIONS,-2.868281526,0,cyproheptadine
TRANSLATION,3.079223291,0,selegiline
EUKARYOTIC_TRANSLATION_INITIATION,2.590858468,0,selegiline
RESPIRATORY_ELECTRON_TRANSPORT,2.333802351,0.009436564,selegiline
RRNA_PROCESSING,2.2814127,0.008923707,selegiline
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.218815168,0.016247301,selegiline
SYNTHESIS_OF_DNA,2.085991567,0.033027973,selegiline
DNA_REPLICATION,2.032691845,0.040442416,selegiline
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1.998364952,0.045541678,selegiline
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.971981124,0.39031246,selegiline
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.913901428,0.07699689,selegiline
EUKARYOTIC_TRANSLATION_ELONGATION,2.866572922,0,floxuridine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.748429461,0,floxuridine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.736482983,0,floxuridine
DNA_REPLICATION,2.715308488,0.000338107,floxuridine
S_PHASE,2.665270244,0.000270486,floxuridine
SYNTHESIS_OF_DNA,2.634951737,0.000225405,floxuridine
DNA_STRAND_ELONGATION,2.603507858,0.000193204,floxuridine
RESPIRATORY_ELECTRON_TRANSPORT,2.598521086,0.000169054,floxuridine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.489904721,0.000767646,floxuridine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.453460922,0.000383823,floxuridine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.842185273,0,propafenone
SARS_COV_2_HOST_INTERACTIONS,-2.449983437,0,propafenone
CELLULAR_RESPONSES_TO_STIMULI,-2.594618477,0,propafenone
VIRAL_INFECTION_PATHWAYS,-2.679238931,0,propafenone
METABOLISM_OF_RNA,-2.82272238,0,propafenone
NERVOUS_SYSTEM_DEVELOPMENT,-3.145140143,0,propafenone
SARS_COV_1_INFECTION,-3.154336262,0,propafenone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.293156403,0,propafenone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.319147159,0,propafenone
SARS_COV_1_HOST_INTERACTIONS,-3.32279949,0,propafenone
GPCR_LIGAND_BINDING,2.951069677,0.001059196,desipramine
COLLAGEN_DEGRADATION,2.777974008,0.001588794,desipramine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.701645186,0.001059196,desipramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.66722284,0.000794397,desipramine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.657388226,0.000635518,desipramine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.641861538,0.000529598,desipramine
SIGNALING_BY_GPCR,2.475213267,0.002269706,desipramine
COLLAGEN_FORMATION,2.445661253,0.00264799,desipramine
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.437368765,0.002471457,desipramine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.360350661,0.004342703,desipramine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.287286993,0.072752974,diosmin
MUSCLE_CONTRACTION,2.301616287,0.018558244,diosmin
GASTRULATION,-2.204209058,0.068989889,diosmin
NEURONAL_SYSTEM,2.216442326,0.02271785,diosmin
SIGNALING_BY_NTRKS,2.192058095,0.017704991,diosmin
PLATELET_HOMEOSTASIS,2.093398102,0.028477305,diosmin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.068511002,0.136307295,diosmin
S_PHASE,-2.003790232,0.156168021,diosmin
NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,-1.99208748,0.133714948,diosmin
CELL_CYCLE_MITOTIC,-1.98915564,0.114146907,diosmin
TRANSLATION,2.412296373,0.004778054,amisulpride
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.110590474,0.112881523,amisulpride
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.125980907,0.145499226,amisulpride
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.042088577,0.131396482,amisulpride
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.036324624,0.104519929,amisulpride
SYNTHESIS_OF_DNA,2.033838727,0.085766068,amisulpride
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,2.006083654,0.088593083,amisulpride
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1.969733064,0.101192356,amisulpride
HEMOSTASIS,-1.948851897,0.25423668,amisulpride
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.924311693,0.121243118,amisulpride
METABOLISM_OF_RNA,-2.551771546,0.0043277,pranlukast
MITOTIC_METAPHASE_AND_ANAPHASE,-2.290310904,0.015146952,pranlukast
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.182139255,0.052990843,pranlukast
CELL_CYCLE_CHECKPOINTS,-2.114266387,0.05914524,pranlukast
NEURONAL_SYSTEM,2.121721787,0.045986306,pranlukast
CHROMATIN_ORGANIZATION,-2.052535848,0.082947592,pranlukast
GASTRULATION,-2.04349183,0.071262801,pranlukast
SEPARATION_OF_SISTER_CHROMATIDS,-2.022114085,0.070445346,pranlukast
M_PHASE,-2.017877678,0.063885102,pranlukast
PROTEASOME_ASSEMBLY,-1.999036314,0.066538394,pranlukast
EUKARYOTIC_TRANSLATION_INITIATION,-2.1394844,0.054570637,diphenidol
GLYCOSAMINOGLYCAN_METABOLISM,2.089410533,0.060342857,diphenidol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.043860447,0.086221607,diphenidol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.036664099,0.061846722,diphenidol
TRANSLATION,-2.02866665,0.04965928,diphenidol
S_PHASE,-2.01741864,0.04452964,diphenidol
SARS_COV_1_INFECTION,-2.010237296,0.039836565,diphenidol
INNATE_IMMUNE_SYSTEM,-2.007691544,0.034613376,diphenidol
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.979879117,0.039427285,diphenidol
CILIUM_ASSEMBLY,1.917705141,0.093942857,diphenidol
EUKARYOTIC_TRANSLATION_ELONGATION,-3.680334496,0,genistein
NERVOUS_SYSTEM_DEVELOPMENT,-2.810261672,0,genistein
SARS_COV_2_HOST_INTERACTIONS,-2.849490155,0,genistein
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.103688545,0,genistein
TRANSLATION,-3.11575148,0,genistein
RRNA_PROCESSING,-3.285884352,0,genistein
SARS_COV_1_INFECTION,-3.304450124,0,genistein
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.356717132,0,genistein
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.398647865,0,genistein
SARS_COV_1_HOST_INTERACTIONS,-3.4406466,0,genistein
EUKARYOTIC_TRANSLATION_ELONGATION,-3.857564481,0,darapladib
SARS_COV_1_INFECTION,-3.079002693,0,darapladib
NERVOUS_SYSTEM_DEVELOPMENT,-3.137635631,0,darapladib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.175125393,0,darapladib
SARS_COV_1_HOST_INTERACTIONS,-3.212122971,0,darapladib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.272651655,0,darapladib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.288037981,0,darapladib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.354949069,0,darapladib
TRANSLATION,-3.441781193,0,darapladib
SIGNALING_BY_ROBO_RECEPTORS,-3.515578005,0,darapladib
G_ALPHA_I_SIGNALLING_EVENTS,-2.196167957,0.01158339,tafamidis-meglumine
GPCR_LIGAND_BINDING,-2.152438986,0.008108373,tafamidis-meglumine
RHO_GTPASE_CYCLE,2.011867096,0.198356475,tafamidis-meglumine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.09368682,0.013127841,tafamidis-meglumine
SIGNALING_BY_GPCR,-2.090421326,0.009845881,tafamidis-meglumine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.065303319,0.010347828,tafamidis-meglumine
MITOCHONDRIAL_BIOGENESIS,1.941974921,0.156701615,tafamidis-meglumine
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,-1.964648471,0.023681596,tafamidis-meglumine
CELLULAR_SENESCENCE,1.73865002,0.297534712,tafamidis-meglumine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.892782165,0.040266068,tafamidis-meglumine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.286262298,0.006611132,pyrazolanthrone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.311467078,0.017571726,pyrazolanthrone
EUKARYOTIC_TRANSLATION_ELONGATION,2.282294326,0.003718761,pyrazolanthrone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.264965621,0.002754638,pyrazolanthrone
EUKARYOTIC_TRANSLATION_INITIATION,2.183519055,0.006817729,pyrazolanthrone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.162272837,0.00776808,pyrazolanthrone
GPCR_LIGAND_BINDING,2.154599443,0.006748863,pyrazolanthrone
NONSENSE_MEDIATED_DECAY_NMD,2.152534934,0.005902796,pyrazolanthrone
SELENOAMINO_ACID_METABOLISM,2.117302969,0.007540822,pyrazolanthrone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.058509478,0.012671335,pyrazolanthrone
GPCR_LIGAND_BINDING,-2.172166901,0.015906026,procaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.04539329,0.032607354,procaine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.960459322,0.319750195,procaine
SIGNALING_BY_GPCR,-2.019199295,0.031812053,procaine
G_ALPHA_S_SIGNALLING_EVENTS,-2.015387317,0.024654341,procaine
MITOTIC_PROMETAPHASE,1.903271146,0.211501431,procaine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.863148766,0.169867291,procaine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.853776694,0.135727296,procaine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.827443525,0.124569347,procaine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.952071839,0.03610668,procaine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.940119181,0,tolfenamic-acid
COLLAGEN_FORMATION,-2.871130624,0,tolfenamic-acid
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.755083455,0,tolfenamic-acid
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.728214556,0,tolfenamic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.721759442,0,tolfenamic-acid
COLLAGEN_DEGRADATION,-2.65155328,0,tolfenamic-acid
CELLULAR_RESPONSE_TO_STARVATION,2.571657811,0.002118565,tolfenamic-acid
ECM_PROTEOGLYCANS,-2.509394697,0.00040378,tolfenamic-acid
GPCR_LIGAND_BINDING,-2.472034102,0.000824384,tolfenamic-acid
SIGNALING_BY_MET,-2.406886151,0.001256205,tolfenamic-acid
GPCR_LIGAND_BINDING,-2.171696959,0.037842652,radezolid
REGULATION_OF_TP53_ACTIVITY,2.019592656,0.259326136,radezolid
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.947436979,0.206740559,radezolid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.84488216,0.412398897,radezolid
SIGNALING_BY_ALK_IN_CANCER,1.714098474,0.504725498,radezolid
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.819229271,0.336283564,radezolid
GASTRULATION,-1.796872865,0.301236108,radezolid
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.788576271,0.255609911,radezolid
MITF_M_DEPENDENT_GENE_EXPRESSION,1.665321581,0.492719659,radezolid
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,1.64063185,0.451227477,radezolid
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.649154613,0.001835009,methyldopa
SELENOAMINO_ACID_METABOLISM,2.345723807,0.014152237,methyldopa
NONSENSE_MEDIATED_DECAY_NMD,2.337053251,0.008164752,methyldopa
EUKARYOTIC_TRANSLATION_ELONGATION,2.325777526,0.006531802,methyldopa
CELLULAR_RESPONSE_TO_STARVATION,2.309790692,0.005443168,methyldopa
EUKARYOTIC_TRANSLATION_INITIATION,2.297120768,0.004789988,methyldopa
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.290468309,0.004173096,methyldopa
GPCR_LIGAND_BINDING,-2.306240985,0.01880884,methyldopa
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.215618973,0.007775955,methyldopa
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.278995161,0.015903409,methyldopa
CELLULAR_RESPONSE_TO_STARVATION,2.616471938,0.001406202,lurasidone
NEUTROPHIL_DEGRANULATION,2.389947551,0.002812405,lurasidone
GPCR_LIGAND_BINDING,-2.079449082,0.067240612,lurasidone
RESPIRATORY_ELECTRON_TRANSPORT,1.757969633,0.19358721,lurasidone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.879403266,0.254020088,lurasidone
PROTEIN_LOCALIZATION,1.699666066,0.193704393,lurasidone
SIGNALING_BY_GPCR,-1.868869238,0.187090776,lurasidone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.662672686,0.187587413,lurasidone
INNATE_IMMUNE_SYSTEM,1.48701071,0.368893787,lurasidone
TRANSLATION,1.464275899,0.352956826,lurasidone
GPCR_LIGAND_BINDING,-2.209706164,0.006851171,simvastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.122780458,0.009896136,simvastatin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.976261695,0.039077049,simvastatin
G_ALPHA_S_SIGNALLING_EVENTS,-1.943775398,0.040345784,simvastatin
SIGNALING_BY_GPCR,-1.927710395,0.03897555,simvastatin
VIRAL_INFECTION_PATHWAYS,1.658424814,1,simvastatin
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.595714657,0.736383131,simvastatin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.584642974,0.518870622,simvastatin
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1.47995577,0.709953538,simvastatin
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,1.46183253,0.621186562,simvastatin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.431029229,0,hydroxyurea
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.969730539,0,hydroxyurea
SIGNALING_BY_ROBO_RECEPTORS,3.010221596,0,hydroxyurea
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.409787695,0,hydroxyurea
TRANSLATION,3.588043669,0,hydroxyurea
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.041864039,0,hydroxyurea
CELLULAR_RESPONSE_TO_STARVATION,3.532575281,0,hydroxyurea
INFLUENZA_INFECTION,4.055862897,0,hydroxyurea
EUKARYOTIC_TRANSLATION_INITIATION,4.113540931,0,hydroxyurea
SELENOAMINO_ACID_METABOLISM,4.211498837,0,hydroxyurea
NONSENSE_MEDIATED_DECAY_NMD,3.783759275,0,canertinib
SIGNALING_BY_ROBO_RECEPTORS,2.949828487,0,canertinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.013984042,0,canertinib
RRNA_PROCESSING,3.033940659,0,canertinib
TRANSLATION,3.064118562,0,canertinib
CELLULAR_RESPONSE_TO_STARVATION,3.424015652,0,canertinib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.22024096,0,canertinib
SELENOAMINO_ACID_METABOLISM,3.567176682,0,canertinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.593156607,0,canertinib
EUKARYOTIC_TRANSLATION_INITIATION,3.672012502,0,canertinib
GPCR_LIGAND_BINDING,-3.585809125,0,ropinirole
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.713820818,0,ropinirole
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.741713629,0,ropinirole
G_ALPHA_S_SIGNALLING_EVENTS,-2.762627478,0,ropinirole
RRNA_PROCESSING,-2.910728776,0,ropinirole
SIGNALING_BY_ROBO_RECEPTORS,-2.939098117,0,ropinirole
CELLULAR_RESPONSE_TO_STARVATION,-2.981929809,0,ropinirole
SIGNALING_BY_GPCR,-2.991175948,0,ropinirole
SELENOAMINO_ACID_METABOLISM,-3.065445317,0,ropinirole
NONSENSE_MEDIATED_DECAY_NMD,-2.862692383,0,ropinirole
EUKARYOTIC_TRANSLATION_INITIATION,2.388238811,0.01503669,naproxen
CELLULAR_RESPONSE_TO_STARVATION,2.342528504,0.008270179,naproxen
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.258951057,0.013031798,naproxen
INFLUENZA_INFECTION,2.126693832,0.025938289,naproxen
SIGNALING_BY_ROBO_RECEPTORS,1.951218052,0.075784915,naproxen
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.913662396,0.411998382,naproxen
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.826207272,0.139590601,naproxen
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.787941709,0.149507656,naproxen
TRANSLATION,1.730135499,0.183259654,naproxen
ECM_PROTEOGLYCANS,-1.832051352,0.419612315,naproxen
CELLULAR_RESPONSE_TO_STARVATION,2.64845383,0.002975874,KD-025
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.216139138,0.012325773,KD-025
GPCR_LIGAND_BINDING,-2.18800657,0.007460336,KD-025
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.183271557,0.005406041,KD-025
RESPIRATORY_ELECTRON_TRANSPORT,2.187442685,0.056541609,KD-025
SIGNALING_BY_ALK_IN_CANCER,2.063022342,0.073404896,KD-025
METABOLISM_OF_RNA,2.058228689,0.056541609,KD-025
G_ALPHA_I_SIGNALLING_EVENTS,-2.069446002,0.015569398,KD-025
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.976400119,0.066064406,KD-025
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.963916492,0.058525525,KD-025
TRANSLATION,6.990224225,0,calcitriol
MITOTIC_METAPHASE_AND_ANAPHASE,3.029026925,0,calcitriol
RESPIRATORY_ELECTRON_TRANSPORT,3.160559598,0,calcitriol
GPCR_LIGAND_BINDING,-2.429503287,0,calcitriol
NERVOUS_SYSTEM_DEVELOPMENT,3.687603171,0,calcitriol
VIRAL_INFECTION_PATHWAYS,4.036335262,0,calcitriol
INFECTIOUS_DISEASE,4.070999249,0,calcitriol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,4.08816295,0,calcitriol
SARS_COV_1_HOST_INTERACTIONS,4.160692423,0,calcitriol
SARS_COV_1_INFECTION,4.212169103,0,calcitriol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.091317136,0,voapaxar
RESPIRATORY_ELECTRON_TRANSPORT,2.905620788,0,voapaxar
METABOLISM_OF_RNA,2.928101966,0,voapaxar
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.06798483,0,voapaxar
SELENOAMINO_ACID_METABOLISM,3.556704494,0,voapaxar
TRANSLATION,3.653793811,0,voapaxar
CELLULAR_RESPONSE_TO_STARVATION,3.389071423,0,voapaxar
NONSENSE_MEDIATED_DECAY_NMD,3.815914093,0,voapaxar
INFLUENZA_INFECTION,3.815933125,0,voapaxar
EUKARYOTIC_TRANSLATION_ELONGATION,3.879514622,0,voapaxar
NONSENSE_MEDIATED_DECAY_NMD,3.112531195,0,imatinib
METABOLISM_OF_RNA,3.096459685,0,imatinib
INFLUENZA_INFECTION,3.078657747,0,imatinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.765829078,0,imatinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.757799216,0,imatinib
GPCR_LIGAND_BINDING,-2.485633993,0,imatinib
RRNA_PROCESSING,2.590681315,0.000363827,imatinib
CELLULAR_RESPONSE_TO_STARVATION,2.579601546,0.000623703,imatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.325053406,0.000860395,imatinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.543808676,0.00081861,imatinib
METABOLISM_OF_RNA,4.119576924,0,biotin
SARS_COV_1_HOST_INTERACTIONS,2.900366759,0,biotin
GPCR_LIGAND_BINDING,-2.78680511,0,biotin
CELLULAR_RESPONSES_TO_STIMULI,2.751123764,0,biotin
S_PHASE,2.737653156,0,biotin
HOST_INTERACTIONS_OF_HIV_FACTORS,2.73493119,0,biotin
VIRAL_INFECTION_PATHWAYS,2.644589756,0,biotin
SIGNALING_BY_NOTCH,2.615145014,0,biotin
G_ALPHA_I_SIGNALLING_EVENTS,-2.588989976,0,biotin
MITOTIC_PROMETAPHASE,2.938710691,0,biotin
TRANSLATION,2.443783034,0,acetylcholine
UB_SPECIFIC_PROCESSING_PROTEASES,-2.178059617,0.027690066,acetylcholine
RESPIRATORY_ELECTRON_TRANSPORT,1.969574006,0.058687873,acetylcholine
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.055832522,0.058149138,acetylcholine
DEUBIQUITINATION,-2.046377209,0.041535098,acetylcholine
DISEASES_OF_GLYCOSYLATION,-2.017083702,0.044073354,acetylcholine
RRNA_PROCESSING,1.786464989,0.138568588,acetylcholine
CILIUM_ASSEMBLY,-1.882822784,0.128666505,acetylcholine
HATS_ACETYLATE_HISTONES,-1.834434417,0.165525059,acetylcholine
CHROMATIN_ORGANIZATION,-1.818189961,0.162448385,acetylcholine
RRNA_PROCESSING,3.118068044,0,oxybuprocaine
EUKARYOTIC_TRANSLATION_INITIATION,3.043214434,0,oxybuprocaine
NONSENSE_MEDIATED_DECAY_NMD,2.949015544,0,oxybuprocaine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.848339688,0,oxybuprocaine
EUKARYOTIC_TRANSLATION_ELONGATION,2.793302373,0,oxybuprocaine
TRANSLATION,2.728451593,0,oxybuprocaine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.702582247,0,oxybuprocaine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.671651557,0,oxybuprocaine
METABOLISM_OF_RNA,2.661652392,0,oxybuprocaine
SELENOAMINO_ACID_METABOLISM,2.555616613,0.000169975,oxybuprocaine
NEDDYLATION,2.409528559,0.00977583,propranolol
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.285325166,0.012219788,propranolol
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.01813242,0.057025676,propranolol
GPCR_LIGAND_BINDING,-2.097367596,0.040173198,propranolol
SIGNALING_BY_GPCR,-2.038444214,0.035425456,propranolol
M_PHASE,1.811881861,0.134417664,propranolol
RHO_GTPASE_CYCLE,1.769570312,0.149570201,propranolol
CELL_CYCLE_MITOTIC,1.722962193,0.165374459,propranolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.938896458,0.062572799,propranolol
CELLULAR_SENESCENCE,1.609161692,0.256266403,propranolol
SELENOAMINO_ACID_METABOLISM,3.205123823,0,oxybenzone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.174847874,0,oxybenzone
EUKARYOTIC_TRANSLATION_ELONGATION,3.142797039,0,oxybenzone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.056058071,0,oxybenzone
CELLULAR_RESPONSE_TO_STARVATION,2.705791862,0.000153469,oxybenzone
EUKARYOTIC_TRANSLATION_INITIATION,2.502959447,0.000639454,oxybenzone
NONSENSE_MEDIATED_DECAY_NMD,2.234905189,0.002630896,oxybenzone
TRANSLATION,2.141908433,0.006522431,oxybenzone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.135135799,0.005968237,oxybenzone
SIGNALING_BY_ROBO_RECEPTORS,2.02954893,0.010205686,oxybenzone
NEUTROPHIL_DEGRANULATION,-2.521315246,0.027078385,remoxipride
DNA_REPAIR,1.884019761,0.655898491,remoxipride
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.879198458,0.33793248,remoxipride
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.857871044,0.937714437,remoxipride
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-1.722010675,1,remoxipride
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.710607987,0.792544207,remoxipride
HOMOLOGY_DIRECTED_REPAIR,1.678866848,0.972699792,remoxipride
GPCR_LIGAND_BINDING,1.656038993,0.848574912,remoxipride
G_ALPHA_Q_SIGNALLING_EVENTS,1.641395146,0.741354976,remoxipride
RAC1_GTPASE_CYCLE,-1.59930558,0.917455793,remoxipride
EUKARYOTIC_TRANSLATION_ELONGATION,-4.060899858,0,mepivacaine
METABOLISM_OF_RNA,-2.526630447,0,mepivacaine
SARS_COV_INFECTIONS,-2.769832362,0,mepivacaine
SARS_COV_2_INFECTION,-2.783561177,0,mepivacaine
SARS_COV_2_HOST_INTERACTIONS,-2.927791919,0,mepivacaine
INFECTIOUS_DISEASE,-2.993738694,0,mepivacaine
CELLULAR_RESPONSES_TO_STIMULI,-3.009708659,0,mepivacaine
NERVOUS_SYSTEM_DEVELOPMENT,-3.035801236,0,mepivacaine
SARS_COV_1_HOST_INTERACTIONS,-3.077839117,0,mepivacaine
SARS_COV_1_INFECTION,-3.091646153,0,mepivacaine
CELL_CELL_COMMUNICATION,-2.357927155,1,ciglitazone
METABOLISM_OF_STEROIDS,-1.569392044,1,ciglitazone
MITOCHONDRIAL_TRANSLATION,-1.483950402,1,ciglitazone
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.651032819,1,ciglitazone
TRANSLATION,-1.279077919,1,ciglitazone
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-1.27688381,1,ciglitazone
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.172934848,1,ciglitazone
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.561848853,1,ciglitazone
DNA_DOUBLE_STRAND_BREAK_REPAIR,-1.131268978,1,ciglitazone
CILIUM_ASSEMBLY,-1.13425563,1,ciglitazone
TRANSLATION,4.33454664,0,fluocinolone
EUKARYOTIC_TRANSLATION_INITIATION,4.234382698,0,fluocinolone
RRNA_PROCESSING,3.580624787,0,fluocinolone
CELLULAR_RESPONSE_TO_STARVATION,2.997024181,0,fluocinolone
INFLUENZA_INFECTION,2.983389228,0,fluocinolone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.949659775,0,fluocinolone
NONSENSE_MEDIATED_DECAY_NMD,2.849760004,0,fluocinolone
SELENOAMINO_ACID_METABOLISM,2.771180292,0,fluocinolone
SIGNALING_BY_ROBO_RECEPTORS,2.421429318,0.000392016,fluocinolone
G_ALPHA_S_SIGNALLING_EVENTS,-2.107844487,0.036081526,fluocinolone
EUKARYOTIC_TRANSLATION_INITIATION,2.755400503,0,buphenine
EUKARYOTIC_TRANSLATION_ELONGATION,2.599604228,0.000576006,buphenine
TRANSLATION,2.583960478,0.000768008,buphenine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.441886858,0.001440015,buphenine
SELENOAMINO_ACID_METABOLISM,2.413034034,0.001382414,buphenine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.390098336,0.001536016,buphenine
CELL_JUNCTION_ORGANIZATION,-2.823801191,0.012457938,buphenine
CELL_CELL_COMMUNICATION,-2.804688493,0.008305292,buphenine
RRNA_PROCESSING,2.212268148,0.010203533,buphenine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.155028661,0.014112145,buphenine
METABOLISM_OF_RNA,-2.913752643,0,mycophenolate-mofetil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.799499787,0,mycophenolate-mofetil
CELL_CYCLE_MITOTIC,-2.687996922,0,mycophenolate-mofetil
CELL_CYCLE,-2.658526455,0,mycophenolate-mofetil
MRNA_SPLICING,-2.543157407,0,mycophenolate-mofetil
MITOTIC_METAPHASE_AND_ANAPHASE,-2.439484441,0.001403374,mycophenolate-mofetil
M_PHASE,-2.381743529,0.001804338,mycophenolate-mofetil
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.238501707,0.006841448,mycophenolate-mofetil
BIOLOGICAL_OXIDATIONS,2.238479836,0.032354278,mycophenolate-mofetil
MUSCLE_CONTRACTION,2.234464752,0.016660039,mycophenolate-mofetil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.248539774,0,BRD-K48195008
EUKARYOTIC_TRANSLATION_INITIATION,3.133652004,0,BRD-K48195008
TRANSLATION,3.036031951,0,BRD-K48195008
EUKARYOTIC_TRANSLATION_ELONGATION,3.010101068,0,BRD-K48195008
SELENOAMINO_ACID_METABOLISM,2.989495579,0,BRD-K48195008
RRNA_PROCESSING,2.622147447,0.000207166,BRD-K48195008
NONSENSE_MEDIATED_DECAY_NMD,2.630099903,0.00022443,BRD-K48195008
CELLULAR_RESPONSE_TO_STARVATION,2.63975739,0.000244833,BRD-K48195008
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.647809866,0.000269316,BRD-K48195008
SIGNALING_BY_ROBO_RECEPTORS,2.77999349,0.00029924,BRD-K48195008
EUKARYOTIC_TRANSLATION_ELONGATION,4.38636459,0,amiloride
SARS_COV_INFECTIONS,2.605335147,0,amiloride
SARS_COV_2_INFECTION,2.707098684,0,amiloride
SARS_COV_2_HOST_INTERACTIONS,3.071051594,0,amiloride
SARS_COV_1_INFECTION,3.213935832,0,amiloride
INFECTIOUS_DISEASE,3.334690886,0,amiloride
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.416396085,0,amiloride
SARS_COV_1_HOST_INTERACTIONS,3.427550985,0,amiloride
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.443723226,0,amiloride
CELLULAR_RESPONSES_TO_STIMULI,3.461507782,0,amiloride
METABOLISM_OF_RNA,6.271058471,0,digoxin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.578642811,0,digoxin
SARS_COV_2_INFECTION,3.470376881,0,digoxin
ISG15_ANTIVIRAL_MECHANISM,3.423292592,0,digoxin
SARS_COV_2_HOST_INTERACTIONS,3.361107855,0,digoxin
SIGNALING_BY_ALK_IN_CANCER,3.22895561,0,digoxin
CELL_CYCLE_MITOTIC,3.221952131,0,digoxin
NERVOUS_SYSTEM_DEVELOPMENT,3.142868926,0,digoxin
SARS_COV_INFECTIONS,3.101775848,0,digoxin
SARS_COV_1_INFECTION,3.611641553,0,digoxin
EUKARYOTIC_TRANSLATION_INITIATION,3.258401873,0,bupropion
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.564540157,0,bupropion
RRNA_PROCESSING,2.608801934,0,bupropion
NONSENSE_MEDIATED_DECAY_NMD,2.685928295,0,bupropion
INFLUENZA_INFECTION,2.727116209,0,bupropion
CELLULAR_RESPONSE_TO_STARVATION,2.784693222,0,bupropion
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.544272085,0,bupropion
TRANSLATION,2.935678316,0,bupropion
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.041561988,0,bupropion
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.153707586,0,bupropion
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.045007617,0,dorsomorphin
NONSENSE_MEDIATED_DECAY_NMD,3.988391579,0,dorsomorphin
SELENOAMINO_ACID_METABOLISM,3.957747329,0,dorsomorphin
EUKARYOTIC_TRANSLATION_ELONGATION,3.93440182,0,dorsomorphin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.880370483,0,dorsomorphin
EUKARYOTIC_TRANSLATION_INITIATION,3.698477509,0,dorsomorphin
CELLULAR_RESPONSE_TO_STARVATION,3.491401263,0,dorsomorphin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.415224614,0,dorsomorphin
INFLUENZA_INFECTION,3.402829593,0,dorsomorphin
TRANSLATION,3.16951355,0,dorsomorphin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.570914945,0,hesperidin
GPCR_LIGAND_BINDING,-2.572788389,0,hesperidin
SIGNALING_BY_GPCR,-2.584276588,0,hesperidin
M_PHASE,2.828104193,0,hesperidin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.155463594,0,hesperidin
VIRAL_INFECTION_PATHWAYS,3.224139132,0,hesperidin
SARS_COV_1_INFECTION,3.292626883,0,hesperidin
SARS_COV_1_HOST_INTERACTIONS,3.334326287,0,hesperidin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.537450583,0,hesperidin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.579053771,0,hesperidin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.02552138,0.160518164,gemfibrozil
APOPTOSIS,1.850382208,0.174786445,gemfibrozil
EUKARYOTIC_TRANSLATION_ELONGATION,-1.970791901,0.125191264,gemfibrozil
INTERFERON_ALPHA_BETA_SIGNALING,1.715395426,0.229481523,gemfibrozil
SENSORY_PERCEPTION,-1.931837367,0.094728057,gemfibrozil
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.69387998,0.187271191,gemfibrozil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.915040009,0.074836556,gemfibrozil
DNA_REPAIR,1.67628822,0.15980475,gemfibrozil
RHO_GTPASE_EFFECTORS,1.663230261,0.143277324,gemfibrozil
CELLULAR_RESPONSE_TO_STARVATION,-1.876863675,0.081582974,gemfibrozil
EUKARYOTIC_TRANSLATION_INITIATION,2.456293956,0.006315699,theophylline
TRANSLATION,2.4476709,0.00315785,theophylline
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,2.244154313,0.013052445,theophylline
DISEASES_OF_METABOLISM,2.060144238,0.04578882,theophylline
RRNA_PROCESSING,1.942500379,0.077556788,theophylline
RESPIRATORY_ELECTRON_TRANSPORT,1.555223998,0.494729781,theophylline
SELENOAMINO_ACID_METABOLISM,1.551662056,0.431452489,theophylline
NUCLEAR_ENVELOPE_BREAKDOWN,-1.72224997,1,theophylline
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.486392793,0.510150613,theophylline
MITOTIC_PROPHASE,-1.694242538,1,theophylline
GPCR_LIGAND_BINDING,-2.680187707,0,BRD-K33211335
CHROMATIN_ORGANIZATION,2.672398594,0,BRD-K33211335
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.37091881,0.000377881,BRD-K33211335
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.485806027,0.006548478,BRD-K33211335
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.258475881,0.001763446,BRD-K33211335
SIGNALING_BY_GPCR,-2.251747686,0.001511525,BRD-K33211335
G_ALPHA_S_SIGNALLING_EVENTS,-2.208357393,0.002116136,BRD-K33211335
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.169872546,0.025320781,BRD-K33211335
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.157029387,0.019645433,BRD-K33211335
G_ALPHA_I_SIGNALLING_EVENTS,-2.147284183,0.003526893,BRD-K33211335
TRANSLATION,3.388813792,0,chloroquine
SIGNALING_BY_ROBO_RECEPTORS,2.586857943,0,chloroquine
RRNA_PROCESSING,2.849776968,0,chloroquine
CELLULAR_RESPONSE_TO_STARVATION,3.027806359,0,chloroquine
INFLUENZA_INFECTION,3.058907004,0,chloroquine
SELENOAMINO_ACID_METABOLISM,3.072650655,0,chloroquine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.915393373,0,chloroquine
EUKARYOTIC_TRANSLATION_ELONGATION,3.129915132,0,chloroquine
NONSENSE_MEDIATED_DECAY_NMD,3.190669851,0,chloroquine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.284519073,0,chloroquine
SELENOAMINO_ACID_METABOLISM,3.911146344,0,mirtazapine
CELLULAR_RESPONSES_TO_STIMULI,2.642239929,0,mirtazapine
INFECTIOUS_DISEASE,2.747012037,0,mirtazapine
METABOLISM_OF_RNA,2.76891015,0,mirtazapine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.774527992,0,mirtazapine
VIRAL_INFECTION_PATHWAYS,2.776205448,0,mirtazapine
SARS_COV_1_INFECTION,2.831827545,0,mirtazapine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.851040175,0,mirtazapine
NERVOUS_SYSTEM_DEVELOPMENT,2.942101162,0,mirtazapine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.036801455,0,mirtazapine
PROGRAMMED_CELL_DEATH,2.290755522,0.034553026,tacrolimus
TRANSLATION,2.275949749,0.020731815,tacrolimus
INFLUENZA_INFECTION,2.163851552,0.032249491,tacrolimus
DEUBIQUITINATION,2.048447914,0.04751041,tacrolimus
APOPTOSIS,1.964558746,0.063577567,tacrolimus
CELL_CYCLE_CHECKPOINTS,1.93127948,0.06277133,tacrolimus
NEURONAL_SYSTEM,-1.990562054,0.081138052,tacrolimus
MITOTIC_SPINDLE_CHECKPOINT,1.911709999,0.058740144,tacrolimus
GPCR_LIGAND_BINDING,-1.9749102,0.050883185,tacrolimus
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.851219094,0.076880482,tacrolimus
EUKARYOTIC_TRANSLATION_ELONGATION,4.377260473,0,prazosin
INFECTIOUS_DISEASE,2.775695288,0,prazosin
VIRAL_INFECTION_PATHWAYS,2.79038107,0,prazosin
SARS_COV_1_INFECTION,2.84389875,0,prazosin
CELLULAR_RESPONSES_TO_STIMULI,2.926424931,0,prazosin
METABOLISM_OF_RNA,2.969454754,0,prazosin
SARS_COV_1_HOST_INTERACTIONS,3.034801828,0,prazosin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.244591699,0,prazosin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.29556724,0,prazosin
NERVOUS_SYSTEM_DEVELOPMENT,3.613004006,0,prazosin
MRNA_SPLICING,2.663751865,0.016883743,toremifene
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.242063944,0.021104679,toremifene
NONSENSE_MEDIATED_DECAY_NMD,-1.994697323,0.04378039,toremifene
EUKARYOTIC_TRANSLATION_ELONGATION,-1.947388197,0.04596941,toremifene
HOST_INTERACTIONS_OF_HIV_FACTORS,1.777226505,0.160395562,toremifene
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.926560613,0.042612913,toremifene
SELENOAMINO_ACID_METABOLISM,-1.911738783,0.037432234,toremifene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.872419165,0.044130633,toremifene
G_ALPHA_Q_SIGNALLING_EVENTS,-1.871635594,0.036921462,toremifene
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.824030066,0.05366225,toremifene
EUKARYOTIC_TRANSLATION_INITIATION,-4.912705654,0,tranilast
VIRAL_INFECTION_PATHWAYS,-2.689494676,0,tranilast
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.841280282,0,tranilast
GPCR_LIGAND_BINDING,-2.878896272,0,tranilast
CELLULAR_RESPONSES_TO_STIMULI,-2.950535007,0,tranilast
SARS_COV_1_INFECTION,-2.9990695,0,tranilast
SARS_COV_1_HOST_INTERACTIONS,-3.283189619,0,tranilast
NERVOUS_SYSTEM_DEVELOPMENT,-3.311447088,0,tranilast
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.489997653,0,tranilast
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.577242917,0,tranilast
METABOLISM_OF_RNA,-2.624420893,0,cytarabine
SIGNALING_BY_ROBO_RECEPTORS,-2.39836888,0.001139871,cytarabine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.306507445,0.001899786,cytarabine
INTERLEUKIN_10_SIGNALING,2.482943646,0.012033307,cytarabine
M_PHASE,-2.292983053,0.002564711,cytarabine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.252316431,0.003875563,cytarabine
MRNA_SPLICING,-2.235285887,0.00398955,cytarabine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.228474522,0.003908131,cytarabine
SEPARATION_OF_SISTER_CHROMATIDS,-2.202291053,0.004986938,cytarabine
SIGNALING_BY_WNT,-2.16922754,0.005952662,cytarabine
TRANSLATION,2.653682971,0,mexiletine
RAC1_GTPASE_CYCLE,-2.355287942,0.009672837,mexiletine
RHO_GTPASE_CYCLE,-2.265021217,0.013190232,mexiletine
GPCR_LIGAND_BINDING,2.300441617,0.017004314,mexiletine
RESPIRATORY_ELECTRON_TRANSPORT,2.205246103,0.031663206,mexiletine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.107139128,0.042803964,mexiletine
DISEASES_OF_METABOLISM,2.089376479,0.037761305,mexiletine
SYNTHESIS_OF_DNA,2.071703691,0.035376792,mexiletine
MAPK6_MAPK4_SIGNALING,2.045286457,0.038029353,mexiletine
RAC2_GTPASE_CYCLE,-2.029608852,0.077675813,mexiletine
SENSORY_PERCEPTION,2.474484682,0,retinol
GPCR_LIGAND_BINDING,2.35698934,0.001311422,retinol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.041208127,0.037768939,retinol
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.911444974,0.860232884,retinol
SIGNALING_BY_GPCR,1.955004237,0.060194247,retinol
VISUAL_PHOTOTRANSDUCTION,1.904715286,0.064521938,retinol
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.787981651,0.871886285,retinol
G_ALPHA_S_SIGNALLING_EVENTS,1.826516723,0.094946917,retinol
FATTY_ACID_METABOLISM,-1.749641606,0.708385536,retinol
G2_M_CHECKPOINTS,-1.740941539,0.556714754,retinol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.986044263,0,amoxapine
SELENOAMINO_ACID_METABOLISM,-2.91729438,0,amoxapine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.902976115,0,amoxapine
EUKARYOTIC_TRANSLATION_INITIATION,-2.859122447,0,amoxapine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.840823943,0,amoxapine
INFLUENZA_INFECTION,-2.806625927,0,amoxapine
NONSENSE_MEDIATED_DECAY_NMD,-2.710688641,0,amoxapine
TRANSLATION,-2.592661345,0,amoxapine
SIGNALING_BY_ROBO_RECEPTORS,-2.541656493,0,amoxapine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.531278824,0,amoxapine
PEROXISOMAL_PROTEIN_IMPORT,1.93502489,0.2425237,buspirone
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.844838012,0.206898749,buspirone
CELL_CYCLE_MITOTIC,-1.883554568,0.902652942,buspirone
CELL_CYCLE,-1.809683065,0.81660669,buspirone
CELL_CYCLE_CHECKPOINTS,-1.762657075,0.766829395,buspirone
VISUAL_PHOTOTRANSDUCTION,-1.744346688,0.655616927,buspirone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.742269236,0.533375736,buspirone
MUSCLE_CONTRACTION,1.579433331,0.569770838,buspirone
HCMV_EARLY_EVENTS,1.570210034,0.445311878,buspirone
PROGRAMMED_CELL_DEATH,-1.722186842,0.509615867,buspirone
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.736323605,0,tamibarotene
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.692947134,0,tamibarotene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.449766074,0.000736431,tamibarotene
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.575743104,0.002271487,tamibarotene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.315925932,0.001472861,tamibarotene
MYD88_INDEPENDENT_TLR4_CASCADE,2.519750948,0.005110846,tamibarotene
NONSENSE_MEDIATED_DECAY_NMD,-2.287929404,0.001718338,tamibarotene
GPCR_LIGAND_BINDING,-2.278785265,0.001472861,tamibarotene
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,2.445243256,0.006133015,tamibarotene
REGULATION_OF_TP53_ACTIVITY,2.379217386,0.006246589,tamibarotene
EUKARYOTIC_TRANSLATION_ELONGATION,3.311222147,0,parecoxib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.678052085,0,parecoxib
CELLULAR_RESPONSE_TO_STARVATION,2.683711762,0,parecoxib
NONSENSE_MEDIATED_DECAY_NMD,2.815129245,0,parecoxib
INFLUENZA_INFECTION,2.853768755,0,parecoxib
TRANSLATION,2.736196798,0,parecoxib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.05719623,0,parecoxib
EUKARYOTIC_TRANSLATION_INITIATION,3.091866985,0,parecoxib
RRNA_PROCESSING,3.215590179,0,parecoxib
SELENOAMINO_ACID_METABOLISM,3.235743286,0,parecoxib
RESPIRATORY_ELECTRON_TRANSPORT,2.624894215,0,cromoglicic-acid
INTERFERON_SIGNALING,2.495918991,0.003219575,cromoglicic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,-2.222287814,0.008131403,cromoglicic-acid
RRNA_PROCESSING,-2.21937974,0.004065702,cromoglicic-acid
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.190443514,0.01931745,cromoglicic-acid
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.173686769,0.016097875,cromoglicic-acid
G_ALPHA_S_SIGNALLING_EVENTS,-2.165654356,0.00758931,cromoglicic-acid
CELLULAR_RESPONSE_TO_STARVATION,-2.108430959,0.009960969,cromoglicic-acid
SELENOAMINO_ACID_METABOLISM,-2.107851287,0.008131403,cromoglicic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.103358646,0.00758931,cromoglicic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.154644441,0.076949945,levodopa
G_ALPHA_I_SIGNALLING_EVENTS,1.976366872,0.170389164,levodopa
SENSORY_PERCEPTION,1.953695833,0.135578475,levodopa
GPCR_LIGAND_BINDING,1.951153001,0.103182881,levodopa
CARDIAC_CONDUCTION,1.883700911,0.132114062,levodopa
SIGNALING_BY_GPCR,1.823526426,0.168223906,levodopa
BIOLOGICAL_OXIDATIONS,-1.853253011,1,levodopa
PROTEIN_LOCALIZATION,-1.85064209,0.57989646,levodopa
MUSCLE_CONTRACTION,1.751311346,0.22399715,levodopa
EUKARYOTIC_TRANSLATION_INITIATION,1.722536191,0.232848535,levodopa
EUKARYOTIC_TRANSLATION_ELONGATION,4.033564689,0,BRD-K19136521
CELLULAR_RESPONSES_TO_STIMULI,2.511308014,0,BRD-K19136521
SARS_COV_2_INFECTION,2.564673892,0,BRD-K19136521
METABOLISM_OF_RNA,2.646986432,0,BRD-K19136521
SARS_COV_2_HOST_INTERACTIONS,2.847315582,0,BRD-K19136521
SARS_COV_1_INFECTION,3.14016233,0,BRD-K19136521
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.178306744,0,BRD-K19136521
SARS_COV_1_HOST_INTERACTIONS,3.260272749,0,BRD-K19136521
SIGNALING_BY_ROBO_RECEPTORS,3.396943888,0,BRD-K19136521
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.417014914,0,BRD-K19136521
ORC1_REMOVAL_FROM_CHROMATIN,1.954903994,0.602851595,gabexate
INTERLEUKIN_1_FAMILY_SIGNALING,1.953339376,0.305452478,gabexate
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.920356347,0.255790085,gabexate
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1.896285854,0.226644588,gabexate
INTERLEUKIN_1_SIGNALING,1.873064736,0.217210651,gabexate
UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D,1.869829599,0.18426857,gabexate
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.868550202,0.158930614,gabexate
SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,1.867287966,0.140502387,gabexate
REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,1.861588976,0.13153823,gabexate
EUKARYOTIC_TRANSLATION_INITIATION,1.840483834,0.136561993,gabexate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,5.497232716,0,risperidone
SARS_COV_1_HOST_INTERACTIONS,3.168059481,0,risperidone
INFECTIOUS_DISEASE,3.515487757,0,risperidone
METABOLISM_OF_RNA,3.99180135,0,risperidone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,4.042473336,0,risperidone
RRNA_PROCESSING,4.423261492,0,risperidone
SIGNALING_BY_ROBO_RECEPTORS,4.70023641,0,risperidone
CELLULAR_RESPONSE_TO_STARVATION,4.709139337,0,risperidone
INFLUENZA_INFECTION,4.767887742,0,risperidone
NONSENSE_MEDIATED_DECAY_NMD,5.075480006,0,risperidone
SELENOAMINO_ACID_METABOLISM,3.196966376,0,tivozanib
EUKARYOTIC_TRANSLATION_ELONGATION,3.09759551,0,tivozanib
NONSENSE_MEDIATED_DECAY_NMD,3.041203893,0,tivozanib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.030055963,0,tivozanib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.952950017,0,tivozanib
EUKARYOTIC_TRANSLATION_INITIATION,2.895547255,0,tivozanib
CELLULAR_RESPONSE_TO_STARVATION,2.859381909,0,tivozanib
INFLUENZA_INFECTION,2.820252585,0,tivozanib
NEUTROPHIL_DEGRANULATION,2.600943,0,tivozanib
TRANSLATION,2.562790198,0.000121933,tivozanib
DISEASES_OF_GLYCOSYLATION,2.355634053,0.009469371,labetalol
DISEASES_OF_METABOLISM,2.060703466,0.030560242,labetalol
SIGNALING_BY_ALK_IN_CANCER,-1.982238206,0.284842894,labetalol
GLYCOSAMINOGLYCAN_METABOLISM,1.708026695,0.141753613,labetalol
MYD88_INDEPENDENT_TLR4_CASCADE,-1.915356263,0.269018289,labetalol
RESPIRATORY_ELECTRON_TRANSPORT,1.692053024,0.118582349,labetalol
RRNA_PROCESSING,1.674819839,0.103474398,labetalol
CILIUM_ASSEMBLY,-1.853356795,0.311047079,labetalol
METABOLISM_OF_STEROIDS,1.593530577,0.131853816,labetalol
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,-1.838157876,0.26493452,labetalol
METABOLISM_OF_RNA,2.805383862,0,rolipram
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-2.05999427,0.012523163,rolipram
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.846856432,0.133454972,rolipram
MYD88_INDEPENDENT_TLR4_CASCADE,1.74799576,0.14457622,rolipram
GPCR_LIGAND_BINDING,-1.921417379,0.041326437,rolipram
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.901345501,0.035899733,rolipram
INTERLEUKIN_1_FAMILY_SIGNALING,1.691985287,0.149094227,rolipram
NEUTROPHIL_DEGRANULATION,1.675277798,0.128450411,rolipram
INTERFERON_ALPHA_BETA_SIGNALING,-1.88670487,0.031725346,rolipram
RSV_HOST_INTERACTIONS,-1.882319957,0.026883056,rolipram
EUKARYOTIC_TRANSLATION_INITIATION,4.842880033,0,procarbazine
SARS_COV_INFECTIONS,2.694677706,0,procarbazine
SARS_COV_2_INFECTION,2.831632828,0,procarbazine
SARS_COV_2_HOST_INTERACTIONS,3.021206043,0,procarbazine
INFECTIOUS_DISEASE,3.26861127,0,procarbazine
CELLULAR_RESPONSES_TO_STIMULI,3.424001379,0,procarbazine
NERVOUS_SYSTEM_DEVELOPMENT,3.456846392,0,procarbazine
VIRAL_INFECTION_PATHWAYS,3.594306493,0,procarbazine
SARS_COV_1_INFECTION,3.862830194,0,procarbazine
SARS_COV_1_HOST_INTERACTIONS,3.932875743,0,procarbazine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.341375222,0.010971787,fenoldopam
G_ALPHA_Q_SIGNALLING_EVENTS,-2.164342417,0.001811517,fenoldopam
MRNA_SPLICING,2.029458483,0.043887147,fenoldopam
METABOLISM_OF_RNA,1.886738881,0.062173459,fenoldopam
GPCR_LIGAND_BINDING,-1.876978478,0.116389995,fenoldopam
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.641269503,0.175548589,fenoldopam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.835381161,0.124390864,fenoldopam
DISEASES_OF_METABOLISM,1.568057771,0.201880878,fenoldopam
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-1.771149389,0.178887347,fenoldopam
HOST_INTERACTIONS_OF_HIV_FACTORS,1.426734855,0.338753918,fenoldopam
GPCR_LIGAND_BINDING,-2.32797695,0.000734551,maprotiline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.172329473,0.005876407,maprotiline
SIGNALING_BY_GPCR,-2.125949496,0.006121258,maprotiline
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.04129902,0.163848495,maprotiline
TOLL_LIKE_RECEPTOR_CASCADES,1.779221689,0.32769699,maprotiline
ADAPTIVE_IMMUNE_SYSTEM,1.759603281,0.244166385,maprotiline
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1.705206425,0.244567974,maprotiline
MITOTIC_PROMETAPHASE,1.699833966,0.200473453,maprotiline
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.927017591,0.041134852,maprotiline
G_ALPHA_Q_SIGNALLING_EVENTS,-1.914290631,0.038490468,maprotiline
CELL_CYCLE_CHECKPOINTS,2.943802769,0,prochlorperazine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.55414283,0.002625077,prochlorperazine
G2_M_CHECKPOINTS,2.498375449,0.001750051,prochlorperazine
CELL_CYCLE_MITOTIC,2.432661014,0.001312539,prochlorperazine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.424460932,0.001050031,prochlorperazine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.398023742,0.000875026,prochlorperazine
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.328850165,0.002250066,prochlorperazine
NEDDYLATION,2.308120229,0.002625077,prochlorperazine
M_PHASE,2.297317288,0.002333402,prochlorperazine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.236735265,0.003675108,prochlorperazine
SIGNALING_BY_INTERLEUKINS,2.658211285,0,anisomycin
DNA_REPLICATION,-2.454972821,0.000867006,anisomycin
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.479672525,0.002511207,anisomycin
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.456164143,0.001674138,anisomycin
SYNTHESIS_OF_DNA,-2.364149047,0.003468025,anisomycin
NGF_STIMULATED_TRANSCRIPTION,2.406447051,0.002825107,anisomycin
FOXO_MEDIATED_TRANSCRIPTION,2.403342817,0.002260086,anisomycin
ECM_PROTEOGLYCANS,2.394738053,0.002092672,anisomycin
COLLAGEN_DEGRADATION,2.344753593,0.003228694,anisomycin
CELL_CYCLE,-2.264668954,0.006069043,anisomycin
GPCR_LIGAND_BINDING,-2.114359255,0.020687938,verapamil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.051870787,0.021929214,verapamil
SIGNALING_BY_GPCR,-1.976850671,0.031997344,verapamil
METABOLISM_OF_RNA,1.749034646,0.43565763,verapamil
AMINE_LIGAND_BINDING_RECEPTORS,-1.925277019,0.038065806,verapamil
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.66327801,0.357996922,verapamil
CELL_CYCLE_MITOTIC,1.637232853,0.263920129,verapamil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.589097966,0.261394578,verapamil
VIRAL_INFECTION_PATHWAYS,1.532083979,0.27427489,verapamil
NEDDYLATION,1.49467076,0.27844205,verapamil
EUKARYOTIC_TRANSLATION_INITIATION,3.204394312,0,moclobemide
TRANSLATION,2.584334704,0.00091511,moclobemide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.136078023,0.017692128,moclobemide
RRNA_PROCESSING,2.049068713,0.02310653,moclobemide
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.937698841,0.032577919,moclobemide
GLYCOSAMINOGLYCAN_METABOLISM,1.915585087,0.031571298,moclobemide
TOLL_LIKE_RECEPTOR_CASCADES,-1.986864413,0.219351154,moclobemide
GPCR_LIGAND_BINDING,-1.965865413,0.130590455,moclobemide
DISEASES_OF_METABOLISM,1.790126833,0.058305585,moclobemide
BIOLOGICAL_OXIDATIONS,1.784305405,0.05353394,moclobemide
GPCR_LIGAND_BINDING,2.364601966,0.011251366,desloratadine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.20676027,0.022502732,desloratadine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.230927581,0.15196689,desloratadine
G_ALPHA_I_SIGNALLING_EVENTS,2.073944189,0.051063892,desloratadine
ESR_MEDIATED_SIGNALING,-2.051027837,0.231687226,desloratadine
SIGNALING_BY_GPCR,1.981181995,0.080057797,desloratadine
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.999521866,0.205944201,desloratadine
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.785742348,0.48922128,desloratadine
GASTRULATION,-1.707541062,0.57323904,desloratadine
RAC3_GTPASE_CYCLE,-1.695431563,0.505518276,desloratadine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.338601341,0,clotrimazole
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.583991657,0,clotrimazole
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2.632678978,0,clotrimazole
G_ALPHA_Q_SIGNALLING_EVENTS,-2.66435208,0,clotrimazole
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.693992622,0,clotrimazole
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.70531252,0,clotrimazole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.732095336,0,clotrimazole
INFLUENZA_INFECTION,-2.774022699,0,clotrimazole
SIGNALING_BY_ROBO_RECEPTORS,-2.846869544,0,clotrimazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.892642817,0,clotrimazole
EXTRACELLULAR_MATRIX_ORGANIZATION,3.18136802,0,sphingosine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.88379872,0,sphingosine
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.727779259,0.000304637,sphingosine
COLLAGEN_DEGRADATION,2.664254235,0.000228477,sphingosine
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,2.606903264,0.000548346,sphingosine
COLLAGEN_FORMATION,2.540065543,0.001066228,sphingosine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.437151862,0.002611171,sphingosine
ECM_PROTEOGLYCANS,2.351228212,0.003884116,sphingosine
GLYCOSAMINOGLYCAN_METABOLISM,2.323303141,0.00385873,sphingosine
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,2.178820172,0.010053007,sphingosine
EUKARYOTIC_TRANSLATION_INITIATION,2.989307631,0,mifepristone
TRANSLATION,2.654408296,0,mifepristone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.568185919,0,mifepristone
EUKARYOTIC_TRANSLATION_ELONGATION,2.543137342,0.000433428,mifepristone
SELENOAMINO_ACID_METABOLISM,2.355304092,0.005547881,mifepristone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.295793097,0.009246468,mifepristone
INFLUENZA_INFECTION,2.262729231,0.010897624,mifepristone
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.207429963,0.014303131,mifepristone
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.146432669,0.020419284,mifepristone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.146013789,0.018550727,mifepristone
GLYCOSAMINOGLYCAN_METABOLISM,2.434032254,0.003155619,pantoprazole
TRANSCRIPTIONAL_REGULATION_BY_TP53,-2.274300125,0.006803807,pantoprazole
SARS_COV_1_INFECTION,-2.222890364,0.009071743,pantoprazole
ESR_MEDIATED_SIGNALING,-2.213380164,0.007181796,pantoprazole
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-2.172175853,0.008504759,pantoprazole
SIGNALING_BY_INSULIN_RECEPTOR,-2.118739342,0.012473646,pantoprazole
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-2.079962488,0.016442534,pantoprazole
SIGNALING_BY_VEGF,-2.054572904,0.022193371,pantoprazole
REGULATION_OF_TP53_ACTIVITY,-2.040649801,0.022821103,pantoprazole
EUKARYOTIC_TRANSLATION_INITIATION,-2.026130621,0.025325282,pantoprazole
EUKARYOTIC_TRANSLATION_ELONGATION,4.220222007,0,rofecoxib
NERVOUS_SYSTEM_DEVELOPMENT,2.632028219,0,rofecoxib
METABOLISM_OF_RNA,2.741663548,0,rofecoxib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.927632226,0,rofecoxib
SARS_COV_1_INFECTION,3.006475744,0,rofecoxib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.015714459,0,rofecoxib
VIRAL_INFECTION_PATHWAYS,3.047208199,0,rofecoxib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.187365556,0,rofecoxib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.196323588,0,rofecoxib
SARS_COV_1_HOST_INTERACTIONS,3.24147214,0,rofecoxib
SELENOAMINO_ACID_METABOLISM,3.973289745,0,naftifine
NONSENSE_MEDIATED_DECAY_NMD,3.877717059,0,naftifine
INFLUENZA_INFECTION,3.841953199,0,naftifine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.83689376,0,naftifine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.764950806,0,naftifine
EUKARYOTIC_TRANSLATION_ELONGATION,3.742317988,0,naftifine
EUKARYOTIC_TRANSLATION_INITIATION,3.641067094,0,naftifine
CELLULAR_RESPONSE_TO_STARVATION,3.349866167,0,naftifine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.096656229,0,naftifine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.010417701,0,naftifine
TRANSLATION,2.839285655,0,prilocaine
RRNA_PROCESSING,2.553802744,0.002000364,prilocaine
KERATINIZATION,2.30654907,0.006251137,prilocaine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.30654907,0.006251137,prilocaine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.256475342,0.007401346,prilocaine
RESPIRATORY_ELECTRON_TRANSPORT,2.221879643,0.007668061,prilocaine
HATS_ACETYLATE_HISTONES,-1.901785974,0.670944474,prilocaine
CELLULAR_RESPONSE_TO_STARVATION,1.805466419,0.113163432,prilocaine
DEUBIQUITINATION,-1.869892642,0.427464624,prilocaine
UB_SPECIFIC_PROCESSING_PROTEASES,-1.824701222,0.39363409,prilocaine
COMPLEMENT_CASCADE,-3.167461079,0,sumatriptan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.799533856,0.001390821,sumatriptan
EUKARYOTIC_TRANSLATION_ELONGATION,2.659464938,0.00069541,sumatriptan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.596386323,0.000463607,sumatriptan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.578665585,0.00069541,sumatriptan
NONSENSE_MEDIATED_DECAY_NMD,2.540703349,0.000556328,sumatriptan
CELLULAR_RESPONSE_TO_STARVATION,2.500962313,0.000463607,sumatriptan
INFLUENZA_INFECTION,2.411556688,0.000993443,sumatriptan
SIGNALING_BY_ROBO_RECEPTORS,2.399878979,0.000869263,sumatriptan
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,-2.514646245,0.002038666,sumatriptan
EUKARYOTIC_TRANSLATION_INITIATION,4.212425979,0,naphazoline
INFECTIOUS_DISEASE,2.672341248,0,naphazoline
SIGNALING_BY_ROBO_RECEPTORS,2.741551667,0,naphazoline
VIRAL_INFECTION_PATHWAYS,2.824770163,0,naphazoline
RRNA_PROCESSING,3.301634649,0,naphazoline
CELLULAR_RESPONSE_TO_STARVATION,3.325035521,0,naphazoline
INFLUENZA_INFECTION,3.366996522,0,naphazoline
GPCR_LIGAND_BINDING,-2.468397565,0,naphazoline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.527373479,0,naphazoline
NONSENSE_MEDIATED_DECAY_NMD,3.635980323,0,naphazoline
CELL_CYCLE_MITOTIC,3.023202438,0,glimepiride
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.384378592,0,glimepiride
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.513536037,0,glimepiride
CELL_CYCLE,2.757774902,0,glimepiride
SIGNALING_BY_GPCR,-2.423493518,0,glimepiride
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.803190011,0,glimepiride
CELL_CYCLE_CHECKPOINTS,2.828065528,0,glimepiride
GPCR_LIGAND_BINDING,-2.794332918,0,glimepiride
CHROMATIN_ORGANIZATION,2.480871625,0.003345966,glimepiride
M_PHASE,2.47683152,0.002788305,glimepiride
SIGNALING_BY_GPCR,2.570167371,0.000578842,procyclidine
GPCR_LIGAND_BINDING,2.504517796,0.000578842,procyclidine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.373402391,0.001929472,procyclidine
MUSCLE_CONTRACTION,2.229988627,0.005064864,procyclidine
CARDIAC_CONDUCTION,2.221502394,0.004399196,procyclidine
TRANSLATION,2.122875507,0.009550887,procyclidine
G_ALPHA_I_SIGNALLING_EVENTS,2.113883646,0.00843455,procyclidine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.084736588,0.008610269,procyclidine
G_ALPHA_Q_SIGNALLING_EVENTS,2.051476933,0.010161886,procyclidine
MITOTIC_PROPHASE,-1.940745688,0.622064322,procyclidine
RESPIRATORY_ELECTRON_TRANSPORT,2.968883529,0,probenecid
TRANSLATION,2.86770085,0,probenecid
MITOCHONDRIAL_TRANSLATION,2.464447731,0.001940975,probenecid
METABOLISM_OF_NUCLEOTIDES,2.242016229,0.008491767,probenecid
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.180127619,0.042466122,probenecid
MUSCLE_CONTRACTION,2.216364468,0.008734389,probenecid
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.156428853,0.033366239,probenecid
CARDIAC_CONDUCTION,2.148111772,0.013263331,probenecid
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.103555276,0.01525052,probenecid
RRNA_PROCESSING,2.073920147,0.016013046,probenecid
GPCR_LIGAND_BINDING,2.600628394,0.001050475,vecuronium
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.282468412,0.009979511,vecuronium
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,-2.296614769,0.030839732,vecuronium
SENSORY_PERCEPTION,2.18433402,0.015757123,vecuronium
SIGNALING_BY_GPCR,2.139292557,0.017595454,vecuronium
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.980484385,0.062398208,vecuronium
G_ALPHA_S_SIGNALLING_EVENTS,1.959973905,0.063378651,vecuronium
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.914176283,0.078335413,vecuronium
NEUTROPHIL_DEGRANULATION,-1.904596458,0.248586934,vecuronium
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-1.871174095,0.207778804,vecuronium
NEUTROPHIL_DEGRANULATION,-3.055993803,0,cetirizine
GPCR_LIGAND_BINDING,2.188236716,0.039899831,cetirizine
ESR_MEDIATED_SIGNALING,-2.14942809,0.070427959,cetirizine
INNATE_IMMUNE_SYSTEM,-2.102687336,0.056249393,cetirizine
SENSORY_PERCEPTION,2.071145338,0.057681277,cetirizine
SIGNALING_BY_GPCR,1.993120124,0.08037792,cetirizine
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.934344046,0.101458099,cetirizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.984048346,0.065054072,cetirizine
NCAM1_INTERACTIONS,1.902822627,0.111025616,cetirizine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.839527607,0.148756978,cetirizine
EUKARYOTIC_TRANSLATION_INITIATION,4.268575458,0,H-89
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.554037293,0,H-89
RESPIRATORY_ELECTRON_TRANSPORT,2.800025726,0,H-89
VIRAL_INFECTION_PATHWAYS,2.938784299,0,H-89
MITOTIC_METAPHASE_AND_ANAPHASE,2.969191159,0,H-89
CELL_CYCLE_MITOTIC,3.005902994,0,H-89
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.007345765,0,H-89
CELLULAR_RESPONSES_TO_STIMULI,3.205948726,0,H-89
SARS_COV_1_HOST_INTERACTIONS,3.271285282,0,H-89
M_PHASE,3.326772055,0,H-89
RESPIRATORY_ELECTRON_TRANSPORT,2.213088381,0.061307796,tiaprofenic-acid
CELL_CYCLE_CHECKPOINTS,2.015522738,0.165758114,tiaprofenic-acid
NEUTROPHIL_DEGRANULATION,-2.00387127,0.320503125,tiaprofenic-acid
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,-1.884905499,0.389682761,tiaprofenic-acid
MITOTIC_METAPHASE_AND_ANAPHASE,1.847695543,0.376172524,tiaprofenic-acid
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.845468152,0.284967717,tiaprofenic-acid
TRANSLATION,1.840708412,0.233196689,tiaprofenic-acid
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.809902857,0.421207658,tiaprofenic-acid
RHO_GTPASES_ACTIVATE_FORMINS,1.788146836,0.274371308,tiaprofenic-acid
SEPARATION_OF_SISTER_CHROMATIDS,1.74550592,0.311729056,tiaprofenic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.139946505,0.008789374,minaprine
SELENOAMINO_ACID_METABOLISM,-2.020036422,0.031739405,minaprine
GPCR_LIGAND_BINDING,-2.019444142,0.021159604,minaprine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.011378188,0.0168463,minaprine
EUKARYOTIC_TRANSLATION_INITIATION,-1.975806401,0.022852372,minaprine
RRNA_PROCESSING,-1.968707268,0.020508539,minaprine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.951765653,0.022182705,minaprine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.722018669,0.282852174,minaprine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.89417993,0.034547122,minaprine
INFLUENZA_INFECTION,-1.893688828,0.030817064,minaprine
NEUTROPHIL_DEGRANULATION,-2.522422516,0.004910217,propidium
SENSORY_PERCEPTION,1.95533567,0.332454624,propidium
GPCR_LIGAND_BINDING,1.950888651,0.172555763,propidium
TRNA_PROCESSING,-1.817749607,0.370721351,propidium
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.799352462,0.271153071,propidium
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.779525083,0.224642408,propidium
G_ALPHA_I_SIGNALLING_EVENTS,1.90194683,0.171008808,propidium
SIGNALING_BY_GPCR,1.895107266,0.136483593,propidium
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.683670334,0.307379557,propidium
TRANSLATION,-1.681197053,0.259423109,propidium
NEUTROPHIL_DEGRANULATION,-2.232504782,0.050456246,emedastine
TRANSLATION,-2.187468894,0.032268529,emedastine
SIGNALING_BY_ROBO_RECEPTORS,-2.082562415,0.05084738,emedastine
METABOLISM_OF_RNA,-2.074979459,0.040775687,emedastine
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,2.0373974,0.11553888,emedastine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.059542402,0.037314154,emedastine
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,2.019250265,0.067602536,emedastine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.004426385,0.048346056,emedastine
NERVOUS_SYSTEM_DEVELOPMENT,-1.955411453,0.062776957,emedastine
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,1.916601916,0.044658645,emedastine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.179927123,0.092719073,acenocoumarol
GASTRULATION,-2.043985126,0.139078609,acenocoumarol
DEVELOPMENTAL_CELL_LINEAGES,-1.960986611,0.182690914,acenocoumarol
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.833723268,0.71377152,acenocoumarol
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.893632207,0.225358857,acenocoumarol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.886392868,0.189765035,acenocoumarol
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.814703908,0.258068086,acenocoumarol
CELL_CYCLE_MITOTIC,-1.775295946,0.286398913,acenocoumarol
COLLAGEN_DEGRADATION,-1.771971327,0.255363779,acenocoumarol
REGULATION_OF_TP53_ACTIVITY,1.656756389,0.984053002,acenocoumarol
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.263600407,0.046367359,paclitaxel
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.169909925,0.04830029,paclitaxel
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.165164082,0.05908099,paclitaxel
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,-2.150365446,0.045370211,paclitaxel
MITOTIC_G2_G2_M_PHASES,-2.144571213,0.034401589,paclitaxel
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.08049008,0.043375916,paclitaxel
METABOLISM_OF_NUCLEOTIDES,-2.022488186,0.056588121,paclitaxel
CELL_CYCLE_CHECKPOINTS,-2.01969302,0.049358801,paclitaxel
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.01443429,0.044871638,paclitaxel
CELL_CYCLE,-1.994930823,0.045536403,paclitaxel
G_ALPHA_Q_SIGNALLING_EVENTS,-1.905847938,0.294884038,FK-866
HOST_INTERACTIONS_OF_HIV_FACTORS,1.61066591,1,FK-866
GPCR_LIGAND_BINDING,-1.85764029,0.231480218,FK-866
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1.393966747,1,FK-866
RSV_HOST_INTERACTIONS,-1.762860203,0.358913142,FK-866
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.754236593,0.28888131,FK-866
C_TYPE_LECTIN_RECEPTORS_CLRS,1.350657801,1,FK-866
AUTOPHAGY,1.348303846,1,FK-866
INFLUENZA_INFECTION,1.339637524,1,FK-866
MITOTIC_METAPHASE_AND_ANAPHASE,1.323732325,1,FK-866
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,-2.03129159,0.137724197,fingolimod
GPCR_LIGAND_BINDING,-1.987964303,0.110075021,fingolimod
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.96970022,0.093902861,fingolimod
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.930328165,0.107988291,fingolimod
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.80954368,0.254163745,fingolimod
SIGNALING_BY_WNT,-1.806412088,0.217541629,fingolimod
MITOCHONDRIAL_TRANSLATION,1.381326081,1,fingolimod
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.724779317,0.372779455,fingolimod
G_ALPHA_Q_SIGNALLING_EVENTS,-1.700696761,0.395565804,fingolimod
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.686194798,0.394971665,fingolimod
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.881883759,0.086422018,zolpidem
KERATINIZATION,1.79763041,0.076513761,zolpidem
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.87695325,0.582141864,zolpidem
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.659109557,0.11853211,zolpidem
MITOCHONDRIAL_TRANSLATION,1.553980096,0.145733945,zolpidem
TRANSLATION,1.456736517,0.192990826,zolpidem
RRNA_PROCESSING,1.437521208,0.178256881,zolpidem
SIGNALING_BY_VEGF,-1.532696844,1,zolpidem
APOPTOSIS,-1.526498287,1,zolpidem
SIGNALING_BY_NOTCH,-1.521799376,1,zolpidem
EUKARYOTIC_TRANSLATION_ELONGATION,3.628114064,0,BRD-K76022557
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.538665691,0,BRD-K76022557
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.606855911,0,BRD-K76022557
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.839074922,0,BRD-K76022557
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.868634302,0,BRD-K76022557
SIGNALING_BY_ROBO_RECEPTORS,3.052918623,0,BRD-K76022557
INFLUENZA_INFECTION,3.278829725,0,BRD-K76022557
GPCR_LIGAND_BINDING,-2.915154368,0,BRD-K76022557
SELENOAMINO_ACID_METABOLISM,3.450197501,0,BRD-K76022557
NONSENSE_MEDIATED_DECAY_NMD,3.45532922,0,BRD-K76022557
GPCR_LIGAND_BINDING,-2.92699505,0,aminoglutethimide
G_ALPHA_S_SIGNALLING_EVENTS,-2.49504417,0,aminoglutethimide
INFLUENZA_INFECTION,-2.515461728,0,aminoglutethimide
SIGNALING_BY_GPCR,-2.540902222,0,aminoglutethimide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.555187233,0,aminoglutethimide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.577061,0,aminoglutethimide
SIGNALING_BY_ROBO_RECEPTORS,-2.612513076,0,aminoglutethimide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.655334273,0,aminoglutethimide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.689921444,0,aminoglutethimide
SELENOAMINO_ACID_METABOLISM,-2.734939514,0,aminoglutethimide
GLYCOSAMINOGLYCAN_METABOLISM,1.621141572,0.584583762,paroxetine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.819222629,0.808676879,paroxetine
METABOLISM_OF_STEROIDS,1.526910053,0.487769784,paroxetine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.446253246,0.505241521,paroxetine
NEURONAL_SYSTEM,-1.749750827,0.773517014,paroxetine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.424866826,0.423946557,paroxetine
TRNA_PROCESSING_IN_THE_NUCLEUS,1.343841043,0.507379239,paroxetine
CILIUM_ASSEMBLY,1.332098102,0.38285127,paroxetine
RHOA_GTPASE_CYCLE,1.332464795,0.445837616,paroxetine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.685156833,0.883554368,paroxetine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.182661408,0,triflupromazine
EUKARYOTIC_TRANSLATION_ELONGATION,3.058060791,0,triflupromazine
SELENOAMINO_ACID_METABOLISM,2.987103824,0,triflupromazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.984497262,0,triflupromazine
NONSENSE_MEDIATED_DECAY_NMD,2.935004634,0,triflupromazine
EUKARYOTIC_TRANSLATION_INITIATION,2.837788853,0,triflupromazine
CELLULAR_RESPONSE_TO_STARVATION,2.832227507,0,triflupromazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.706419745,0,triflupromazine
INFLUENZA_INFECTION,2.555530844,0.00052984,triflupromazine
TRANSLATION,2.467109323,0.000867012,triflupromazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.065378008,0,TTNPB
MITOTIC_METAPHASE_AND_ANAPHASE,-2.631436394,0,TTNPB
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.625431415,0,TTNPB
PROTEASOME_ASSEMBLY,-2.61663339,0,TTNPB
SEPARATION_OF_SISTER_CHROMATIDS,-2.605109274,0,TTNPB
DNA_REPLICATION,-2.604364567,0,TTNPB
SYNTHESIS_OF_DNA,-2.604364567,0,TTNPB
CELLULAR_RESPONSE_TO_STARVATION,-2.591006709,0,TTNPB
SIGNALING_BY_ROBO_RECEPTORS,-2.650869839,0,TTNPB
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,-2.573267091,0,TTNPB
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.900248621,0,amrinone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.732147366,0,amrinone
NONSENSE_MEDIATED_DECAY_NMD,2.670095797,0,amrinone
SELENOAMINO_ACID_METABOLISM,2.648135456,0,amrinone
ECM_PROTEOGLYCANS,-2.629660394,0,amrinone
EUKARYOTIC_TRANSLATION_ELONGATION,2.628693303,0,amrinone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.548620629,0.000305454,amrinone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.528267908,0.000219066,amrinone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.471346428,0.001018181,amrinone
INFLUENZA_INFECTION,2.470026235,0.000872726,amrinone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.803271425,0,trimipramine
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.542450475,0.00422462,trimipramine
SUMOYLATION,2.538501514,0.002816413,trimipramine
CELL_CYCLE_CHECKPOINTS,2.412463834,0.003168465,trimipramine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.295716115,0.003405863,trimipramine
CELL_CYCLE,2.266764955,0.005069544,trimipramine
DNA_REPAIR,2.257806243,0.004928723,trimipramine
GPCR_LIGAND_BINDING,-2.221237226,0.002724691,trimipramine
CHROMATIN_ORGANIZATION,2.249814913,0.004828137,trimipramine
DNA_DOUBLE_STRAND_BREAK_REPAIR,2.212410806,0.00422462,trimipramine
GPCR_LIGAND_BINDING,-2.500724753,0,benzthiazide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.398573345,0,benzthiazide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.337658828,0,benzthiazide
SIGNALING_BY_GPCR,-2.330158166,0,benzthiazide
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.564084178,0.003837502,benzthiazide
CELL_CYCLE_MITOTIC,2.398303826,0.007675003,benzthiazide
G_ALPHA_I_SIGNALLING_EVENTS,-2.214337702,0.001012357,benzthiazide
CHROMATIN_ORGANIZATION,2.028633274,0.042212518,benzthiazide
CELL_CYCLE,2.004910819,0.036456266,benzthiazide
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.934658872,0.053725023,benzthiazide
MEMBRANE_TRAFFICKING,2.077949485,0.031403337,paracetamol
RAB_REGULATION_OF_TRAFFICKING,1.942372421,0.043179588,paracetamol
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.9164596,0.037945698,paracetamol
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.904934069,0.032384691,paracetamol
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.848672327,0.032973503,paracetamol
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.733579598,0.055610075,paracetamol
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.570816826,0.116640965,paracetamol
FATTY_ACID_METABOLISM,1.55097004,0.11138371,paracetamol
GPCR_LIGAND_BINDING,-1.861036566,0.291813649,paracetamol
AMINE_LIGAND_BINDING_RECEPTORS,-1.849280334,0.162021907,paracetamol
SELENOAMINO_ACID_METABOLISM,2.35505475,0.011970592,fomepizole
NONSENSE_MEDIATED_DECAY_NMD,2.276943184,0.010338239,fomepizole
ECM_PROTEOGLYCANS,-2.312276889,0.020742295,fomepizole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.266709328,0.008705885,fomepizole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.247453583,0.007345591,fomepizole
CELLULAR_RESPONSE_TO_STARVATION,2.162017899,0.015017652,fomepizole
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.16315236,0.043370254,fomepizole
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.145326188,0.033941938,fomepizole
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.136641096,0.026870701,fomepizole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.099832632,0.022852949,fomepizole
MITOTIC_METAPHASE_AND_ANAPHASE,-3.731724937,0,sunitinib
G2_M_CHECKPOINTS,-2.962722183,0,sunitinib
CELL_CYCLE_MITOTIC,-3.10359899,0,sunitinib
CELL_CYCLE,-3.146777144,0,sunitinib
DNA_REPLICATION,-3.153392567,0,sunitinib
DNA_REPLICATION_PRE_INITIATION,-3.130982979,0,sunitinib
CELL_CYCLE_CHECKPOINTS,-3.385006527,0,sunitinib
SEPARATION_OF_SISTER_CHROMATIDS,-3.42491633,0,sunitinib
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-3.455619632,0,sunitinib
KERATINIZATION,-3.455619632,0,sunitinib
METABOLISM_OF_RNA,2.78438548,0,istradefylline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.698072252,0,istradefylline
MRNA_SPLICING,2.537897536,0.001206162,istradefylline
EUKARYOTIC_TRANSLATION_ELONGATION,2.444653576,0.002261554,istradefylline
SELENOAMINO_ACID_METABOLISM,2.422295587,0.002171092,istradefylline
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.390835844,0.003015406,istradefylline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.376443424,0.002584633,istradefylline
SIGNALING_BY_ROBO_RECEPTORS,2.355201762,0.003166176,istradefylline
NONSENSE_MEDIATED_DECAY_NMD,2.328108113,0.003618487,istradefylline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.327965016,0.003256638,istradefylline
NONSENSE_MEDIATED_DECAY_NMD,4.565949675,0,methimazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.813538943,0,methimazole
METABOLISM_OF_RNA,2.919140825,0,methimazole
SIGNALING_BY_ROBO_RECEPTORS,3.522222557,0,methimazole
CELLULAR_RESPONSE_TO_STARVATION,3.626511119,0,methimazole
RRNA_PROCESSING,3.635319837,0,methimazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,4.128521882,0,methimazole
INFLUENZA_INFECTION,4.109677775,0,methimazole
TRANSLATION,4.329323276,0,methimazole
EUKARYOTIC_TRANSLATION_INITIATION,4.343893595,0,methimazole
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.479652385,0.010259028,alectinib
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,2.44315705,0.007694271,alectinib
VESICLE_MEDIATED_TRANSPORT,2.164780629,0.027927353,alectinib
MEMBRANE_TRAFFICKING,2.108347186,0.029494705,alectinib
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.059263849,0.031461018,alectinib
POTASSIUM_CHANNELS,-2.066400063,0.080243844,alectinib
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.990200353,0.040751138,alectinib
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.95660531,0.042013161,alectinib
RHO_GTPASE_CYCLE,1.909885334,0.047875463,alectinib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.8875729,0.047115535,alectinib
EXTRACELLULAR_MATRIX_ORGANIZATION,2.307577282,0.027990465,glipizide
TRANSLATION,2.188272372,0.02573317,glipizide
RESPIRATORY_ELECTRON_TRANSPORT,2.040315577,0.046650775,glipizide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.985341548,0.277784527,glipizide
DISEASES_OF_METABOLISM,1.813251857,0.128214389,glipizide
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1.79497959,0.112142444,glipizide
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.855460263,0.446107493,glipizide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.656377263,0.211583839,glipizide
RRNA_PROCESSING,1.643028093,0.193998432,glipizide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.600881808,0.209815624,glipizide
NEUTROPHIL_DEGRANULATION,-3.149739228,0,methantheline
TOLL_LIKE_RECEPTOR_CASCADES,-2.360572705,0.039670725,methantheline
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.233495654,0.073623147,methantheline
INNATE_IMMUNE_SYSTEM,-2.224207343,0.057897815,methantheline
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-2.103982295,0.084487922,methantheline
GPCR_LIGAND_BINDING,2.064681937,0.127604645,methantheline
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.032279169,0.106503388,methantheline
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.947645491,0.14305968,methantheline
ESR_MEDIATED_SIGNALING,-1.889592552,0.166456218,methantheline
SENSORY_PERCEPTION,1.945333249,0.188101148,methantheline
PEROXISOMAL_PROTEIN_IMPORT,2.344539063,0.012137405,ketoprofen
MUSCLE_CONTRACTION,2.301681595,0.010788804,ketoprofen
NEURONAL_SYSTEM,2.206193595,0.014609839,ketoprofen
BIOLOGICAL_OXIDATIONS,1.900969173,0.090356234,ketoprofen
VISUAL_PHOTOTRANSDUCTION,1.889469595,0.077409669,ketoprofen
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.932211365,0.674339045,ketoprofen
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.83477195,0.085973282,ketoprofen
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.787016011,0.095943293,ketoprofen
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.689088118,0.149357506,ketoprofen
CELL_JUNCTION_ORGANIZATION,1.611591739,0.200866554,ketoprofen
GPCR_LIGAND_BINDING,2.429638253,0.005999935,terazosin
SIGNALING_BY_GPCR,2.257730504,0.012857004,terazosin
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,-2.254313808,0.069492173,terazosin
NEUTROPHIL_DEGRANULATION,-2.098360225,0.104238259,terazosin
NCAM1_INTERACTIONS,2.07326733,0.049999461,terazosin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.034687857,0.053142284,terazosin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.018444211,0.123265878,terazosin
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.965353934,0.070799237,terazosin
MRNA_SPLICING,-1.955473949,0.136192249,terazosin
METABOLISM_OF_RNA,-1.936199003,0.121859488,terazosin
EUKARYOTIC_TRANSLATION_INITIATION,3.994243027,0,triamterene
EUKARYOTIC_TRANSLATION_ELONGATION,3.944127916,0,triamterene
TRANSLATION,3.842746931,0,triamterene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.642358229,0,triamterene
CELLULAR_RESPONSE_TO_STARVATION,3.604455835,0,triamterene
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.57554909,0,triamterene
SELENOAMINO_ACID_METABOLISM,3.488595438,0,triamterene
RESPIRATORY_ELECTRON_TRANSPORT,3.240766123,0,triamterene
RRNA_PROCESSING,3.185080219,0,triamterene
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.943580637,0,triamterene
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-2.29296536,0.046253204,propoxycaine
TOLL_LIKE_RECEPTOR_CASCADES,-2.129610697,0.088854839,propoxycaine
INNATE_IMMUNE_SYSTEM,-1.990495055,0.134296584,propoxycaine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.97142208,0.111981441,propoxycaine
GPCR_LIGAND_BINDING,1.995591333,0.341576216,propoxycaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.971061191,0.20767834,propoxycaine
NEUTROPHIL_DEGRANULATION,-1.798375784,0.236378217,propoxycaine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.777250428,0.221731369,propoxycaine
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.675316568,0.333683829,propoxycaine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.660180414,0.314947804,propoxycaine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,5.155631485,0,melperone
NERVOUS_SYSTEM_DEVELOPMENT,2.868718489,0,melperone
SARS_COV_1_INFECTION,2.88945839,0,melperone
SARS_COV_1_HOST_INTERACTIONS,3.078931705,0,melperone
CELLULAR_RESPONSES_TO_STIMULI,3.117991799,0,melperone
VIRAL_INFECTION_PATHWAYS,3.143212723,0,melperone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.252424938,0,melperone
METABOLISM_OF_RNA,3.588707259,0,melperone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,4.198094504,0,melperone
CELLULAR_RESPONSE_TO_STARVATION,4.599663848,0,melperone
METABOLISM_OF_RNA,3.83125317,0,IC-261
EUKARYOTIC_TRANSLATION_INITIATION,3.303514881,0,IC-261
RRNA_PROCESSING,3.272234105,0,IC-261
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.08775577,0,IC-261
NONSENSE_MEDIATED_DECAY_NMD,3.03772527,0,IC-261
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.02757258,0,IC-261
EUKARYOTIC_TRANSLATION_ELONGATION,2.967671007,0,IC-261
SIGNALING_BY_ROBO_RECEPTORS,2.94276455,0,IC-261
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2.938545836,0,IC-261
TRANSLATION,2.68229583,0.000160613,IC-261
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.390659443,0.003194159,amitriptyline
MRNA_SPLICING,2.307805124,0.004791239,amitriptyline
G_ALPHA_Q_SIGNALLING_EVENTS,-2.076423328,0.011869785,amitriptyline
NEURONAL_SYSTEM,-1.945122069,0.030130993,amitriptyline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.926632047,0.027087458,amitriptyline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.876852111,0.044055163,amitriptyline
GPCR_LIGAND_BINDING,-1.870342397,0.0378007,amitriptyline
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.85262033,0.038196359,amitriptyline
UNFOLDED_PROTEIN_RESPONSE_UPR,1.558398825,0.334322002,amitriptyline
POTASSIUM_CHANNELS,-1.793628466,0.063914227,amitriptyline
GPCR_LIGAND_BINDING,-2.246436211,0.002111293,perhexiline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.223066667,0.002111293,perhexiline
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.138046049,0.005160939,perhexiline
G_ALPHA_I_SIGNALLING_EVENTS,-2.107608635,0.005806057,perhexiline
SIGNALING_BY_GPCR,-2.09619379,0.00534861,perhexiline
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.958250093,0.213807646,perhexiline
G_ALPHA_Q_SIGNALLING_EVENTS,-2.045763663,0.007975997,perhexiline
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.702829613,0.478637572,perhexiline
SARS_COV_1_INFECTION,1.649378794,0.422756028,perhexiline
AMINE_LIGAND_BINDING_RECEPTORS,-1.874093058,0.036495213,perhexiline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.312136211,0.000983515,aliskiren
GPCR_LIGAND_BINDING,-2.174680589,0.001475273,aliskiren
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.927001711,0.103148024,aliskiren
NEURONAL_SYSTEM,-1.857934497,0.136380806,aliskiren
SIGNALING_BY_GPCR,-1.808483324,0.167935259,aliskiren
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.532754151,0.407317482,aliskiren
EXTRACELLULAR_MATRIX_ORGANIZATION,1.52801214,0.27896852,aliskiren
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.789762979,0.159526202,aliskiren
POTASSIUM_CHANNELS,-1.788491126,0.134577694,aliskiren
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.758010976,0.153709411,aliskiren
EUKARYOTIC_TRANSLATION_INITIATION,3.866860301,0,doconexent
S_PHASE,2.655256947,0,doconexent
CELLULAR_RESPONSE_TO_STARVATION,2.704947524,0,doconexent
SIGNALING_BY_ROBO_RECEPTORS,2.705920789,0,doconexent
DNA_REPLICATION_PRE_INITIATION,2.748057697,0,doconexent
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.757714547,0,doconexent
CELL_CYCLE_MITOTIC,2.771672196,0,doconexent
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.78236586,0,doconexent
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.911580623,0,doconexent
MITOTIC_METAPHASE_AND_ANAPHASE,2.948171854,0,doconexent
TRANSLATION,3.344565071,0,proxymetacaine
RRNA_PROCESSING,2.465242132,0.004494405,proxymetacaine
CILIUM_ASSEMBLY,-2.155039667,0.049491131,proxymetacaine
SYNTHESIS_OF_DNA,2.129974095,0.032102892,proxymetacaine
DNA_REPLICATION,2.071495236,0.034992153,proxymetacaine
RESPIRATORY_ELECTRON_TRANSPORT,2.062990684,0.03030513,proxymetacaine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.057595657,0.026324372,proxymetacaine
S_PHASE,2.043540325,0.025315424,proxymetacaine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.920373749,0.048635882,proxymetacaine
PEROXISOMAL_PROTEIN_IMPORT,-1.974107033,0.169094699,proxymetacaine
METABOLISM_OF_RNA,5.679179702,0,PJ-34
SEPARATION_OF_SISTER_CHROMATIDS,2.822497623,0,PJ-34
HIV_LIFE_CYCLE,2.842994616,0,PJ-34
MRNA_SPLICING,2.956643806,0,PJ-34
MITOTIC_SPINDLE_CHECKPOINT,3.007433522,0,PJ-34
CELL_CYCLE,3.074778244,0,PJ-34
SARS_COV_INFECTIONS,3.089381729,0,PJ-34
CELL_CYCLE_MITOTIC,3.115163994,0,PJ-34
HIV_INFECTION,3.128189524,0,PJ-34
SARS_COV_2_INFECTION,3.134096581,0,PJ-34
EUKARYOTIC_TRANSLATION_ELONGATION,-2.738436351,0,thioridazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.508678726,0,thioridazine
NONSENSE_MEDIATED_DECAY_NMD,-2.587412992,0,thioridazine
CELLULAR_RESPONSE_TO_STARVATION,-2.59556695,0,thioridazine
INFLUENZA_INFECTION,-2.447327585,0,thioridazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.631236503,0,thioridazine
EUKARYOTIC_TRANSLATION_INITIATION,-2.668376612,0,thioridazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.686810631,0,thioridazine
SELENOAMINO_ACID_METABOLISM,-2.610389652,0,thioridazine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.433022683,9.01E-05,thioridazine
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,2.83520545,0,irbesartan
RRNA_PROCESSING,2.743763936,0,irbesartan
METABOLISM_OF_RNA,2.419645475,0.003708649,irbesartan
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.947686551,0.043391188,irbesartan
GLYCOSAMINOGLYCAN_METABOLISM,1.938637657,0.03693814,irbesartan
CELLULAR_RESPONSE_TO_HEAT_STRESS,1.873100529,0.044874648,irbesartan
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.784959948,0.069934516,irbesartan
G2_M_CHECKPOINTS,1.707428502,0.089285714,irbesartan
GPCR_LIGAND_BINDING,-1.872631008,0.326739338,irbesartan
POTASSIUM_CHANNELS,-1.869605963,0.167238951,irbesartan
GPCR_LIGAND_BINDING,-2.606923738,0,imiquimod
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.449156144,0.000443713,imiquimod
G_ALPHA_S_SIGNALLING_EVENTS,-2.262488954,0.004732939,imiquimod
SIGNALING_BY_GPCR,-2.252239349,0.003993417,imiquimod
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.247001914,0.003372219,imiquimod
CHROMATIN_ORGANIZATION,2.00843557,0.134418754,imiquimod
RHOA_GTPASE_CYCLE,1.906855772,0.129181659,imiquimod
G_ALPHA_I_SIGNALLING_EVENTS,-1.989978122,0.034461709,imiquimod
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.782365376,0.194354389,imiquimod
RHO_GTPASE_CYCLE,1.769169155,0.153621433,imiquimod
NONSENSE_MEDIATED_DECAY_NMD,2.486170437,0.001210392,dicycloverine
EUKARYOTIC_TRANSLATION_ELONGATION,2.465716336,0.000605196,dicycloverine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.438221666,0.001210392,dicycloverine
EUKARYOTIC_TRANSLATION_INITIATION,2.436132062,0.000907794,dicycloverine
SIGNALING_BY_ROBO_RECEPTORS,2.395375726,0.001210392,dicycloverine
RRNA_PROCESSING,2.353710309,0.001613856,dicycloverine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.342641255,0.001729132,dicycloverine
SELENOAMINO_ACID_METABOLISM,2.290208139,0.003933775,dicycloverine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.283705934,0.003900153,dicycloverine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.277681937,0.003752216,dicycloverine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.181039148,0,citalopram
RESPIRATORY_ELECTRON_TRANSPORT,2.532540458,0,citalopram
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.743679538,0,citalopram
CELLULAR_RESPONSES_TO_STIMULI,2.804692236,0,citalopram
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.871050176,0,citalopram
INFECTIOUS_DISEASE,2.927031412,0,citalopram
METABOLISM_OF_RNA,2.937016436,0,citalopram
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.997196178,0,citalopram
NERVOUS_SYSTEM_DEVELOPMENT,3.048038963,0,citalopram
SARS_COV_1_INFECTION,3.147917344,0,citalopram
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.841454469,0,rescinnamine
EUKARYOTIC_TRANSLATION_ELONGATION,3.838154875,0,rescinnamine
EUKARYOTIC_TRANSLATION_INITIATION,3.763471519,0,rescinnamine
TRANSLATION,3.646578681,0,rescinnamine
SELENOAMINO_ACID_METABOLISM,3.639981425,0,rescinnamine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.594014333,0,rescinnamine
INFLUENZA_INFECTION,3.579296393,0,rescinnamine
CELLULAR_RESPONSE_TO_STARVATION,3.488373599,0,rescinnamine
RRNA_PROCESSING,3.398857092,0,rescinnamine
NONSENSE_MEDIATED_DECAY_NMD,3.377594142,0,rescinnamine
EUKARYOTIC_TRANSLATION_ELONGATION,3.384660674,0,tolbutamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.770291994,0,tolbutamide
TRANSLATION,2.802488267,0,tolbutamide
RRNA_PROCESSING,2.863415573,0,tolbutamide
INFLUENZA_INFECTION,3.035067464,0,tolbutamide
EUKARYOTIC_TRANSLATION_INITIATION,3.129218358,0,tolbutamide
SIGNALING_BY_ROBO_RECEPTORS,3.053511043,0,tolbutamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.137751168,0,tolbutamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.176202766,0,tolbutamide
NONSENSE_MEDIATED_DECAY_NMD,3.205126427,0,tolbutamide
SARS_COV_1_HOST_INTERACTIONS,2.437100528,0.0070018,riboflavin
SARS_COV_1_INFECTION,2.341861669,0.0070018,riboflavin
EUKARYOTIC_TRANSLATION_INITIATION,2.295536436,0.009335734,riboflavin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.26241515,0.009452431,riboflavin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.242197111,0.008962305,riboflavin
NONSENSE_MEDIATED_DECAY_NMD,2.215607859,0.009102341,riboflavin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.197893065,0.011002829,riboflavin
EUKARYOTIC_TRANSLATION_ELONGATION,2.16200573,0.014003601,riboflavin
SIGNALING_BY_ROBO_RECEPTORS,2.148769992,0.014159196,riboflavin
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.126183671,0.015824069,riboflavin
EUKARYOTIC_TRANSLATION_ELONGATION,3.463903275,0,bendroflumethiazide
RRNA_PROCESSING,3.418567735,0,bendroflumethiazide
EUKARYOTIC_TRANSLATION_INITIATION,3.36331922,0,bendroflumethiazide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.260838924,0,bendroflumethiazide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.169860088,0,bendroflumethiazide
CELLULAR_RESPONSE_TO_STARVATION,3.141807864,0,bendroflumethiazide
SELENOAMINO_ACID_METABOLISM,3.137151136,0,bendroflumethiazide
TRANSLATION,3.113262105,0,bendroflumethiazide
NONSENSE_MEDIATED_DECAY_NMD,2.892349717,0,bendroflumethiazide
INFLUENZA_INFECTION,2.881087131,0,bendroflumethiazide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.168136504,0.103818532,naltrexone
CELL_CYCLE_MITOTIC,2.09911645,0.084430734,naltrexone
TRANSLATION,2.097726523,0.057537982,naltrexone
MITOTIC_SPINDLE_CHECKPOINT,2.06029769,0.053785504,naltrexone
RESPIRATORY_ELECTRON_TRANSPORT,2.052605068,0.04527989,naltrexone
MITOTIC_METAPHASE_AND_ANAPHASE,2.015366965,0.04398737,naltrexone
UNFOLDED_PROTEIN_RESPONSE_UPR,2.009052224,0.040383801,naltrexone
CELL_CYCLE,1.981355943,0.041589954,naltrexone
CELL_CYCLE_CHECKPOINTS,1.893323181,0.069629296,naltrexone
M_PHASE,1.866863626,0.075049541,naltrexone
GPCR_LIGAND_BINDING,-2.336484938,0,atomoxetine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.569922784,0.008877864,atomoxetine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.19340468,0.001039719,atomoxetine
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2.448653326,0.008877864,atomoxetine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.18105969,0.000924195,atomoxetine
SIGNALING_BY_GPCR,-2.132526128,0.001386292,atomoxetine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.248060331,0.017755728,atomoxetine
MITOCHONDRIAL_BIOGENESIS,2.054351479,0.043279587,atomoxetine
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.03679058,0.035511456,atomoxetine
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.035727602,0.030332702,atomoxetine
SELENOAMINO_ACID_METABOLISM,3.651729725,0,quetiapine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.615679501,0,quetiapine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.608036246,0,quetiapine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.583724131,0,quetiapine
EUKARYOTIC_TRANSLATION_ELONGATION,3.561761287,0,quetiapine
NONSENSE_MEDIATED_DECAY_NMD,3.516128345,0,quetiapine
CELLULAR_RESPONSE_TO_STARVATION,3.475989553,0,quetiapine
TRANSLATION,3.405556447,0,quetiapine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.238831548,0,quetiapine
EUKARYOTIC_TRANSLATION_INITIATION,3.103693544,0,quetiapine
PEROXISOMAL_PROTEIN_IMPORT,2.379438331,0.008329665,probucol
G_ALPHA_S_SIGNALLING_EVENTS,-2.139151007,0.087434403,probucol
SIGNALING_BY_HEDGEHOG,-2.123301658,0.051003401,probucol
GPCR_LIGAND_BINDING,-2.097001105,0.045452011,probucol
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.095708503,0.03434923,probucol
SIGNALING_BY_NTRKS,2.085194168,0.082371133,probucol
SIGNALING_BY_GPCR,-2.01029031,0.056832362,probucol
GASTRULATION,-2.008726839,0.048054225,probucol
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.974207496,0.111062202,probucol
HEDGEHOG_OFF_STATE,-1.930055474,0.075092472,probucol
TRANSLATION,3.101246875,0,minoxidil
RRNA_PROCESSING,2.789729186,0,minoxidil
RESPIRATORY_ELECTRON_TRANSPORT,2.379885959,0.007165314,minoxidil
CILIUM_ASSEMBLY,-2.040438564,0.161647562,minoxidil
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.98567932,0.07792279,minoxidil
METABOLISM_OF_RNA,1.800696,0.174731301,minoxidil
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.880939673,0.33129331,minoxidil
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,-1.803861779,0.415063791,minoxidil
RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK,-1.758513206,0.421799106,minoxidil
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.722407464,0.440321223,minoxidil
EUKARYOTIC_TRANSLATION_ELONGATION,-4.414211847,0,proguanil
INFECTIOUS_DISEASE,-2.784412193,0,proguanil
SARS_COV_1_INFECTION,-3.022454457,0,proguanil
VIRAL_INFECTION_PATHWAYS,-3.130780942,0,proguanil
NERVOUS_SYSTEM_DEVELOPMENT,-3.193367762,0,proguanil
CELLULAR_RESPONSES_TO_STIMULI,-3.254072564,0,proguanil
SARS_COV_1_HOST_INTERACTIONS,-3.2937344,0,proguanil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.386272162,0,proguanil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.392330367,0,proguanil
METABOLISM_OF_RNA,-3.743634322,0,proguanil
TRANSLATION,3.278532237,0,tianeptine
MITOTIC_SPINDLE_CHECKPOINT,2.463052877,0.010335303,tianeptine
CELL_CYCLE_CHECKPOINTS,2.439981417,0.006890202,tianeptine
RESPIRATORY_ELECTRON_TRANSPORT,2.377125971,0.007105521,tianeptine
RHO_GTPASES_ACTIVATE_FORMINS,2.349626973,0.006201182,tianeptine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.295457775,0.007751478,tianeptine
METABOLISM_OF_RNA,2.230133692,0.011811775,tianeptine
GPCR_LIGAND_BINDING,-2.10383443,0.04834626,tianeptine
MITOTIC_METAPHASE_AND_ANAPHASE,2.100081924,0.023254433,tianeptine
MRNA_SPLICING,2.097916413,0.020670607,tianeptine
TRANSLATION,4.342061402,0,etacrynic-acid
RRNA_PROCESSING,3.049410662,0,etacrynic-acid
SIGNALING_BY_ROBO_RECEPTORS,3.287127524,0,etacrynic-acid
INFLUENZA_INFECTION,3.438538895,0,etacrynic-acid
CELLULAR_RESPONSE_TO_STARVATION,3.532416071,0,etacrynic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.734196916,0,etacrynic-acid
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.187586886,0,etacrynic-acid
SELENOAMINO_ACID_METABOLISM,4.056325349,0,etacrynic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.063219164,0,etacrynic-acid
NONSENSE_MEDIATED_DECAY_NMD,4.092918738,0,etacrynic-acid
SIGNALING_BY_ROBO_RECEPTORS,4.236577878,0,pioglitazone
KEAP1_NFE2L2_PATHWAY,2.788307821,0,pioglitazone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.057455334,0,pioglitazone
SARS_COV_1_INFECTION,3.060521697,0,pioglitazone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.091118678,0,pioglitazone
SARS_COV_1_HOST_INTERACTIONS,3.122167235,0,pioglitazone
INFECTIOUS_DISEASE,3.137177179,0,pioglitazone
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,3.2038892,0,pioglitazone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.211140313,0,pioglitazone
VIRAL_INFECTION_PATHWAYS,3.261751315,0,pioglitazone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.460870555,0,mevastatin
EUKARYOTIC_TRANSLATION_INITIATION,3.43404993,0,mevastatin
EUKARYOTIC_TRANSLATION_ELONGATION,3.361827095,0,mevastatin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.361055491,0,mevastatin
CELLULAR_RESPONSE_TO_STARVATION,3.012914712,0,mevastatin
SELENOAMINO_ACID_METABOLISM,2.842490345,0,mevastatin
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.668575237,0,mevastatin
NONSENSE_MEDIATED_DECAY_NMD,2.656485098,0,mevastatin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.602791319,0,mevastatin
INFLUENZA_INFECTION,2.54155342,0,mevastatin
CELLULAR_RESPONSE_TO_STARVATION,3.231494553,0,obatoclax
UNFOLDED_PROTEIN_RESPONSE_UPR,3.173946143,0,obatoclax
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.930368263,0,obatoclax
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.928942611,0,obatoclax
TRANSLATION,2.638059946,0.00045966,obatoclax
IRE1ALPHA_ACTIVATES_CHAPERONES,2.585344198,0.0007661,obatoclax
EUKARYOTIC_TRANSLATION_INITIATION,2.488298811,0.001313315,obatoclax
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.479689502,0.001292794,obatoclax
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.239362325,0.006767221,obatoclax
CELLULAR_RESPONSES_TO_STIMULI,2.186967356,0.008963375,obatoclax
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.313837168,0,topiramate
GPCR_LIGAND_BINDING,-2.523175944,0,topiramate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.597931975,0,topiramate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.673103846,0,topiramate
METABOLISM_OF_RNA,-2.726269936,0,topiramate
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.734141067,0,topiramate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.751241406,0,topiramate
INFLUENZA_INFECTION,-2.984931024,0,topiramate
SIGNALING_BY_ROBO_RECEPTORS,-2.994099887,0,topiramate
RRNA_PROCESSING,-3.033091861,0,topiramate
EUKARYOTIC_TRANSLATION_ELONGATION,3.884374712,0,cisapride
SARS_COV_1_INFECTION,2.780579477,0,cisapride
METABOLISM_OF_RNA,2.825661368,0,cisapride
SARS_COV_1_HOST_INTERACTIONS,2.864692525,0,cisapride
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.897549789,0,cisapride
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.923924717,0,cisapride
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.001103084,0,cisapride
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.041261416,0,cisapride
SIGNALING_BY_ROBO_RECEPTORS,3.059885188,0,cisapride
VIRAL_INFECTION_PATHWAYS,2.733434679,0,cisapride
NEUTROPHIL_DEGRANULATION,-2.507846562,0.005557761,argatroban
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.852248449,0.291782453,argatroban
ESR_MEDIATED_SIGNALING,-1.835321859,0.214900093,argatroban
INNATE_IMMUNE_SYSTEM,-1.822955726,0.172985312,argatroban
GPCR_LIGAND_BINDING,1.854071986,0.836494184,argatroban
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.610172359,0.421556173,argatroban
RHO_GTPASE_CYCLE,-1.590103009,0.391590578,argatroban
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.55322643,0.401548233,argatroban
TOLL_LIKE_RECEPTOR_CASCADES,-1.541710795,0.372196308,argatroban
RAC3_GTPASE_CYCLE,-1.525976727,0.361871995,argatroban
INTERFERON_ALPHA_BETA_SIGNALING,2.857414785,0,cladribine
METABOLISM_OF_RNA,-2.55342698,0,cladribine
DNA_REPAIR,-2.595496767,0,cladribine
MITOTIC_PROMETAPHASE,-2.713908197,0,cladribine
M_PHASE,-2.730296886,0,cladribine
MITOTIC_SPINDLE_CHECKPOINT,-2.547824897,0,cladribine
CELL_CYCLE_MITOTIC,-2.786530047,0,cladribine
GPCR_LIGAND_BINDING,2.821037404,0,cladribine
MUSCLE_CONTRACTION,2.844136222,0,cladribine
CELL_CYCLE,-2.779843481,0,cladribine
EUKARYOTIC_TRANSLATION_INITIATION,2.827866687,0,pargyline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.7983178,0,pargyline
EUKARYOTIC_TRANSLATION_ELONGATION,2.772855215,0,pargyline
RRNA_PROCESSING,2.644741666,0,pargyline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.627820389,0,pargyline
TRANSLATION,2.627277697,0,pargyline
NONSENSE_MEDIATED_DECAY_NMD,2.585024046,0,pargyline
SELENOAMINO_ACID_METABOLISM,2.558239357,0,pargyline
INFLUENZA_INFECTION,2.372101045,0.002032201,pargyline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.27752799,0.004502107,pargyline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.426606514,0,cirazoline
TRANSLATION,3.382810357,0,cirazoline
EUKARYOTIC_TRANSLATION_INITIATION,3.345171973,0,cirazoline
SELENOAMINO_ACID_METABOLISM,3.089490951,0,cirazoline
EUKARYOTIC_TRANSLATION_ELONGATION,2.969032678,0,cirazoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.833124105,0,cirazoline
RRNA_PROCESSING,2.746548123,0,cirazoline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.616899071,0,cirazoline
METABOLISM_OF_RNA,2.606963564,0,cirazoline
INFLUENZA_INFECTION,2.590850229,0,cirazoline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.46141032,0.004712425,vincristine
EUKARYOTIC_TRANSLATION_ELONGATION,2.335275575,0.01335187,vincristine
EUKARYOTIC_TRANSLATION_INITIATION,2.287784946,0.01518448,vincristine
CILIUM_ASSEMBLY,-2.236509214,0.025655575,vincristine
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.184555841,0.02670374,vincristine
TRANSLATION,2.153905153,0.02858871,vincristine
SIGNALING_BY_ROBO_RECEPTORS,2.067187825,0.050789467,vincristine
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.064572448,0.044655834,vincristine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.026702449,0.050265864,vincristine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.991167145,0.057770837,vincristine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.33520717,0,lamotrigine
SARS_COV_1_HOST_INTERACTIONS,2.595113333,0,lamotrigine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.05454152,0,lamotrigine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.233271175,0,lamotrigine
SIGNALING_BY_ROBO_RECEPTORS,3.281403954,0,lamotrigine
RESPIRATORY_ELECTRON_TRANSPORT,3.429693737,0,lamotrigine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.584128644,0,lamotrigine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.598029425,0,lamotrigine
RRNA_PROCESSING,3.58078286,0,lamotrigine
NONSENSE_MEDIATED_DECAY_NMD,3.874845437,0,lamotrigine
TRANSLATION,2.795688424,0,niflumic-acid
EUKARYOTIC_TRANSLATION_INITIATION,2.774685053,0,niflumic-acid
PEROXISOMAL_PROTEIN_IMPORT,-2.167009586,0.053300313,niflumic-acid
CHROMATIN_ORGANIZATION,-2.149248391,0.03228769,niflumic-acid
EXTRACELLULAR_MATRIX_ORGANIZATION,2.190145895,0.022199483,niflumic-acid
HATS_ACETYLATE_HISTONES,-2.137939427,0.023575138,niflumic-acid
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.086863816,0.026906408,niflumic-acid
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.034412289,0.036695215,niflumic-acid
RRNA_PROCESSING,1.959179923,0.060735909,niflumic-acid
RESPIRATORY_ELECTRON_TRANSPORT,1.945782523,0.055154771,niflumic-acid
EUKARYOTIC_TRANSLATION_INITIATION,4.874851347,0,mephenytoin
INFECTIOUS_DISEASE,3.672392542,0,mephenytoin
VIRAL_INFECTION_PATHWAYS,3.598371002,0,mephenytoin
SARS_COV_2_HOST_INTERACTIONS,3.337707049,0,mephenytoin
CELLULAR_RESPONSES_TO_STIMULI,3.295070818,0,mephenytoin
SARS_COV_2_INFECTION,3.218118709,0,mephenytoin
MRNA_SPLICING,3.18673185,0,mephenytoin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.013860948,0,mephenytoin
SARS_COV_INFECTIONS,2.913486066,0,mephenytoin
MITOTIC_G2_G2_M_PHASES,2.798110899,0,mephenytoin
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,3.364211198,0,diazepam
AMINE_LIGAND_BINDING_RECEPTORS,-2.49030139,0,diazepam
HATS_ACETYLATE_HISTONES,2.714012518,0,diazepam
G_ALPHA_Q_SIGNALLING_EVENTS,-2.779884122,0,diazepam
G_ALPHA_I_SIGNALLING_EVENTS,-2.807531411,0,diazepam
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.809848205,0,diazepam
MITOTIC_PROMETAPHASE,2.897265922,0,diazepam
M_PHASE,2.839256508,0,diazepam
SIGNALING_BY_GPCR,-3.001282526,0,diazepam
CELL_CYCLE,3.054899142,0,diazepam
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.985293922,0,loxoprofen
MRNA_SPLICING,2.482808731,0.001560803,loxoprofen
G_ALPHA_Q_SIGNALLING_EVENTS,-1.855729087,0.202972364,loxoprofen
HOST_INTERACTIONS_OF_HIV_FACTORS,1.516749565,0.3444173,loxoprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.792791342,0.205727645,loxoprofen
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.455361644,0.355863192,loxoprofen
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.374754982,0.428908795,loxoprofen
RAB_REGULATION_OF_TRAFFICKING,1.343361862,0.414133189,loxoprofen
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.225239476,0.608267411,loxoprofen
MITOTIC_G2_G2_M_PHASES,1.219819405,0.544330212,loxoprofen
EUKARYOTIC_TRANSLATION_INITIATION,2.957736988,0,perospirone
TRANSLATION,2.874886286,0,perospirone
EUKARYOTIC_TRANSLATION_ELONGATION,2.72621934,0.000503668,perospirone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.65986364,0.000377751,perospirone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.621258397,0.000302201,perospirone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.44775376,0.000755503,perospirone
INFLUENZA_INFECTION,2.419754647,0.001726863,perospirone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.379598645,0.002077632,perospirone
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.31383608,0.003693569,perospirone
SIGNALING_BY_ROBO_RECEPTORS,2.263456688,0.005439619,perospirone
COLLAGEN_FORMATION,-2.644488979,0,cediranib
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.403334721,0.009798442,cediranib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.377285966,0.009606316,cediranib
ECM_PROTEOGLYCANS,-2.159863478,0.036888252,cediranib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.10903425,0.043574248,cediranib
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.067239693,0.046686694,cediranib
S_PHASE,-1.909244126,0.131908438,cediranib
SYNTHESIS_OF_DNA,-1.890242989,0.114763452,cediranib
DNA_REPLICATION,-1.890242989,0.114763452,cediranib
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.81350921,1,cediranib
NEUTROPHIL_DEGRANULATION,-2.271348206,0.048584265,ethionamide
KEAP1_NFE2L2_PATHWAY,-2.262006703,0.026235503,ethionamide
SIGNALING_BY_ROBO_RECEPTORS,-2.159789638,0.034332881,ethionamide
GPCR_LIGAND_BINDING,2.120280105,0.081145212,ethionamide
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-2.036872363,0.070933027,ethionamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.983293117,0.077734824,ethionamide
G_ALPHA_I_SIGNALLING_EVENTS,1.950243967,0.163726623,ethionamide
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-1.825702778,0.165186501,ethionamide
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.793264442,0.17462573,ethionamide
NEURONAL_SYSTEM,1.909741655,0.152476402,ethionamide
METABOLISM_OF_RNA,-4.164570186,0,mitotane
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.677234244,0,mitotane
MRNA_SPLICING,-3.526543492,0,mitotane
MEMBRANE_TRAFFICKING,-3.136870591,0,mitotane
VESICLE_MEDIATED_TRANSPORT,-3.03552838,0,mitotane
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.992823533,0,mitotane
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.797419096,0,mitotane
GPCR_LIGAND_BINDING,2.413372027,0.000594723,mitotane
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.53151366,0.001780927,mitotane
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.26616174,0.002676252,mitotane
G2_M_CHECKPOINTS,-2.086683856,0.180424291,clomifene
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.065748796,0.102767444,clomifene
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.038206956,0.08494202,clomifene
APOPTOSIS,1.943914069,0.503316783,clomifene
BASE_EXCISION_REPAIR,-1.909662622,0.142060879,clomifene
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-1.873535761,0.136899256,clomifene
DNA_REPLICATION_PRE_INITIATION,-1.85899388,0.122607916,clomifene
DNA_DOUBLE_STRAND_BREAK_REPAIR,-1.76117769,0.18427724,clomifene
PROGRAMMED_CELL_DEATH,1.797952569,0.761201774,clomifene
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.764415764,0.65137148,clomifene
NEUTROPHIL_DEGRANULATION,-2.630515326,0.007692154,butamben
GPCR_LIGAND_BINDING,2.354107255,0.00474563,butamben
SIGNALING_BY_GPCR,2.318322991,0.004406656,butamben
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.028199545,0.050394071,butamben
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.058949058,0.262494742,butamben
NEURONAL_SYSTEM,1.927261245,0.086099288,butamben
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-1.89073477,0.45319605,butamben
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.856443537,0.392780593,butamben
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-1.837019392,0.350377597,butamben
G_ALPHA_I_SIGNALLING_EVENTS,1.876170679,0.100471767,butamben
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.733454463,0,cyclophosphamide
GPCR_LIGAND_BINDING,2.631168156,0.000291556,cyclophosphamide
CHROMATIN_ORGANIZATION,-2.186277781,0.041868091,cyclophosphamide
MEMBRANE_TRAFFICKING,-2.098633397,0.0597236,cyclophosphamide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.01811192,0.086609482,cyclophosphamide
EXTRACELLULAR_MATRIX_ORGANIZATION,2.024359347,0.040429137,cyclophosphamide
MRNA_SPLICING,-2.008270532,0.072345598,cyclophosphamide
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.979965161,0.041692548,cyclophosphamide
VESICLE_MEDIATED_TRANSPORT,-1.864006012,0.201213119,cyclophosphamide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.698965084,0.199774361,cyclophosphamide
TRANSLATION,3.285532181,0,tropisetron
EUKARYOTIC_TRANSLATION_ELONGATION,3.162373121,0,tropisetron
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.15107155,0,tropisetron
EUKARYOTIC_TRANSLATION_INITIATION,3.031903351,0,tropisetron
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.931343975,0,tropisetron
SELENOAMINO_ACID_METABOLISM,2.751425295,0,tropisetron
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.649828446,0.000211114,tropisetron
SIGNALING_BY_ROBO_RECEPTORS,2.627480896,0.000184725,tropisetron
NONSENSE_MEDIATED_DECAY_NMD,2.487831706,0.000454707,tropisetron
INFLUENZA_INFECTION,2.493986068,0.0004926,tropisetron
GPCR_LIGAND_BINDING,3.754992367,0,tofacitinib
SIGNALING_BY_GPCR,3.381329504,0,tofacitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.357226841,0,tofacitinib
G_ALPHA_Q_SIGNALLING_EVENTS,2.708385637,0,tofacitinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.69058744,0,tofacitinib
G_ALPHA_I_SIGNALLING_EVENTS,2.652612653,0,tofacitinib
MEMBRANE_TRAFFICKING,-2.585595122,0.004589734,tofacitinib
VESICLE_MEDIATED_TRANSPORT,-2.42918345,0.006119645,tofacitinib
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.34664648,0.00099336,tofacitinib
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.238278004,0.024478581,tofacitinib
EUKARYOTIC_TRANSLATION_INITIATION,3.211517194,0,loperamide
CELLULAR_RESPONSE_TO_STARVATION,2.996581932,0,loperamide
TRANSLATION,2.715479237,0,loperamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.279170519,0.002267527,loperamide
BIOLOGICAL_OXIDATIONS,2.094719143,0.012179858,loperamide
INFLUENZA_INFECTION,1.990070304,0.022459313,loperamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.96843638,0.022027403,loperamide
NONSENSE_MEDIATED_DECAY_NMD,1.940918423,0.021865437,loperamide
MUSCLE_CONTRACTION,1.870106347,0.03325706,loperamide
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.861869528,0.031615802,loperamide
COLLAGEN_FORMATION,-2.120236676,0.103524842,BRD-K82225283
REGULATION_OF_TP53_ACTIVITY,2.037484582,0.235468641,BRD-K82225283
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.022828218,0.134805797,BRD-K82225283
MITOTIC_METAPHASE_AND_ANAPHASE,-1.956594345,0.21195819,BRD-K82225283
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.902007637,0.209727051,BRD-K82225283
SYNTHESIS_OF_DNA,-1.886112933,0.173805716,BRD-K82225283
DNA_REPLICATION,-1.84531632,0.187951136,BRD-K82225283
S_PHASE,-1.841056131,0.161831938,BRD-K82225283
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.824701062,0.156307213,BRD-K82225283
RHO_GTPASES_ACTIVATE_FORMINS,-1.810469669,0.152052112,BRD-K82225283
NEUTROPHIL_DEGRANULATION,-2.786494269,0,esatenolol
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-2.17699809,0.08064029,esatenolol
INNATE_IMMUNE_SYSTEM,-1.817575504,0.41679251,esatenolol
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.785946555,0.366958623,esatenolol
TRNA_PROCESSING,-1.774992484,0.31205074,esatenolol
SENSORY_PERCEPTION,1.857189953,0.66595853,esatenolol
GPCR_LIGAND_BINDING,1.838136055,0.392893746,esatenolol
KEAP1_NFE2L2_PATHWAY,-1.709793692,0.378133494,esatenolol
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-1.681623117,0.371747853,esatenolol
NEURONAL_SYSTEM,1.802515498,0.339394351,esatenolol
NEUTROPHIL_DEGRANULATION,-2.488334495,0.006438662,tetryzoline
INNATE_IMMUNE_SYSTEM,-1.863275153,0.378271367,tetryzoline
TRANSLATION,1.722436214,1,tetryzoline
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.650941878,0.857415099,tetryzoline
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,1.680599872,1,tetryzoline
RESPIRATORY_ELECTRON_TRANSPORT,1.672997691,1,tetryzoline
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.630084264,1,tetryzoline
CELL_CYCLE_MITOTIC,1.629739443,1,tetryzoline
RHOG_GTPASE_CYCLE,-1.566581293,0.987529719,tetryzoline
EPH_EPHRIN_SIGNALING,-1.553914519,0.843303699,tetryzoline
NEUTROPHIL_DEGRANULATION,-3.29147235,0,tridihexethyl
GPCR_LIGAND_BINDING,2.444552188,0.002708998,tridihexethyl
VISUAL_PHOTOTRANSDUCTION,2.35860314,0.002370373,tridihexethyl
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.346829862,0.001580249,tridihexethyl
VESICLE_MEDIATED_TRANSPORT,-2.362576365,0.03550793,tridihexethyl
SENSORY_PERCEPTION,2.200568256,0.006941806,tridihexethyl
SIGNALING_BY_GPCR,2.085067171,0.014493137,tridihexethyl
ECM_PROTEOGLYCANS,2.052029634,0.016479735,tridihexethyl
INNATE_IMMUNE_SYSTEM,-2.064211398,0.144183716,tridihexethyl
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.982459488,0.026799725,tridihexethyl
EUKARYOTIC_TRANSLATION_INITIATION,-2.772121533,0,equilin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.761867026,0,equilin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.761867026,0,equilin
NONSENSE_MEDIATED_DECAY_NMD,-2.74921796,0,equilin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.746342252,0,equilin
CELLULAR_RESPONSE_TO_STARVATION,-2.64105266,0,equilin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.638672435,0,equilin
SELENOAMINO_ACID_METABOLISM,-2.581322269,0,equilin
INFLUENZA_INFECTION,-2.562434992,0,equilin
SIGNALING_BY_ROBO_RECEPTORS,-2.502197103,0,equilin
SELENOAMINO_ACID_METABOLISM,3.350021433,0,gliquidone
EUKARYOTIC_TRANSLATION_INITIATION,3.286108997,0,gliquidone
CELLULAR_RESPONSE_TO_STARVATION,3.285723378,0,gliquidone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.282765325,0,gliquidone
EUKARYOTIC_TRANSLATION_ELONGATION,3.276749807,0,gliquidone
NONSENSE_MEDIATED_DECAY_NMD,3.229782692,0,gliquidone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.189062024,0,gliquidone
INFLUENZA_INFECTION,2.913408523,0.000230098,gliquidone
GPCR_LIGAND_BINDING,-2.466536324,0.000618062,gliquidone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.631314305,0.000409063,gliquidone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,5.523881792,0,vemurafenib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.140831086,0,vemurafenib
SIGNALING_BY_ROBO_RECEPTORS,4.241765282,0,vemurafenib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,4.264030963,0,vemurafenib
RRNA_PROCESSING,4.273759301,0,vemurafenib
TRANSLATION,4.764152848,0,vemurafenib
INFLUENZA_INFECTION,4.94464845,0,vemurafenib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,4.394690732,0,vemurafenib
NONSENSE_MEDIATED_DECAY_NMD,4.982295664,0,vemurafenib
EUKARYOTIC_TRANSLATION_INITIATION,5.167232525,0,vemurafenib
EUKARYOTIC_TRANSLATION_INITIATION,4.765481939,0,palbociclib
GPCR_LIGAND_BINDING,-2.404356343,0,palbociclib
PROTEIN_LOCALIZATION,2.671454457,0,palbociclib
CELL_CYCLE,-2.684853523,0,palbociclib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.713233202,0,palbociclib
CELL_CYCLE_MITOTIC,-2.739258823,0,palbociclib
RESPIRATORY_ELECTRON_TRANSPORT,3.080985514,0,palbociclib
RRNA_PROCESSING,3.207602342,0,palbociclib
SIGNALING_BY_ROBO_RECEPTORS,3.522389772,0,palbociclib
TRANSLATION,3.657996355,0,palbociclib
EUKARYOTIC_TRANSLATION_ELONGATION,3.011026283,0,cilostazol
NONSENSE_MEDIATED_DECAY_NMD,2.949813851,0,cilostazol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.928789931,0,cilostazol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.919290775,0,cilostazol
SELENOAMINO_ACID_METABOLISM,2.919048558,0,cilostazol
CELLULAR_RESPONSE_TO_STARVATION,2.854612031,0,cilostazol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.803261871,0,cilostazol
EUKARYOTIC_TRANSLATION_INITIATION,2.789939133,0,cilostazol
INFLUENZA_INFECTION,2.72234085,0,cilostazol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.703511844,0.00015582,cilostazol
METABOLISM_OF_RNA,3.887884197,0,E-7438
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.905606013,0,E-7438
CELL_CYCLE_CHECKPOINTS,2.908887826,0,E-7438
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.063789925,0,E-7438
EUKARYOTIC_TRANSLATION_INITIATION,3.065751209,0,E-7438
RRNA_PROCESSING,3.076092816,0,E-7438
MRNA_SPLICING,3.092263996,0,E-7438
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.898726154,0,E-7438
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.14795181,0,E-7438
CELLULAR_RESPONSE_TO_STARVATION,3.152953885,0,E-7438
EUKARYOTIC_TRANSLATION_ELONGATION,3.478538052,0,azilsartan-medoxomil
TRANSLATION,2.70004765,0,azilsartan-medoxomil
NONSENSE_MEDIATED_DECAY_NMD,3.437968161,0,azilsartan-medoxomil
CELLULAR_RESPONSE_TO_STARVATION,3.421357709,0,azilsartan-medoxomil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.416312457,0,azilsartan-medoxomil
SELENOAMINO_ACID_METABOLISM,3.267366187,0,azilsartan-medoxomil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.111653852,0,azilsartan-medoxomil
EUKARYOTIC_TRANSLATION_INITIATION,3.039885071,0,azilsartan-medoxomil
INFLUENZA_INFECTION,3.02304115,0,azilsartan-medoxomil
METABOLISM_OF_RNA,2.701737085,0,azilsartan-medoxomil
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.876850563,0,axitinib
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.868720346,0,axitinib
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.749272167,0,axitinib
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,-2.728827096,0,axitinib
VESICLE_MEDIATED_TRANSPORT,-2.712284133,0,axitinib
MEMBRANE_TRAFFICKING,-2.687535009,0.000217295,axitinib
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-2.415311215,0.001862528,axitinib
NUCLEOTIDE_EXCISION_REPAIR,-2.328567912,0.002281596,axitinib
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.287422557,0.003331855,axitinib
GPCR_LIGAND_BINDING,2.274801272,0.018680519,axitinib
SIGNALING_BY_GPCR,1.902203585,0.464973414,FR-180204
GPCR_LIGAND_BINDING,1.838850649,0.389548337,FR-180204
KEAP1_NFE2L2_PATHWAY,-1.621545792,1,FR-180204
METABOLISM_OF_RNA,-1.619870507,0.797086306,FR-180204
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.59354406,0.61099999,FR-180204
MRNA_SPLICING,-1.536378707,0.592963549,FR-180204
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.534093191,0.479147386,FR-180204
L1CAM_INTERACTIONS,1.762827697,0.481241567,FR-180204
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.749652446,0.402414968,FR-180204
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.511909751,0.44705496,FR-180204
EUKARYOTIC_TRANSLATION_INITIATION,3.052229225,0,metergoline
EUKARYOTIC_TRANSLATION_ELONGATION,3.03509235,0,metergoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.869063484,0,metergoline
NONSENSE_MEDIATED_DECAY_NMD,2.840062103,0,metergoline
INFLUENZA_INFECTION,2.826802453,0,metergoline
RRNA_PROCESSING,2.82265927,0,metergoline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.795158548,0,metergoline
CELLULAR_RESPONSE_TO_STARVATION,2.7202178,0,metergoline
METABOLISM_OF_RNA,2.601945142,0.000179455,metergoline
SELENOAMINO_ACID_METABOLISM,2.627545429,0.000199394,metergoline
NEUTROPHIL_DEGRANULATION,-2.630496971,0,hexylcaine
INNATE_IMMUNE_SYSTEM,-1.772440764,0.437828754,hexylcaine
ESR_MEDIATED_SIGNALING,-1.7470836,0.336527199,hexylcaine
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.667548709,0.377949233,hexylcaine
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-1.655547474,0.320130083,hexylcaine
TRANSLATION,-1.570870587,0.411430255,hexylcaine
NEURONAL_SYSTEM,1.767982987,1,hexylcaine
SENSORY_PERCEPTION,1.733587588,1,hexylcaine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.450873914,0.632644153,hexylcaine
CARDIAC_CONDUCTION,1.678669272,1,hexylcaine
S_PHASE,2.701533543,0,raltitrexed
SYNTHESIS_OF_DNA,2.650957083,0,raltitrexed
DNA_REPLICATION,2.529683033,0,raltitrexed
RESPIRATORY_ELECTRON_TRANSPORT,2.498510887,0.000692953,raltitrexed
EUKARYOTIC_TRANSLATION_INITIATION,2.469842562,0.000831544,raltitrexed
CILIUM_ASSEMBLY,-2.479655741,0.003430394,raltitrexed
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.420951531,0.00161689,raltitrexed
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.34535853,0.002771812,raltitrexed
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.345302321,0.002425335,raltitrexed
SIGNALING_BY_INTERLEUKINS,2.328438724,0.002463833,raltitrexed
EUKARYOTIC_TRANSLATION_INITIATION,4.726493113,0,telmisartan
SARS_COV_2_INFECTION,2.609998282,0,telmisartan
SARS_COV_2_HOST_INTERACTIONS,2.77832067,0,telmisartan
SARS_COV_1_INFECTION,3.185515829,0,telmisartan
METABOLISM_OF_RNA,3.266469499,0,telmisartan
VIRAL_INFECTION_PATHWAYS,3.302886542,0,telmisartan
INFECTIOUS_DISEASE,3.322889798,0,telmisartan
SARS_COV_1_HOST_INTERACTIONS,3.400814811,0,telmisartan
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.401490388,0,telmisartan
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.574260843,0,telmisartan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.416184903,0,hydroflumethiazide
SARS_COV_2_HOST_INTERACTIONS,-2.503815875,0,hydroflumethiazide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.76364815,0,hydroflumethiazide
SARS_COV_1_HOST_INTERACTIONS,-2.827440538,0,hydroflumethiazide
SARS_COV_1_INFECTION,-2.858923053,0,hydroflumethiazide
SIGNALING_BY_ROBO_RECEPTORS,-2.86801201,0,hydroflumethiazide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.882508188,0,hydroflumethiazide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.974462408,0,hydroflumethiazide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.979824408,0,hydroflumethiazide
NERVOUS_SYSTEM_DEVELOPMENT,-2.41605368,0,hydroflumethiazide
METABOLISM_OF_RNA,2.199418427,0.1,scopolamine
INNATE_IMMUNE_SYSTEM,-2.167219939,0.060184528,scopolamine
MITOTIC_G2_G2_M_PHASES,2.164446968,0.065714286,scopolamine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.11911719,0.045422285,scopolamine
NEUTROPHIL_DEGRANULATION,-2.084234259,0.041258576,scopolamine
UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D,2.051521571,0.0775,scopolamine
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.051521571,0.0775,scopolamine
MITOTIC_METAPHASE_AND_ANAPHASE,2.035221216,0.072571429,scopolamine
EUKARYOTIC_TRANSLATION_INITIATION,2.025782985,0.06452381,scopolamine
GPCR_LIGAND_BINDING,-2.037957261,0.04556423,scopolamine
INFLUENZA_INFECTION,3.458021253,0,abiraterone
TRANSLATION,2.730153816,0,abiraterone
TRNA_PROCESSING,2.715728996,0,abiraterone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.556712227,0.001936317,abiraterone
MRNA_SPLICING,2.532400559,0.001549053,abiraterone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.489527508,0.001290878,abiraterone
CELLULAR_RESPONSE_TO_STARVATION,2.351153687,0.004425867,abiraterone
SIGNALING_BY_ROBO_RECEPTORS,2.103210241,0.018395009,abiraterone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.072354293,0.01979346,abiraterone
GPCR_LIGAND_BINDING,-2.063031056,0.023368251,abiraterone
EUKARYOTIC_TRANSLATION_ELONGATION,2.785562266,0,betaxolol
EUKARYOTIC_TRANSLATION_INITIATION,2.749035225,0,betaxolol
RRNA_PROCESSING,2.706842357,0,betaxolol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.703212278,0,betaxolol
SELENOAMINO_ACID_METABOLISM,2.687827915,0,betaxolol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.685142833,0,betaxolol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.55463416,0.000154027,betaxolol
TRANSLATION,2.548884825,0.000134774,betaxolol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.462683792,0.000239598,betaxolol
INFLUENZA_INFECTION,2.389755232,0.000862553,betaxolol
GPCR_LIGAND_BINDING,-3.672505716,0,papaverine
SIGNALING_BY_GPCR,-3.594052418,0,papaverine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.443298872,0,papaverine
G_ALPHA_Q_SIGNALLING_EVENTS,-3.000441371,0,papaverine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.945169897,0,papaverine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.892547304,0,papaverine
G_ALPHA_I_SIGNALLING_EVENTS,-2.739694108,0,papaverine
G_ALPHA_S_SIGNALLING_EVENTS,-2.658913954,0,papaverine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.621624482,0.000879588,papaverine
CILIUM_ASSEMBLY,2.537441269,0.000586392,papaverine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.621325724,0,rucaparib
DEVELOPMENTAL_CELL_LINEAGES,2.578615951,0.000578732,rucaparib
EUKARYOTIC_TRANSLATION_INITIATION,2.565426985,0.000771642,rucaparib
EUKARYOTIC_TRANSLATION_ELONGATION,2.381208544,0.002604293,rucaparib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.373307945,0.00254642,rucaparib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.306758566,0.003665301,rucaparib
SELENOAMINO_ACID_METABOLISM,2.250889295,0.004960558,rucaparib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.239473844,0.005063903,rucaparib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.226703958,0.005530104,rucaparib
NONSENSE_MEDIATED_DECAY_NMD,2.214584617,0.005555825,rucaparib
GPCR_LIGAND_BINDING,3.080688497,0,AS-604850
SIGNALING_BY_GPCR,2.699092739,0,AS-604850
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.695155897,0,AS-604850
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.305952676,0.001747504,AS-604850
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.279712199,0.001980504,AS-604850
G_ALPHA_Q_SIGNALLING_EVENTS,2.091103849,0.009222937,AS-604850
M_PHASE,-2.109075138,0.182905173,AS-604850
REGULATION_OF_TP53_ACTIVITY,-2.000696269,0.196223511,AS-604850
MEMBRANE_TRAFFICKING,-1.978318294,0.148573458,AS-604850
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.92460352,0.158488221,AS-604850
RESPIRATORY_ELECTRON_TRANSPORT,2.366502968,0.011958481,profenamine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.070525534,0.098325286,profenamine
TRANSLATION,1.994259577,0.112498301,profenamine
CELL_CYCLE_MITOTIC,1.883867319,0.183695552,profenamine
CELL_CELL_COMMUNICATION,-1.897891553,0.723117201,profenamine
CELL_CYCLE,1.81285849,0.227742623,profenamine
SYNTHESIS_OF_DNA,1.761926129,0.248249203,profenamine
CELL_CYCLE_CHECKPOINTS,1.728514862,0.262327309,profenamine
DNA_REPLICATION,1.675009453,0.30942569,profenamine
MITOTIC_G2_G2_M_PHASES,1.639606956,0.331146573,profenamine
SIGNALING_BY_ALK_IN_CANCER,2.473365537,0.007357294,istaroxime
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.157118623,0.048478925,istaroxime
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.140369343,0.060697674,istaroxime
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.090733838,0.062536998,istaroxime
MRNA_SPLICING,1.993907214,0.083689218,istaroxime
MITF_M_DEPENDENT_GENE_EXPRESSION,1.956974196,0.087183932,istaroxime
TCR_SIGNALING,1.92717484,0.087367865,istaroxime
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.929503121,0.208686622,istaroxime
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.795973515,0.157393537,istaroxime
INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,1.76077566,0.166458774,istaroxime
MUSCLE_CONTRACTION,2.045917631,0.146352668,diazoxide
CILIUM_ASSEMBLY,-2.041897632,0.342935883,diazoxide
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-1.976968178,0.277958558,diazoxide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.928292252,0.157509598,diazoxide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.926865484,0.105881452,diazoxide
RESPIRATORY_ELECTRON_TRANSPORT,1.850121406,0.126499896,diazoxide
CLEC7A_DECTIN_1_SIGNALING,-1.867691762,0.427566844,diazoxide
SIGNALING_BY_NTRKS,1.765016977,0.173523074,diazoxide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.753912983,0.15236866,diazoxide
CHROMATIN_ORGANIZATION,-1.788206887,0.548998234,diazoxide
GPCR_LIGAND_BINDING,-2.876935181,0,physostigmine
SIGNALING_BY_GPCR,-2.826998391,0,physostigmine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.8166579,0,physostigmine
G_ALPHA_S_SIGNALLING_EVENTS,-2.598846018,0,physostigmine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.516555747,0,physostigmine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.495372071,0,physostigmine
G_ALPHA_I_SIGNALLING_EVENTS,-2.346205899,0.000641722,physostigmine
SUMOYLATION,2.378683592,0.018625422,physostigmine
SENSORY_PERCEPTION,-2.249586118,0.001123013,physostigmine
RHO_GTPASE_CYCLE,2.356554384,0.012416948,physostigmine
EUKARYOTIC_TRANSLATION_ELONGATION,5.46032716,0,fluticasone-propionate
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.746466775,0,fluticasone-propionate
SARS_COV_INFECTIONS,3.129544814,0,fluticasone-propionate
SARS_COV_2_INFECTION,3.378741087,0,fluticasone-propionate
INFECTIOUS_DISEASE,3.614740515,0,fluticasone-propionate
SARS_COV_2_HOST_INTERACTIONS,3.660699334,0,fluticasone-propionate
NERVOUS_SYSTEM_DEVELOPMENT,3.827379278,0,fluticasone-propionate
CELLULAR_RESPONSES_TO_STIMULI,3.894423717,0,fluticasone-propionate
SARS_COV_1_INFECTION,3.929765854,0,fluticasone-propionate
VIRAL_INFECTION_PATHWAYS,4.016760601,0,fluticasone-propionate
EUKARYOTIC_TRANSLATION_ELONGATION,3.880568826,0,repaglinide
SARS_COV_1_INFECTION,2.589817785,0,repaglinide
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.598630984,0,repaglinide
RRNA_PROCESSING,3.091665346,0,repaglinide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.239646151,0,repaglinide
SIGNALING_BY_ROBO_RECEPTORS,3.406889705,0,repaglinide
TRANSLATION,3.462367799,0,repaglinide
INFLUENZA_INFECTION,3.424190262,0,repaglinide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.495607276,0,repaglinide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.721675357,0,repaglinide
NEUTROPHIL_DEGRANULATION,-2.902813375,0,promazine
INNATE_IMMUNE_SYSTEM,-2.346519081,0.015116042,promazine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.17178007,0.050997557,promazine
CELL_CELL_COMMUNICATION,-2.039635044,0.09458978,promazine
EUKARYOTIC_TRANSLATION_INITIATION,1.929313689,0.653537702,promazine
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,-1.952635234,0.126058632,promazine
CELL_JUNCTION_ORGANIZATION,-1.950702445,0.106270358,promazine
EUKARYOTIC_TRANSLATION_ELONGATION,1.907093975,0.384188298,promazine
HEMOSTASIS,-1.841671387,0.166472778,promazine
CELL_CYCLE_CHECKPOINTS,1.814744852,0.525474936,promazine
GPCR_LIGAND_BINDING,-3.769521343,0,carprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.435854383,0,carprofen
SIGNALING_BY_GPCR,-3.396723668,0,carprofen
PEPTIDE_LIGAND_BINDING_RECEPTORS,-3.015076277,0,carprofen
G_ALPHA_Q_SIGNALLING_EVENTS,-2.893772138,0,carprofen
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.822701927,0,carprofen
G_ALPHA_S_SIGNALLING_EVENTS,-2.782957112,0,carprofen
TRANSLATION,-2.637440588,0,carprofen
G_ALPHA_I_SIGNALLING_EVENTS,-2.61945011,0,carprofen
EUKARYOTIC_TRANSLATION_ELONGATION,-2.575776385,0,carprofen
EUKARYOTIC_TRANSLATION_ELONGATION,3.336687174,0,mepyramine
NONSENSE_MEDIATED_DECAY_NMD,3.333762661,0,mepyramine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.273600841,0,mepyramine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.208948956,0,mepyramine
EUKARYOTIC_TRANSLATION_INITIATION,3.112510144,0,mepyramine
SELENOAMINO_ACID_METABOLISM,3.017693044,0,mepyramine
INFLUENZA_INFECTION,2.914511781,0,mepyramine
CELLULAR_RESPONSE_TO_STARVATION,2.888034995,0,mepyramine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.838951253,0,mepyramine
SIGNALING_BY_ROBO_RECEPTORS,2.617898023,0,mepyramine
GPCR_LIGAND_BINDING,-2.477214172,0,fostamatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.416092057,0,fostamatinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.310293822,0,fostamatinib
G_ALPHA_I_SIGNALLING_EVENTS,-2.292112695,0,fostamatinib
SIGNALING_BY_GPCR,-2.266124401,0.00012372,fostamatinib
CHROMATIN_ORGANIZATION,2.781497203,0.00921322,fostamatinib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.622976238,0.00460661,fostamatinib
AUTOPHAGY,2.39898612,0.006142147,fostamatinib
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.367636552,0.00460661,fostamatinib
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2.301524346,0.007370576,fostamatinib
TRANSLATION,3.177665843,0,naloxone
RESPIRATORY_ELECTRON_TRANSPORT,2.667555067,0.000719658,naloxone
RRNA_PROCESSING,2.505620789,0.003838177,naloxone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.307180632,0.008635899,naloxone
EXTRACELLULAR_MATRIX_ORGANIZATION,2.060164971,0.027059151,naloxone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.018434269,0.03190485,naloxone
PEROXISOMAL_PROTEIN_IMPORT,-2.013190566,0.202085631,naloxone
METABOLISM_OF_NUCLEOTIDES,1.877107463,0.061273762,naloxone
RHO_GTPASES_ACTIVATE_FORMINS,1.844302061,0.066748305,naloxone
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,1.678185598,0.137742594,naloxone
TRANSLATION,5.001637919,0,orciprenaline
RESPIRATORY_ELECTRON_TRANSPORT,3.846802807,0,orciprenaline
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.570723095,0,orciprenaline
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.962518412,0.00043344,orciprenaline
DNA_REPLICATION,2.515055153,0.000693504,orciprenaline
S_PHASE,2.142142951,0.006357118,orciprenaline
METABOLISM_OF_RNA,1.792438224,0.055232626,orciprenaline
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.614748586,0.120929729,orciprenaline
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.804702033,1,orciprenaline
INFLUENZA_INFECTION,1.484689799,0.203427787,orciprenaline
TRANSLATION,3.095842137,0,tolazoline
RESPIRATORY_ELECTRON_TRANSPORT,2.442360878,0,tolazoline
RRNA_PROCESSING,2.375925422,0.003012031,tolazoline
EXTRACELLULAR_MATRIX_ORGANIZATION,2.298234709,0.007341825,tolazoline
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,2.15374393,0.018298087,tolazoline
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.971825337,0.049133752,tolazoline
RHO_GTPASE_CYCLE,-1.941126496,0.392639821,tolazoline
DISEASES_OF_GLYCOSYLATION,1.857190222,0.082938418,tolazoline
DISEASES_OF_METABOLISM,1.856288341,0.072994683,tolazoline
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-1.910998785,0.256069448,tolazoline
EUKARYOTIC_TRANSLATION_INITIATION,4.701226488,0,haloperidol
VIRAL_INFECTION_PATHWAYS,2.882318438,0,haloperidol
METABOLISM_OF_RNA,2.892462186,0,haloperidol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.985972094,0,haloperidol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.860215656,0,haloperidol
SIGNALING_BY_ROBO_RECEPTORS,3.945947317,0,haloperidol
RRNA_PROCESSING,3.989560918,0,haloperidol
INFLUENZA_INFECTION,4.009866154,0,haloperidol
RESPIRATORY_ELECTRON_TRANSPORT,3.00835235,0,haloperidol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,4.343404389,0,haloperidol
TRANS_GOLGI_NETWORK_VESICLE_BUDDING,-2.316412067,0.032117211,practolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.183122802,0.069594128,practolol
GPCR_LIGAND_BINDING,2.13086569,0.058352,practolol
EUKARYOTIC_TRANSLATION_INITIATION,1.916107538,0.238404501,practolol
NEURONAL_SYSTEM,1.877569385,0.235549357,practolol
SARS_COV_1_HOST_INTERACTIONS,1.83255107,0.260174971,practolol
HOMOLOGY_DIRECTED_REPAIR,-1.758207565,0.536010206,practolol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,1.789845568,0.293009124,practolol
SELENOAMINO_ACID_METABOLISM,1.773063356,0.278682421,practolol
EUKARYOTIC_TRANSLATION_ELONGATION,1.77051644,0.249602017,practolol
TRANSLATION,3.482650731,0,fluocinonide
RRNA_PROCESSING,2.57165373,0.002756293,fluocinonide
RESPIRATORY_ELECTRON_TRANSPORT,2.220367896,0.015618994,fluocinonide
UB_SPECIFIC_PROCESSING_PROTEASES,-2.047567396,0.124489958,fluocinonide
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.80369516,0.13402475,fluocinonide
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.787062909,0.118796231,fluocinonide
CILIUM_ASSEMBLY,-1.905657163,0.25827021,fluocinonide
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.831968265,0.334450632,fluocinonide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.561393851,0.319729996,fluocinonide
RHO_GTPASES_ACTIVATE_FORMINS,1.548533135,0.294332724,fluocinonide
METABOLISM_OF_RNA,-3.892520399,0,doxorubicin
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.663470998,0,doxorubicin
RHO_GTPASE_EFFECTORS,-2.703347157,0,doxorubicin
RRNA_PROCESSING,-2.903732782,0,doxorubicin
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.907338047,0,doxorubicin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.990600933,0,doxorubicin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.999060926,0,doxorubicin
CHROMATIN_ORGANIZATION,-3.002140314,0,doxorubicin
RHO_GTPASES_ACTIVATE_FORMINS,-2.960404041,0,doxorubicin
MITOTIC_PROMETAPHASE,-3.107906371,0,doxorubicin
TRANSLATION,2.912318196,0,nomifensine
RRNA_PROCESSING,2.706940096,0,nomifensine
RESPIRATORY_ELECTRON_TRANSPORT,2.18812932,0.014858798,nomifensine
RHO_GTPASE_CYCLE,-1.999756624,0.231937396,nomifensine
MEMBRANE_TRAFFICKING,-1.994389912,0.121648797,nomifensine
VESICLE_MEDIATED_TRANSPORT,-1.982920211,0.089619347,nomifensine
METABOLISM_OF_NUCLEOTIDES,1.878334891,0.100598081,nomifensine
CILIUM_ASSEMBLY,-1.942196757,0.102478462,nomifensine
RHOG_GTPASE_CYCLE,-1.907065098,0.112844643,nomifensine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-1.837580734,0.164880666,nomifensine
INTERFERON_ALPHA_BETA_SIGNALING,-2.836683217,0,ALW-II-49-7
NONSENSE_MEDIATED_DECAY_NMD,2.211822267,0.021176924,ALW-II-49-7
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.175635369,0.017326574,ALW-II-49-7
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.171134715,0.012192774,ALW-II-49-7
TNF_SIGNALING,-1.989139939,0.083828775,ALW-II-49-7
SELENOAMINO_ACID_METABOLISM,2.041856883,0.038503497,ALW-II-49-7
EUKARYOTIC_TRANSLATION_ELONGATION,2.036604108,0.032342938,ALW-II-49-7
SIGNALING_BY_ROBO_RECEPTORS,1.979321697,0.044599884,ALW-II-49-7
TCR_SIGNALING,1.885094424,0.095708694,ALW-II-49-7
DEUBIQUITINATION,-1.681588211,0.359492667,ALW-II-49-7
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.413565308,0.005090984,bethanechol
GPCR_LIGAND_BINDING,2.392806066,0.003181865,bethanechol
EXTRACELLULAR_MATRIX_ORGANIZATION,2.28254598,0.00636373,bethanechol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.24932131,0.006681917,bethanechol
COLLAGEN_FORMATION,2.20575192,0.006618279,bethanechol
HATS_ACETYLATE_HISTONES,-2.142243525,0.11813733,bethanechol
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,2.100343738,0.012409274,bethanechol
CHROMATIN_ORGANIZATION,-2.073089328,0.102079829,bethanechol
SIGNALING_BY_GPCR,2.019768077,0.018182086,bethanechol
RESPIRATORY_ELECTRON_TRANSPORT,1.857402763,0.041602886,bethanechol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.060705247,0,alfuzosin
EUKARYOTIC_TRANSLATION_ELONGATION,2.966632529,0,alfuzosin
EUKARYOTIC_TRANSLATION_INITIATION,2.920375967,0,alfuzosin
SELENOAMINO_ACID_METABOLISM,2.909533534,0,alfuzosin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.853385382,0,alfuzosin
RRNA_PROCESSING,2.804356706,0,alfuzosin
NONSENSE_MEDIATED_DECAY_NMD,2.782383556,0,alfuzosin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.714275439,0,alfuzosin
CELLULAR_RESPONSE_TO_STARVATION,2.625333075,0,alfuzosin
TRANSLATION,2.609194293,0,alfuzosin
NEUTROPHIL_DEGRANULATION,-2.334165353,0.068663687,propofol
GPCR_LIGAND_BINDING,2.182947876,0.059559853,propofol
CELL_JUNCTION_ORGANIZATION,-2.135721376,0.119905245,propofol
CELL_CELL_COMMUNICATION,-2.056639867,0.11546431,propofol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.954378293,0.255114702,propofol
GLYCOSAMINOGLYCAN_METABOLISM,-1.884897904,0.199585867,propofol
SIGNALING_BY_GPCR,1.808293647,0.544310876,propofol
TOLL_LIKE_RECEPTOR_CASCADES,-1.710963686,0.382466987,propofol
MITOTIC_PROPHASE,-1.68856507,0.35493319,propofol
INNATE_IMMUNE_SYSTEM,-1.688297729,0.304374853,propofol
NEUTROPHIL_DEGRANULATION,-2.758928654,0.001627706,pramocaine
GPCR_LIGAND_BINDING,2.287635745,0.014832073,pramocaine
INNATE_IMMUNE_SYSTEM,-2.295780343,0.04638961,pramocaine
TRNA_PROCESSING_IN_THE_NUCLEUS,-2.199320951,0.05968254,pramocaine
KEAP1_NFE2L2_PATHWAY,-2.12275971,0.066329004,pramocaine
SENSORY_PERCEPTION,2.079435878,0.055034796,pramocaine
INTERFERON_ALPHA_BETA_SIGNALING,-2.110038474,0.061201732,pramocaine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.99506146,0.083267776,pramocaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.98643736,0.06615885,pramocaine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.884386349,0.185829726,pramocaine
EUKARYOTIC_TRANSLATION_INITIATION,3.427409072,0,albendazole
EUKARYOTIC_TRANSLATION_ELONGATION,3.327108627,0,albendazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.263686196,0,albendazole
NONSENSE_MEDIATED_DECAY_NMD,3.240333021,0,albendazole
TRANSLATION,3.215461557,0,albendazole
RRNA_PROCESSING,3.071014754,0,albendazole
SELENOAMINO_ACID_METABOLISM,3.050844018,0,albendazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.897515408,0,albendazole
METABOLISM_OF_RNA,2.700203257,0,albendazole
INFLUENZA_INFECTION,2.697379373,0,albendazole
NEUTROPHIL_DEGRANULATION,-2.561638817,0.035249376,BRD-K14965640
SENSORY_PERCEPTION,1.882923474,0.826983283,BRD-K14965640
INNATE_IMMUNE_SYSTEM,-1.833759392,1,BRD-K14965640
ECM_PROTEOGLYCANS,1.798473363,0.793387087,BRD-K14965640
SIGNALING_BY_NTRKS,-1.670424907,1,BRD-K14965640
HCMV_EARLY_EVENTS,-1.583914959,1,BRD-K14965640
ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,-1.548893684,1,BRD-K14965640
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.513812849,1,BRD-K14965640
METABOLISM_OF_NUCLEOTIDES,-1.47757798,1,BRD-K14965640
RAC3_GTPASE_CYCLE,-1.463375679,0.954032014,BRD-K14965640
EUKARYOTIC_TRANSLATION_ELONGATION,3.406357676,0,rutin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.569893003,0,rutin
SARS_COV_1_INFECTION,2.579093508,0,rutin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.641978806,0,rutin
SARS_COV_1_HOST_INTERACTIONS,2.732502461,0,rutin
SIGNALING_BY_ROBO_RECEPTORS,2.852515214,0,rutin
NONSENSE_MEDIATED_DECAY_NMD,2.992776893,0,rutin
RRNA_PROCESSING,3.022322433,0,rutin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.754931971,0,rutin
CELLULAR_RESPONSE_TO_STARVATION,3.035780755,0,rutin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.501876467,0,benzylpenicillin
RRNA_PROCESSING,3.007803281,0,benzylpenicillin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.368392182,0,benzylpenicillin
SIGNALING_BY_ROBO_RECEPTORS,3.391616825,0,benzylpenicillin
TRANSLATION,3.708797627,0,benzylpenicillin
EUKARYOTIC_TRANSLATION_INITIATION,4.091046938,0,benzylpenicillin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.915259211,0,benzylpenicillin
NONSENSE_MEDIATED_DECAY_NMD,4.190965457,0,benzylpenicillin
CELLULAR_RESPONSE_TO_STARVATION,4.249577465,0,benzylpenicillin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.366862189,0,benzylpenicillin
GPCR_LIGAND_BINDING,2.979119173,0,L-2167
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.535216045,0.000279515,L-2167
SIGNALING_BY_GPCR,2.534885331,0.000186344,L-2167
ECM_PROTEOGLYCANS,2.024849118,0.026274446,L-2167
G_ALPHA_I_SIGNALLING_EVENTS,1.918470535,0.047853033,L-2167
METABOLISM_OF_LIPIDS,-1.934466741,0.720732429,L-2167
NEUTROPHIL_DEGRANULATION,-1.928621236,0.371990931,L-2167
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-1.923974409,0.257404439,L-2167
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.897085058,0.048822019,L-2167
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.893562983,0.237061185,L-2167
TRANSLATION,2.798203623,0.002553463,icosapent
CELL_CYCLE_CHECKPOINTS,2.759791311,0.001276732,icosapent
CELL_CYCLE_MITOTIC,2.673180128,0.000851154,icosapent
DNA_REPLICATION,2.565154864,0.000638366,icosapent
RESPIRATORY_ELECTRON_TRANSPORT,2.506266407,0.001532078,icosapent
MITOTIC_SPINDLE_CHECKPOINT,2.471373002,0.001702309,icosapent
CELL_CYCLE,2.392858251,0.002553463,icosapent
S_PHASE,2.381308759,0.002553463,icosapent
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.322894086,0.002837181,icosapent
SEPARATION_OF_SISTER_CHROMATIDS,2.311766003,0.002553463,icosapent
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.18557727,0.037280312,clozapine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,2.077589883,0.052192437,clozapine
TRANSLATION,-2.011590571,0.058221902,clozapine
MRNA_SPLICING,1.898919338,0.101899521,clozapine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.880140914,0.080152672,clozapine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.983945389,0.043238324,clozapine
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.831027218,0.079034262,clozapine
EUKARYOTIC_TRANSLATION_ELONGATION,-1.951755401,0.039670806,clozapine
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.724463914,0.119918338,clozapine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.900142126,0.054368982,clozapine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.938227096,0.104167854,imipramine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.496879391,0.534608587,imipramine
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,-1.718535421,1,imipramine
INTERFERON_GAMMA_SIGNALING,1.276343016,1,imipramine
MRNA_SPLICING,1.267145592,0.786048235,imipramine
REGULATED_NECROSIS,-1.665989436,1,imipramine
NEURONAL_SYSTEM,-1.656979949,1,imipramine
METABOLISM_OF_STEROIDS,1.2392757,0.716962199,imipramine
TOLL_LIKE_RECEPTOR_CASCADES,-1.638153867,1,imipramine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.624754027,0.876457055,imipramine
TRANSLATION,3.55615992,0,tropicamide
RRNA_PROCESSING,2.336338308,0.009686139,tropicamide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.068966318,0.031928384,tropicamide
RESPIRATORY_ELECTRON_TRANSPORT,2.04760202,0.027175001,tropicamide
METABOLISM_OF_NUCLEOTIDES,1.906197214,0.051228913,tropicamide
EXTRACELLULAR_MATRIX_ORGANIZATION,1.780436808,0.093094559,tropicamide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.666454713,0.14144838,tropicamide
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-1.837936676,0.982963217,tropicamide
HATS_ACETYLATE_HISTONES,-1.837085605,0.495409533,tropicamide
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,1.629422541,0.151884042,tropicamide
GPCR_LIGAND_BINDING,2.685351678,0,phenelzine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.400849159,0.002880527,phenelzine
CARDIAC_CONDUCTION,2.121917864,0.042887842,phenelzine
SIGNALING_BY_GPCR,2.109891889,0.034566321,phenelzine
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-2.049404677,0.227340253,phenelzine
SENSORY_PERCEPTION,2.012508453,0.051849481,phenelzine
MUSCLE_CONTRACTION,1.925191322,0.080494719,phenelzine
G_ALPHA_Q_SIGNALLING_EVENTS,1.911532987,0.077499886,phenelzine
EUKARYOTIC_TRANSLATION_INITIATION,1.841125121,0.115221069,phenelzine
NEURONAL_SYSTEM,1.837972598,0.105085882,phenelzine
HIV_INFECTION,2.880249021,0,flecainide
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.419211725,0.009953162,flecainide
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.920364691,0.087919594,flecainide
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.871077771,0.092066745,flecainide
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.84050021,0.084601874,flecainide
CIRCADIAN_CLOCK,1.772424068,0.106167057,flecainide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.769618443,0.095265975,flecainide
G_ALPHA_I_SIGNALLING_EVENTS,-1.935470909,0.155797805,flecainide
SIGNALING_BY_GPCR,-1.911887003,0.097844032,flecainide
GPCR_LIGAND_BINDING,-1.891037458,0.080282283,flecainide
NEUTROPHIL_DEGRANULATION,-2.208369275,0.139081568,hydroxychloroquine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.059317088,0.173532965,hydroxychloroquine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.86766489,0.380666676,hydroxychloroquine
TRNA_PROCESSING,-1.714812889,0.662551412,hydroxychloroquine
TRNA_PROCESSING_IN_THE_NUCLEUS,-1.696188573,0.57521074,hydroxychloroquine
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-1.689840265,0.493165375,hydroxychloroquine
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,1.75126971,1,hydroxychloroquine
DEUBIQUITINATION,-1.654503648,0.504740315,hydroxychloroquine
G_ALPHA_I_SIGNALLING_EVENTS,1.705399834,1,hydroxychloroquine
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-1.556306862,0.699076274,hydroxychloroquine
SIGNALING_BY_ROBO_RECEPTORS,3.409455212,0,galantamine
VIRAL_INFECTION_PATHWAYS,2.549493618,0,galantamine
SARS_COV_1_INFECTION,2.707055988,0,galantamine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.770692887,0,galantamine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.831354129,0,galantamine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.838900495,0,galantamine
TRANSLATION,2.869598145,0,galantamine
NERVOUS_SYSTEM_DEVELOPMENT,2.898985374,0,galantamine
SARS_COV_1_HOST_INTERACTIONS,2.924936347,0,galantamine
INFLUENZA_INFECTION,2.941399955,0,galantamine
EUKARYOTIC_TRANSLATION_INITIATION,3.72168338,0,enalaprilat
INFLUENZA_INFECTION,2.896878072,0,enalaprilat
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.935920421,0,enalaprilat
NONSENSE_MEDIATED_DECAY_NMD,3.03586493,0,enalaprilat
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.051148293,0,enalaprilat
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.158832039,0,enalaprilat
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.188125032,0,enalaprilat
SIGNALING_BY_ROBO_RECEPTORS,3.216634247,0,enalaprilat
CELLULAR_RESPONSE_TO_STARVATION,3.301201687,0,enalaprilat
SELENOAMINO_ACID_METABOLISM,3.303874761,0,enalaprilat
TRANSLATION,3.179503853,0,diltiazem
RRNA_PROCESSING,2.585407231,0.00134561,diltiazem
RESPIRATORY_ELECTRON_TRANSPORT,2.348414172,0.006279515,diltiazem
MITOCHONDRIAL_TRANSLATION,2.202028886,0.011437687,diltiazem
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.098590548,0.12984406,diltiazem
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-2.017867538,0.122572792,diltiazem
CILIUM_ASSEMBLY,-1.972062489,0.118417782,diltiazem
SUMOYLATION,-1.942311751,0.119975911,diltiazem
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,1.858194909,0.083786666,diltiazem
SIGNALING_BY_ALK_IN_CANCER,-1.883168825,0.162876388,diltiazem
EUKARYOTIC_TRANSLATION_ELONGATION,3.924456351,0,didanosine
SARS_COV_2_HOST_INTERACTIONS,2.794098953,0,didanosine
SARS_COV_2_INFECTION,2.823957181,0,didanosine
NERVOUS_SYSTEM_DEVELOPMENT,2.8495733,0,didanosine
VIRAL_INFECTION_PATHWAYS,2.864534338,0,didanosine
CELLULAR_RESPONSES_TO_STIMULI,2.941372485,0,didanosine
SARS_COV_1_INFECTION,3.126026399,0,didanosine
METABOLISM_OF_RNA,3.156533328,0,didanosine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.212198414,0,didanosine
SIGNALING_BY_ROBO_RECEPTORS,3.223710638,0,didanosine
NEUTROPHIL_DEGRANULATION,-2.8509737,0,oxibendazole
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.160250346,0.036554046,oxibendazole
GPCR_LIGAND_BINDING,2.142724606,0.076979945,oxibendazole
METABOLISM_OF_LIPIDS,-1.870514423,0.164992581,oxibendazole
METABOLISM_OF_STEROIDS,-1.844535994,0.142620705,oxibendazole
FATTY_ACID_METABOLISM,-1.815779943,0.138306129,oxibendazole
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.81363346,0.117452346,oxibendazole
PROTEIN_LOCALIZATION,-1.80914998,0.102899212,oxibendazole
RHO_GTPASES_ACTIVATE_FORMINS,1.875258826,0.443104075,oxibendazole
NEURONAL_SYSTEM,1.866949722,0.311049047,oxibendazole
SENSORY_PERCEPTION,2.198291802,0.034409347,vigabatrin
GPCR_LIGAND_BINDING,2.18818944,0.020215492,vigabatrin
NEUTROPHIL_DEGRANULATION,-2.1913263,0.101185558,vigabatrin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.099488656,0.031828646,vigabatrin
L1CAM_INTERACTIONS,1.997448896,0.062797059,vigabatrin
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.892394873,0.339484881,vigabatrin
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.955594943,0.076388751,vigabatrin
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1.953015945,0.065951249,vigabatrin
G_ALPHA_I_SIGNALLING_EVENTS,1.904290294,0.083442668,vigabatrin
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.811642485,0.146884902,vigabatrin
NEUTROPHIL_DEGRANULATION,2.500232127,0.003508033,aminolevulinic-acid
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.998804175,0.065249421,aminolevulinic-acid
G_ALPHA_Q_SIGNALLING_EVENTS,-1.956320328,0.348426209,aminolevulinic-acid
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.865774624,0.099160411,aminolevulinic-acid
INNATE_IMMUNE_SYSTEM,1.792562671,0.114888094,aminolevulinic-acid
CELL_CYCLE,-1.826114493,0.543071714,aminolevulinic-acid
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.825798648,0.364557052,aminolevulinic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.823229074,0.279332431,aminolevulinic-acid
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.650791455,0.194625693,aminolevulinic-acid
CELL_CYCLE_MITOTIC,-1.780958213,0.30820664,aminolevulinic-acid
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.906023396,0,sotalol
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.718165307,0.002125058,sotalol
TOLL_LIKE_RECEPTOR_CASCADES,2.491142285,0.002833411,sotalol
GPCR_LIGAND_BINDING,-2.279773283,0.002798347,sotalol
MYD88_INDEPENDENT_TLR4_CASCADE,2.318580287,0.006375175,sotalol
MITOTIC_PROMETAPHASE,2.154577182,0.020400559,sotalol
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.149299103,0.017000466,sotalol
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.116745218,0.018821944,sotalol
CHROMATIN_ORGANIZATION,2.082869922,0.02337564,sotalol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.01053013,0.027389639,sotalol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.250224664,0.009118688,lomitapide
GPCR_LIGAND_BINDING,-2.02202108,0.060100445,lomitapide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.975645953,0.064107141,lomitapide
SARS_COV_1_INFECTION,1.725087344,0.864503594,lomitapide
MITF_M_DEPENDENT_GENE_EXPRESSION,1.655363661,0.614804741,lomitapide
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.653981846,0.414765883,lomitapide
SIGNALING_BY_NTRKS,1.608682309,0.392383913,lomitapide
PEROXISOMAL_PROTEIN_IMPORT,1.595464286,0.338247523,lomitapide
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.566713618,0.336079269,lomitapide
NEUTROPHIL_DEGRANULATION,1.541015297,0.326437037,lomitapide
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,3.348135963,0,ibuprofen
CHROMATIN_ORGANIZATION,3.105030471,0,ibuprofen
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,3.06329969,0,ibuprofen
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2.966868203,0,ibuprofen
GPCR_LIGAND_BINDING,-2.815958001,0,ibuprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.562252464,0,ibuprofen
SIGNALING_BY_GPCR,-2.519978868,0,ibuprofen
G_ALPHA_S_SIGNALLING_EVENTS,-2.496971909,0,ibuprofen
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.343064118,0.000589364,ibuprofen
G_ALPHA_Q_SIGNALLING_EVENTS,-2.25954892,0.001105058,ibuprofen
GPCR_LIGAND_BINDING,-2.367050576,0.00079018,levocetirizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.275744698,0.001580361,levocetirizine
SIGNALING_BY_GPCR,-2.218832406,0.001580361,levocetirizine
G_ALPHA_S_SIGNALLING_EVENTS,-2.174728212,0.001580361,levocetirizine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.129024744,0.002686613,levocetirizine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.128713865,0.069791171,levocetirizine
G_ALPHA_I_SIGNALLING_EVENTS,-2.10676501,0.003029025,levocetirizine
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.076190291,0.045915244,levocetirizine
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.002579039,0.050200667,levocetirizine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.964698931,0.044996939,levocetirizine
EUKARYOTIC_TRANSLATION_ELONGATION,-4.075975414,0,itraconazole
SARS_COV_INFECTIONS,-2.634705207,0,itraconazole
SARS_COV_2_INFECTION,-2.684337692,0,itraconazole
CELLULAR_RESPONSES_TO_STIMULI,-2.727144031,0,itraconazole
INFECTIOUS_DISEASE,-2.8337058,0,itraconazole
VIRAL_INFECTION_PATHWAYS,-2.923046441,0,itraconazole
SARS_COV_2_HOST_INTERACTIONS,-2.947697667,0,itraconazole
SARS_COV_1_INFECTION,-3.106764706,0,itraconazole
SARS_COV_1_HOST_INTERACTIONS,-3.174773019,0,itraconazole
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.198674876,0,itraconazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.956973193,0.173117258,valrubicin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.956328531,0.086558629,valrubicin
CELLULAR_RESPONSE_TO_STARVATION,1.84609313,0.116295885,valrubicin
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.718932886,0.17494129,valrubicin
GASTRULATION,-1.857206872,1,valrubicin
RHO_GTPASES_ACTIVATE_FORMINS,-1.785579612,1,valrubicin
MITOTIC_SPINDLE_CHECKPOINT,-1.764544582,0.855396491,valrubicin
SIGNALING_BY_HEDGEHOG,-1.747453618,0.727835763,valrubicin
RHO_GTPASE_EFFECTORS,-1.725951223,0.680664774,valrubicin
NEURONAL_SYSTEM,1.507744067,0.413093595,valrubicin
EUKARYOTIC_TRANSLATION_ELONGATION,4.751859203,0,tacrine
GPCR_LIGAND_BINDING,-2.720738974,0,tacrine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.830865663,0,tacrine
CELLULAR_RESPONSES_TO_STIMULI,2.889567629,0,tacrine
INFECTIOUS_DISEASE,2.898722683,0,tacrine
VIRAL_INFECTION_PATHWAYS,3.083776541,0,tacrine
SARS_COV_1_HOST_INTERACTIONS,3.104019195,0,tacrine
SARS_COV_1_INFECTION,3.216207296,0,tacrine
METABOLISM_OF_RNA,3.266007845,0,tacrine
RRNA_PROCESSING,4.072341871,0,tacrine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.718714744,0.003647994,linagliptin
RHO_GTPASE_CYCLE,2.717429302,0.001823997,linagliptin
GPCR_LIGAND_BINDING,-2.431638552,0.000668796,linagliptin
MITOTIC_PROPHASE,2.545598835,0.003647994,linagliptin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.326063536,0.001337592,linagliptin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.209901005,0.002675184,linagliptin
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.2837716,0.010943981,linagliptin
SIGNALING_BY_GPCR,-2.165081855,0.003009582,linagliptin
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.196444763,0.014591974,linagliptin
SUMOYLATION,2.109206013,0.023103959,linagliptin
METABOLISM_OF_RNA,6.235596808,0,Y-27632
CELL_CYCLE_CHECKPOINTS,3.666408615,0,Y-27632
CELL_CYCLE,3.562912711,0,Y-27632
M_PHASE,3.559665021,0,Y-27632
S_PHASE,3.526021747,0,Y-27632
INFECTIOUS_DISEASE,3.501586056,0,Y-27632
MITOTIC_METAPHASE_AND_ANAPHASE,3.45829287,0,Y-27632
DNA_REPLICATION_PRE_INITIATION,3.454521226,0,Y-27632
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,3.369299652,0,Y-27632
G2_M_CHECKPOINTS,3.223302393,0,Y-27632
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.922128194,0.161093132,perindopril
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.751689543,0.196332255,perindopril
INTERFERON_ALPHA_BETA_SIGNALING,-1.883555657,0.19309122,perindopril
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.594356559,0.307643134,perindopril
RSV_HOST_INTERACTIONS,-1.824844704,0.181296055,perindopril
L1CAM_INTERACTIONS,1.473907803,0.424547525,perindopril
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.446167649,0.382596188,perindopril
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.364852016,0.469295617,perindopril
METABOLISM_OF_RNA,1.352577599,0.424307803,perindopril
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,-1.730720272,0.307839245,perindopril
EUKARYOTIC_TRANSLATION_ELONGATION,2.864837962,0,alitretinoin
CELLULAR_RESPONSE_TO_STARVATION,2.671905439,0,alitretinoin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.671707285,0,alitretinoin
NONSENSE_MEDIATED_DECAY_NMD,2.664815082,0,alitretinoin
RRNA_PROCESSING,2.662871977,0,alitretinoin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.651135412,0,alitretinoin
EUKARYOTIC_TRANSLATION_INITIATION,2.614586815,0,alitretinoin
SELENOAMINO_ACID_METABOLISM,2.605281983,0,alitretinoin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.601410123,0,alitretinoin
INFLUENZA_INFECTION,2.582887274,0,alitretinoin
RRNA_PROCESSING,2.460324456,0.003277329,dexamethasone
ECM_PROTEOGLYCANS,2.249893553,0.016796312,dexamethasone
EXTRACELLULAR_MATRIX_ORGANIZATION,2.186137675,0.018844643,dexamethasone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.172676983,0.016591479,dexamethasone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.121330191,0.166587826,dexamethasone
TRANSLATION,2.093869509,0.023924503,dexamethasone
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.967196344,0.053120044,dexamethasone
DISEASES_OF_METABOLISM,1.966614713,0.045648513,dexamethasone
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.924386285,0.054280764,dexamethasone
COPII_MEDIATED_VESICLE_TRANSPORT,-1.922760349,0.354292418,dexamethasone
TRANSLATION,3.306323724,0,carbinoxamine
DISEASES_OF_METABOLISM,2.609448517,0.001566792,carbinoxamine
RRNA_PROCESSING,2.581849338,0.001044528,carbinoxamine
CILIUM_ASSEMBLY,-2.436037284,0.001956959,carbinoxamine
MITOCHONDRIAL_TRANSLATION,2.420164532,0.002872452,carbinoxamine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-2.259484501,0.017612634,carbinoxamine
GLYCOSAMINOGLYCAN_METABOLISM,2.201245561,0.015459012,carbinoxamine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.190875555,0.013927038,carbinoxamine
RESPIRATORY_ELECTRON_TRANSPORT,2.142321408,0.015369481,carbinoxamine
RHO_GTPASE_CYCLE,-1.999496638,0.113503643,carbinoxamine
EUKARYOTIC_TRANSLATION_INITIATION,3.060117211,0,DPPE
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.970018949,0,DPPE
EUKARYOTIC_TRANSLATION_ELONGATION,2.964796966,0,DPPE
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.912765559,0,DPPE
TRANSLATION,2.779169488,0,DPPE
RRNA_PROCESSING,2.744383052,0,DPPE
SELENOAMINO_ACID_METABOLISM,2.666491287,0.000255093,DPPE
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2.644443165,0.000223206,DPPE
METABOLISM_OF_RNA,2.592767521,0.000595216,DPPE
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.566316238,0.000714259,DPPE
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.532133211,0,clofazimine
SELENOAMINO_ACID_METABOLISM,3.510065684,0,clofazimine
EUKARYOTIC_TRANSLATION_ELONGATION,3.473740468,0,clofazimine
EUKARYOTIC_TRANSLATION_INITIATION,3.469471355,0,clofazimine
NONSENSE_MEDIATED_DECAY_NMD,3.346015651,0,clofazimine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.310902193,0,clofazimine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.249685323,0,clofazimine
SIGNALING_BY_ROBO_RECEPTORS,3.144770906,0,clofazimine
CELLULAR_RESPONSE_TO_STARVATION,3.118864581,0,clofazimine
INFLUENZA_INFECTION,3.103827015,0,clofazimine
EUKARYOTIC_TRANSLATION_INITIATION,2.994494529,0,alprazolam
EUKARYOTIC_TRANSLATION_ELONGATION,2.975937112,0,alprazolam
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.957286629,0,alprazolam
SELENOAMINO_ACID_METABOLISM,2.858947633,0.00035523,alprazolam
TRANSLATION,2.786567874,0.000284184,alprazolam
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.614942816,0.00023682,alprazolam
SIGNALING_BY_ROBO_RECEPTORS,2.564185979,0.000405977,alprazolam
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.548583596,0.00035523,alprazolam
CELLULAR_RESPONSE_TO_STARVATION,2.518643605,0.00047364,alprazolam
INFLUENZA_INFECTION,2.356191159,0.002841841,alprazolam
EUKARYOTIC_TRANSLATION_INITIATION,4.467344943,0,W-7
VIRAL_INFECTION_PATHWAYS,2.976202471,0,W-7
SARS_COV_1_HOST_INTERACTIONS,3.17317715,0,W-7
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.262051041,0,W-7
SIGNALING_BY_ROBO_RECEPTORS,3.308717472,0,W-7
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.397431992,0,W-7
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.506496965,0,W-7
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.631048905,0,W-7
METABOLISM_OF_RNA,3.738152237,0,W-7
CELLULAR_RESPONSE_TO_STARVATION,3.762388769,0,W-7
EUKARYOTIC_TRANSLATION_INITIATION,3.233832088,0,dobutamine
TRANSLATION,3.073821182,0,dobutamine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.930476705,0,dobutamine
NONSENSE_MEDIATED_DECAY_NMD,2.871955449,0,dobutamine
SELENOAMINO_ACID_METABOLISM,2.865829873,0,dobutamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.830020777,0,dobutamine
EUKARYOTIC_TRANSLATION_ELONGATION,2.827833498,0,dobutamine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.694841542,0,dobutamine
RRNA_PROCESSING,2.682935668,0,dobutamine
METABOLISM_OF_RNA,2.64536031,0,dobutamine
EUKARYOTIC_TRANSLATION_INITIATION,2.761255683,0.001718464,oxprenolol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.662117698,0.001718464,oxprenolol
TRANSLATION,2.632073508,0.001145643,oxprenolol
SYNTHESIS_OF_DNA,2.513159746,0.00214808,oxprenolol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.489145563,0.00240585,oxprenolol
RRNA_PROCESSING,2.341644686,0.006301034,oxprenolol
RESPIRATORY_ELECTRON_TRANSPORT,2.334917105,0.005646382,oxprenolol
DNA_REPLICATION,2.317521722,0.005799816,oxprenolol
S_PHASE,2.258565469,0.00878326,oxprenolol
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.198462917,0.011513708,oxprenolol
SELENOAMINO_ACID_METABOLISM,2.652422846,0,BRD-K72166146
NONSENSE_MEDIATED_DECAY_NMD,2.526879905,0.000405838,BRD-K72166146
CELLULAR_RESPONSE_TO_STARVATION,2.517664304,0.000270559,BRD-K72166146
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.49491586,0.000405838,BRD-K72166146
PEROXISOMAL_PROTEIN_IMPORT,2.239644933,0.00633108,BRD-K72166146
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.031007251,0.22093728,BRD-K72166146
NEUTROPHIL_DEGRANULATION,1.982190848,0.038960494,BRD-K72166146
INFLUENZA_INFECTION,1.975985178,0.034554247,BRD-K72166146
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.98557567,0.162968588,BRD-K72166146
EUKARYOTIC_TRANSLATION_INITIATION,1.93486822,0.03997509,BRD-K72166146
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.584183504,0,zosuquidar
SELENOAMINO_ACID_METABOLISM,2.448182677,0.001691475,zosuquidar
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.431923684,0.001503533,zosuquidar
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.419538798,0.015728934,zosuquidar
EUKARYOTIC_TRANSLATION_ELONGATION,2.358100236,0.003664862,zosuquidar
COLLAGEN_FORMATION,-2.392951492,0.012233616,zosuquidar
NONSENSE_MEDIATED_DECAY_NMD,2.285958374,0.00541272,zosuquidar
INFLUENZA_INFECTION,2.238641213,0.007141783,zosuquidar
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.299841192,0.016602764,zosuquidar
EUKARYOTIC_TRANSLATION_INITIATION,2.136287179,0.0180424,zosuquidar
EUKARYOTIC_TRANSLATION_INITIATION,3.580121238,0,nitrazepam
INFLUENZA_INFECTION,2.730460965,0,nitrazepam
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.92004613,0,nitrazepam
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.963886972,0,nitrazepam
RRNA_PROCESSING,2.993364994,0,nitrazepam
NONSENSE_MEDIATED_DECAY_NMD,3.11948204,0,nitrazepam
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.161091025,0,nitrazepam
SIGNALING_BY_ROBO_RECEPTORS,2.89755639,0,nitrazepam
CELLULAR_RESPONSE_TO_STARVATION,3.375980265,0,nitrazepam
TRANSLATION,3.381129172,0,nitrazepam
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,4.481288411,0,daunorubicin
RESPIRATORY_ELECTRON_TRANSPORT,3.637834324,0,daunorubicin
METABOLISM_OF_VITAMINS_AND_COFACTORS,2.596970622,0.003010471,daunorubicin
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.559809518,0.002257853,daunorubicin
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.4146773,0.004967277,daunorubicin
TRANSLATION,2.401856011,0.004515707,daunorubicin
CHROMATIN_ORGANIZATION,-2.209265854,0.010319674,daunorubicin
TRANSPORT_OF_SMALL_MOLECULES,2.232547354,0.007418661,daunorubicin
PROTEIN_LOCALIZATION,2.09179267,0.014111584,daunorubicin
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.067478576,0.033340485,daunorubicin
EUKARYOTIC_TRANSLATION_INITIATION,3.602660591,0,noretynodrel
SEPARATION_OF_SISTER_CHROMATIDS,2.662529264,0,noretynodrel
RESPIRATORY_ELECTRON_TRANSPORT,2.701556217,0,noretynodrel
M_PHASE,2.726272534,0,noretynodrel
CELLULAR_RESPONSE_TO_STARVATION,2.770124696,0,noretynodrel
SIGNALING_BY_ROBO_RECEPTORS,2.812591418,0,noretynodrel
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.818969605,0,noretynodrel
CELL_CYCLE_CHECKPOINTS,2.821122991,0,noretynodrel
MITOTIC_METAPHASE_AND_ANAPHASE,2.822632172,0,noretynodrel
SARS_COV_1_HOST_INTERACTIONS,2.837071299,0,noretynodrel
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.609471524,0,ranolazine
SELENOAMINO_ACID_METABOLISM,2.692283762,0.001007368,ranolazine
EUKARYOTIC_TRANSLATION_ELONGATION,2.59302796,0.001007368,ranolazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.563824684,0.001343158,ranolazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.519762415,0.001511053,ranolazine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.514445982,0.001208842,ranolazine
NONSENSE_MEDIATED_DECAY_NMD,2.510376911,0.001007368,ranolazine
EUKARYOTIC_TRANSLATION_INITIATION,2.344724215,0.003885564,ranolazine
CELLULAR_RESPONSE_TO_STARVATION,2.32005224,0.003903553,ranolazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.252848906,0.005932281,ranolazine
CDC42_GTPASE_CYCLE,2.203080425,0.071769468,yohimbine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.054756043,0.087718238,yohimbine
SIGNALING_BY_VEGF,2.052792806,0.058478826,yohimbine
GPCR_LIGAND_BINDING,-2.016128475,0.085535791,yohimbine
RHOA_GTPASE_CYCLE,1.812408749,0.162478101,yohimbine
RESPIRATORY_ELECTRON_TRANSPORT,1.810694985,0.130779919,yohimbine
RHO_GTPASE_CYCLE,1.80240203,0.114299523,yohimbine
REGULATION_OF_TP53_ACTIVITY,1.786049808,0.105375806,yohimbine
GASTRULATION,-1.934748785,0.105973546,yohimbine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.931033896,0.073929164,yohimbine
EUKARYOTIC_TRANSLATION_ELONGATION,3.055929457,0,BRD-A20239487
SELENOAMINO_ACID_METABOLISM,2.816449307,0.000503748,BRD-A20239487
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.62367632,0.00167916,BRD-A20239487
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.605621006,0.001763118,BRD-A20239487
EUKARYOTIC_TRANSLATION_INITIATION,2.542787899,0.001813492,BRD-A20239487
NONSENSE_MEDIATED_DECAY_NMD,2.423461003,0.003694151,BRD-A20239487
CELLULAR_RESPONSE_TO_STARVATION,2.368402043,0.004893551,BRD-A20239487
TRANSLATION,2.123738537,0.019646167,BRD-A20239487
INFLUENZA_INFECTION,2.097889467,0.021493243,BRD-A20239487
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.767880001,0.125332474,BRD-A20239487
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.959786173,0,escitalopram
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.925155639,0,escitalopram
EUKARYOTIC_TRANSLATION_ELONGATION,2.910009004,0,escitalopram
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.910009004,0,escitalopram
SELENOAMINO_ACID_METABOLISM,2.843095734,0,escitalopram
EUKARYOTIC_TRANSLATION_INITIATION,2.818937708,0.000147235,escitalopram
CELLULAR_RESPONSE_TO_STARVATION,2.683883956,0.000126202,escitalopram
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.634667929,0.000220853,escitalopram
NONSENSE_MEDIATED_DECAY_NMD,2.587538363,0.000196314,escitalopram
SIGNALING_BY_ROBO_RECEPTORS,2.466492406,0.000441706,escitalopram
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.681282805,0,dofetilide
EUKARYOTIC_TRANSLATION_INITIATION,2.667920267,0,dofetilide
EUKARYOTIC_TRANSLATION_ELONGATION,2.58899437,0.000363234,dofetilide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.479697674,0.00054485,dofetilide
TRANSLATION,2.416400138,0.001089701,dofetilide
SELENOAMINO_ACID_METABOLISM,2.412366137,0.000908084,dofetilide
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.331197267,0.015065278,dofetilide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.306372858,0.002335073,dofetilide
RRNA_PROCESSING,2.199142394,0.008717606,dofetilide
SIGNALING_BY_ROBO_RECEPTORS,2.159708382,0.011260241,dofetilide
CELL_CYCLE,2.767777293,0,CS-1657
CELL_CYCLE_MITOTIC,2.65148215,0.002479981,CS-1657
DNA_REPLICATION,2.522557365,0.003306641,CS-1657
MITOTIC_METAPHASE_AND_ANAPHASE,2.437021335,0.003719971,CS-1657
SARS_COV_1_INFECTION,2.318513252,0.008431935,CS-1657
MITOTIC_SPINDLE_CHECKPOINT,2.302692334,0.007439943,CS-1657
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,2.302312022,0.006377094,CS-1657
M_PHASE,2.298909024,0.005889955,CS-1657
CELL_CYCLE_CHECKPOINTS,2.281046121,0.005786622,CS-1657
SEPARATION_OF_SISTER_CHROMATIDS,2.227401108,0.007191945,CS-1657
CELLULAR_RESPONSE_TO_STARVATION,2.812652005,0,etoricoxib
EUKARYOTIC_TRANSLATION_INITIATION,2.43081339,0.006218283,etoricoxib
INFLUENZA_INFECTION,2.296150486,0.010594112,etoricoxib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.179015053,0.018309389,etoricoxib
SIGNALING_BY_ROBO_RECEPTORS,2.080451403,0.021280347,etoricoxib
TRANSLATION,2.033987963,0.026254973,etoricoxib
GPCR_LIGAND_BINDING,-2.092293701,0.124536607,etoricoxib
G_ALPHA_Q_SIGNALLING_EVENTS,-2.08318017,0.068987905,etoricoxib
DISEASES_OF_METABOLISM,-2.010308101,0.096762256,etoricoxib
NEUTROPHIL_DEGRANULATION,1.881989805,0.066130948,etoricoxib
GPCR_LIGAND_BINDING,-2.171491828,0.039665957,miconazole
SIGNALING_BY_NTRKS,1.857595218,0.739280203,miconazole
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.805353862,0.518337828,miconazole
REGULATION_OF_TP53_ACTIVITY,1.799546798,0.357248624,miconazole
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.788360494,0.286874386,miconazole
PEROXISOMAL_PROTEIN_IMPORT,1.784898305,0.233427373,miconazole
CELLULAR_RESPONSE_TO_STARVATION,1.770400726,0.212291722,miconazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.843079509,0.444589265,miconazole
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.810288202,0.377652963,miconazole
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.713039471,0.253507579,miconazole
CELLULAR_RESPONSE_TO_STARVATION,2.29957854,0.015641347,nimodipine
EUKARYOTIC_TRANSLATION_INITIATION,2.181430561,0.021403948,nimodipine
TRANSLATION,2.109010836,0.024422454,nimodipine
NONSENSE_MEDIATED_DECAY_NMD,2.071756394,0.024285249,nimodipine
MUSCLE_CONTRACTION,2.016525923,0.031282693,nimodipine
INFLUENZA_INFECTION,1.991800127,0.030871079,nimodipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.95431666,0.436589786,nimodipine
SIGNALING_BY_GPCR,-1.95211153,0.220414261,nimodipine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.89710484,0.2398418,nimodipine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.785904916,0.091025581,nimodipine
RESPIRATORY_ELECTRON_TRANSPORT,2.596308339,0.00645386,hexylresorcinol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.458263127,0.00645386,hexylresorcinol
DNA_REPLICATION,2.155994998,0.036571873,hexylresorcinol
HOST_INTERACTIONS_OF_HIV_FACTORS,2.130628898,0.036034052,hexylresorcinol
MITOTIC_METAPHASE_AND_ANAPHASE,2.107790586,0.034420587,hexylresorcinol
SYNTHESIS_OF_DNA,2.095977814,0.032627848,hexylresorcinol
S_PHASE,1.970233413,0.065767907,hexylresorcinol
CELL_CYCLE_MITOTIC,1.916782488,0.076908499,hexylresorcinol
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1.916522008,0.06836311,hexylresorcinol
M_PHASE,1.914543668,0.062387314,hexylresorcinol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.689994817,0,flumazenil
RESPIRATORY_ELECTRON_TRANSPORT,2.642537674,0,flumazenil
SARS_COV_1_INFECTION,2.664171397,0,flumazenil
SARS_COV_1_HOST_INTERACTIONS,2.795233904,0,flumazenil
METABOLISM_OF_RNA,3.144114422,0,flumazenil
INFECTIOUS_DISEASE,3.380069806,0,flumazenil
SIGNALING_BY_ROBO_RECEPTORS,3.736561924,0,flumazenil
RRNA_PROCESSING,3.74443905,0,flumazenil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.918247951,0,flumazenil
VIRAL_INFECTION_PATHWAYS,2.991036184,0,flumazenil
EUKARYOTIC_TRANSLATION_INITIATION,2.223832076,0.040997521,sibutramine
EUKARYOTIC_TRANSLATION_ELONGATION,2.170783657,0.034847893,sibutramine
NEUTROPHIL_DEGRANULATION,-2.224216788,0.072233794,sibutramine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.156994971,0.05394082,sibutramine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.083318544,0.055347972,sibutramine
TRANSLATION,2.077233499,0.053638423,sibutramine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.976224288,0.079269553,sibutramine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.990688204,0.092244422,sibutramine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,1.986116191,0.076460377,sibutramine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.979568058,0.068670848,sibutramine
EUKARYOTIC_TRANSLATION_INITIATION,3.475386852,0,tegafur
RRNA_PROCESSING,2.732283343,0,tegafur
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.775690657,0,tegafur
CELLULAR_RESPONSE_TO_STARVATION,2.838465225,0,tegafur
SIGNALING_BY_ROBO_RECEPTORS,2.992917602,0,tegafur
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.009946419,0,tegafur
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.847237603,0,tegafur
SELENOAMINO_ACID_METABOLISM,3.117243119,0,tegafur
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.239515008,0,tegafur
EUKARYOTIC_TRANSLATION_ELONGATION,3.29645934,0,tegafur
EUKARYOTIC_TRANSLATION_INITIATION,3.32285985,0,mometasone
EUKARYOTIC_TRANSLATION_ELONGATION,2.986445816,0,mometasone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.979983599,0,mometasone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.929106786,0,mometasone
TRANSLATION,2.745293362,0.000372766,mometasone
SELENOAMINO_ACID_METABOLISM,2.604264826,0.001553192,mometasone
RRNA_PROCESSING,2.489115123,0.002662615,mometasone
INFLUENZA_INFECTION,2.381620801,0.005358513,mometasone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.349816755,0.005591492,mometasone
NONSENSE_MEDIATED_DECAY_NMD,2.269080214,0.008014472,mometasone
NEURONAL_SYSTEM,3.625692585,0,thalidomide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.979249428,0,thalidomide
MUSCLE_CONTRACTION,2.881864518,0,thalidomide
POTASSIUM_CHANNELS,2.793069751,0.000152955,thalidomide
GPCR_LIGAND_BINDING,2.692113297,0.000244729,thalidomide
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.681978679,0.000203941,thalidomide
CARDIAC_CONDUCTION,2.432748812,0.001223644,thalidomide
GABA_RECEPTOR_ACTIVATION,2.415154438,0.001070688,thalidomide
PLATELET_HOMEOSTASIS,2.299038509,0.002719208,thalidomide
SIGNALING_BY_GPCR,2.254884041,0.00336502,thalidomide
CELL_CYCLE,-2.499183308,0,nitazoxanide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.597466707,0.000933786,nitazoxanide
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.446858408,0.001400679,nitazoxanide
CELLULAR_RESPONSE_TO_STARVATION,2.445600578,0.001245048,nitazoxanide
INTERLEUKIN_10_SIGNALING,2.432870535,0.000933786,nitazoxanide
EUKARYOTIC_TRANSLATION_INITIATION,2.39795536,0.001494058,nitazoxanide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.378062639,0.002023203,nitazoxanide
EUKARYOTIC_TRANSLATION_ELONGATION,2.351087357,0.00200097,nitazoxanide
G2_M_CHECKPOINTS,-2.286316106,0.004697286,nitazoxanide
MITOTIC_PROMETAPHASE,-2.292743339,0.009394572,nitazoxanide
EUKARYOTIC_TRANSLATION_INITIATION,2.755091933,0,mebendazole
NEUTROPHIL_DEGRANULATION,2.355626304,0.008564785,mebendazole
TRANSLATION,2.013589446,0.05660206,mebendazole
RRNA_PROCESSING,1.775844252,0.174460954,mebendazole
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.66805119,0.243239905,mebendazole
CELLULAR_RESPONSE_TO_STARVATION,1.66624701,0.204313576,mebendazole
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.623897452,0.214917596,mebendazole
CILIUM_ASSEMBLY,-1.783776419,1,mebendazole
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.762931311,1,mebendazole
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.754245054,1,mebendazole
GPCR_LIGAND_BINDING,2.203429082,0.047266381,alendronic-acid
NEUTROPHIL_DEGRANULATION,-2.192860674,0.075095929,alendronic-acid
NEURONAL_SYSTEM,2.146491291,0.041478661,alendronic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.123561108,0.034404781,alendronic-acid
SENSORY_PERCEPTION,2.00882689,0.072828812,alendronic-acid
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.88954835,0.229705194,alendronic-acid
CARDIAC_CONDUCTION,1.933534978,0.114018087,alendronic-acid
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.92706409,0.099838172,alendronic-acid
SIGNALING_BY_GPCR,1.906339337,0.100733891,alendronic-acid
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.595326244,0.745437529,alendronic-acid
EUKARYOTIC_TRANSLATION_INITIATION,-2.544291609,0,tioconazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.524125535,0,tioconazole
RRNA_PROCESSING,-2.457607119,0,tioconazole
NONSENSE_MEDIATED_DECAY_NMD,-2.430478354,0,tioconazole
SELENOAMINO_ACID_METABOLISM,-2.421689739,0,tioconazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.375834466,0,tioconazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.239680425,0.000444823,tioconazole
CELLULAR_RESPONSE_TO_STARVATION,-2.207182445,0.0006487,tioconazole
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-2.15385571,0.001614543,tioconazole
INFLUENZA_INFECTION,-2.120609875,0.002179633,tioconazole
EUKARYOTIC_TRANSLATION_ELONGATION,2.767187734,0.001528154,flufenamic-acid
EUKARYOTIC_TRANSLATION_INITIATION,2.656192998,0.000764077,flufenamic-acid
RRNA_PROCESSING,2.606579231,0.000509385,flufenamic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.56744387,0.001146116,flufenamic-acid
INFLUENZA_INFECTION,2.493397135,0.000916893,flufenamic-acid
SELENOAMINO_ACID_METABOLISM,2.4694143,0.000764077,flufenamic-acid
TRANSLATION,2.438570408,0.001091539,flufenamic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.428331254,0.000955096,flufenamic-acid
NONSENSE_MEDIATED_DECAY_NMD,2.366846862,0.001358359,flufenamic-acid
SARS_COV_1_HOST_INTERACTIONS,2.348868102,0.001375339,flufenamic-acid
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.801157996,0,suprofen
GPCR_LIGAND_BINDING,-2.375850288,0.000767128,suprofen
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.401233547,0.002777361,suprofen
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.207835232,0.012961017,suprofen
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.151109789,0.016664165,suprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.179434691,0.01112335,suprofen
RHO_GTPASE_CYCLE,2.139379975,0.01555322,suprofen
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.095879806,0.015738378,suprofen
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.126288677,0.011251205,suprofen
SIGNALING_BY_GPCR,-2.115926397,0.009589095,suprofen
CELL_CYCLE_MITOTIC,-1.96462611,0.482949787,ketanserin
APOPTOSIS,-1.960832953,0.248199511,ketanserin
S_PHASE,-1.956626281,0.175655155,ketanserin
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-1.956590155,0.131741366,ketanserin
CELL_CYCLE,-1.929448198,0.138160319,ketanserin
TOLL_LIKE_RECEPTOR_CASCADES,-1.927871306,0.115744928,ketanserin
VIRAL_INFECTION_PATHWAYS,-1.899681658,0.12488575,ketanserin
HIV_INFECTION,-1.898185341,0.110803353,ketanserin
RHO_GTPASES_ACTIVATE_FORMINS,-1.896827611,0.099850378,ketanserin
PROTEASOME_ASSEMBLY,-1.890877778,0.093411047,ketanserin
METABOLISM_OF_RNA,4.355848677,0,DR-2313
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.635687081,0,DR-2313
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.635687081,0,DR-2313
SARS_COV_1_HOST_INTERACTIONS,2.676580849,0,DR-2313
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.680466617,0,DR-2313
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,2.683472869,0,DR-2313
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.708917211,0,DR-2313
MITOTIC_G2_G2_M_PHASES,2.73376495,0,DR-2313
MRNA_SPLICING,2.736543328,0,DR-2313
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2.752346008,0,DR-2313
TOLL_LIKE_RECEPTOR_CASCADES,-2.647558104,0,bicalutamide
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,-2.256557089,0.0184417,bicalutamide
MYD88_INDEPENDENT_TLR4_CASCADE,-2.134019131,0.037267603,bicalutamide
MAPK_FAMILY_SIGNALING_CASCADES,-2.116484262,0.033425582,bicalutamide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.059684947,0.082392144,bicalutamide
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-2.065454144,0.043799038,bicalutamide
INNATE_IMMUNE_SYSTEM,-2.058287916,0.038420209,bicalutamide
COLLAGEN_FORMATION,1.941502045,0.091579757,bicalutamide
MAPK1_MAPK3_SIGNALING,-1.99218012,0.061417448,bicalutamide
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,1.900154034,0.079230814,bicalutamide
GPCR_LIGAND_BINDING,2.76169565,0.00079634,flurbiprofen
TRANSLATION,2.725751287,0.00079634,flurbiprofen
RESPIRATORY_ELECTRON_TRANSPORT,2.702601631,0.000530893,flurbiprofen
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.269159344,0.037355063,flurbiprofen
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.182704873,0.039552419,flurbiprofen
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.167656317,0.031129219,flurbiprofen
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.093417848,0.031654497,flurbiprofen
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,1.929670932,0.071670558,flurbiprofen
CHROMATIN_ORGANIZATION,-1.934655922,0.151068268,flurbiprofen
HATS_ACETYLATE_HISTONES,-1.910479578,0.147882101,flurbiprofen
GPCR_LIGAND_BINDING,2.24101836,0.019770147,nisoldipine
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-2.258658683,0.090332183,nisoldipine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.140564621,0.090332183,nisoldipine
KEAP1_NFE2L2_PATHWAY,-2.135882292,0.06349436,nisoldipine
NEUTROPHIL_DEGRANULATION,-2.128461251,0.050566385,nisoldipine
ESR_MEDIATED_SIGNALING,-1.923816218,0.13667652,nisoldipine
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,-1.90996849,0.123061234,nisoldipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.966889216,0.140156219,nisoldipine
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.767802397,0.25865302,nisoldipine
RAC3_GTPASE_CYCLE,-1.751595008,0.246449759,nisoldipine
GPCR_LIGAND_BINDING,-2.441523231,0,irinotecan
MRNA_SPLICING,2.39095547,0.027972028,irinotecan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.237444904,0.003019826,irinotecan
SIGNALING_BY_GPCR,-2.229498947,0.002236908,irinotecan
INFLUENZA_INFECTION,2.30126227,0.025641026,irinotecan
HOST_INTERACTIONS_OF_HIV_FACTORS,2.131439091,0.041958042,irinotecan
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.12300243,0.032634033,irinotecan
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.080666999,0.030769231,irinotecan
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.065021995,0.026418026,irinotecan
CELL_CYCLE_CHECKPOINTS,2.063015459,0.022644023,irinotecan
SELENOAMINO_ACID_METABOLISM,-2.451511743,0,torasemide
GPCR_LIGAND_BINDING,-2.615269096,0,torasemide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.593071102,0,torasemide
CELLULAR_RESPONSE_TO_STARVATION,-2.566514549,0,torasemide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.546221718,0,torasemide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.546192265,0,torasemide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.516027938,0,torasemide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.483212149,0,torasemide
SIGNALING_BY_ROBO_RECEPTORS,-2.427095064,7.21E-05,torasemide
RRNA_PROCESSING,-2.432671429,7.86E-05,torasemide
EUKARYOTIC_TRANSLATION_INITIATION,3.280878283,0,lorcaserin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.157203899,0,lorcaserin
INFLUENZA_INFECTION,2.937422235,0,lorcaserin
CELLULAR_RESPONSE_TO_STARVATION,2.738464949,0,lorcaserin
TRANSLATION,2.642304493,0,lorcaserin
SIGNALING_BY_ROBO_RECEPTORS,2.589496759,0.000265362,lorcaserin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.522432231,0.000682359,lorcaserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.084372181,0.061944887,lorcaserin
NEUTROPHIL_DEGRANULATION,2.076250554,0.013334434,lorcaserin
GPCR_LIGAND_BINDING,-2.026812033,0.060122979,lorcaserin
EUKARYOTIC_TRANSLATION_ELONGATION,-3.63588792,0,BRD-K45330754
VIRAL_INFECTION_PATHWAYS,-2.461266709,0,BRD-K45330754
NERVOUS_SYSTEM_DEVELOPMENT,-2.569649985,0,BRD-K45330754
SARS_COV_2_HOST_INTERACTIONS,-2.641003433,0,BRD-K45330754
SARS_COV_1_INFECTION,-2.971319472,0,BRD-K45330754
RRNA_PROCESSING,-2.974553151,0,BRD-K45330754
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.053730188,0,BRD-K45330754
SIGNALING_BY_ROBO_RECEPTORS,-3.107311592,0,BRD-K45330754
TRANSLATION,-3.127749742,0,BRD-K45330754
SARS_COV_1_HOST_INTERACTIONS,-3.128148639,0,BRD-K45330754
GPCR_LIGAND_BINDING,-2.789695207,0,ellagic-acid
SIGNALING_BY_GPCR,-2.682308007,0,ellagic-acid
CHROMATIN_ORGANIZATION,2.671922487,0,ellagic-acid
G_ALPHA_I_SIGNALLING_EVENTS,-2.604422042,0,ellagic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.54869075,0.00019511,ellagic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.493796512,0.000156088,ellagic-acid
G_ALPHA_S_SIGNALLING_EVENTS,-2.426952229,0.000390219,ellagic-acid
RHO_GTPASE_CYCLE,2.422957015,0.007023967,ellagic-acid
HATS_ACETYLATE_HISTONES,2.332081711,0.01092617,ellagic-acid
MITOTIC_PROMETAPHASE,2.133824199,0.023998553,ellagic-acid
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.545466669,0.005077873,topiroxostat
GPCR_LIGAND_BINDING,-2.138762996,0.022366879,topiroxostat
ASPARAGINE_N_LINKED_GLYCOSYLATION,2.170241247,0.050778734,topiroxostat
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.035969136,0.04212429,topiroxostat
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.984893298,0.098172218,topiroxostat
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.938518207,0.09140172,topiroxostat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.983424979,0.049704177,topiroxostat
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.881619284,0.106127553,topiroxostat
NEUTROPHIL_DEGRANULATION,1.858667391,0.097749062,topiroxostat
MYD88_INDEPENDENT_TLR4_CASCADE,1.857709653,0.084147616,topiroxostat
NONSENSE_MEDIATED_DECAY_NMD,4.602377724,0,chlorpropamide
VIRAL_INFECTION_PATHWAYS,2.624797718,0,chlorpropamide
MRNA_SPLICING,2.664969618,0,chlorpropamide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.836010742,0,chlorpropamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.948230494,0,chlorpropamide
RESPIRATORY_ELECTRON_TRANSPORT,3.015245765,0,chlorpropamide
SARS_COV_1_HOST_INTERACTIONS,3.094480178,0,chlorpropamide
SIGNALING_BY_ROBO_RECEPTORS,3.614981691,0,chlorpropamide
RRNA_PROCESSING,3.689112326,0,chlorpropamide
TRANSLATION,3.754227204,0,chlorpropamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.806714318,0,linifanib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.21254133,0.03564377,linifanib
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,2.189025852,0.029797437,linifanib
SELENOAMINO_ACID_METABOLISM,2.175058144,0.024328288,linifanib
SIGNALING_BY_TGFB_FAMILY_MEMBERS,2.153508665,0.022857275,linifanib
CELL_CYCLE_MITOTIC,-2.080061322,0.141135433,linifanib
CELL_CYCLE,-2.001815994,0.141599694,linifanib
SIGNALING_BY_NTRKS,1.963941494,0.069778809,linifanib
DNA_REPLICATION_PRE_INITIATION,-1.960153053,0.136183312,linifanib
CHROMOSOME_MAINTENANCE,-1.934521691,0.124886287,linifanib
CELL_CYCLE_MITOTIC,-2.98633537,0,decitabine
SYNTHESIS_OF_DNA,-2.853845482,0,decitabine
M_PHASE,-2.839572896,0,decitabine
METABOLISM_OF_RNA,-2.797591391,0,decitabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.768560036,0,decitabine
CELL_CYCLE,-2.766837273,0,decitabine
DNA_REPLICATION,-2.729633761,0,decitabine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.592765002,0.000347235,decitabine
GPCR_LIGAND_BINDING,2.550829378,0.00046298,decitabine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.50765933,0.000897675,decitabine
SELENOAMINO_ACID_METABOLISM,3.02079484,0,phentermine
INFLUENZA_INFECTION,2.955614024,0,phentermine
EUKARYOTIC_TRANSLATION_INITIATION,2.487832477,0.000789191,phentermine
SIGNALING_BY_ALK_IN_CANCER,2.42722135,0.002367572,phentermine
CELLULAR_RESPONSE_TO_STARVATION,2.405227017,0.002841086,phentermine
TRANSLATION,2.296559186,0.004735144,phentermine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.248401543,0.005411593,phentermine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.220192905,0.012496418,phentermine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.216453671,0.006248209,phentermine
GPCR_LIGAND_BINDING,-2.214719865,0.004165473,phentermine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,6.509940758,0,ceritinib
INFECTIOUS_DISEASE,4.220084088,0,ceritinib
SARS_COV_2_HOST_INTERACTIONS,3.702209414,0,ceritinib
SARS_COV_INFECTIONS,3.673444945,0,ceritinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.454476604,0,ceritinib
MEMBRANE_TRAFFICKING,3.380470422,0,ceritinib
SARS_COV_2_INFECTION,3.377736663,0,ceritinib
MRNA_SPLICING,3.260184563,0,ceritinib
NERVOUS_SYSTEM_DEVELOPMENT,3.127340976,0,ceritinib
RESPIRATORY_ELECTRON_TRANSPORT,3.054294291,0,ceritinib
GPCR_LIGAND_BINDING,-2.126275482,0.042321853,clofarabine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.058532224,0.216703896,clofarabine
NEUTROPHIL_DEGRANULATION,2.010290013,0.146877085,clofarabine
INNATE_IMMUNE_SYSTEM,1.903312088,0.179783973,clofarabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.975466156,0.099237449,clofarabine
SIGNALING_BY_GPCR,-1.94818704,0.083914019,clofarabine
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,-1.927238072,0.077164414,clofarabine
CELLULAR_SENESCENCE,1.75083807,0.335289084,clofarabine
G_ALPHA_S_SIGNALLING_EVENTS,-1.885330613,0.085665269,clofarabine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.736531412,0.290864785,clofarabine
INTERFERON_ALPHA_BETA_SIGNALING,-3.217471972,0,VX-745
G_ALPHA_Q_SIGNALLING_EVENTS,2.080636893,0.065969201,VX-745
GPCR_LIGAND_BINDING,2.070035419,0.039169213,VX-745
G_ALPHA_S_SIGNALLING_EVENTS,1.928923894,0.114896358,VX-745
IRE1ALPHA_ACTIVATES_CHAPERONES,1.923692237,0.090295344,VX-745
SIGNALING_BY_GPCR,1.881492692,0.106705182,VX-745
SARS_COV_1_HOST_INTERACTIONS,-1.764138059,1,VX-745
INTERFERON_SIGNALING,-1.761391455,0.694316234,VX-745
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.862375913,0.104451235,VX-745
SIGNALING_BY_WNT,-1.643706145,0.862537914,VX-745
RAB_GERANYLGERANYLATION,1.857373948,0.135278918,piretanide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.794023689,0.092719258,piretanide
RAB_REGULATION_OF_TRAFFICKING,1.518202302,0.289304352,piretanide
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.464888925,0.291077671,piretanide
MRNA_SPLICING,1.379735722,0.359933121,piretanide
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.360168041,0.328064042,piretanide
G_ALPHA_Q_SIGNALLING_EVENTS,-1.733248951,1,piretanide
DNA_REPLICATION,1.297060935,0.379779819,piretanide
SYNTHESIS_OF_DNA,1.288051144,0.34750722,piretanide
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.687606698,1,piretanide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.885707641,0,molindone
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.796364953,0,molindone
RESPIRATORY_ELECTRON_TRANSPORT,2.761525426,0,molindone
TRANSLATION,2.748411882,0,molindone
EUKARYOTIC_TRANSLATION_INITIATION,2.716263118,0,molindone
CELLULAR_RESPONSE_TO_STARVATION,2.325930045,0.006306203,molindone
MITOCHONDRIAL_TRANSLATION,2.168190936,0.016891615,molindone
RRNA_PROCESSING,2.117346358,0.018623005,molindone
SIGNALING_BY_ROBO_RECEPTORS,2.099364278,0.019181367,molindone
INFLUENZA_INFECTION,2.085679767,0.019391574,molindone
SELENOAMINO_ACID_METABOLISM,2.781189882,0,glycopyrrolate
EUKARYOTIC_TRANSLATION_ELONGATION,2.690284313,0,glycopyrrolate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.686560452,0,glycopyrrolate
NONSENSE_MEDIATED_DECAY_NMD,2.605491812,0,glycopyrrolate
EUKARYOTIC_TRANSLATION_INITIATION,2.559206457,0,glycopyrrolate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.460444778,0.000181897,glycopyrrolate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.446853693,0.000155912,glycopyrrolate
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.862841467,0.001456066,glycopyrrolate
CELLULAR_RESPONSE_TO_STARVATION,2.346990911,0.000545691,glycopyrrolate
SIGNALING_BY_ROBO_RECEPTORS,2.301246167,0.001697704,glycopyrrolate
EUKARYOTIC_TRANSLATION_INITIATION,3.051560861,0,phentolamine
TRANSLATION,2.983436618,0,phentolamine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.983078968,0,phentolamine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.96824644,0,phentolamine
NONSENSE_MEDIATED_DECAY_NMD,2.910339493,0,phentolamine
EUKARYOTIC_TRANSLATION_ELONGATION,2.885485834,0,phentolamine
SELENOAMINO_ACID_METABOLISM,2.868448127,0,phentolamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.818979904,0,phentolamine
CELLULAR_RESPONSE_TO_STARVATION,2.801393814,0,phentolamine
SIGNALING_BY_ROBO_RECEPTORS,2.731012628,0,phentolamine
METABOLISM_OF_RNA,4.79412589,0,hydroxyfasudil
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.932659603,0,hydroxyfasudil
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.865086797,0,hydroxyfasudil
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.858884835,0,hydroxyfasudil
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,2.853975389,0,hydroxyfasudil
AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,2.839301505,0,hydroxyfasudil
CELLULAR_RESPONSES_TO_STIMULI,2.822020338,0,hydroxyfasudil
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.818567672,0,hydroxyfasudil
ORC1_REMOVAL_FROM_CHROMATIN,2.802613439,0,hydroxyfasudil
DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,2.792597807,0,hydroxyfasudil
NONSENSE_MEDIATED_DECAY_NMD,3.006529805,0,cabergoline
SELENOAMINO_ACID_METABOLISM,2.999896511,0,cabergoline
INFLUENZA_INFECTION,2.98976465,0,cabergoline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.857931161,0,cabergoline
EUKARYOTIC_TRANSLATION_ELONGATION,2.839545165,0,cabergoline
GPCR_LIGAND_BINDING,-2.701189121,0,cabergoline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.595912272,0,cabergoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.764102502,0.000378054,cabergoline
EUKARYOTIC_TRANSLATION_INITIATION,2.737949228,0.000324046,cabergoline
CELLULAR_RESPONSE_TO_STARVATION,2.7356346,0.00028354,cabergoline
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.140247507,0.038721968,ketotifen
MAPK1_MAPK3_SIGNALING,-2.138130562,0.021573668,ketotifen
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,-2.120321961,0.018070252,ketotifen
DISEASES_OF_GLYCOSYLATION,2.005888275,0.035831082,ketotifen
MAPK_FAMILY_SIGNALING_CASCADES,-1.916215773,0.132484449,ketotifen
NEURONAL_SYSTEM,-1.909571823,0.111519269,ketotifen
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.893670682,0.110081025,ketotifen
MITOTIC_G2_G2_M_PHASES,-1.878068469,0.106208828,ketotifen
GPCR_LIGAND_BINDING,-1.877458643,0.093485895,ketotifen
INTERFERON_ALPHA_BETA_SIGNALING,1.663183896,0.135475615,ketotifen
NEUTROPHIL_DEGRANULATION,-2.189148192,0.149855451,tolmetin
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.953060047,0.333567133,tolmetin
REPRODUCTION,-1.94176414,0.182046622,tolmetin
MEIOSIS,-1.94176414,0.182046622,tolmetin
GPCR_LIGAND_BINDING,1.852252222,1,tolmetin
INNATE_IMMUNE_SYSTEM,-1.74758566,0.429363618,tolmetin
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.653406314,0.56112541,tolmetin
METABOLISM_OF_STEROIDS,-1.60965918,0.590065749,tolmetin
EUKARYOTIC_TRANSLATION_INITIATION,1.707050995,1,tolmetin
SIGNALING_BY_NTRKS,-1.562122631,0.638550726,tolmetin
EUKARYOTIC_TRANSLATION_INITIATION,3.876381794,0,GW-9662
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.689599327,0,GW-9662
GPCR_LIGAND_BINDING,-2.704865528,0,GW-9662
INFLUENZA_INFECTION,2.991364714,0,GW-9662
RRNA_PROCESSING,3.050330013,0,GW-9662
CELLULAR_RESPONSE_TO_STARVATION,3.153515489,0,GW-9662
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.19500893,0,GW-9662
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.000786582,0,GW-9662
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.403454829,0,GW-9662
NONSENSE_MEDIATED_DECAY_NMD,3.442278084,0,GW-9662
EUKARYOTIC_TRANSLATION_INITIATION,2.716560803,0,etomidate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.645418509,0.000754854,etomidate
EUKARYOTIC_TRANSLATION_ELONGATION,2.643590843,0.000503236,etomidate
SARS_COV_1_HOST_INTERACTIONS,2.543191052,0.000754854,etomidate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.441273561,0.000603883,etomidate
SARS_COV_1_INFECTION,2.431449618,0.001006472,etomidate
SELENOAMINO_ACID_METABOLISM,2.417159914,0.001078362,etomidate
VISUAL_PHOTOTRANSDUCTION,2.341402088,0.002830701,etomidate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.319767823,0.003522651,etomidate
SYNTHESIS_OF_DNA,2.249537684,0.00603883,etomidate
NEUTROPHIL_DEGRANULATION,-2.122637218,0.150048672,ethotoin
ECM_PROTEOGLYCANS,1.983933208,0.452230905,ethotoin
PCP_CE_PATHWAY,1.811699912,0.749550983,ethotoin
EUKARYOTIC_TRANSLATION_INITIATION,1.787882926,0.587030502,ethotoin
SYNTHESIS_OF_DNA,1.76048781,0.52180489,ethotoin
RESPIRATORY_ELECTRON_TRANSPORT,1.74652531,0.453752836,ethotoin
DNA_REPLICATION,1.700299334,0.496801739,ethotoin
TRANSLATION,1.690108319,0.450522615,ethotoin
PROTEIN_LOCALIZATION,-1.666559653,1,ethotoin
DNA_REPLICATION_PRE_INITIATION,1.679305057,0.420297533,ethotoin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.272265179,0,menadione
G_ALPHA_I_SIGNALLING_EVENTS,-2.499792031,0,menadione
G_ALPHA_Q_SIGNALLING_EVENTS,-2.673448611,0,menadione
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.931804064,0,menadione
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.935609455,0,menadione
SIGNALING_BY_GPCR,-3.041064092,0,menadione
GPCR_LIGAND_BINDING,-3.099173943,0,menadione
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.283014695,0,menadione
METABOLISM_OF_RNA,3.287210418,0,menadione
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.331801616,0,menadione
GPCR_LIGAND_BINDING,2.960277585,0,H-7
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.793471869,0,H-7
SIGNALING_BY_GPCR,2.762421403,0,H-7
M_PHASE,-2.621559507,0.001331253,H-7
CELL_CYCLE_CHECKPOINTS,-2.588832523,0.001331253,H-7
CELL_CYCLE,-2.586568757,0.000887502,H-7
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.490475145,0.00199688,H-7
G_ALPHA_Q_SIGNALLING_EVENTS,2.376172575,0.001036193,H-7
COPII_MEDIATED_VESICLE_TRANSPORT,-2.403059401,0.003461258,H-7
MRNA_SPLICING,-2.378004822,0.003771884,H-7
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.71524138,0,alprenolol
METABOLISM_OF_RNA,2.65601862,0,alprenolol
SARS_COV_2_HOST_INTERACTIONS,2.731685686,0,alprenolol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.859581766,0,alprenolol
VIRAL_INFECTION_PATHWAYS,2.937137797,0,alprenolol
SARS_COV_1_INFECTION,2.963109758,0,alprenolol
TRANSLATION,3.034517434,0,alprenolol
SARS_COV_1_HOST_INTERACTIONS,3.077478598,0,alprenolol
SIGNALING_BY_ROBO_RECEPTORS,3.085369481,0,alprenolol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.121577659,0,alprenolol
GPCR_LIGAND_BINDING,2.681966815,0.000494081,somatostatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.308377924,0.002223363,somatostatin
G_ALPHA_Q_SIGNALLING_EVENTS,2.250205608,0.002346883,somatostatin
SIGNALING_BY_GPCR,2.252027023,0.003129178,somatostatin
G2_M_CHECKPOINTS,-2.506417346,0.101956852,somatostatin
CELL_CYCLE_CHECKPOINTS,-2.496024329,0.057664121,somatostatin
SYNTHESIS_OF_DNA,-2.460078021,0.052371279,somatostatin
CELL_CYCLE,-2.403868304,0.056828409,somatostatin
DNA_REPAIR,-2.38113093,0.052816992,somatostatin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.053605932,0.016107031,somatostatin
TRANSLATION,3.67592763,0,captopril
RRNA_PROCESSING,2.904843377,0,captopril
HATS_ACETYLATE_HISTONES,-2.291515849,0.010077515,captopril
EXTRACELLULAR_MATRIX_ORGANIZATION,2.275322521,0.004533385,captopril
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.147987211,0.012142996,captopril
CILIUM_ASSEMBLY,-2.09790873,0.056937959,captopril
RESPIRATORY_ELECTRON_TRANSPORT,1.827567961,0.083543812,captopril
METABOLISM_OF_NUCLEOTIDES,1.819683371,0.073505602,captopril
CHROMATIN_ORGANIZATION,-1.835347471,0.36917296,captopril
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.568485245,0.259929501,captopril
EUKARYOTIC_TRANSLATION_INITIATION,3.051018416,0,triclosan
EUKARYOTIC_TRANSLATION_ELONGATION,3.023372933,0,triclosan
SELENOAMINO_ACID_METABOLISM,2.963543078,0,triclosan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.90179128,0,triclosan
NONSENSE_MEDIATED_DECAY_NMD,2.855656432,0,triclosan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.84851459,0,triclosan
CELLULAR_RESPONSE_TO_STARVATION,2.846427413,0,triclosan
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.82057538,0,triclosan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.796933053,0,triclosan
TRANSLATION,2.724900284,0,triclosan
EUKARYOTIC_TRANSLATION_ELONGATION,3.282755774,0,propentofylline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.157575017,0,propentofylline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.140426876,0,propentofylline
SELENOAMINO_ACID_METABOLISM,3.134762461,0,propentofylline
EUKARYOTIC_TRANSLATION_INITIATION,2.937475071,0,propentofylline
MUSCLE_CONTRACTION,2.796837514,0.000141381,propentofylline
CELLULAR_RESPONSE_TO_STARVATION,2.729294204,0.000242367,propentofylline
NONSENSE_MEDIATED_DECAY_NMD,2.589795728,0.000318107,propentofylline
TRANSLATION,2.564783251,0.00047127,propentofylline
CARDIAC_CONDUCTION,2.549408545,0.000462701,propentofylline
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.303626981,0.001622353,mianserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.19503842,0.002027942,mianserin
GPCR_LIGAND_BINDING,-2.184825029,0.001351961,mianserin
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.175459021,0.049826004,mianserin
ADAPTIVE_IMMUNE_SYSTEM,1.976218035,0.099652009,mianserin
SIGNALING_BY_GPCR,-2.020983138,0.013790004,mianserin
MITOTIC_PROPHASE,1.871110555,0.112701677,mianserin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.993650818,0.014763417,mianserin
G_ALPHA_S_SIGNALLING_EVENTS,-1.960858996,0.019603438,mianserin
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1.720022884,0.202863018,mianserin
GPCR_LIGAND_BINDING,3.041867229,0,NPI-2358
SIGNALING_BY_GPCR,2.945219379,0,NPI-2358
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.771188194,0,NPI-2358
G_ALPHA_Q_SIGNALLING_EVENTS,2.547330603,0,NPI-2358
MUSCLE_CONTRACTION,2.394837742,0.000740563,NPI-2358
TRANSLATION,-2.373927253,0.035294003,NPI-2358
INFLUENZA_INFECTION,-2.309034099,0.030542887,NPI-2358
PROTEIN_LOCALIZATION,-2.260065858,0.028959182,NPI-2358
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.237528476,0.024773675,NPI-2358
CARDIAC_CONDUCTION,2.202619052,0.006479922,NPI-2358
GPCR_LIGAND_BINDING,2.286872756,0.0229018,phenothiazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.143794257,0.052570041,phenothiazine
CELL_CELL_COMMUNICATION,-2.144218721,0.183503594,phenothiazine
TRANSLATION,2.07932275,0.056907503,phenothiazine
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.065578831,0.169315172,phenothiazine
CELL_JUNCTION_ORGANIZATION,-1.99560174,0.168999874,phenothiazine
CILIUM_ASSEMBLY,-1.954515493,0.157255013,phenothiazine
GLYCOSAMINOGLYCAN_METABOLISM,-1.933456681,0.141505865,phenothiazine
NEUTROPHIL_DEGRANULATION,-1.876536885,0.162693908,phenothiazine
ECM_PROTEOGLYCANS,1.858630294,0.241509889,phenothiazine
GPCR_LIGAND_BINDING,3.218586758,0,reversine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.184391262,0,reversine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.774152166,0,reversine
SIGNALING_BY_GPCR,2.66885511,0,reversine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.690661492,0.00386045,reversine
MITOTIC_PROMETAPHASE,-2.646719415,0.002895337,reversine
M_PHASE,-2.438227394,0.007720899,reversine
NCAM1_INTERACTIONS,2.20327405,0.003245628,reversine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.200212547,0.037156827,reversine
NEUTROPHIL_DEGRANULATION,-2.160009792,0.04130681,reversine
EUKARYOTIC_TRANSLATION_INITIATION,2.254105849,0.08060093,T-0901317
ECM_PROTEOGLYCANS,2.060216445,0.168951949,T-0901317
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,2.051756686,0.117284687,T-0901317
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.037451361,0.096876118,T-0901317
RESPIRATORY_ELECTRON_TRANSPORT,1.989908886,0.109741266,T-0901317
SARS_COV_1_HOST_INTERACTIONS,1.940239714,0.13175152,T-0901317
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.933250523,0.119351377,T-0901317
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.910071018,0.122838917,T-0901317
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.909988597,0.109190149,T-0901317
EXTRACELLULAR_MATRIX_ORGANIZATION,1.903184968,0.103696196,T-0901317
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.548376441,0,diclofenac
METABOLISM_OF_RNA,2.27609763,0.013594345,diclofenac
VIRAL_INFECTION_PATHWAYS,2.119475484,0.032626427,diclofenac
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.094349099,0.031266993,diclofenac
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-2.031360008,0.049821975,diclofenac
INFLUENZA_INFECTION,1.918674364,0.075040783,diclofenac
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.912615789,0.065252855,diclofenac
GPCR_LIGAND_BINDING,-1.970189617,0.047400073,diclofenac
INFECTIOUS_DISEASE,1.73665727,0.139050726,diclofenac
AMINE_LIGAND_BINDING_RECEPTORS,-1.9291921,0.048668688,diclofenac
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.434761134,0.004135262,chlorothiazide
NEUTROPHIL_DEGRANULATION,-2.343642132,0.047251088,chlorothiazide
NEURONAL_SYSTEM,-1.970042074,0.260845292,chlorothiazide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.941972593,0.201540355,chlorothiazide
BIOLOGICAL_OXIDATIONS,-1.885630286,0.212629896,chlorothiazide
SIGNALING_BY_NOTCH,1.75561806,0.672496905,chlorothiazide
INNATE_IMMUNE_SYSTEM,-1.776116188,0.310121427,chlorothiazide
CHROMATIN_ORGANIZATION,1.713954137,0.585139505,chlorothiazide
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.692697455,0.494163752,chlorothiazide
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,1.683657719,0.416627598,chlorothiazide
SELENOAMINO_ACID_METABOLISM,2.508540872,0.001226437,primaquine
MUSCLE_CONTRACTION,2.222728316,0.015330457,primaquine
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.217254411,0.01042471,primaquine
CELLULAR_RESPONSE_TO_STARVATION,2.144852662,0.013030888,primaquine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.091177704,0.016556893,primaquine
RAB_REGULATION_OF_TRAFFICKING,1.94571249,0.041596639,primaquine
NONSENSE_MEDIATED_DECAY_NMD,1.939267236,0.036880698,primaquine
CARDIAC_CONDUCTION,1.931521323,0.034186918,primaquine
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.970922473,0.739077174,primaquine
EUKARYOTIC_TRANSLATION_INITIATION,1.891928231,0.039995458,primaquine
TRANSLATION,2.444330856,0.008607601,quinethazone
RESPIRATORY_ELECTRON_TRANSPORT,2.367677639,0.010452087,quinethazone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.335239072,0.00778783,quinethazone
SARS_COV_1_HOST_INTERACTIONS,2.070168189,0.05533458,quinethazone
CELL_CYCLE_CHECKPOINTS,2.032148777,0.059269483,quinethazone
DNA_REPLICATION,1.988404436,0.06742621,quinethazone
CELL_CYCLE_MITOTIC,1.927362192,0.080981718,quinethazone
CELL_CELL_COMMUNICATION,-1.889425164,0.826520566,quinethazone
SYNTHESIS_OF_DNA,1.816098694,0.13664567,quinethazone
RHO_GTPASES_ACTIVATE_FORMINS,1.808520416,0.126927962,quinethazone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.50330888,0.001106334,caffeine
EUKARYOTIC_TRANSLATION_INITIATION,-2.434181716,0.001106334,caffeine
NONSENSE_MEDIATED_DECAY_NMD,-2.408511926,0.001106334,caffeine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.3895491,0.000829751,caffeine
TRANSLATION,-2.366382831,0.001106334,caffeine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.358777241,0.000921945,caffeine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.344854488,0.000790239,caffeine
INFLUENZA_INFECTION,-2.301028759,0.001521209,caffeine
GLYCOSAMINOGLYCAN_METABOLISM,2.264400911,0.009397674,caffeine
SELENOAMINO_ACID_METABOLISM,-2.262102558,0.002335594,caffeine
TRANSLATION,-5.330043533,0,bosutinib
CELLULAR_RESPONSES_TO_STIMULI,-3.196924848,0,bosutinib
S_PHASE,-3.14669347,0,bosutinib
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,-3.117708774,0,bosutinib
DNA_REPLICATION_PRE_INITIATION,-3.109221105,0,bosutinib
VIRAL_INFECTION_PATHWAYS,-3.051725937,0,bosutinib
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,-2.962292026,0,bosutinib
NERVOUS_SYSTEM_DEVELOPMENT,-2.92944535,0,bosutinib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.916053337,0,bosutinib
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.913043641,0,bosutinib
GPCR_LIGAND_BINDING,-2.485645669,0,AZD-8330
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.687726192,0.002155246,AZD-8330
SIGNALING_BY_GPCR,-2.410834521,0.000968603,AZD-8330
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.240053007,0.00290581,AZD-8330
TRANSLATION,2.400522253,0.008082173,AZD-8330
G_ALPHA_Q_SIGNALLING_EVENTS,-2.173150059,0.008233129,AZD-8330
NEUTROPHIL_DEGRANULATION,1.9388799,0.119616161,AZD-8330
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.802163671,0.196935616,AZD-8330
CELLULAR_RESPONSE_TO_STARVATION,1.732934685,0.229749239,AZD-8330
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.808603085,0.219098092,AZD-8330
RAB_REGULATION_OF_TRAFFICKING,1.867157906,0.270603714,oxiconazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.854883757,0.144835321,oxiconazole
NEUTROPHIL_DEGRANULATION,1.854158009,0.096801329,oxiconazole
ECM_PROTEOGLYCANS,-1.981516785,0.738438184,oxiconazole
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.980620107,0.372439026,oxiconazole
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.782487998,0.110734853,oxiconazole
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.94845382,0.314480215,oxiconazole
DISEASES_OF_GLYCOSYLATION,-1.879334105,0.386392073,oxiconazole
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.810541952,0.481272793,oxiconazole
SIGNALING_BY_ROBO_RECEPTORS,1.532613523,0.333671246,oxiconazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.008790525,0,indometacin
EUKARYOTIC_TRANSLATION_ELONGATION,2.99347693,0,indometacin
TRANSLATION,2.985276707,0,indometacin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.944692997,0,indometacin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.913725232,0,indometacin
EUKARYOTIC_TRANSLATION_INITIATION,2.870284242,0,indometacin
NONSENSE_MEDIATED_DECAY_NMD,2.777393897,0,indometacin
RRNA_PROCESSING,2.627027208,0.000215345,indometacin
CELLULAR_RESPONSE_TO_STARVATION,2.610461185,0.000191418,indometacin
SELENOAMINO_ACID_METABOLISM,2.602916988,0.000172276,indometacin
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.689236262,0.549173467,PF-02545920
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-1.875394065,0.217618482,PF-02545920
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.500722975,0.772180372,PF-02545920
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.44791172,0.658401339,PF-02545920
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.76931293,0.327749293,PF-02545920
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.416679672,0.581031597,PF-02545920
EPH_EPHRIN_SIGNALING,1.399301846,0.500020925,PF-02545920
INTERFERON_ALPHA_BETA_SIGNALING,-1.732177231,0.318938828,PF-02545920
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.333646836,0.575974751,PF-02545920
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.316686731,0.53183571,PF-02545920
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.19408023,0.044421797,safinamide
PROTEIN_LOCALIZATION,2.044284398,0.066243031,safinamide
GASTRULATION,-2.03911524,0.267292208,safinamide
ECM_PROTEOGLYCANS,-2.025773472,0.155201927,safinamide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.998585397,0.13616095,safinamide
DEVELOPMENTAL_CELL_LINEAGES,-1.878639095,0.273758955,safinamide
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.801919922,0.388435935,safinamide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.491740418,1,safinamide
FORMATION_OF_PARAXIAL_MESODERM,-1.658185129,0.858460661,safinamide
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-1.648495522,0.77924301,safinamide
EUKARYOTIC_TRANSLATION_ELONGATION,5.107730807,0,droxidopa
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.587587282,0,droxidopa
SENSORY_PERCEPTION,-2.637318123,0,droxidopa
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.917158847,0,droxidopa
SARS_COV_INFECTIONS,2.972688309,0,droxidopa
SIGNALING_BY_GPCR,-3.039390095,0,droxidopa
SARS_COV_2_INFECTION,3.09691654,0,droxidopa
SARS_COV_2_HOST_INTERACTIONS,3.150149752,0,droxidopa
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.22853726,0,droxidopa
MRNA_SPLICING,3.264498557,0,droxidopa
EUKARYOTIC_TRANSLATION_ELONGATION,5.637345827,0,vildagliptin
SIGNALING_BY_GPCR,-2.832529046,0,vildagliptin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.989235004,0,vildagliptin
SARS_COV_INFECTIONS,3.104618121,0,vildagliptin
GPCR_LIGAND_BINDING,-3.197425142,0,vildagliptin
SARS_COV_2_HOST_INTERACTIONS,3.365400501,0,vildagliptin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.498532432,0,vildagliptin
INFECTIOUS_DISEASE,3.503262263,0,vildagliptin
MRNA_SPLICING,3.641556545,0,vildagliptin
CELLULAR_RESPONSES_TO_STIMULI,3.693509625,0,vildagliptin
EUKARYOTIC_TRANSLATION_INITIATION,4.750314953,0,BRD-K71860425
CELL_CYCLE,2.763504984,0,BRD-K71860425
MRNA_SPLICING,2.820277605,0,BRD-K71860425
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.825692983,0,BRD-K71860425
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.925555367,0,BRD-K71860425
VIRAL_INFECTION_PATHWAYS,2.932583393,0,BRD-K71860425
SARS_COV_1_INFECTION,2.996493793,0,BRD-K71860425
NERVOUS_SYSTEM_DEVELOPMENT,3.048940065,0,BRD-K71860425
SARS_COV_1_HOST_INTERACTIONS,3.129093489,0,BRD-K71860425
CELLULAR_RESPONSES_TO_STIMULI,3.247604485,0,BRD-K71860425
EUKARYOTIC_TRANSLATION_INITIATION,3.209101658,0,fenofibrate
METABOLISM_OF_RNA,2.705992367,0,fenofibrate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.77654431,0,fenofibrate
TRANSLATION,2.785081819,0,fenofibrate
NONSENSE_MEDIATED_DECAY_NMD,3.031582355,0,fenofibrate
CELLULAR_RESPONSE_TO_STARVATION,3.068294623,0,fenofibrate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.786957505,0,fenofibrate
INFLUENZA_INFECTION,3.098308358,0,fenofibrate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.137895291,0,fenofibrate
RRNA_PROCESSING,3.155511929,0,fenofibrate
EXTRACELLULAR_MATRIX_ORGANIZATION,2.378946554,0.011320464,BRD-A04553218
INTERFERON_ALPHA_BETA_SIGNALING,2.160262732,0.033332478,BRD-A04553218
GLYCOSAMINOGLYCAN_METABOLISM,2.151813463,0.023060205,BRD-A04553218
BIOLOGICAL_OXIDATIONS,1.958126504,0.052828833,BRD-A04553218
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.895711229,0.060375809,BRD-A04553218
DISEASES_OF_GLYCOSYLATION,1.774356074,0.100416709,BRD-A04553218
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.736175202,0.109790533,BRD-A04553218
DNA_DOUBLE_STRAND_BREAK_REPAIR,-1.810375177,1,BRD-A04553218
GPCR_LIGAND_BINDING,-1.793261734,0.614429207,BRD-A04553218
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.544619841,0.266659821,BRD-A04553218
TRANSLATION,3.588514612,0,estropipate
EUKARYOTIC_TRANSLATION_INITIATION,3.390335889,0,estropipate
EUKARYOTIC_TRANSLATION_ELONGATION,3.195925543,0,estropipate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.183260397,0,estropipate
RRNA_PROCESSING,2.916441357,0,estropipate
SELENOAMINO_ACID_METABOLISM,2.906582012,0,estropipate
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.900242906,0,estropipate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.717238404,0,estropipate
INFLUENZA_INFECTION,2.674506642,0.000399271,estropipate
RESPIRATORY_ELECTRON_TRANSPORT,2.533262646,0.001078031,estropipate
EUKARYOTIC_TRANSLATION_ELONGATION,3.858773905,0,salmeterol
CELLULAR_RESPONSES_TO_STIMULI,2.722369021,0,salmeterol
SARS_COV_1_HOST_INTERACTIONS,2.741978677,0,salmeterol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.742314611,0,salmeterol
RESPIRATORY_ELECTRON_TRANSPORT,2.796254959,0,salmeterol
METABOLISM_OF_RNA,3.012728583,0,salmeterol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.120008896,0,salmeterol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.130202257,0,salmeterol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.152496938,0,salmeterol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.29520984,0,salmeterol
EUKARYOTIC_TRANSLATION_INITIATION,2.285456183,0.031007903,ezetimibe
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.353467446,0.019314479,ezetimibe
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.235610409,0.025370102,ezetimibe
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.154635024,0.036175886,ezetimibe
RESPIRATORY_ELECTRON_TRANSPORT,2.139213519,0.031712628,ezetimibe
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.135723778,0.027343332,ezetimibe
TRANSLATION,2.10617045,0.029598453,ezetimibe
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.063583187,0.035236253,ezetimibe
SIGNALING_BY_ROBO_RECEPTORS,1.986147283,0.056378005,ezetimibe
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.007415596,0.105674619,ezetimibe
SELENOAMINO_ACID_METABOLISM,3.422406317,0,guanaben-acetate
SIGNALING_BY_ROBO_RECEPTORS,2.56913069,0,guanaben-acetate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.813418363,0,guanaben-acetate
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.860219521,0,guanaben-acetate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.880794521,0,guanaben-acetate
INFLUENZA_INFECTION,2.923412309,0,guanaben-acetate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.060745038,0,guanaben-acetate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.086270837,0,guanaben-acetate
NONSENSE_MEDIATED_DECAY_NMD,2.975598421,0,guanaben-acetate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.238021514,0,guanaben-acetate
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.673655438,0,ondansetron
GPCR_LIGAND_BINDING,-2.3689035,0,ondansetron
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.28917102,0,ondansetron
RESPIRATORY_ELECTRON_TRANSPORT,2.613454998,0.002168112,ondansetron
G_ALPHA_S_SIGNALLING_EVENTS,-2.239019283,0.000517668,ondansetron
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.226549745,0.001358878,ondansetron
SIGNALING_BY_GPCR,-2.124383958,0.004037808,ondansetron
CELL_CYCLE_MITOTIC,2.040603593,0.053480098,ondansetron
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1.914628935,0.083472315,ondansetron
G_ALPHA_Q_SIGNALLING_EVENTS,-1.995333728,0.015271198,ondansetron
MITOTIC_PROMETAPHASE,-2.224784979,0.026460283,wortmannin
KINESINS,-2.130957878,0.032566502,wortmannin
CELL_CYCLE_MITOTIC,-2.063163522,0.044439706,wortmannin
MITOTIC_G2_G2_M_PHASES,-2.030754388,0.04477894,wortmannin
CELL_CYCLE,-2.0001154,0.049256834,wortmannin
RHO_GTPASES_ACTIVATE_FORMINS,-1.994943774,0.044100472,wortmannin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.963248792,0.04972207,wortmannin
MITOTIC_SPINDLE_CHECKPOINT,-1.946592601,0.051394011,wortmannin
M_PHASE,-1.934003817,0.051902863,wortmannin
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-1.904586118,0.059332096,wortmannin
METABOLISM_OF_RNA,6.339819469,0,nifedipine
RESPIRATORY_ELECTRON_TRANSPORT,3.69152502,0,nifedipine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.670601861,0,nifedipine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.612941458,0,nifedipine
SARS_COV_1_INFECTION,3.590293288,0,nifedipine
SARS_COV_INFECTIONS,3.049767149,0,nifedipine
HIV_INFECTION,3.037021383,0,nifedipine
INFECTIOUS_DISEASE,3.7871479,0,nifedipine
CELL_CYCLE_CHECKPOINTS,3.027760526,0,nifedipine
TRNA_PROCESSING,2.935445241,0,nifedipine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.660090186,0,fexofenadine
SELENOAMINO_ACID_METABOLISM,2.569543207,0,fexofenadine
EUKARYOTIC_TRANSLATION_ELONGATION,2.458698786,0.001221613,fexofenadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.374682498,0.001628817,fexofenadine
NONSENSE_MEDIATED_DECAY_NMD,2.373210386,0.001221613,fexofenadine
CELLULAR_RESPONSE_TO_STARVATION,2.326624355,0.001710258,fexofenadine
EUKARYOTIC_TRANSLATION_INITIATION,2.255013323,0.00285043,fexofenadine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.244027684,0.002617741,fexofenadine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.008976866,0.035121365,fexofenadine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.001018954,0.033119277,fexofenadine
EUKARYOTIC_TRANSLATION_ELONGATION,5.254527732,0,moxifloxacin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.657370637,0,moxifloxacin
GPCR_LIGAND_BINDING,-2.700598358,0,moxifloxacin
SARS_COV_2_INFECTION,3.086298976,0,moxifloxacin
SARS_COV_INFECTIONS,3.135508103,0,moxifloxacin
SARS_COV_2_HOST_INTERACTIONS,3.199510624,0,moxifloxacin
CELLULAR_RESPONSES_TO_STIMULI,3.589769722,0,moxifloxacin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.756284451,0,moxifloxacin
INFECTIOUS_DISEASE,3.853814587,0,moxifloxacin
SARS_COV_1_HOST_INTERACTIONS,3.887214502,0,moxifloxacin
EUKARYOTIC_TRANSLATION_ELONGATION,4.234131393,0,DNQX
NERVOUS_SYSTEM_DEVELOPMENT,3.027031734,0,DNQX
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.202831527,0,DNQX
SARS_COV_1_HOST_INTERACTIONS,3.216540905,0,DNQX
TRANSLATION,3.685680735,0,DNQX
SIGNALING_BY_ROBO_RECEPTORS,3.786844885,0,DNQX
INFLUENZA_INFECTION,4.011776089,0,DNQX
METABOLISM_OF_RNA,4.012772022,0,DNQX
CELLULAR_RESPONSE_TO_STARVATION,3.562163316,0,DNQX
EUKARYOTIC_TRANSLATION_INITIATION,4.11377544,0,DNQX
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.023874073,0,thenoyltrifluoroacetone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.561997554,0,thenoyltrifluoroacetone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.728142696,0,thenoyltrifluoroacetone
SIGNALING_BY_ROBO_RECEPTORS,2.744600818,0,thenoyltrifluoroacetone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.774575283,0,thenoyltrifluoroacetone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.790452112,0,thenoyltrifluoroacetone
CELLULAR_RESPONSE_TO_STARVATION,2.809317168,0,thenoyltrifluoroacetone
NONSENSE_MEDIATED_DECAY_NMD,2.84342306,0,thenoyltrifluoroacetone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.755603773,0,thenoyltrifluoroacetone
RRNA_PROCESSING,2.87954586,0,thenoyltrifluoroacetone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.661962175,0,levocabastine
SELENOAMINO_ACID_METABOLISM,-2.610137399,0,levocabastine
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2.587737428,0,levocabastine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.561416868,0,levocabastine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.417079326,0,levocabastine
CELLULAR_RESPONSE_TO_STARVATION,-2.537736082,0,levocabastine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.523585592,0,levocabastine
EUKARYOTIC_TRANSLATION_INITIATION,-2.492166572,0,levocabastine
NONSENSE_MEDIATED_DECAY_NMD,-2.432741181,0,levocabastine
GPCR_LIGAND_BINDING,-2.42421625,0,levocabastine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.885177007,0.192951062,andarine
RAB_REGULATION_OF_TRAFFICKING,1.795977353,0.151948961,andarine
INTERFERON_ALPHA_BETA_SIGNALING,-1.956263426,0.124679955,andarine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.764686145,0.128634041,andarine
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-1.91108273,0.104946437,andarine
MEMBRANE_TRAFFICKING,1.684807651,0.153154905,andarine
GPCR_LIGAND_BINDING,-1.876896735,0.101657517,andarine
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.610822363,0.177997355,andarine
FATTY_ACID_METABOLISM,1.57355046,0.178479732,andarine
BIOLOGICAL_OXIDATIONS,1.504133125,0.21362439,andarine
GPCR_LIGAND_BINDING,-2.468398024,0,quercetin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.356625467,0.000787155,quercetin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.318244622,0.00052477,quercetin
SIGNALING_BY_GPCR,-2.027184676,0.032273337,quercetin
SIGNALING_BY_NTRKS,1.836074859,0.777018112,quercetin
G_ALPHA_I_SIGNALLING_EVENTS,-1.944329201,0.061712917,quercetin
NEUTROPHIL_DEGRANULATION,1.507401155,1,quercetin
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.503437301,1,quercetin
INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,1.48182515,1,quercetin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.698717786,0.369175484,quercetin
TRANSLATION,4.175368289,0,budesonide
RRNA_PROCESSING,2.554016312,0.001490802,budesonide
MITOCHONDRIAL_TRANSLATION,2.543531799,0.000993868,budesonide
RESPIRATORY_ELECTRON_TRANSPORT,2.390821929,0.003354304,budesonide
SIGNALING_BY_GPCR,-2.122867398,0.041757023,budesonide
METABOLISM_OF_RNA,2.099310152,0.01669698,budesonide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.004183104,0.026089031,budesonide
GPCR_LIGAND_BINDING,-2.044311431,0.055827324,budesonide
DISEASES_OF_METABOLISM,1.950279996,0.032584667,budesonide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.983457492,0.072620909,budesonide
CHROMATIN_ORGANIZATION,3.431386144,0,nicardipine
MITOTIC_PROPHASE,3.006561524,0,nicardipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.880170559,0,nicardipine
GPCR_LIGAND_BINDING,-2.847891329,0,nicardipine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.800535287,0,nicardipine
SIGNALING_BY_GPCR,-2.634933214,0,nicardipine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.447523823,0,nicardipine
G_ALPHA_I_SIGNALLING_EVENTS,-2.321621932,0.00029863,nicardipine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.254994337,0.001023875,nicardipine
EUKARYOTIC_TRANSLATION_INITIATION,-2.221595827,0.001343836,nicardipine
GPCR_LIGAND_BINDING,-2.716995165,0,vanoxerine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.481108089,0,vanoxerine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.455668799,0,vanoxerine
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.668338091,0.009324539,vanoxerine
SIGNALING_BY_GPCR,-2.319996921,0.000742476,vanoxerine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.323340055,0.000928095,vanoxerine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.549122616,0.009324539,vanoxerine
MYD88_INDEPENDENT_TLR4_CASCADE,2.520083415,0.00621636,vanoxerine
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2.519050931,0.00466227,vanoxerine
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.513581893,0.003729816,vanoxerine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.761556707,0,azithromycin
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.671606225,0,azithromycin
SARS_COV_2_INFECTION,2.673339519,0,azithromycin
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.685649091,0,azithromycin
SYNTHESIS_OF_DNA,2.715322949,0,azithromycin
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.742557604,0,azithromycin
ORC1_REMOVAL_FROM_CHROMATIN,2.749014149,0,azithromycin
PCP_CE_PATHWAY,2.767022962,0,azithromycin
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.780908538,0,azithromycin
INFECTIOUS_DISEASE,2.847810998,0,azithromycin
NEUTROPHIL_DEGRANULATION,-2.424927458,0.009039548,isocarboxazid
RSV_HOST_INTERACTIONS,1.954014942,0.594964202,isocarboxazid
EUKARYOTIC_TRANSLATION_INITIATION,1.831181845,0.769648459,isocarboxazid
GASTRULATION,-1.729414636,0.541081517,isocarboxazid
RRNA_PROCESSING,1.773090099,0.784061352,isocarboxazid
VIRAL_INFECTION_PATHWAYS,1.755664942,0.668758212,isocarboxazid
INTERLEUKIN_1_SIGNALING,1.752651202,0.547459309,isocarboxazid
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.748496479,0.472935046,isocarboxazid
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.693359384,0.578821763,isocarboxazid
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.566832999,0.82259887,isocarboxazid
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.268482612,0.027077717,metyrapone
RESPIRATORY_ELECTRON_TRANSPORT,2.046422209,0.102024968,metyrapone
TRANSLATION,1.849139654,0.262718321,metyrapone
RRNA_PROCESSING,1.840945344,0.207192885,metyrapone
MITOCHONDRIAL_TRANSLATION,1.840033057,0.167881843,metyrapone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.816500886,1,metyrapone
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-1.724319517,1,metyrapone
CELL_CYCLE_MITOTIC,1.656861773,0.437756418,metyrapone
RHO_GTPASE_CYCLE,-1.692269632,1,metyrapone
NEUTROPHIL_DEGRANULATION,-1.691232455,0.786668817,metyrapone
CELL_CYCLE_CHECKPOINTS,2.746314291,0,NU-1025
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.583014003,0.003957374,NU-1025
M_PHASE,2.581003646,0.003517666,NU-1025
RESPIRATORY_ELECTRON_TRANSPORT,2.566432043,0.002638249,NU-1025
MITOTIC_SPINDLE_CHECKPOINT,2.5534028,0.002638249,NU-1025
CELL_CYCLE_MITOTIC,2.526736629,0.002638249,NU-1025
CELL_CYCLE,2.451845915,0.003392035,NU-1025
MITOTIC_METAPHASE_AND_ANAPHASE,2.394036512,0.003957374,NU-1025
RHO_GTPASES_ACTIVATE_FORMINS,2.38025491,0.003517666,NU-1025
METABOLISM_OF_RNA,2.314309597,0.005276499,NU-1025
RRNA_PROCESSING,2.2749558,0.027959389,thioproperazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.152949495,0.050926031,thioproperazine
INNATE_IMMUNE_SYSTEM,-2.179438573,0.109628406,thioproperazine
NEUTROPHIL_DEGRANULATION,-2.078680679,0.105605345,thioproperazine
EUKARYOTIC_TRANSLATION_ELONGATION,2.053094876,0.095195064,thioproperazine
EUKARYOTIC_TRANSLATION_INITIATION,2.051541639,0.07214521,thioproperazine
SELENOAMINO_ACID_METABOLISM,1.960983063,0.127215221,thioproperazine
NONSENSE_MEDIATED_DECAY_NMD,1.941999826,0.121157354,thioproperazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.927640565,0.116687655,thioproperazine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.866635844,0.256134868,thioproperazine
EUKARYOTIC_TRANSLATION_INITIATION,3.017742366,0,aniracetam
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.014846594,0,aniracetam
EUKARYOTIC_TRANSLATION_ELONGATION,2.998046852,0,aniracetam
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.998046852,0,aniracetam
NONSENSE_MEDIATED_DECAY_NMD,2.899199985,0,aniracetam
SELENOAMINO_ACID_METABOLISM,2.852809095,0,aniracetam
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.780410543,0,aniracetam
SIGNALING_BY_ROBO_RECEPTORS,2.748318972,0,aniracetam
CELLULAR_RESPONSE_TO_STARVATION,2.698136963,0,aniracetam
TRANSLATION,2.634284395,0,aniracetam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.056420143,0.202585375,dioxybenzone
NEUTROPHIL_DEGRANULATION,-2.018567442,0.321272366,dioxybenzone
RAC3_GTPASE_CYCLE,-1.940081924,0.271073559,dioxybenzone
METABOLISM_OF_STEROIDS,-1.859729597,0.296468249,dioxybenzone
GPCR_LIGAND_BINDING,1.84975923,0.476750916,dioxybenzone
RHO_GTPASE_CYCLE,-1.767563079,0.375605192,dioxybenzone
PROTEASOME_ASSEMBLY,-1.756976619,0.315602853,dioxybenzone
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,-1.676625587,0.403952754,dioxybenzone
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-1.620687502,0.471109478,dioxybenzone
RAC2_GTPASE_CYCLE,-1.592428254,0.474969302,dioxybenzone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.953641827,0,nateglinide
MRNA_SPLICING,2.419874447,0.001508569,nateglinide
RRNA_PROCESSING,-1.854644141,0.231722465,nateglinide
SELENOAMINO_ACID_METABOLISM,-1.844738028,0.13057377,nateglinide
INTERFERON_ALPHA_BETA_SIGNALING,-1.843789386,0.087355691,nateglinide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.840816251,0.067125952,nateglinide
EUKARYOTIC_TRANSLATION_ELONGATION,-1.840473022,0.053700762,nateglinide
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.497973752,0.383176442,nateglinide
NONSENSE_MEDIATED_DECAY_NMD,-1.796060657,0.07310292,nateglinide
RSV_HOST_INTERACTIONS,-1.788841378,0.068045486,nateglinide
GPCR_LIGAND_BINDING,2.179983242,0.037903805,acepromazine
SENSORY_PERCEPTION,2.026957935,0.090811199,acepromazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.832361859,0.281646327,acepromazine
NEUTROPHIL_DEGRANULATION,-1.90743585,1,acepromazine
SIGNALING_BY_GPCR,1.818300149,0.235319454,acepromazine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.813188284,0.195046662,acepromazine
G_ALPHA_S_SIGNALLING_EVENTS,1.78732014,0.194125389,acepromazine
TRNA_PROCESSING,-1.764310292,1,acepromazine
NEURONAL_SYSTEM,1.758910224,0.20801969,acepromazine
SIGNALING_BY_INSULIN_RECEPTOR,-1.646203613,1,acepromazine
CELL_CYCLE,-2.487490916,0.003265188,thiomersal
CELL_CYCLE_MITOTIC,-2.46638029,0.001632594,thiomersal
NEURONAL_SYSTEM,2.442258714,0.005895978,thiomersal
DNA_REPLICATION,-2.354095872,0.004353584,thiomersal
SIGNALING_BY_ALK_IN_CANCER,2.368405764,0.008422826,thiomersal
M_PHASE,-2.286869921,0.006258278,thiomersal
METABOLISM_OF_RNA,-2.275962853,0.00565966,thiomersal
S_PHASE,-2.244267158,0.007074575,thiomersal
SYNTHESIS_OF_DNA,-2.220859906,0.008085228,thiomersal
CHROMOSOME_MAINTENANCE,-2.177617941,0.009795565,thiomersal
EUKARYOTIC_TRANSLATION_ELONGATION,3.777210841,0,tiagabine
CELLULAR_RESPONSE_TO_STARVATION,3.73876339,0,tiagabine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.699977569,0,tiagabine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.63715445,0,tiagabine
SELENOAMINO_ACID_METABOLISM,3.555704718,0,tiagabine
EUKARYOTIC_TRANSLATION_INITIATION,3.444826368,0,tiagabine
INFLUENZA_INFECTION,3.325762493,0,tiagabine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.131741311,0,tiagabine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.12059773,0,tiagabine
NONSENSE_MEDIATED_DECAY_NMD,3.118896374,0,tiagabine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.390189165,0.016133369,benzbromarone
TOLL_LIKE_RECEPTOR_CASCADES,2.139234969,0.040333423,benzbromarone
RNA_POLYMERASE_II_TRANSCRIPTION,2.11181678,0.041229721,benzbromarone
KERATINIZATION,-2.10763846,0.020301763,benzbromarone
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.085851378,0.040333423,benzbromarone
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.846298107,0.107555795,benzbromarone
GPCR_LIGAND_BINDING,-1.974725151,0.0437538,benzbromarone
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.794672405,0.117415076,benzbromarone
INTERFERON_ALPHA_BETA_SIGNALING,1.785215952,0.107555795,benzbromarone
MYD88_INDEPENDENT_TLR4_CASCADE,1.750550942,0.108900242,benzbromarone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.911703211,0,dactinomycin
EXTRACELLULAR_MATRIX_ORGANIZATION,2.691893735,0.000447236,dactinomycin
COLLAGEN_FORMATION,2.673184286,0.000298157,dactinomycin
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.65416885,0.000223618,dactinomycin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.519104388,0.000536683,dactinomycin
GPCR_LIGAND_BINDING,2.45082021,0.00104355,dactinomycin
BIOLOGICAL_OXIDATIONS,2.371491135,0.001788942,dactinomycin
SIGNALING_BY_GPCR,2.318018383,0.002124369,dactinomycin
DEVELOPMENTAL_CELL_LINEAGES,2.272317258,0.00298157,dactinomycin
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.110727968,0.009213052,dactinomycin
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.341802699,0.024788886,olopatadine
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.246899325,0.043155818,olopatadine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.153564856,0.048200611,olopatadine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.144094232,0.056102563,olopatadine
GPCR_LIGAND_BINDING,2.12102321,0.042076922,olopatadine
MUSCLE_CONTRACTION,2.101529734,0.038300788,olopatadine
CARDIAC_CONDUCTION,2.047660755,0.04488205,olopatadine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.027152001,0.042256738,olopatadine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.969234111,0.057181459,olopatadine
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.947766193,0.06149704,olopatadine
COMPLEMENT_CASCADE,-2.564275085,0,gabapentin
DRUG_ADME,-2.192494285,0.04610655,gabapentin
CELLULAR_RESPONSE_TO_STARVATION,2.022342298,0.293756507,gabapentin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.065949227,0.09378135,gabapentin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.065563386,0.070336013,gabapentin
SIGNALING_BY_VEGF,1.888742172,0.380695473,gabapentin
GASTRULATION,-1.936508622,0.15375123,gabapentin
COLLAGEN_FORMATION,-1.833570979,0.250135875,gabapentin
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.707465271,0.781910702,gabapentin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.587956011,1,gabapentin
BIOLOGICAL_OXIDATIONS,-2.233297778,0.160214969,chlorzoxazone
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-2.142731399,0.145012089,chlorzoxazone
CELLULAR_RESPONSE_TO_HEAT_STRESS,-2.054446712,0.174248397,chlorzoxazone
NEUTROPHIL_DEGRANULATION,-1.994426476,0.187404736,chlorzoxazone
INNATE_IMMUNE_SYSTEM,-1.860260929,0.325107747,chlorzoxazone
MUSCLE_CONTRACTION,1.755888408,1,chlorzoxazone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.707959199,0.55490513,chlorzoxazone
RRNA_PROCESSING,1.625968855,1,chlorzoxazone
SIGNALING_BY_NOTCH,1.590625827,0.936015831,chlorzoxazone
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.609170587,0.71804373,chlorzoxazone
MITOTIC_METAPHASE_AND_ANAPHASE,-2.618234893,0.001484743,AT-7867
RRNA_PROCESSING,-2.59239074,0.000742371,AT-7867
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.540555567,0.001755564,AT-7867
GPCR_LIGAND_BINDING,2.516622575,0.000877782,AT-7867
SIGNALING_BY_GPCR,2.381533131,0.00146297,AT-7867
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.367722599,0.001097227,AT-7867
CELL_CYCLE_CHECKPOINTS,-2.543037857,0.001979657,AT-7867
CELL_CYCLE,-2.533618064,0.001855929,AT-7867
M_PHASE,-2.463179065,0.001781692,AT-7867
RESPIRATORY_ELECTRON_TRANSPORT,-2.325998297,0.005444058,AT-7867
CELL_CYCLE,-3.520301618,0,RAF-265
CELL_CYCLE_MITOTIC,-3.202275206,0,RAF-265
CELL_CYCLE_CHECKPOINTS,-3.153127117,0,RAF-265
GPCR_LIGAND_BINDING,2.965889782,0,RAF-265
M_PHASE,-2.859400967,0,RAF-265
MITOTIC_METAPHASE_AND_ANAPHASE,-2.808889522,0,RAF-265
G2_M_CHECKPOINTS,-2.672854207,0,RAF-265
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.567929648,0.000309074,RAF-265
METABOLISM_OF_RNA,-2.654781619,0.000430224,RAF-265
SEPARATION_OF_SISTER_CHROMATIDS,-2.654678587,0.000376446,RAF-265
GPCR_LIGAND_BINDING,-2.404906731,0.00327793,dabrafenib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.319776533,0.003687671,dabrafenib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.199686899,0.008741146,dabrafenib
SIGNALING_BY_GPCR,-2.1435487,0.011063013,dabrafenib
SENSORY_PERCEPTION,-2.071163686,0.020323164,dabrafenib
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.982308551,0.234925874,dabrafenib
KERATINIZATION,-2.039933884,0.023355249,dabrafenib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1.837680458,0.299576018,dabrafenib
G_ALPHA_I_SIGNALLING_EVENTS,-1.942561718,0.046710498,dabrafenib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.93044151,0.045583709,dabrafenib
INFLUENZA_INFECTION,2.423331037,0.007967502,paricalcitol
NEUTROPHIL_DEGRANULATION,2.403663179,0.004780501,paricalcitol
EUKARYOTIC_TRANSLATION_INITIATION,2.358345016,0.004780501,paricalcitol
ECM_PROTEOGLYCANS,-2.234386604,0.013668129,paricalcitol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.908643138,0.100788895,paricalcitol
GPCR_LIGAND_BINDING,-1.975689408,0.122158903,paricalcitol
DEVELOPMENTAL_CELL_LINEAGES,-1.973173959,0.082578279,paricalcitol
CELLULAR_RESPONSE_TO_STARVATION,1.868011329,0.09911572,paricalcitol
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.948754051,0.079232435,paricalcitol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.944325234,0.065948722,paricalcitol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.226768571,0.079882148,carmustine
DEVELOPMENTAL_CELL_LINEAGES,-1.986859076,0.257075276,carmustine
METABOLISM_OF_STEROIDS,1.839011985,0.755665847,carmustine
SIGNALING_BY_PDGF,-1.759440243,0.723296539,carmustine
SIGNALING_BY_INTERLEUKINS,-1.723306199,0.671736244,carmustine
INTERLEUKIN_1_FAMILY_SIGNALING,-1.722566757,0.539422359,carmustine
MITOTIC_G2_G2_M_PHASES,-1.690385083,0.52940078,carmustine
SIGNALING_BY_HEDGEHOG,-1.684457474,0.468711096,carmustine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.653913962,0.487644203,carmustine
ONCOGENIC_MAPK_SIGNALING,1.704709795,0.926541637,carmustine
METABOLISM_OF_RNA,3.437108202,0,xaliproden
NONSENSE_MEDIATED_DECAY_NMD,3.313916398,0,xaliproden
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.072762331,0,xaliproden
MRNA_SPLICING,2.766374508,0,xaliproden
TRANSLATION,2.678494283,0,xaliproden
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.563382018,0,xaliproden
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.47646068,0.000773557,xaliproden
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.299069465,0.001203311,xaliproden
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.324696871,0.001353725,xaliproden
VIRAL_INFECTION_PATHWAYS,2.235790902,0.002165959,xaliproden
GPCR_LIGAND_BINDING,-2.350147747,0.001613033,agomelatine
PEROXISOMAL_PROTEIN_IMPORT,2.392920622,0.014264813,agomelatine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.167010882,0.019759658,agomelatine
REGULATION_OF_TP53_ACTIVITY,2.232963463,0.039624482,agomelatine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.162874692,0.044907746,agomelatine
SIGNALING_BY_ALK_IN_CANCER,2.07999572,0.056266764,agomelatine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.999639468,0.06989811,agomelatine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.94488458,0.103657644,agomelatine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.908818569,0.12299379,agomelatine
COLLAGEN_FORMATION,-1.904309985,0.103556738,agomelatine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.457578108,0,sorafenib
GPCR_LIGAND_BINDING,-2.342943122,0.001265022,sorafenib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.231776692,0.002248928,sorafenib
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.326243477,0.019876325,sorafenib
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,2.258564576,0.019876325,sorafenib
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.24604671,0.016011484,sorafenib
ISG15_ANTIVIRAL_MECHANISM,2.172404975,0.019876325,sorafenib
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,2.162423427,0.01590106,sorafenib
MEMBRANE_TRAFFICKING,2.120706718,0.016563604,sorafenib
SIGNALING_BY_GPCR,-2.089789943,0.013915244,sorafenib
EUKARYOTIC_TRANSLATION_ELONGATION,2.399571034,0.007258362,vismodegib
COMPLEMENT_CASCADE,-2.538998168,0.008169802,vismodegib
INFLUENZA_INFECTION,2.294857712,0.008468089,vismodegib
SARS_COV_1_INFECTION,2.284813983,0.007258362,vismodegib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.275879676,0.005443772,vismodegib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.258235527,0.005080854,vismodegib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.231310139,0.006048635,vismodegib
EUKARYOTIC_TRANSLATION_INITIATION,2.225846507,0.005530181,vismodegib
NONSENSE_MEDIATED_DECAY_NMD,2.215123647,0.004435666,vismodegib
SARS_COV_1_HOST_INTERACTIONS,2.220182066,0.004990124,vismodegib
EUKARYOTIC_TRANSLATION_INITIATION,4.278081027,0,talniflumate
INFECTIOUS_DISEASE,2.937527613,0,talniflumate
M_PHASE,2.965865496,0,talniflumate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.984210713,0,talniflumate
MITOTIC_METAPHASE_AND_ANAPHASE,2.99755906,0,talniflumate
VIRAL_INFECTION_PATHWAYS,3.126595295,0,talniflumate
SARS_COV_1_HOST_INTERACTIONS,3.146417166,0,talniflumate
CELL_CYCLE,3.192288938,0,talniflumate
CELL_CYCLE_MITOTIC,3.219767039,0,talniflumate
CELLULAR_RESPONSES_TO_STIMULI,3.23715741,0,talniflumate
EUKARYOTIC_TRANSLATION_INITIATION,4.88505231,0,LY-364947
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.604063029,0,LY-364947
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.746930198,0,LY-364947
MRNA_SPLICING,2.762826223,0,LY-364947
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.902315084,0,LY-364947
SARS_COV_INFECTIONS,2.933186119,0,LY-364947
SARS_COV_2_INFECTION,2.946712776,0,LY-364947
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.963915365,0,LY-364947
SIGNALING_BY_GPCR,-3.031949387,0,LY-364947
CELLULAR_RESPONSES_TO_STIMULI,3.055116391,0,LY-364947
NEUTROPHIL_DEGRANULATION,-2.065152026,0.18360585,brinzolamide
INNATE_IMMUNE_SYSTEM,-1.836705958,0.381466813,brinzolamide
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.827819363,0.268756389,brinzolamide
FCERI_MEDIATED_NF_KB_ACTIVATION,-1.795965023,0.248038959,brinzolamide
CELLULAR_RESPONSE_TO_HEAT_STRESS,-1.651466387,0.422635578,brinzolamide
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.634950416,0.385458244,brinzolamide
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-1.624050961,0.346684338,brinzolamide
ESR_MEDIATED_SIGNALING,-1.608417792,0.292324842,brinzolamide
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.610041087,0.325729322,brinzolamide
DOWNSTREAM_TCR_SIGNALING,-1.598669981,0.275864939,brinzolamide
EUKARYOTIC_TRANSLATION_INITIATION,4.659967815,0,halcinonide
GPCR_LIGAND_BINDING,-2.624542471,0,halcinonide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.595813804,0,halcinonide
MRNA_SPLICING,2.990049204,0,halcinonide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.007101963,0,halcinonide
CELL_CYCLE,3.051180654,0,halcinonide
M_PHASE,3.077736564,0,halcinonide
CELL_CYCLE_MITOTIC,3.14824614,0,halcinonide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.163098909,0,halcinonide
CELLULAR_RESPONSES_TO_STIMULI,3.340354745,0,halcinonide
EUKARYOTIC_TRANSLATION_INITIATION,3.451010798,0,flunarizine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.834130282,0,flunarizine
CELLULAR_RESPONSE_TO_STARVATION,2.953640222,0,flunarizine
INFLUENZA_INFECTION,3.181968081,0,flunarizine
RRNA_PROCESSING,3.338805441,0,flunarizine
NONSENSE_MEDIATED_DECAY_NMD,3.142877202,0,flunarizine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.376656052,0,flunarizine
TRANSLATION,3.388123398,0,flunarizine
SELENOAMINO_ACID_METABOLISM,3.419720944,0,flunarizine
EUKARYOTIC_TRANSLATION_ELONGATION,3.450528162,0,flunarizine
RRNA_PROCESSING,4.029750901,0,dydrogesterone
SARS_COV_1_HOST_INTERACTIONS,2.68721331,0,dydrogesterone
VIRAL_INFECTION_PATHWAYS,2.758068127,0,dydrogesterone
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2.767673823,0,dydrogesterone
CELL_CYCLE_MITOTIC,2.834026508,0,dydrogesterone
MITOTIC_G2_G2_M_PHASES,2.856469601,0,dydrogesterone
M_PHASE,2.933398826,0,dydrogesterone
MRNA_SPLICING,2.995608882,0,dydrogesterone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.020893008,0,dydrogesterone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.097842812,0,dydrogesterone
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.098738951,0.153152902,febuxostat
PROTEASOME_ASSEMBLY,-2.08765441,0.085328045,febuxostat
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,-2.061043787,0.070377405,febuxostat
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.056145623,0.054697465,febuxostat
GASTRULATION,-2.023210406,0.056447784,febuxostat
APOPTOSIS,-2.004619277,0.05451514,febuxostat
TRANSCRIPTIONAL_REGULATION_BY_TP53,-1.973205604,0.059542097,febuxostat
TCR_SIGNALING,-1.949580045,0.062765341,febuxostat
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-1.94634801,0.057250013,febuxostat
PTEN_REGULATION,-1.927865908,0.059510842,febuxostat
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.11764156,0.147804717,miglitol
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.945817884,0.190333432,miglitol
GPCR_LIGAND_BINDING,1.973737771,0.327584909,miglitol
NEUTROPHIL_DEGRANULATION,-1.699642735,0.550316932,miglitol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.693990753,1,miglitol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-1.449023917,1,miglitol
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.412103886,1,miglitol
VISUAL_PHOTOTRANSDUCTION,1.595150885,1,miglitol
TRANSLATION,1.583365244,1,miglitol
RHO_GTPASE_CYCLE,-1.351591949,1,miglitol
EUKARYOTIC_TRANSLATION_ELONGATION,-3.961263257,0,olanzapine
SARS_COV_2_HOST_INTERACTIONS,-2.646294503,0,olanzapine
CELLULAR_RESPONSES_TO_STIMULI,-2.711563471,0,olanzapine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.801509006,0,olanzapine
INFECTIOUS_DISEASE,-2.804388077,0,olanzapine
VIRAL_INFECTION_PATHWAYS,-3.003666451,0,olanzapine
SARS_COV_1_HOST_INTERACTIONS,-3.070064745,0,olanzapine
SARS_COV_1_INFECTION,-3.093712048,0,olanzapine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.108826406,0,olanzapine
NERVOUS_SYSTEM_DEVELOPMENT,-3.162993724,0,olanzapine
EUKARYOTIC_TRANSLATION_INITIATION,4.013317238,0,parachlorophenol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.831028925,0,parachlorophenol
SIGNALING_BY_ROBO_RECEPTORS,2.935562625,0,parachlorophenol
METABOLISM_OF_RNA,3.021520357,0,parachlorophenol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.120228733,0,parachlorophenol
CELLULAR_RESPONSE_TO_STARVATION,3.188856055,0,parachlorophenol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.224410107,0,parachlorophenol
INFLUENZA_INFECTION,3.334387411,0,parachlorophenol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.83152283,0,parachlorophenol
TRANSLATION,3.565257945,0,parachlorophenol
EUKARYOTIC_TRANSLATION_ELONGATION,3.459107624,0,piribedil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.686269558,0,piribedil
SARS_COV_1_INFECTION,2.700570354,0,piribedil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.721444896,0,piribedil
TRANSLATION,2.864764832,0,piribedil
RRNA_PROCESSING,2.902593915,0,piribedil
SIGNALING_BY_ROBO_RECEPTORS,2.972677074,0,piribedil
SARS_COV_1_HOST_INTERACTIONS,3.170796352,0,piribedil
INFLUENZA_INFECTION,3.132454163,0,piribedil
SELENOAMINO_ACID_METABOLISM,3.273478183,0,piribedil
SELENOAMINO_ACID_METABOLISM,3.126948328,0,rabeprazole
EUKARYOTIC_TRANSLATION_INITIATION,3.119651436,0,rabeprazole
EUKARYOTIC_TRANSLATION_ELONGATION,3.115580451,0,rabeprazole
NONSENSE_MEDIATED_DECAY_NMD,3.111737704,0,rabeprazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.024276359,0,rabeprazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.003795519,0,rabeprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.846851229,0,rabeprazole
CELLULAR_RESPONSE_TO_STARVATION,2.84680972,0,rabeprazole
SIGNALING_BY_ROBO_RECEPTORS,2.728945159,0.00018962,rabeprazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.478561426,0.000620575,rabeprazole
RAC3_GTPASE_CYCLE,-2.48643805,0.010267461,hydroxyzine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.068783291,0.128343263,hydroxyzine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.006230892,0.125871467,hydroxyzine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.83105767,0.255545697,hydroxyzine
DEVELOPMENTAL_CELL_LINEAGES,-1.791075127,0.256914691,hydroxyzine
TRNA_PROCESSING,-1.739791943,0.283686145,hydroxyzine
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.738298638,0.24511526,hydroxyzine
GPCR_LIGAND_BINDING,1.741483275,1,hydroxyzine
SIGNALING_BY_NOTCH,1.709662224,1,hydroxyzine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.593751385,0.457615034,hydroxyzine
SELENOAMINO_ACID_METABOLISM,2.647615022,0,loratadine
EUKARYOTIC_TRANSLATION_ELONGATION,2.554416475,0.000647273,loratadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.425287129,0.000863031,loratadine
CELLULAR_RESPONSE_TO_STARVATION,2.418484705,0.00097091,loratadine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.356142591,0.001553456,loratadine
EUKARYOTIC_TRANSLATION_INITIATION,2.300957271,0.003667882,loratadine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.291308283,0.003513769,loratadine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.198948676,0.040135336,loratadine
NONSENSE_MEDIATED_DECAY_NMD,2.182249793,0.01051819,loratadine
REGULATION_OF_TP53_ACTIVITY,2.132355771,0.014815365,loratadine
NEUTROPHIL_DEGRANULATION,-2.846432225,0,thiamine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.24928986,0.023643817,thiamine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.209153282,0.023389583,thiamine
INNATE_IMMUNE_SYSTEM,-2.157146171,0.024406521,thiamine
TRNA_PROCESSING,-2.04140516,0.046067309,thiamine
GPCR_LIGAND_BINDING,1.977344632,0.307210355,thiamine
SENSORY_PERCEPTION,1.922910406,0.236860016,thiamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.908797498,0.179552936,thiamine
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-1.718979228,0.259065052,thiamine
PROTEIN_LOCALIZATION,-1.649087328,0.327744712,thiamine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.189802052,0.078977357,aceclofenac
GPCR_LIGAND_BINDING,2.162069086,0.048212921,aceclofenac
BIOLOGICAL_OXIDATIONS,-2.075370049,0.219790146,aceclofenac
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.068326469,0.066120578,aceclofenac
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,2.061993177,0.052575043,aceclofenac
RHOA_GTPASE_CYCLE,2.011297007,0.064100227,aceclofenac
COLLAGEN_FORMATION,1.778213011,0.289277527,aceclofenac
HIGH_LAMINAR_FLOW_SHEAR_STRESS_ACTIVATES_SIGNALING_BY_PIEZO1_AND_PECAM1_CDH5_KDR_IN_ENDOTHELIAL_CELLS,1.766685142,0.268286867,aceclofenac
EXTRACELLULAR_MATRIX_ORGANIZATION,1.764563329,0.23739124,aceclofenac
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.663976835,1,aceclofenac
CELL_CYCLE_MITOTIC,-2.543171754,0.001495149,azelastine
CELL_CYCLE,-2.542440222,0.000747575,azelastine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.472087035,0.001495149,azelastine
NEURONAL_SYSTEM,2.330241785,0.007038248,azelastine
MUSCLE_CONTRACTION,2.328186032,0.003519124,azelastine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.326870465,0.002346083,azelastine
M_PHASE,-2.276630937,0.017568002,azelastine
METABOLISM_OF_RNA,-2.27117413,0.015250521,azelastine
CELL_CYCLE_CHECKPOINTS,-2.208260751,0.020433705,azelastine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.182447435,0.020504903,azelastine
NEUTROPHIL_DEGRANULATION,-2.463767083,0.084026573,trihexyphenidyl
GPCR_LIGAND_BINDING,2.040653432,0.149783042,trihexyphenidyl
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.978289069,0.126279852,trihexyphenidyl
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.818617805,0.323202061,trihexyphenidyl
NEURONAL_SYSTEM,1.789684764,0.295383314,trihexyphenidyl
HOST_INTERACTIONS_OF_HIV_FACTORS,-1.777031984,1,trihexyphenidyl
SIGNALING_BY_GPCR,1.740439652,0.332390879,trihexyphenidyl
L1CAM_INTERACTIONS,1.733377039,0.291864474,trihexyphenidyl
SENSORY_PERCEPTION,1.710558009,0.294671958,trihexyphenidyl
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.709206718,0.259730169,trihexyphenidyl
EUKARYOTIC_TRANSLATION_INITIATION,3.276482161,0,pergolide
SARS_COV_1_HOST_INTERACTIONS,2.605471625,0,pergolide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.670184786,0,pergolide
SIGNALING_BY_ROBO_RECEPTORS,2.712748994,0,pergolide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.764122342,0,pergolide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.770002605,0,pergolide
INFLUENZA_INFECTION,2.916966792,0,pergolide
RRNA_PROCESSING,2.998832039,0,pergolide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.856462599,0,pergolide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.015943933,0,pergolide
RRNA_PROCESSING,2.158797858,0.038724131,nicotine
MRNA_SPLICING,1.765969075,0.160177086,nicotine
TCR_SIGNALING,-1.841968088,0.785270433,nicotine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.523687693,0.342649883,nicotine
DOWNSTREAM_TCR_SIGNALING,-1.807909313,0.52875531,nicotine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.793483987,0.394764652,nicotine
RESPIRATORY_ELECTRON_TRANSPORT,1.47415838,0.333848944,nicotine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.438182792,0.32152763,nicotine
CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,-1.746873006,0.429736542,nicotine
SIGNALING_BY_GPCR,-1.738224565,0.367769958,nicotine
EUKARYOTIC_TRANSLATION_INITIATION,2.58490725,0.002198118,diphenhydramine
TRANSLATION,2.545303333,0.001099059,diphenhydramine
EUKARYOTIC_TRANSLATION_ELONGATION,2.540108416,0.000732706,diphenhydramine
RRNA_PROCESSING,2.443073223,0.001373824,diphenhydramine
SELENOAMINO_ACID_METABOLISM,2.442064426,0.001099059,diphenhydramine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.43633018,0.000915882,diphenhydramine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.414038755,0.000785042,diphenhydramine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.377854406,0.000961677,diphenhydramine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.357317312,0.001221177,diphenhydramine
INFLUENZA_INFECTION,2.316442171,0.001538683,diphenhydramine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,4.586715187,0,epirubicin
RESPIRATORY_ELECTRON_TRANSPORT,4.226819123,0,epirubicin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,4.219248304,0,epirubicin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.189997439,0,epirubicin
SELENOAMINO_ACID_METABOLISM,3.752534992,0,epirubicin
TRANSLATION,3.601213341,0,epirubicin
EUKARYOTIC_TRANSLATION_INITIATION,3.392776324,0,epirubicin
EUKARYOTIC_TRANSLATION_ELONGATION,3.281893313,0,epirubicin
CELLULAR_RESPONSE_TO_STARVATION,3.280916241,0,epirubicin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.06247623,0,epirubicin
SELENOAMINO_ACID_METABOLISM,3.367334151,0,mepacrine
NONSENSE_MEDIATED_DECAY_NMD,3.350110275,0,mepacrine
EUKARYOTIC_TRANSLATION_ELONGATION,3.343562703,0,mepacrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.260530131,0,mepacrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.220951065,0,mepacrine
EUKARYOTIC_TRANSLATION_INITIATION,3.183570854,0,mepacrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.097279559,0,mepacrine
CELLULAR_RESPONSE_TO_STARVATION,3.074957945,0,mepacrine
SIGNALING_BY_ROBO_RECEPTORS,2.819928587,0,mepacrine
INFLUENZA_INFECTION,2.737341997,0,mepacrine
MITOTIC_PROPHASE,2.577553897,0.00352952,methocarbamol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.552237496,0.00176476,methocarbamol
GPCR_LIGAND_BINDING,-2.25919533,0.008772614,methocarbamol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.253490559,0.005482884,methocarbamol
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.229238821,0.024706637,methocarbamol
MITOCHONDRIAL_BIOGENESIS,2.205893362,0.021177118,methocarbamol
ISG15_ANTIVIRAL_MECHANISM,2.197765303,0.016941694,methocarbamol
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.195515807,0.015882838,methocarbamol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.139916393,0.011696818,methocarbamol
SELENOAMINO_ACID_METABOLISM,-2.133989477,0.008772614,methocarbamol
RESPIRATORY_ELECTRON_TRANSPORT,2.880915341,0.001160298,tegaserod
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.385819436,0.01102283,tegaserod
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-2.29717703,0.019776177,tegaserod
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.16693526,0.043148022,tegaserod
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.120798089,0.049506045,tegaserod
RNA_POLYMERASE_II_TRANSCRIPTION,-2.045815218,0.08120218,tegaserod
CILIUM_ASSEMBLY,-2.037500586,0.064722033,tegaserod
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1.99864645,0.089923089,tegaserod
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,1.985650304,0.079132318,tegaserod
TRANSLATION,1.934605728,0.092243685,tegaserod
EUKARYOTIC_TRANSLATION_ELONGATION,3.319398893,0,terbinafine
SELENOAMINO_ACID_METABOLISM,3.171995347,0,terbinafine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.130483302,0,terbinafine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.072413301,0,terbinafine
NONSENSE_MEDIATED_DECAY_NMD,2.898241766,0,terbinafine
EUKARYOTIC_TRANSLATION_INITIATION,2.871370288,0,terbinafine
INFLUENZA_INFECTION,2.836468329,0.000133831,terbinafine
CELLULAR_RESPONSE_TO_STARVATION,2.769578067,0.000118961,terbinafine
TRANSLATION,2.840696809,0.00015295,terbinafine
RRNA_PROCESSING,2.38404824,0.001498908,terbinafine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.963157175,0,chlortalidone
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.818544627,0,chlortalidone
GPCR_LIGAND_BINDING,-2.796321813,0,chlortalidone
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,2.785240761,0,chlortalidone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.609105323,0,chlortalidone
SIGNALING_BY_GPCR,-2.520156333,0,chlortalidone
G_ALPHA_S_SIGNALLING_EVENTS,-2.428399902,0,chlortalidone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.353072623,0.0003002,chlortalidone
PLATELET_HOMEOSTASIS,-2.333482131,0.000500333,chlortalidone
CHROMATIN_ORGANIZATION,2.354813674,0.004602992,chlortalidone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.842538124,0,cyclobenzaprine
SARS_COV_2_INFECTION,-2.255640167,0,cyclobenzaprine
SARS_COV_1_INFECTION,-2.360653847,0,cyclobenzaprine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.37075089,0,cyclobenzaprine
SARS_COV_2_HOST_INTERACTIONS,-2.404703535,0,cyclobenzaprine
SARS_COV_1_HOST_INTERACTIONS,-2.404958346,0,cyclobenzaprine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.424293535,0,cyclobenzaprine
SIGNALING_BY_ROBO_RECEPTORS,-2.436029853,0,cyclobenzaprine
CELLULAR_RESPONSE_TO_STARVATION,-2.453308038,0,cyclobenzaprine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.468310478,0,cyclobenzaprine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.06923878,0,lofexidine
NERVOUS_SYSTEM_DEVELOPMENT,-2.614826406,0,lofexidine
CELLULAR_RESPONSE_TO_STARVATION,-2.621517872,0,lofexidine
SARS_COV_1_INFECTION,-2.623703176,0,lofexidine
RRNA_PROCESSING,-2.692562405,0,lofexidine
SIGNALING_BY_ROBO_RECEPTORS,-2.723847899,0,lofexidine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.735293909,0,lofexidine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.74788754,0,lofexidine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.851349302,0,lofexidine
SELENOAMINO_ACID_METABOLISM,-2.942656729,0,lofexidine
NEUTROPHIL_DEGRANULATION,-1.896063109,0.673065107,triflusal
RAC3_GTPASE_CYCLE,-1.878435033,0.363567025,triflusal
SENSORY_PERCEPTION,1.872657507,0.623724242,triflusal
G_ALPHA_I_SIGNALLING_EVENTS,1.831988385,0.433796032,triflusal
NEURONAL_SYSTEM,1.821783608,0.317053492,triflusal
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.67481987,0.737077763,triflusal
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-1.656215168,0.592427806,triflusal
DEUBIQUITINATION,-1.653270949,0.48102714,triflusal
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.581679363,0.585125391,triflusal
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.745927824,0.411004647,triflusal
CELLULAR_RESPONSE_TO_STARVATION,-3.574078581,0,acebutolol
CELLULAR_RESPONSES_TO_STIMULI,-2.497439613,0,acebutolol
NERVOUS_SYSTEM_DEVELOPMENT,-2.613989692,0,acebutolol
METABOLISM_OF_RNA,-2.725611324,0,acebutolol
SARS_COV_1_INFECTION,-2.863142127,0,acebutolol
SARS_COV_1_HOST_INTERACTIONS,-3.035796394,0,acebutolol
TRANSLATION,-3.079477284,0,acebutolol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.089541367,0,acebutolol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.096644979,0,acebutolol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.191399646,0,acebutolol
G_ALPHA_S_SIGNALLING_EVENTS,2.052937822,0.170082973,cinchocaine
DEATH_RECEPTOR_SIGNALING,1.961472311,0.170528217,cinchocaine
CELL_JUNCTION_ORGANIZATION,1.922276194,0.150195435,cinchocaine
GPCR_LIGAND_BINDING,1.780906633,0.312783479,cinchocaine
CELL_CELL_COMMUNICATION,1.753008862,0.302409308,cinchocaine
CARDIAC_CONDUCTION,1.683664451,0.394634054,cinchocaine
SIGNALING_BY_GPCR,1.656126052,0.398683649,cinchocaine
SIGNALING_BY_NOTCH,1.628679107,0.409846537,cinchocaine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.57609246,0.48996561,cinchocaine
INTEGRATION_OF_ENERGY_METABOLISM,1.524355731,0.582645495,cinchocaine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.052212351,0.128728745,levomepromazine
NEUTROPHIL_DEGRANULATION,-2.002154368,0.091865514,levomepromazine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.911112,0.107273954,levomepromazine
SYNTHESIS_OF_DNA,1.753679684,1,levomepromazine
DNA_REPLICATION,1.753132858,1,levomepromazine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.615594059,0.438555429,levomepromazine
FATTY_ACID_METABOLISM,-1.599548069,0.380920059,levomepromazine
DNA_REPLICATION_PRE_INITIATION,1.687677535,1,levomepromazine
INTERLEUKIN_1_SIGNALING,1.675033906,1,levomepromazine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-1.570215316,0.366876924,levomepromazine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.325105421,0.020108794,trimetazidine
DEVELOPMENTAL_CELL_LINEAGES,-2.2532188,0.016589755,trimetazidine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.133087333,0.035525536,trimetazidine
NEURONAL_SYSTEM,2.148433245,0.110287632,trimetazidine
PEROXISOMAL_PROTEIN_IMPORT,2.0624713,0.108797259,trimetazidine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.054145549,0.054293743,trimetazidine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.053360212,0.078824193,trimetazidine
GASTRULATION,-2.041310222,0.048864369,trimetazidine
TCR_SIGNALING,1.993710452,0.092899942,trimetazidine
ECM_PROTEOGLYCANS,-1.836004586,0.173941066,trimetazidine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.681579963,0,setiptiline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.578008112,0,setiptiline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.569169324,0,setiptiline
EUKARYOTIC_TRANSLATION_INITIATION,-2.562672218,0,setiptiline
NONSENSE_MEDIATED_DECAY_NMD,-2.533170592,0,setiptiline
SELENOAMINO_ACID_METABOLISM,-2.523738315,0,setiptiline
CELLULAR_RESPONSE_TO_STARVATION,-2.512674133,0,setiptiline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.438157124,0.000195701,setiptiline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.410233974,0.000260934,setiptiline
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.37899406,0.000391402,setiptiline
GPCR_LIGAND_BINDING,-2.193664783,0.04721359,mCPP
DNA_REPLICATION,-2.068547807,0.053152407,mCPP
SYNTHESIS_OF_DNA,-2.068547807,0.053152407,mCPP
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.010820721,0.268384722,mCPP
DNA_REPLICATION_PRE_INITIATION,-1.981981688,0.076833437,mCPP
S_PHASE,-1.977882046,0.063782888,mCPP
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.960455771,0.06176369,mCPP
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-1.93602399,0.064011957,mCPP
SIGNALING_BY_HEDGEHOG,-1.93190648,0.057569401,mCPP
SIGNALING_BY_NTRKS,1.850005055,0.375862862,mCPP
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.281278848,0.037413395,riociguat
REGULATION_OF_TP53_ACTIVITY,2.033655333,0.113625866,riociguat
PEROXISOMAL_PROTEIN_IMPORT,2.001089337,0.086836028,riociguat
GPCR_LIGAND_BINDING,-1.89813855,0.563682864,riociguat
TCR_SIGNALING,1.76077806,0.277136259,riociguat
DNA_REPLICATION,-1.846293086,0.299217236,riociguat
SYNTHESIS_OF_DNA,-1.846293086,0.299217236,riociguat
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.834923809,0.247826087,riociguat
GASTRULATION,-1.827819278,0.208509649,riociguat
DOWNSTREAM_TCR_SIGNALING,1.623963493,0.470577367,riociguat
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.109881811,0.105707935,VX-809
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.975921061,0.302291265,VX-809
COLLAGEN_FORMATION,-1.97969888,0.184741905,VX-809
SIGNALING_BY_ALK_IN_CANCER,1.856494653,0.328933885,VX-809
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.898455011,0.2407243,VX-809
MITOTIC_METAPHASE_AND_ANAPHASE,-1.874105274,0.213391719,VX-809
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-1.861335886,0.185137075,VX-809
REGULATION_OF_TP53_ACTIVITY,1.765088147,0.382560697,VX-809
SIGNALING_BY_NTRKS,1.734832298,0.339693405,VX-809
PEROXISOMAL_PROTEIN_IMPORT,1.727401059,0.284461204,VX-809
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.686187476,0.001965937,navitoclax
EUKARYOTIC_TRANSLATION_INITIATION,2.607917167,0.001965937,navitoclax
NONSENSE_MEDIATED_DECAY_NMD,2.46034436,0.004587186,navitoclax
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.256722252,0.020150852,navitoclax
REGULATION_OF_TP53_ACTIVITY,2.246394726,0.016907056,navitoclax
GPCR_LIGAND_BINDING,-2.141655295,0.056570242,navitoclax
INFLUENZA_INFECTION,2.184414247,0.020642336,navitoclax
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.017635579,0.085580623,navitoclax
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.982849084,0.061786583,navitoclax
CELLULAR_RESPONSE_TO_STARVATION,1.910987246,0.081832117,navitoclax
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.3002258,0.012348192,sonidegib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.276936873,0.02165664,sonidegib
CHROMATIN_ORGANIZATION,-2.170134403,0.01985192,sonidegib
CELL_CYCLE_CHECKPOINTS,-2.091678785,0.021055067,sonidegib
GPCR_LIGAND_BINDING,2.150152108,0.022491349,sonidegib
G_ALPHA_Q_SIGNALLING_EVENTS,2.120839123,0.018228283,sonidegib
RESPIRATORY_ELECTRON_TRANSPORT,-2.035318382,0.02301018,sonidegib
SIGNALING_BY_GPCR,2.103514602,0.015214736,sonidegib
CELL_CYCLE_MITOTIC,-1.998345692,0.022739472,sonidegib
MRNA_SPLICING,-1.888814885,0.040305414,sonidegib
RAB_REGULATION_OF_TRAFFICKING,2.222542326,0.029467848,dexfenfluramine
DISEASES_OF_GLYCOSYLATION,-2.304115712,0.147095128,dexfenfluramine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.225234166,0.161238891,dexfenfluramine
CELLULAR_RESPONSE_TO_STARVATION,1.974938052,0.092715912,dexfenfluramine
DISEASES_OF_METABOLISM,-2.215054192,0.113150099,dexfenfluramine
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.190486852,0.102400839,dexfenfluramine
NEURONAL_SYSTEM,1.914665838,0.098465736,dexfenfluramine
MUSCLE_CONTRACTION,1.901523176,0.079778808,dexfenfluramine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.831993066,0.099328209,dexfenfluramine
DEVELOPMENTAL_CELL_LINEAGES,-2.026121708,0.260924128,dexfenfluramine
CELLULAR_RESPONSE_TO_STARVATION,2.523129175,0.016819915,GDC-0199
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.52180976,0.008409957,GDC-0199
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.306760129,0.004686856,GDC-0199
EUKARYOTIC_TRANSLATION_INITIATION,2.414072438,0.011213277,GDC-0199
GPCR_LIGAND_BINDING,-2.28928792,0.002929285,GDC-0199
TRANS_GOLGI_NETWORK_VESICLE_BUDDING,2.363404775,0.011213277,GDC-0199
CELLULAR_RESPONSES_TO_STIMULI,2.306762148,0.012334604,GDC-0199
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.202369604,0.005467999,GDC-0199
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.125732174,0.03270539,GDC-0199
UNFOLDED_PROTEIN_RESPONSE_UPR,2.092682992,0.034841252,GDC-0199
RESPIRATORY_ELECTRON_TRANSPORT,3.541146866,0,tandutinib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.679915851,0,tandutinib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.14241658,0.029979709,tandutinib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.92278461,0.104736635,tandutinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.834862188,0.129271397,tandutinib
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.829624592,0.107870487,tandutinib
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.933437073,0.121043075,tandutinib
SENSORY_PERCEPTION,-1.918960389,0.095685237,tandutinib
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.912898858,0.075511392,tandutinib
GPCR_LIGAND_BINDING,-1.907828173,0.063107287,tandutinib
GPCR_LIGAND_BINDING,3.176329492,0,nialamide
SIGNALING_BY_GPCR,3.123772284,0,nialamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.946558587,0,nialamide
G_ALPHA_Q_SIGNALLING_EVENTS,2.627638275,0.00019873,nialamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.349737821,0.001589839,nialamide
POTASSIUM_CHANNELS,2.167526912,0.009406547,nialamide
AMINE_LIGAND_BINDING_RECEPTORS,2.1142632,0.013627191,nialamide
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.061362399,0.016991404,nialamide
G_ALPHA_S_SIGNALLING_EVENTS,2.033155393,0.019254717,nialamide
SENSORY_PERCEPTION,2.010484293,0.020588415,nialamide
EUKARYOTIC_TRANSLATION_ELONGATION,3.993147718,0,leflunomide
SARS_COV_INFECTIONS,2.584078909,0,leflunomide
CELLULAR_RESPONSES_TO_STIMULI,2.593797974,0,leflunomide
SARS_COV_2_INFECTION,2.624789971,0,leflunomide
SARS_COV_2_HOST_INTERACTIONS,2.767856932,0,leflunomide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.95017278,0,leflunomide
INFECTIOUS_DISEASE,2.99230373,0,leflunomide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.154426482,0,leflunomide
VIRAL_INFECTION_PATHWAYS,3.157597243,0,leflunomide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.18234173,0,leflunomide
CELL_CYCLE_MITOTIC,-2.411096735,0.005526347,semaxanib
S_PHASE,-2.302418972,0.009671108,semaxanib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.274651996,0.00875005,semaxanib
SEPARATION_OF_SISTER_CHROMATIDS,-2.265130212,0.007944124,semaxanib
RHO_GTPASES_ACTIVATE_FORMINS,-2.248747587,0.008013203,semaxanib
CELL_CYCLE,-2.208860628,0.011743488,semaxanib
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.197616401,0.011250064,semaxanib
DNA_REPLICATION,-2.195436308,0.008903559,semaxanib
SYNTHESIS_OF_DNA,-2.195436308,0.008903559,semaxanib
MITOTIC_SPINDLE_CHECKPOINT,-2.058592522,0.026388308,semaxanib
TRANSLATION,2.640256046,0.003130846,BRD-K34685430
METABOLISM_OF_RNA,2.50988947,0.007044405,BRD-K34685430
RESPIRATORY_ELECTRON_TRANSPORT,2.283157779,0.019306887,BRD-K34685430
RRNA_PROCESSING,2.207458111,0.025829483,BRD-K34685430
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.173509884,0.026612195,BRD-K34685430
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.147650196,0.02556858,BRD-K34685430
SIGNALING_BY_ROBO_RECEPTORS,1.838563703,0.153858741,BRD-K34685430
DISEASES_OF_GLYCOSYLATION,1.827493369,0.145780039,BRD-K34685430
CELLULAR_RESPONSE_TO_STARVATION,1.811294369,0.145236489,BRD-K34685430
MITOTIC_METAPHASE_AND_ANAPHASE,1.8008986,0.139166126,BRD-K34685430
TRANSLATION,2.152393821,0.087590516,lansoprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.146774171,0.047359988,lansoprazole
SELENOAMINO_ACID_METABOLISM,2.104109873,0.05058522,lansoprazole
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.12973249,0.256996067,lansoprazole
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.096818334,0.155067176,lansoprazole
EUKARYOTIC_TRANSLATION_INITIATION,2.016093635,0.08224342,lansoprazole
SENSORY_PERCEPTION,1.997981099,0.075572282,lansoprazole
EUKARYOTIC_TRANSLATION_ELONGATION,1.987135907,0.069766864,lansoprazole
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.009602264,0.180026067,lansoprazole
CILIUM_ASSEMBLY,-2.003828965,0.139608766,lansoprazole
NEUTROPHIL_DEGRANULATION,-2.433277796,0.020554449,alverine
INNATE_IMMUNE_SYSTEM,-2.197066379,0.04432053,alverine
ESR_MEDIATED_SIGNALING,-2.056333167,0.077507401,alverine
SIGNALING_BY_NUCLEAR_RECEPTORS,-2.000458654,0.081254305,alverine
SIGNALING_BY_NTRKS,-1.953467215,0.08864106,alverine
RAC3_GTPASE_CYCLE,-1.943874405,0.07772151,alverine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.980328833,0.375036952,alverine
ADAPTIVE_IMMUNE_SYSTEM,-1.886850089,0.091026845,alverine
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,-1.830780402,0.110801326,alverine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.817302993,0.104770593,alverine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,5.38435248,0,bisoprolol
SARS_COV_INFECTIONS,2.914928837,0,bisoprolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.966508014,0,bisoprolol
RESPIRATORY_ELECTRON_TRANSPORT,2.972295201,0,bisoprolol
SARS_COV_2_INFECTION,3.061126063,0,bisoprolol
SIGNALING_BY_GPCR,-3.1230698,0,bisoprolol
GPCR_LIGAND_BINDING,-3.198511513,0,bisoprolol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.255082948,0,bisoprolol
INFECTIOUS_DISEASE,3.807692534,0,bisoprolol
SARS_COV_1_INFECTION,3.89474897,0,bisoprolol
TRANSLATION,3.443144368,0,loteprednol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.792880395,0,loteprednol
RRNA_PROCESSING,2.798625083,0,loteprednol
CELLULAR_RESPONSE_TO_STARVATION,2.938493342,0,loteprednol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.965217,0,loteprednol
SIGNALING_BY_ROBO_RECEPTORS,2.800950427,0,loteprednol
SELENOAMINO_ACID_METABOLISM,3.199756601,0,loteprednol
EUKARYOTIC_TRANSLATION_ELONGATION,3.241076625,0,loteprednol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.338023528,0,loteprednol
EUKARYOTIC_TRANSLATION_INITIATION,3.412710424,0,loteprednol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.35375737,0.009698333,puromycin
CELLULAR_RESPONSES_TO_STIMULI,2.208361008,0.023707037,puromycin
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.204371468,0.016882284,puromycin
UNFOLDED_PROTEIN_RESPONSE_UPR,2.194649085,0.013469907,puromycin
ATTENUATION_PHASE,2.188367718,0.011422481,puromycin
SIGNALING_BY_NOTCH4,2.188137444,0.009518735,puromycin
SIGNALING_BY_NOTCH1,2.184497342,0.008466799,puromycin
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.183683234,0.007408449,puromycin
NONSENSE_MEDIATED_DECAY_NMD,2.181107853,0.006705021,puromycin
IRE1ALPHA_ACTIVATES_CHAPERONES,2.173343122,0.006681074,puromycin
EUKARYOTIC_TRANSLATION_INITIATION,4.117642576,0,gavestinel
SIGNALING_BY_ROBO_RECEPTORS,2.899992761,0,gavestinel
METABOLISM_OF_RNA,3.198910761,0,gavestinel
CELLULAR_RESPONSE_TO_STARVATION,3.246790007,0,gavestinel
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.468141343,0,gavestinel
INFLUENZA_INFECTION,3.65625666,0,gavestinel
NONSENSE_MEDIATED_DECAY_NMD,3.674655395,0,gavestinel
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.014456678,0,gavestinel
RRNA_PROCESSING,3.782164342,0,gavestinel
SELENOAMINO_ACID_METABOLISM,3.821691394,0,gavestinel
METABOLISM_OF_RNA,4.739529403,0,pseudoephedrine
NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,2.709242597,0,pseudoephedrine
CELLULAR_RESPONSES_TO_STIMULI,2.727369455,0,pseudoephedrine
SARS_COV_1_INFECTION,2.799396186,0,pseudoephedrine
UCH_PROTEINASES,2.826811624,0,pseudoephedrine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.848078208,0,pseudoephedrine
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.900671217,0,pseudoephedrine
SARS_COV_1_HOST_INTERACTIONS,2.905395687,0,pseudoephedrine
SIGNALING_BY_NOTCH4,2.949435391,0,pseudoephedrine
CELL_CYCLE,2.983570927,0,pseudoephedrine
GPCR_LIGAND_BINDING,2.437026837,0.007102559,alvespimycin
SIGNALING_BY_GPCR,2.361764457,0.003847219,alvespimycin
G_ALPHA_Q_SIGNALLING_EVENTS,2.297052695,0.004537746,alvespimycin
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.238259603,0.076144876,alvespimycin
PI_METABOLISM,-2.215118423,0.04398023,alvespimycin
HIV_LIFE_CYCLE,-2.200701067,0.031945839,alvespimycin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.020624233,0.031665575,alvespimycin
NEURONAL_SYSTEM,1.954059614,0.037761938,alvespimycin
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-1.995927834,0.116186578,alvespimycin
CHROMATIN_ORGANIZATION,-1.951885863,0.125245193,alvespimycin
GPCR_LIGAND_BINDING,3.41285497,0,calcifediol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.36422199,0,calcifediol
SIGNALING_BY_GPCR,3.116058856,0,calcifediol
G_ALPHA_Q_SIGNALLING_EVENTS,2.832615713,0,calcifediol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.795423243,0,calcifediol
MEMBRANE_TRAFFICKING,-2.394318579,0.015883965,calcifediol
VESICLE_MEDIATED_TRANSPORT,-2.373523087,0.008663981,calcifediol
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,2.343168247,0.000906269,calcifediol
COLLAGEN_FORMATION,2.328300462,0.000971003,calcifediol
SIGNALING_BY_VEGF,-2.320183331,0.008182649,calcifediol
EUKARYOTIC_TRANSLATION_INITIATION,3.073792802,0,GW-3965
EUKARYOTIC_TRANSLATION_ELONGATION,2.962439718,0,GW-3965
SELENOAMINO_ACID_METABOLISM,2.890892794,0,GW-3965
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.857592831,0,GW-3965
NONSENSE_MEDIATED_DECAY_NMD,2.840343767,0,GW-3965
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.832638113,0,GW-3965
CELLULAR_RESPONSE_TO_STARVATION,2.822443197,0,GW-3965
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.780916519,0,GW-3965
RRNA_PROCESSING,2.72826071,0,GW-3965
INFLUENZA_INFECTION,2.554845527,0.000111067,GW-3965
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.090462231,0,tetracaine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.792998748,0.000557664,tetracaine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.493729154,0.003717758,tetracaine
ECM_PROTEOGLYCANS,-2.266347235,0.015335752,tetracaine
SIGNALING_BY_PDGF,-1.986238794,0.072719348,tetracaine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.941786614,0.489543343,tetracaine
GPCR_LIGAND_BINDING,-1.902037387,0.099450028,tetracaine
S_PHASE,-1.896049195,0.087792201,tetracaine
INFLUENZA_INFECTION,1.865066715,0.461824479,tetracaine
CELLULAR_RESPONSE_TO_STARVATION,1.824846617,0.411554673,tetracaine
GPCR_LIGAND_BINDING,2.539690808,0,guaiacol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.331151066,0.002030576,guaiacol
SIGNALING_BY_GPCR,2.273796724,0.002707435,guaiacol
SENSORY_PERCEPTION,2.12761952,0.010733046,guaiacol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.034438487,0.021930223,guaiacol
VISUAL_PHOTOTRANSDUCTION,2.00540134,0.022723115,guaiacol
G_ALPHA_Q_SIGNALLING_EVENTS,1.857043711,0.065558604,guaiacol
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-3.131969563,1,guaiacol
NEUTROPHIL_DEGRANULATION,-3.034461044,1,guaiacol
POTASSIUM_CHANNELS,1.762217927,0.116395531,guaiacol
NEUTROPHIL_DEGRANULATION,-2.390716394,0.017535852,acamprosate
KEAP1_NFE2L2_PATHWAY,-1.903770756,0.219198155,acamprosate
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.825600428,0.224458911,acamprosate
SENSORY_PERCEPTION,1.97296812,0.364222731,acamprosate
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.761026079,0.243748349,acamprosate
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.711889336,0.263388503,acamprosate
TRNA_PROCESSING,-1.704944996,0.226797025,acamprosate
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.703299722,0.19565001,acamprosate
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-1.673441857,0.200566312,acamprosate
RAC3_GTPASE_CYCLE,-1.627364684,0.225627968,acamprosate
AMINE_LIGAND_BINDING_RECEPTORS,-2.042905272,0.050959604,carvedilol
GPCR_LIGAND_BINDING,-2.009615142,0.033190795,carvedilol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.939137607,0.048054013,carvedilol
REGULATION_OF_BETA_CELL_DEVELOPMENT,-1.920686818,0.04241046,carvedilol
VIRAL_INFECTION_PATHWAYS,1.708339641,1,carvedilol
SIGNALING_BY_GPCR,-1.892328624,0.043315664,carvedilol
CELL_CYCLE_CHECKPOINTS,1.602544336,1,carvedilol
G_ALPHA_S_SIGNALLING_EVENTS,-1.847683703,0.054200456,carvedilol
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.552214155,0.913211348,carvedilol
SARS_COV_2_INFECTION,1.517221276,0.825919087,carvedilol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.991720841,0,pipamperone
VIRAL_INFECTION_PATHWAYS,2.776772215,0,pipamperone
CELLULAR_RESPONSES_TO_STIMULI,2.792451828,0,pipamperone
SARS_COV_1_INFECTION,2.80088408,0,pipamperone
SARS_COV_1_HOST_INTERACTIONS,2.836906847,0,pipamperone
NERVOUS_SYSTEM_DEVELOPMENT,2.896362615,0,pipamperone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.975059478,0,pipamperone
METABOLISM_OF_RNA,3.00480208,0,pipamperone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.059125872,0,pipamperone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.219680274,0,pipamperone
NEUTROPHIL_DEGRANULATION,-2.324158633,0.023321379,bromhexine
GPCR_LIGAND_BINDING,1.852695135,1,bromhexine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.531587316,1,bromhexine
NUCLEOTIDE_EXCISION_REPAIR,-1.524432509,1,bromhexine
METABOLISM_OF_STEROIDS,-1.468885351,1,bromhexine
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,-1.425681265,1,bromhexine
INTERLEUKIN_17_SIGNALING,-1.415669512,0.903191986,bromhexine
G_ALPHA_S_SIGNALLING_EVENTS,1.646195196,1,bromhexine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.634766803,1,bromhexine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-1.320624775,1,bromhexine
NEUTROPHIL_DEGRANULATION,-2.754101091,0,bepridil
EUKARYOTIC_TRANSLATION_INITIATION,2.576827217,0.000983648,bepridil
EUKARYOTIC_TRANSLATION_ELONGATION,2.462621404,0.001967295,bepridil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.43474566,0.001967295,bepridil
RRNA_PROCESSING,2.412422972,0.001475472,bepridil
NONSENSE_MEDIATED_DECAY_NMD,2.383426909,0.001377107,bepridil
CELLULAR_RESPONSE_TO_STARVATION,2.358310883,0.001639413,bepridil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.285973912,0.00252938,bepridil
SELENOAMINO_ACID_METABOLISM,2.271932785,0.002705031,bepridil
INFLUENZA_INFECTION,2.234309937,0.003716002,bepridil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.441992463,0.002740793,pregnenolone
GPCR_LIGAND_BINDING,2.418585924,0.001370396,pregnenolone
SIGNALING_BY_GPCR,2.122825167,0.013932363,pregnenolone
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.951239953,0.447107268,pregnenolone
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.917646674,0.083080277,pregnenolone
NEUTROPHIL_DEGRANULATION,-1.763249304,0.711890056,pregnenolone
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.850869696,0.115387371,pregnenolone
CELLULAR_RESPONSE_TO_HEAT_STRESS,-1.718512758,0.606526663,pregnenolone
NEURONAL_SYSTEM,1.790672134,0.151314594,pregnenolone
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.656523403,0.637219477,pregnenolone
EUKARYOTIC_TRANSLATION_ELONGATION,-3.075032231,0,anastrozole
NERVOUS_SYSTEM_DEVELOPMENT,-2.379302778,0,anastrozole
TRANSLATION,-2.631058024,0,anastrozole
INFLUENZA_INFECTION,-2.635782662,0,anastrozole
RRNA_PROCESSING,-2.69961038,0,anastrozole
SIGNALING_BY_ROBO_RECEPTORS,-2.724763666,0,anastrozole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.769584561,0,anastrozole
SARS_COV_1_INFECTION,-2.786876415,0,anastrozole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.788110462,0,anastrozole
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.527421612,0,anastrozole
GPCR_LIGAND_BINDING,-2.906707445,0,oxaprozin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.819922704,0,oxaprozin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.811261329,0,oxaprozin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.702184908,0,oxaprozin
EUKARYOTIC_TRANSLATION_INITIATION,-2.601304477,0.000201244,oxaprozin
CHROMATIN_ORGANIZATION,2.693691066,0.002951761,oxaprozin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.448755319,0.000838516,oxaprozin
SIGNALING_BY_GPCR,-2.4067225,0.001437457,oxaprozin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.387553906,0.001635107,oxaprozin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.37022396,0.001565231,oxaprozin
EUKARYOTIC_TRANSLATION_INITIATION,4.028556944,0,bumetanide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.899887748,0,bumetanide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.991559644,0,bumetanide
CELLULAR_RESPONSE_TO_STARVATION,3.15095233,0,bumetanide
INFLUENZA_INFECTION,3.186154694,0,bumetanide
SIGNALING_BY_ROBO_RECEPTORS,3.242379805,0,bumetanide
SELENOAMINO_ACID_METABOLISM,3.546561426,0,bumetanide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.543275209,0,bumetanide
NONSENSE_MEDIATED_DECAY_NMD,3.632158284,0,bumetanide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.711577276,0,bumetanide
GPCR_LIGAND_BINDING,-2.205504616,0.005823346,phenformin
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.235116757,0.056117047,phenformin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.203375674,0.035710848,phenformin
SIGNALING_BY_GPCR,-2.141901998,0.00837106,phenformin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.132500302,0.005823346,phenformin
AMINE_LIGAND_BINDING_RECEPTORS,-2.040632195,0.012010651,phenformin
NEDDYLATION,1.883005775,0.122437193,phenformin
G_ALPHA_I_SIGNALLING_EVENTS,-1.981802517,0.017906788,phenformin
CELLULAR_RESPONSE_TO_STARVATION,1.69603987,0.27293291,phenformin
G_ALPHA_Q_SIGNALLING_EVENTS,-1.898730158,0.032635,phenformin
GPCR_LIGAND_BINDING,2.490192655,0.000801133,streptozotocin
NEUTROPHIL_DEGRANULATION,-2.582009353,0.016354199,streptozotocin
SIGNALING_BY_GPCR,2.201701216,0.016423236,streptozotocin
G_ALPHA_I_SIGNALLING_EVENTS,2.176673235,0.014153358,streptozotocin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.175707498,0.010615018,streptozotocin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.155623332,0.009613601,streptozotocin
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.155214412,0.118567941,streptozotocin
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.943185951,0.249128961,streptozotocin
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.842215721,0.308685502,streptozotocin
G_ALPHA_S_SIGNALLING_EVENTS,1.863705652,0.104948483,streptozotocin
NEUTROPHIL_DEGRANULATION,-2.022263478,0.180929971,pyridoxine
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,-1.815223643,0.276228963,pyridoxine
SENSORY_PERCEPTION,1.857811935,0.91395289,pyridoxine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.545187903,0.759629649,pyridoxine
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-1.537013372,0.590784695,pyridoxine
NEURONAL_SYSTEM,1.757476836,0.958412986,pyridoxine
DEUBIQUITINATION,-1.521322336,0.506327689,pyridoxine
P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,-1.427121592,0.577713146,pyridoxine
KEAP1_NFE2L2_PATHWAY,-1.430221463,0.66525142,pyridoxine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.414728817,0.53484833,pyridoxine
GASTRULATION,-1.999117562,0.348609321,cyclizine
SIGNALING_BY_NTRKS,1.821936214,0.640572277,cyclizine
CELL_CYCLE_MITOTIC,-1.859877234,0.527531323,cyclizine
MITOTIC_METAPHASE_AND_ANAPHASE,-1.83999655,0.406326096,cyclizine
GLYCOSAMINOGLYCAN_METABOLISM,1.731948583,0.601700634,cyclizine
PLATELET_HOMEOSTASIS,1.704199934,0.47320826,cyclizine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.720812416,0.650756637,cyclizine
CELL_CYCLE,-1.71693825,0.533303,cyclizine
SIGNALING_BY_HEDGEHOG,-1.711604418,0.458655972,cyclizine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.652949415,0.493588878,cyclizine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.026400141,0.113960114,tretinoin
EUKARYOTIC_TRANSLATION_INITIATION,-1.988077344,0.091168091,tretinoin
EUKARYOTIC_TRANSLATION_ELONGATION,-1.986818085,0.062044951,tretinoin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.982059595,0.049382716,tretinoin
POTENTIAL_THERAPEUTICS_FOR_SARS,-1.965043874,0.050332384,tretinoin
CELLULAR_RESPONSE_TO_STARVATION,-1.925997764,0.061411839,tretinoin
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1.671402486,0.647058824,tretinoin
INFLUENZA_INFECTION,-1.897158974,0.068511735,tretinoin
NONSENSE_MEDIATED_DECAY_NMD,-1.87315636,0.075261159,tretinoin
CHROMATIN_ORGANIZATION,-1.825680539,0.099926137,tretinoin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.064198853,0.166375956,tolcapone
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.052512834,0.089427076,tolcapone
INTERFERON_SIGNALING,1.88658341,0.142806029,tolcapone
NEDDYLATION,1.845595233,0.144539112,tolcapone
SENSORY_PERCEPTION,-1.93111197,0.275326944,tolcapone
KERATINIZATION,-1.894754601,0.19069776,tolcapone
MITOTIC_METAPHASE_AND_ANAPHASE,1.531978508,0.608935999,tolcapone
NUCLEOTIDE_EXCISION_REPAIR,1.493844772,0.601033141,tolcapone
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1.419176283,0.728489007,tolcapone
DNA_REPLICATION,1.410814869,0.6608245,tolcapone
METABOLISM_OF_RNA,5.093502167,0,moexipril
VIRAL_INFECTION_PATHWAYS,3.57230167,0,moexipril
MITOTIC_METAPHASE_AND_ANAPHASE,3.525419422,0,moexipril
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.450778654,0,moexipril
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.438176116,0,moexipril
SARS_COV_1_HOST_INTERACTIONS,3.374932506,0,moexipril
SEPARATION_OF_SISTER_CHROMATIDS,3.259319628,0,moexipril
CELLULAR_RESPONSES_TO_STIMULI,3.240225056,0,moexipril
MRNA_SPLICING,3.058997292,0,moexipril
MITOTIC_PROMETAPHASE,3.039784675,0,moexipril
NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,1.554924185,1,flavoxate
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.524799735,1,flavoxate
SIGNALING_BY_ERBB4,1.476935593,1,flavoxate
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.689716453,1,flavoxate
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.682974623,1,flavoxate
SENSORY_PERCEPTION,1.448602945,1,flavoxate
CARDIAC_CONDUCTION,1.444391629,0.816228647,flavoxate
APOPTOSIS,-1.657301056,1,flavoxate
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.405378439,0.810939553,flavoxate
TRANSCRIPTIONAL_REGULATION_BY_TP53,-1.595708527,1,flavoxate
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.212152962,0.044550869,ilomastat
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.055030042,0.054038554,ilomastat
SYNTHESIS_OF_DNA,-1.815639168,1,ilomastat
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.680409528,0.318456214,ilomastat
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.665743758,0.256167498,ilomastat
PTEN_REGULATION,-1.781850298,0.793104049,ilomastat
DISEASES_OF_GLYCOSYLATION,-1.780585862,0.533638221,ilomastat
DISEASES_OF_METABOLISM,-1.764039129,0.459054926,ilomastat
NEUTROPHIL_DEGRANULATION,1.595281863,0.298985834,ilomastat
S_PHASE,-1.738569836,0.44707958,ilomastat
NONSENSE_MEDIATED_DECAY_NMD,3.589149542,0,MK-1775
SELENOAMINO_ACID_METABOLISM,3.543907944,0,MK-1775
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.382902196,0,MK-1775
EUKARYOTIC_TRANSLATION_ELONGATION,3.37434128,0,MK-1775
EUKARYOTIC_TRANSLATION_INITIATION,3.238661186,0,MK-1775
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.139764313,0,MK-1775
INFLUENZA_INFECTION,2.730646153,0,MK-1775
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.617193646,0.000287452,MK-1775
CELLULAR_RESPONSE_TO_STARVATION,2.543596752,0.000766538,MK-1775
CELL_CYCLE_MITOTIC,-2.267187391,0.025099232,MK-1775
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.527601729,0,bupivacaine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.270565088,0,bupivacaine
RRNA_PROCESSING,-2.31448732,0,bupivacaine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.330400205,0,bupivacaine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.337363864,0,bupivacaine
TRANSLATION,-2.30681419,0,bupivacaine
SELENOAMINO_ACID_METABOLISM,-2.400754506,0,bupivacaine
EUKARYOTIC_TRANSLATION_INITIATION,-2.431459212,0,bupivacaine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.509281617,0,bupivacaine
NONSENSE_MEDIATED_DECAY_NMD,-2.3686325,0,bupivacaine
CELLULAR_RESPONSE_TO_STARVATION,2.401536075,0.00452319,dabigatran-etexilate
INFLUENZA_INFECTION,2.242391224,0.012212612,dabigatran-etexilate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.110404487,0.022012856,dabigatran-etexilate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.040449938,0.029853051,dabigatran-etexilate
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.124052851,0.220381288,dabigatran-etexilate
NEUTROPHIL_DEGRANULATION,1.932165321,0.045412824,dabigatran-etexilate
RAB_REGULATION_OF_TRAFFICKING,1.897389205,0.045533442,dabigatran-etexilate
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.05830593,0.189117896,dabigatran-etexilate
DISEASES_OF_METABOLISM,-2.032435797,0.149995946,dabigatran-etexilate
MITOTIC_G2_G2_M_PHASES,-2.010787767,0.134022574,dabigatran-etexilate
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.393920491,0,ibutilide
GPCR_LIGAND_BINDING,-2.300591913,0.000864828,ibutilide
NEUTROPHIL_DEGRANULATION,2.308002475,0.018368703,ibutilide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.155281708,0.008071728,ibutilide
SIGNALING_BY_GPCR,-2.050549642,0.0216207,ibutilide
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.873124834,0.165318326,ibutilide
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.848698229,0.12919321,ibutilide
PEROXISOMAL_PROTEIN_IMPORT,1.682211617,0.235119397,ibutilide
TOLL_LIKE_RECEPTOR_CASCADES,1.655695843,0.216015946,ibutilide
G_ALPHA_I_SIGNALLING_EVENTS,-1.859751059,0.116405851,ibutilide
MHC_CLASS_II_ANTIGEN_PRESENTATION,2.218880581,0.03631162,conivaptan
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.203409694,0.01815581,conivaptan
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.93382711,0.052046655,conivaptan
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.843023536,0.059006382,conivaptan
BIOLOGICAL_OXIDATIONS,1.734240349,0.082790493,conivaptan
L1CAM_INTERACTIONS,1.634817134,0.122854313,conivaptan
S_PHASE,1.599760189,0.127609406,conivaptan
G_ALPHA_Q_SIGNALLING_EVENTS,-1.86820781,0.251146789,conivaptan
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.469959062,0.236479423,conivaptan
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1.396721971,0.302193369,conivaptan
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.949420626,0,PS-178990
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.421424759,0.01027744,PS-178990
MRNA_SPLICING,2.308664779,0.018597273,PS-178990
GPCR_LIGAND_BINDING,-2.123242185,0.036855349,PS-178990
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.120733393,0.019063112,PS-178990
METABOLISM_OF_RNA,2.04830925,0.060930539,PS-178990
G_ALPHA_Q_SIGNALLING_EVENTS,-2.063066102,0.022663922,PS-178990
NEUTROPHIL_DEGRANULATION,1.986982881,0.067537465,PS-178990
MITF_M_DEPENDENT_GENE_EXPRESSION,1.976360948,0.060685838,PS-178990
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.038111759,0.022716875,PS-178990
EUKARYOTIC_TRANSLATION_ELONGATION,5.151935789,0,alogliptin
SARS_COV_INFECTIONS,2.81160082,0,alogliptin
SARS_COV_2_INFECTION,3.144386165,0,alogliptin
INFECTIOUS_DISEASE,3.173565838,0,alogliptin
CELLULAR_RESPONSES_TO_STIMULI,3.345514213,0,alogliptin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.379626587,0,alogliptin
MRNA_SPLICING,3.415236314,0,alogliptin
NERVOUS_SYSTEM_DEVELOPMENT,3.51658743,0,alogliptin
VIRAL_INFECTION_PATHWAYS,3.518376144,0,alogliptin
SARS_COV_1_INFECTION,3.594382797,0,alogliptin
SELENOAMINO_ACID_METABOLISM,4.2893041,0,rizatriptan
CELLULAR_RESPONSES_TO_STIMULI,2.762667588,0,rizatriptan
SARS_COV_1_INFECTION,2.807575135,0,rizatriptan
INFECTIOUS_DISEASE,2.821887253,0,rizatriptan
NERVOUS_SYSTEM_DEVELOPMENT,2.872489248,0,rizatriptan
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.037565128,0,rizatriptan
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.051748641,0,rizatriptan
VIRAL_INFECTION_PATHWAYS,3.052242661,0,rizatriptan
SARS_COV_1_HOST_INTERACTIONS,3.177295195,0,rizatriptan
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.327782186,0,rizatriptan
EUKARYOTIC_TRANSLATION_INITIATION,3.837837899,0,pravastatin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.691455381,0,pravastatin
SARS_COV_1_HOST_INTERACTIONS,2.693886387,0,pravastatin
SIGNALING_BY_ROBO_RECEPTORS,2.875468818,0,pravastatin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.913680882,0,pravastatin
NONSENSE_MEDIATED_DECAY_NMD,3.009968575,0,pravastatin
CELLULAR_RESPONSE_TO_STARVATION,3.031089868,0,pravastatin
METABOLISM_OF_RNA,3.070262794,0,pravastatin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.944605882,0,pravastatin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.387127642,0,pravastatin
CELL_CYCLE_CHECKPOINTS,2.596813315,0.004860499,phenethyl-isothiocyanate
RHO_GTPASES_ACTIVATE_FORMINS,2.421267485,0.012151247,phenethyl-isothiocyanate
KEAP1_NFE2L2_PATHWAY,2.267801516,0.022682328,phenethyl-isothiocyanate
MITOTIC_SPINDLE_CHECKPOINT,2.242273115,0.018834433,phenethyl-isothiocyanate
M_PHASE,2.136276331,0.029162993,phenethyl-isothiocyanate
SEPARATION_OF_SISTER_CHROMATIDS,2.117894154,0.025922661,phenethyl-isothiocyanate
MITOTIC_METAPHASE_AND_ANAPHASE,2.110101913,0.023260959,phenethyl-isothiocyanate
RESPIRATORY_ELECTRON_TRANSPORT,2.072848663,0.027947869,phenethyl-isothiocyanate
CELL_CYCLE,2.059565015,0.026192689,phenethyl-isothiocyanate
CELL_CYCLE_MITOTIC,2.045444872,0.025031569,phenethyl-isothiocyanate
EUKARYOTIC_TRANSLATION_INITIATION,2.992086891,0,mefenamic-acid
RRNA_PROCESSING,2.730849379,0,mefenamic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,2.649785614,0.000487759,mefenamic-acid
TRANSLATION,2.634751166,0.000365819,mefenamic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.54905056,0.00058531,mefenamic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.51000471,0.000487759,mefenamic-acid
NONSENSE_MEDIATED_DECAY_NMD,2.505976053,0.000418079,mefenamic-acid
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.48855306,0.000365819,mefenamic-acid
SELENOAMINO_ACID_METABOLISM,2.427459723,0.000487759,mefenamic-acid
INFLUENZA_INFECTION,2.318962666,0.004975139,mefenamic-acid
INFLUENZA_INFECTION,2.829342542,0,forskolin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.807005013,0,forskolin
SELENOAMINO_ACID_METABOLISM,2.662222422,0,forskolin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.384664965,0.002999595,forskolin
CELLULAR_RESPONSE_TO_STARVATION,2.29877802,0.003599514,forskolin
EUKARYOTIC_TRANSLATION_INITIATION,2.257940162,0.004999324,forskolin
ADAPTIVE_IMMUNE_SYSTEM,2.177198877,0.011141352,forskolin
EUKARYOTIC_TRANSLATION_ELONGATION,2.012323261,0.029246048,forskolin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.949043277,0.035328559,forskolin
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.93604913,0.032395622,forskolin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.393184434,0.00463097,pentobarbital
MRNA_SPLICING,1.993916592,0.040520984,pentobarbital
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.947469014,0.0355041,pentobarbital
NEURONAL_SYSTEM,-2.024536549,0.047729678,pentobarbital
G_ALPHA_Q_SIGNALLING_EVENTS,-1.933559616,0.070190702,pentobarbital
POTASSIUM_CHANNELS,-1.892912676,0.078925545,pentobarbital
GABA_RECEPTOR_ACTIVATION,-1.89141069,0.061065911,pentobarbital
EUKARYOTIC_TRANSLATION_ELONGATION,-1.850791884,0.076554659,pentobarbital
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,1.470276002,0.357163531,pentobarbital
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.807245207,0.104662136,pentobarbital
SENSORY_PERCEPTION,2.244232051,0.016271017,chlorotrianisene
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.001260127,0.103320956,chlorotrianisene
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.767378394,0.649744605,chlorotrianisene
GPCR_LIGAND_BINDING,1.898451175,0.15918478,chlorotrianisene
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.885976432,0.130778297,chlorotrianisene
INTERFERON_ALPHA_BETA_SIGNALING,-1.446469299,1,chlorotrianisene
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.76941226,0.245529642,chlorotrianisene
SIGNALING_BY_GPCR,1.757372468,0.225760357,chlorotrianisene
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.755532266,0.195484644,chlorotrianisene
VISUAL_PHOTOTRANSDUCTION,1.752528456,0.174506654,chlorotrianisene
NEUTROPHIL_DEGRANULATION,-2.973130305,0,pefloxacin
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.111821906,0.087079169,pefloxacin
INNATE_IMMUNE_SYSTEM,-2.095287932,0.066674479,pefloxacin
GPCR_LIGAND_BINDING,2.040960729,0.148726842,pefloxacin
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.925013136,0.149586493,pefloxacin
RHOG_GTPASE_CYCLE,-1.888821718,0.151052182,pefloxacin
ESR_MEDIATED_SIGNALING,-1.880069574,0.131337228,pefloxacin
SIGNALING_BY_NTRKS,-1.787677157,0.197806429,pefloxacin
EPH_EPHRIN_SIGNALING,-1.69590589,0.286887064,pefloxacin
RAC3_GTPASE_CYCLE,-1.634060865,0.350615796,pefloxacin
GPCR_LIGAND_BINDING,-3.220563553,0,BRD-K26619122
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.002724806,0,BRD-K26619122
SIGNALING_BY_GPCR,-2.744528768,0,BRD-K26619122
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.727236739,0,BRD-K26619122
G_ALPHA_Q_SIGNALLING_EVENTS,-2.602133496,0.00017797,BRD-K26619122
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.590976241,0.000148309,BRD-K26619122
EUKARYOTIC_TRANSLATION_INITIATION,-2.424496613,0.000381365,BRD-K26619122
TRANSLATION,-2.375116284,0.00077862,BRD-K26619122
G_ALPHA_S_SIGNALLING_EVENTS,-2.365525046,0.000889851,BRD-K26619122
EUKARYOTIC_TRANSLATION_ELONGATION,-2.358672394,0.000800866,BRD-K26619122
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.809754912,0,tolterodine
SARS_COV_1_INFECTION,2.603862626,0,tolterodine
SARS_COV_1_HOST_INTERACTIONS,2.683520681,0,tolterodine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.039995291,0,tolterodine
SIGNALING_BY_ROBO_RECEPTORS,3.062052849,0,tolterodine
NONSENSE_MEDIATED_DECAY_NMD,3.107349347,0,tolterodine
RRNA_PROCESSING,3.138417346,0,tolterodine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.175476425,0,tolterodine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.241045631,0,tolterodine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.035925266,0,tolterodine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.217142347,0.018938113,amodiaquine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.001184401,0.074114597,amodiaquine
GPCR_LIGAND_BINDING,-1.982849628,0.043384154,amodiaquine
MEMBRANE_TRAFFICKING,1.817907768,0.112445046,amodiaquine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.971564714,0.033140673,amodiaquine
SLC_TRANSPORTER_DISORDERS,1.708267158,0.139668583,amodiaquine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.706769436,0.105343253,amodiaquine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.5709369,0.178491715,amodiaquine
BIOLOGICAL_OXIDATIONS,1.567525861,0.153477624,amodiaquine
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.550248543,0.144064931,amodiaquine
NEUTROPHIL_DEGRANULATION,-1.891217311,0.521949379,epothilone
UB_SPECIFIC_PROCESSING_PROTEASES,-1.845904757,0.340335414,epothilone
DEUBIQUITINATION,-1.810177392,0.303198665,epothilone
INNATE_IMMUNE_SYSTEM,-1.801976546,0.232740586,epothilone
EUKARYOTIC_TRANSLATION_INITIATION,-1.77812446,0.214884423,epothilone
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.719331957,0.258939799,epothilone
TRANSLATION,-1.700457439,0.244186844,epothilone
CELL_CYCLE,-1.657711281,0.267460903,epothilone
NRAGE_SIGNALS_DEATH_THROUGH_JNK,-1.5790705,0.357462408,epothilone
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.573905277,0.329957473,epothilone
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.568671925,0.006194341,metamizole
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.527064131,0.005574907,metamizole
GASTRULATION,-2.112098097,0.068550704,metamizole
DNA_REPLICATION,-2.035434751,0.085791619,metamizole
SYNTHESIS_OF_DNA,-1.970924469,0.113728095,metamizole
S_PHASE,-1.96168221,0.099315929,metamizole
MITOTIC_METAPHASE_AND_ANAPHASE,-1.954881831,0.088844544,metamizole
CELL_CYCLE_MITOTIC,-1.874838816,0.137514364,metamizole
NEURONAL_SYSTEM,1.863996687,0.837618048,metamizole
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.813735267,0.180874749,metamizole
GPCR_LIGAND_BINDING,-2.124965899,0.013571995,ketorolac
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.073030654,0.014056709,ketorolac
GLYCOSAMINOGLYCAN_METABOLISM,2.033072616,0.07904831,ketorolac
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.923421781,0.06979883,ketorolac
PROGRAMMED_CELL_DEATH,-1.921393637,0.053076194,ketorolac
REGULATED_NECROSIS,-1.86201314,0.083176939,ketorolac
APOPTOSIS,-1.854013791,0.074807543,ketorolac
NEURONAL_SYSTEM,-1.851795508,0.0648132,ketorolac
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,-1.848761062,0.05913512,ketorolac
SIGNALING_BY_GPCR,-1.839324104,0.058273406,ketorolac
GPCR_LIGAND_BINDING,2.056472079,0.204101951,BRD-K49668410
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.956843066,0.229490243,BRD-K49668410
NEUTROPHIL_DEGRANULATION,-1.922071235,0.426016729,BRD-K49668410
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.823751061,0.370493222,BRD-K49668410
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.859572956,0.309637595,BRD-K49668410
G_ALPHA_I_SIGNALLING_EVENTS,1.847966534,0.252389486,BRD-K49668410
HOMOLOGY_DIRECTED_REPAIR,1.838173591,0.21744325,BRD-K49668410
SIGNALING_BY_GPCR,1.788621894,0.261018187,BRD-K49668410
SIGNALING_BY_HEDGEHOG,1.761341261,0.268248279,BRD-K49668410
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.64804694,0.648783771,BRD-K49668410
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.194992076,0,neratinib
CELLULAR_RESPONSE_TO_STARVATION,2.472557895,0.003870493,neratinib
NONSENSE_MEDIATED_DECAY_NMD,2.454775756,0.003096395,neratinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.363000489,0.004257543,neratinib
NEUTROPHIL_DEGRANULATION,2.116906695,0.026628994,neratinib
SIGNALING_BY_ALK_IN_CANCER,2.027537268,0.037414769,neratinib
INFLUENZA_INFECTION,1.986088499,0.041580157,neratinib
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1.934062226,0.049542314,neratinib
GPCR_LIGAND_BINDING,-1.904885044,0.433636492,neratinib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.790746168,0.111298185,neratinib
GPCR_LIGAND_BINDING,3.174188132,0,rivaroxaban
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.963938526,0,rivaroxaban
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.932136583,0,rivaroxaban
SIGNALING_BY_GPCR,2.799516733,0,rivaroxaban
G_ALPHA_Q_SIGNALLING_EVENTS,2.481169022,0,rivaroxaban
NEUTROPHIL_DEGRANULATION,-2.466667147,0.015885423,rivaroxaban
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.11173834,0.064676366,rivaroxaban
TOLL_LIKE_RECEPTOR_CASCADES,-2.035727289,0.07110618,rivaroxaban
INNATE_IMMUNE_SYSTEM,-2.00524617,0.06240702,rivaroxaban
G_ALPHA_I_SIGNALLING_EVENTS,2.073221625,0.013149415,rivaroxaban
DISEASES_OF_METABOLISM,-3.567719982,1,pentolinium
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,-2.024542938,1,pentolinium
G2_M_CHECKPOINTS,-1.844193853,1,pentolinium
REPRODUCTION,-1.834549024,1,pentolinium
BIOLOGICAL_OXIDATIONS,-1.720427698,1,pentolinium
VISUAL_PHOTOTRANSDUCTION,1.676321109,1,pentolinium
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.672726853,1,pentolinium
SIGNALING_BY_ALK_IN_CANCER,-1.66210907,0.979503106,pentolinium
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-1.640438148,0.881521739,pentolinium
RAC3_GTPASE_CYCLE,-1.613360706,0.81884058,pentolinium
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-2.649595001,0.003803862,celiprolol
NEUTROPHIL_DEGRANULATION,-2.587570577,0.003169885,celiprolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.969843286,0.318847512,celiprolol
SENSORY_PERCEPTION,1.951982881,0.194800209,celiprolol
SIGNALING_BY_INSULIN_RECEPTOR,-1.823864655,0.545220229,celiprolol
INNATE_IMMUNE_SYSTEM,-1.77160032,0.50686462,celiprolol
NEURONAL_SYSTEM,1.803391696,0.428499202,celiprolol
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.674463594,0.587569893,celiprolol
PROTEIN_LOCALIZATION,-1.648990216,0.531484061,celiprolol
FATTY_ACID_METABOLISM,-1.603653371,0.524570692,celiprolol
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.340849287,0.020343976,carisoprodol
DEVELOPMENTAL_CELL_LINEAGES,-2.166149508,0.056337164,carisoprodol
REGULATION_OF_PTEN_GENE_TRANSCRIPTION,2.013934138,0.34695201,carisoprodol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.005473104,0.14188619,carisoprodol
CELLULAR_RESPONSE_TO_STARVATION,1.894145895,0.374844231,carisoprodol
GPCR_LIGAND_BINDING,-1.946688269,0.159230734,carisoprodol
ECM_PROTEOGLYCANS,-1.933195813,0.135522177,carisoprodol
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.823362572,0.414981816,carisoprodol
SIGNALING_BY_NTRKS,1.773545574,0.410900028,carisoprodol
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.84199714,0.202396477,carisoprodol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.225651888,0.012846292,BMS-927711
CELLULAR_RESPONSE_TO_STARVATION,2.314890718,0.015247189,BMS-927711
ECM_PROTEOGLYCANS,-2.163835345,0.018198914,BMS-927711
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.983747267,0.087782995,BMS-927711
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.876050143,0.123429628,BMS-927711
DEVELOPMENTAL_CELL_LINEAGES,-1.922346332,0.114010841,BMS-927711
GPCR_LIGAND_BINDING,-1.909923039,0.102342126,BMS-927711
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.719795761,0.204021914,BMS-927711
RAB_REGULATION_OF_TRAFFICKING,1.697346389,0.170804823,BMS-927711
NEUTROPHIL_DEGRANULATION,1.634443023,0.1871774,BMS-927711
NEURONAL_SYSTEM,2.126501103,0.100455083,aripiprazole
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.149090992,0.097698355,aripiprazole
COLLAGEN_FORMATION,-2.125992617,0.058892934,aripiprazole
MUSCLE_CONTRACTION,1.97224422,0.196151767,aripiprazole
SELENOAMINO_ACID_METABOLISM,1.952018005,0.155793497,aripiprazole
EUKARYOTIC_TRANSLATION_ELONGATION,1.879414052,0.207783409,aripiprazole
POTASSIUM_CHANNELS,1.854751303,0.192873759,aripiprazole
NONSENSE_MEDIATED_DECAY_NMD,1.835253815,0.184343889,aripiprazole
CHROMATIN_ORGANIZATION,-1.792540047,0.331139597,aripiprazole
METABOLISM_OF_RNA,-1.782073192,0.264789935,aripiprazole
NONSENSE_MEDIATED_DECAY_NMD,3.339190356,0,vandetanib
SARS_COV_1_INFECTION,2.731464586,0,vandetanib
CELLULAR_RESPONSE_TO_STARVATION,2.886061441,0,vandetanib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.899098872,0,vandetanib
SIGNALING_BY_ROBO_RECEPTORS,2.942597476,0,vandetanib
INFLUENZA_INFECTION,3.06289969,0,vandetanib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.701471153,0,vandetanib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.15937045,0,vandetanib
EUKARYOTIC_TRANSLATION_INITIATION,3.215104238,0,vandetanib
EUKARYOTIC_TRANSLATION_ELONGATION,3.216144814,0,vandetanib
METABOLISM_OF_RNA,-2.481844113,0,pralatrexate
MITOTIC_METAPHASE_AND_ANAPHASE,-2.456944921,0,pralatrexate
CELL_CYCLE_MITOTIC,-2.437363662,0.000778397,pralatrexate
M_PHASE,-2.43557412,0.000583798,pralatrexate
SEPARATION_OF_SISTER_CHROMATIDS,-2.41810216,0.000467038,pralatrexate
CELL_CYCLE,-2.406458849,0.000389199,pralatrexate
GASTRULATION,-2.404154485,0.000333599,pralatrexate
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,-2.338186677,0.001167596,pralatrexate
FORMATION_OF_PARAXIAL_MESODERM,-2.256142329,0.002594658,pralatrexate
MITOTIC_PROMETAPHASE,-2.195456506,0.004787144,pralatrexate
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.209509933,0.027859238,mecamylamine
RESPIRATORY_ELECTRON_TRANSPORT,2.102352294,0.047012463,mecamylamine
GPCR_LIGAND_BINDING,-2.099444471,0.039125734,mecamylamine
SIGNALING_BY_GPCR,-2.084097799,0.023156047,mecamylamine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,2.009835471,0.066165689,mecamylamine
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.926345012,0.074871701,mecamylamine
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.833982736,0.097507331,mecamylamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.992080654,0.047909062,mecamylamine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.765708222,0.119562561,mecamylamine
RHO_GTPASE_CYCLE,1.750106169,0.110939464,mecamylamine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.716740449,1,camostat-mesilate
CLEC7A_DECTIN_1_SIGNALING,1.692830048,0.90436287,camostat-mesilate
C_TYPE_LECTIN_RECEPTORS_CLRS,1.58644001,1,camostat-mesilate
DNA_REPLICATION_PRE_INITIATION,1.569999393,0.827891009,camostat-mesilate
L1CAM_INTERACTIONS,1.565387723,0.677385522,camostat-mesilate
SIGNALING_BY_INTERLEUKINS,1.563497513,0.567443369,camostat-mesilate
DNA_REPLICATION,1.519317145,0.601008658,camostat-mesilate
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.517426928,0.529207439,camostat-mesilate
INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,1.512382922,0.481735777,camostat-mesilate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.355595677,1,camostat-mesilate
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.06606655,0.080825623,cariprazine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.02461762,0.068798,cariprazine
CELLULAR_RESPONSE_TO_STARVATION,1.924070372,0.282375628,cariprazine
NEUTROPHIL_DEGRANULATION,1.917776084,0.145205354,cariprazine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.794134233,0.209677296,cariprazine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.664507245,0.317959549,cariprazine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.802494661,0.395468227,cariprazine
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,1.626866617,0.317041254,cariprazine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.603435489,0.294428247,cariprazine
INFLUENZA_INFECTION,1.599149633,0.258926317,cariprazine
METABOLISM_OF_RNA,5.917669874,0,deserpidine
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,2.673008452,0,deserpidine
GPCR_LIGAND_BINDING,-2.702632407,0,deserpidine
HIV_LIFE_CYCLE,2.789263172,0,deserpidine
HIV_INFECTION,2.904756095,0,deserpidine
SARS_COV_2_HOST_INTERACTIONS,3.426327892,0,deserpidine
SARS_COV_2_INFECTION,3.545971694,0,deserpidine
NERVOUS_SYSTEM_DEVELOPMENT,3.656771042,0,deserpidine
INFECTIOUS_DISEASE,3.849555897,0,deserpidine
MRNA_SPLICING,3.893600138,0,deserpidine
EUKARYOTIC_TRANSLATION_INITIATION,4.131871317,0,BRD-K65856711
CELLULAR_RESPONSES_TO_STIMULI,2.996304087,0,BRD-K65856711
MRNA_SPLICING,3.07262587,0,BRD-K65856711
VIRAL_INFECTION_PATHWAYS,3.07709195,0,BRD-K65856711
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.119003732,0,BRD-K65856711
SARS_COV_1_HOST_INTERACTIONS,3.1582776,0,BRD-K65856711
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.238223412,0,BRD-K65856711
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.240821253,0,BRD-K65856711
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.761045483,0,BRD-K65856711
SIGNALING_BY_ROBO_RECEPTORS,3.391674495,0,BRD-K65856711
TRANSLATION,2.951486217,0,sulfinpyrazone
RESPIRATORY_ELECTRON_TRANSPORT,2.857597903,0,sulfinpyrazone
RRNA_PROCESSING,2.702576362,0,sulfinpyrazone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.494606937,0.001636546,sulfinpyrazone
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-2.036358165,0.158066137,sulfinpyrazone
UB_SPECIFIC_PROCESSING_PROTEASES,-1.937252352,0.182735419,sulfinpyrazone
DEUBIQUITINATION,-1.914081241,0.14771113,sulfinpyrazone
EXTRACELLULAR_MATRIX_ORGANIZATION,1.80426631,0.129614476,sulfinpyrazone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.893753849,0.13202634,sulfinpyrazone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.650936634,0.252900973,sulfinpyrazone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.565161501,0,olmesartan
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.815201851,0,olmesartan
NONSENSE_MEDIATED_DECAY_NMD,2.867019626,0,olmesartan
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.885865109,0,olmesartan
SIGNALING_BY_ROBO_RECEPTORS,2.905182722,0,olmesartan
INFLUENZA_INFECTION,3.011541633,0,olmesartan
CELLULAR_RESPONSE_TO_STARVATION,3.143037229,0,olmesartan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.047618223,0,olmesartan
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.20148387,0,olmesartan
RRNA_PROCESSING,3.235920798,0,olmesartan
EUKARYOTIC_TRANSLATION_INITIATION,6.79542965,0,metoclopramide
MRNA_SPLICING,4.000503787,0,metoclopramide
RESPIRATORY_ELECTRON_TRANSPORT,3.357331846,0,metoclopramide
HIV_INFECTION,3.280281093,0,metoclopramide
NUCLEOTIDE_EXCISION_REPAIR,2.988527967,0,metoclopramide
HOST_INTERACTIONS_OF_HIV_FACTORS,2.974984954,0,metoclopramide
GPCR_LIGAND_BINDING,-2.96541259,0,metoclopramide
TRANSCRIPTIONAL_REGULATION_BY_TP53,2.908346682,0,metoclopramide
HIV_LIFE_CYCLE,2.907763768,0,metoclopramide
S_PHASE,2.865947408,0,metoclopramide
EUKARYOTIC_TRANSLATION_INITIATION,3.635040341,0,danazol
TRANSLATION,3.423620416,0,danazol
EUKARYOTIC_TRANSLATION_ELONGATION,3.19524828,0,danazol
METABOLISM_OF_RNA,2.928936615,0,danazol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.922605129,0,danazol
NONSENSE_MEDIATED_DECAY_NMD,2.853108111,0,danazol
RRNA_PROCESSING,2.817822877,0,danazol
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.762871974,0,danazol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.738433528,0.000247575,danazol
MRNA_SPLICING,2.708705713,0.000445636,danazol
GPCR_LIGAND_BINDING,2.398117776,0.004968658,BRD-K14643723
CILIUM_ASSEMBLY,-2.160681599,0.081522467,BRD-K14643723
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-2.111529043,0.060171344,BRD-K14643723
EUKARYOTIC_TRANSLATION_INITIATION,2.096518504,0.03260682,BRD-K14643723
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.032335325,0.038300075,BRD-K14643723
SIGNALING_BY_GPCR,2.00803284,0.033538444,BRD-K14643723
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-1.978265223,0.124656047,BRD-K14643723
MEMBRANE_TRAFFICKING,-1.912879144,0.15366338,BRD-K14643723
TRANSLATION,1.864440166,0.076020473,BRD-K14643723
DISEASES_OF_METABOLISM,1.824014778,0.082396918,BRD-K14643723
EUKARYOTIC_TRANSLATION_INITIATION,3.292650625,0,candesartan-cilextil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.640168683,0,candesartan-cilextil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.644765982,0,candesartan-cilextil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.681117192,0,candesartan-cilextil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.704437504,0,candesartan-cilextil
SIGNALING_BY_ROBO_RECEPTORS,2.73324977,0,candesartan-cilextil
INFLUENZA_INFECTION,2.775521748,0,candesartan-cilextil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.811973631,0,candesartan-cilextil
TRANSLATION,2.946045524,0,candesartan-cilextil
CELLULAR_RESPONSE_TO_STARVATION,2.989961112,0,candesartan-cilextil
EUKARYOTIC_TRANSLATION_ELONGATION,-3.334129696,0,cholic-acid
CELLULAR_RESPONSES_TO_STIMULI,-2.222395637,0,cholic-acid
SARS_COV_INFECTIONS,-2.252043093,0,cholic-acid
VIRAL_INFECTION_PATHWAYS,-2.276874349,0,cholic-acid
SARS_COV_2_INFECTION,-2.388617507,0,cholic-acid
SARS_COV_2_HOST_INTERACTIONS,-2.6143223,0,cholic-acid
NERVOUS_SYSTEM_DEVELOPMENT,-2.633920439,0,cholic-acid
SARS_COV_1_INFECTION,-2.81713017,0,cholic-acid
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.81931573,0,cholic-acid
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.912677931,0,cholic-acid
METABOLISM_OF_RNA,2.768426908,0,diclofenamide
NONSENSE_MEDIATED_DECAY_NMD,2.738205181,0,diclofenamide
EUKARYOTIC_TRANSLATION_INITIATION,2.712626809,0,diclofenamide
EUKARYOTIC_TRANSLATION_ELONGATION,2.701109893,0,diclofenamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.647571775,0,diclofenamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.633537791,0,diclofenamide
INFLUENZA_INFECTION,2.612636728,0,diclofenamide
SIGNALING_BY_ROBO_RECEPTORS,2.524267591,0.000821387,diclofenamide
TRANSLATION,2.511147393,0.000730122,diclofenamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.507350244,0.000821387,diclofenamide
EUKARYOTIC_TRANSLATION_ELONGATION,3.738000343,0,sulfapyridine
SARS_COV_2_HOST_INTERACTIONS,2.552345688,0,sulfapyridine
SARS_COV_1_INFECTION,2.865633142,0,sulfapyridine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.914888152,0,sulfapyridine
SARS_COV_1_HOST_INTERACTIONS,3.049991987,0,sulfapyridine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.17935832,0,sulfapyridine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.231620801,0,sulfapyridine
SIGNALING_BY_ROBO_RECEPTORS,3.271445516,0,sulfapyridine
TRANSLATION,3.274150575,0,sulfapyridine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.353761853,0,sulfapyridine
VIRAL_INFECTION_PATHWAYS,2.525542508,0.009708738,phenylbutazone
ADAPTIVE_IMMUNE_SYSTEM,2.016411402,0.101941748,phenylbutazone
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.006889546,0.072815534,phenylbutazone
NEDDYLATION,1.939466978,0.08131068,phenylbutazone
GPCR_LIGAND_BINDING,-1.982450477,0.101912385,phenylbutazone
INFLUENZA_INFECTION,1.810985952,0.138834951,phenylbutazone
KERATINIZATION,-1.966984137,0.060854158,phenylbutazone
SUMOYLATION,1.696974561,0.197411003,phenylbutazone
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.672346345,0.192094313,phenylbutazone
SIGNALING_BY_GPCR,-1.912933564,0.074784628,phenylbutazone
TRNA_PROCESSING,-2.635147767,0.008927024,lovastatin
METABOLISM_OF_RNA,-2.539598912,0.016180231,lovastatin
DNA_REPLICATION,-2.373815518,0.039427688,lovastatin
SUMOYLATION,-2.234120436,0.079227336,lovastatin
SYNTHESIS_OF_DNA,-2.234095786,0.063381869,lovastatin
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-2.21495749,0.059699471,lovastatin
GPCR_LIGAND_BINDING,1.983161119,0.30477874,lovastatin
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.977159156,0.158645825,lovastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.922427587,0.149261142,lovastatin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.073928765,0.121630699,lovastatin
METABOLISM_OF_RNA,7.235945546,0,roscovitine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.607850605,0,roscovitine
CELL_CYCLE_MITOTIC,2.790453336,0,roscovitine
M_PHASE,2.857645336,0,roscovitine
HIV_INFECTION,2.910318966,0,roscovitine
HIV_LIFE_CYCLE,2.990682805,0,roscovitine
MRNA_SPLICING,3.386039345,0,roscovitine
CELLULAR_RESPONSES_TO_STIMULI,3.584976428,0,roscovitine
SARS_COV_1_INFECTION,3.648820598,0,roscovitine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.943363539,0,roscovitine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.62482604,0,diethylcarbamazine
GPCR_LIGAND_BINDING,-2.696731988,0,diethylcarbamazine
SARS_COV_1_HOST_INTERACTIONS,2.74607897,0,diethylcarbamazine
TRANSLATION,2.863476633,0,diethylcarbamazine
RRNA_PROCESSING,2.885673168,0,diethylcarbamazine
INFLUENZA_INFECTION,3.069002817,0,diethylcarbamazine
SIGNALING_BY_ROBO_RECEPTORS,3.209841817,0,diethylcarbamazine
METABOLISM_OF_RNA,2.719976663,0,diethylcarbamazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.462484048,0,diethylcarbamazine
CELLULAR_RESPONSE_TO_STARVATION,3.491825385,0,diethylcarbamazine
EUKARYOTIC_TRANSLATION_ELONGATION,3.966040749,0,ritanserin
METABOLISM_OF_RNA,2.694624059,0,ritanserin
VIRAL_INFECTION_PATHWAYS,2.738504099,0,ritanserin
SARS_COV_1_INFECTION,2.9419209,0,ritanserin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.022404363,0,ritanserin
SARS_COV_1_HOST_INTERACTIONS,3.113979462,0,ritanserin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.157690746,0,ritanserin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.267783632,0,ritanserin
INFLUENZA_INFECTION,3.524636122,0,ritanserin
SIGNALING_BY_ROBO_RECEPTORS,3.538591251,0,ritanserin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.943635894,0,orlistat
NONSENSE_MEDIATED_DECAY_NMD,2.909186021,0.000711931,orlistat
EUKARYOTIC_TRANSLATION_ELONGATION,2.869496732,0.000474621,orlistat
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.850949374,0.000355966,orlistat
SELENOAMINO_ACID_METABOLISM,2.816384024,0.000284772,orlistat
EUKARYOTIC_TRANSLATION_INITIATION,2.724255314,0.00023731,orlistat
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.600894131,0.000203409,orlistat
CELLULAR_RESPONSE_TO_STARVATION,2.383622657,0.002313776,orlistat
TRANSLATION,2.267455455,0.005695449,orlistat
INFLUENZA_INFECTION,2.17776284,0.00868556,orlistat
TRANSLATION,2.473247858,0.002896152,clobetasol
RESPIRATORY_ELECTRON_TRANSPORT,2.345628059,0.002896152,clobetasol
METABOLISM_OF_NUCLEOTIDES,2.124237606,0.015928837,clobetasol
EXTRACELLULAR_MATRIX_ORGANIZATION,1.964292141,0.038374017,clobetasol
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,1.928720662,0.035912288,clobetasol
RRNA_PROCESSING,1.810954395,0.059853813,clobetasol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.707394425,0.099296649,clobetasol
HATS_ACETYLATE_HISTONES,-1.848401716,0.742275213,clobetasol
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.58676815,0.169243897,clobetasol
SIGNALING_BY_ALK_IN_CANCER,-1.786739419,0.659331581,clobetasol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.814424919,0,diphenoxylate
RESPIRATORY_ELECTRON_TRANSPORT,2.791172767,0,diphenoxylate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.71521246,0.000369635,diphenoxylate
EUKARYOTIC_TRANSLATION_ELONGATION,2.690163891,0.000277226,diphenoxylate
EUKARYOTIC_TRANSLATION_INITIATION,2.610920775,0.000443562,diphenoxylate
SELENOAMINO_ACID_METABOLISM,2.530902428,0.000369635,diphenoxylate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.509451609,0.00031683,diphenoxylate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.470466755,0.000415839,diphenoxylate
CELLULAR_RESPONSE_TO_STARVATION,2.283299775,0.003449927,diphenoxylate
SIGNALING_BY_ROBO_RECEPTORS,2.145407923,0.012087065,diphenoxylate
SIGNALING_BY_NTRKS,1.813222229,0.60055618,metformin
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.836421375,1,metformin
COLLAGEN_FORMATION,-1.80683248,1,metformin
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-1.784469403,0.801007604,metformin
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.606824672,0.943908644,metformin
GASTRULATION,-1.751426571,0.748890877,metformin
CELL_CELL_COMMUNICATION,1.514300985,0.987949431,metformin
MUSCLE_CONTRACTION,1.417697093,1,metformin
INTERLEUKIN_17_SIGNALING,1.31455166,1,metformin
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.549903025,1,metformin
EUKARYOTIC_TRANSLATION_ELONGATION,-4.162611471,0,diphenylpyraline
HOST_INTERACTIONS_OF_HIV_FACTORS,-2.469529095,0,diphenylpyraline
PCP_CE_PATHWAY,-2.480150818,0,diphenylpyraline
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.513492392,0,diphenylpyraline
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.519758104,0,diphenylpyraline
G1_S_DNA_DAMAGE_CHECKPOINTS,-2.540633691,0,diphenylpyraline
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.016824719,0,diphenylpyraline
SARS_COV_2_INFECTION,-3.042237516,0,diphenylpyraline
SARS_COV_INFECTIONS,-3.074198792,0,diphenylpyraline
METABOLISM_OF_RNA,-3.09452981,0,diphenylpyraline
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.93085098,0.149431617,tizanidine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.907112811,0.084411753,tizanidine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.86023984,0.076997207,tizanidine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.949582565,0.52412163,tizanidine
DISEASES_OF_GLYCOSYLATION,1.815743231,0.073717697,tizanidine
METABOLISM_OF_NUCLEOTIDES,1.801606724,0.065590214,tizanidine
DISEASES_OF_METABOLISM,1.774817627,0.06359399,tizanidine
RRNA_PROCESSING,1.739839509,0.066730913,tizanidine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.738952552,0.05860343,tizanidine
FCERI_MEDIATED_NF_KB_ACTIVATION,-1.846457076,0.626471562,tizanidine
BIOLOGICAL_OXIDATIONS,-2.090105943,0.244466801,ampicillin
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-2.019778267,0.192663122,ampicillin
NEUTROPHIL_DEGRANULATION,-1.790087788,0.47185973,ampicillin
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-1.771194174,0.388236562,ampicillin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.731336339,0.37508192,ampicillin
DEUBIQUITINATION,-1.728150645,0.317030756,ampicillin
UB_SPECIFIC_PROCESSING_PROTEASES,-1.660924491,0.372354535,ampicillin
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.631477234,0.379505605,ampicillin
RAC3_GTPASE_CYCLE,-1.626407866,0.346133947,ampicillin
HEMOSTASIS,-1.601259558,0.350053176,ampicillin
EUKARYOTIC_TRANSLATION_INITIATION,2.857032648,0,diphemanil
TRANSLATION,2.842979976,0,diphemanil
RRNA_PROCESSING,2.683189753,0,diphemanil
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.608966638,0,diphemanil
METABOLISM_OF_RNA,2.439901736,0.002465806,diphemanil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.430328551,0.002311693,diphemanil
RESPIRATORY_ELECTRON_TRANSPORT,2.323707445,0.00528387,diphemanil
CELL_CYCLE_MITOTIC,2.06008831,0.033134271,diphemanil
S_PHASE,1.977099385,0.056508059,diphemanil
MITOTIC_G2_G2_M_PHASES,1.976486816,0.051011366,diphemanil
CHOLESTEROL_BIOSYNTHESIS,3.20677472,0,ketoconazole
METABOLISM_OF_STEROIDS,2.765561061,0.000611797,ketoconazole
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.269907904,0.013459541,ketoconazole
G2_M_DNA_DAMAGE_CHECKPOINT,-2.079975034,0.104555791,ketoconazole
ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,2.042490067,0.039766824,ketoconazole
EXTRACELLULAR_MATRIX_ORGANIZATION,1.999690487,0.039889184,ketoconazole
TRANSLATION,1.882782511,0.064646581,ketoconazole
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.800261369,0.085826421,ketoconazole
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-1.903620826,0.271369804,ketoconazole
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,-1.892426395,0.204042211,ketoconazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.514722096,0,estrone
NONSENSE_MEDIATED_DECAY_NMD,-2.485918512,0.001025959,estrone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.4508754,0.000683973,estrone
SELENOAMINO_ACID_METABOLISM,-2.401552713,0.00051298,estrone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.387263882,0.000410384,estrone
EUKARYOTIC_TRANSLATION_INITIATION,-2.363226267,0.000341986,estrone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.354421992,0.000439697,estrone
CELLULAR_RESPONSE_TO_STARVATION,-2.351745358,0.000384735,estrone
GPCR_LIGAND_BINDING,2.467443815,0.004076087,estrone
SIGNALING_BY_ROBO_RECEPTORS,-2.254797413,0.001481941,estrone
SIGNALING_BY_GPCR,-2.096229307,0.039635178,solifenacin-succinate
GPCR_LIGAND_BINDING,-2.085534491,0.021313256,solifenacin-succinate
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.96096538,0.32921907,solifenacin-succinate
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.885273916,0.244954665,solifenacin-succinate
KERATINIZATION,-1.998495437,0.034400344,solifenacin-succinate
RESPIRATORY_ELECTRON_TRANSPORT,1.802843167,0.249527152,solifenacin-succinate
PI3K_AKT_SIGNALING_IN_CANCER,1.731927482,0.272389588,solifenacin-succinate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.922252558,0.053844016,solifenacin-succinate
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.698664433,0.267294531,solifenacin-succinate
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.895588713,0.057433617,solifenacin-succinate
NONSENSE_MEDIATED_DECAY_NMD,3.19462636,0,levomequitazine
EUKARYOTIC_TRANSLATION_INITIATION,2.995664533,0,levomequitazine
EUKARYOTIC_TRANSLATION_ELONGATION,2.952113078,0,levomequitazine
SELENOAMINO_ACID_METABOLISM,2.916935882,0,levomequitazine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.892684894,0,levomequitazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.872233763,0,levomequitazine
INFLUENZA_INFECTION,2.849759862,0,levomequitazine
CELLULAR_RESPONSE_TO_STARVATION,2.842583785,0,levomequitazine
TRANSLATION,2.612291456,0,levomequitazine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.470985061,0.000961504,levomequitazine
EXTRACELLULAR_MATRIX_ORGANIZATION,3.018294451,0,AT-7519
INTERFERON_ALPHA_BETA_SIGNALING,2.756088002,0,AT-7519
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.354400299,0.004991184,AT-7519
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.314466993,0.005444928,AT-7519
METABOLISM_OF_RNA,-2.196486823,0.032337218,AT-7519
M_PHASE,-2.191287106,0.016168609,AT-7519
CELL_CYCLE_MITOTIC,-2.158921751,0.013174422,AT-7519
GLYCOSAMINOGLYCAN_METABOLISM,2.191665113,0.01824051,AT-7519
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.170367061,0.016561657,AT-7519
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.044611669,0.030316142,AT-7519
EUKARYOTIC_TRANSLATION_ELONGATION,4.496240991,0,trametinib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.593033954,0,trametinib
INFECTIOUS_DISEASE,2.663836812,0,trametinib
VIRAL_INFECTION_PATHWAYS,2.753762329,0,trametinib
SARS_COV_2_INFECTION,2.867941483,0,trametinib
NERVOUS_SYSTEM_DEVELOPMENT,2.890715164,0,trametinib
SARS_COV_1_INFECTION,2.954176276,0,trametinib
SARS_COV_2_HOST_INTERACTIONS,2.997934548,0,trametinib
SARS_COV_1_HOST_INTERACTIONS,3.134127728,0,trametinib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.223528925,0,trametinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.010134144,0,tazarotene
CELLULAR_RESPONSE_TO_STARVATION,2.995817388,0,tazarotene
INFLUENZA_INFECTION,2.973585449,0,tazarotene
EUKARYOTIC_TRANSLATION_ELONGATION,2.951538425,0,tazarotene
NONSENSE_MEDIATED_DECAY_NMD,2.908730038,0,tazarotene
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.893761386,0,tazarotene
SELENOAMINO_ACID_METABOLISM,2.875606053,0,tazarotene
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.822962703,0,tazarotene
EUKARYOTIC_TRANSLATION_INITIATION,2.712348472,0,tazarotene
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.579832285,0.00109543,tazarotene
GPCR_LIGAND_BINDING,-1.96902608,0.213083704,sacubitril
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.847776313,0.616164619,sacubitril
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.818403305,0.353167525,sacubitril
GASTRULATION,-1.923927776,0.161391176,sacubitril
INTERLEUKIN_17_SIGNALING,1.761617489,0.297705553,sacubitril
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.885451967,0.158892046,sacubitril
MITOTIC_PROPHASE,1.67225738,0.352630797,sacubitril
MYD88_INDEPENDENT_TLR4_CASCADE,1.655609965,0.259418902,sacubitril
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.655691699,0.311302682,sacubitril
TOLL_LIKE_RECEPTOR_CASCADES,1.60076287,0.293820659,sacubitril
MITF_M_DEPENDENT_GENE_EXPRESSION,1.964214531,0.078037904,piclamilast
HOST_INTERACTIONS_OF_HIV_FACTORS,-1.983363309,0.278612935,piclamilast
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.933756644,0.214899124,piclamilast
APOPTOSIS,-1.933437268,0.143626048,piclamilast
SIGNALING_BY_ALK_IN_CANCER,1.635067867,0.276134122,piclamilast
G_ALPHA_I_SIGNALLING_EVENTS,-1.810019322,0.301020758,piclamilast
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.562187121,0.267129749,piclamilast
PROGRAMMED_CELL_DEATH,-1.770960712,0.33260769,piclamilast
MITOTIC_G2_G2_M_PHASES,-1.753378342,0.319828931,piclamilast
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.722938304,0.346183514,piclamilast
HIV_INFECTION,-2.398769638,0.002344524,doxapram
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.271721912,0.01230875,doxapram
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.25153718,0.011331865,doxapram
METABOLISM_OF_RNA,-2.216136122,0.012601815,doxapram
PROTEASOME_ASSEMBLY,-2.212070327,0.010784809,doxapram
SIGNALING_BY_GPCR,2.213287994,0.026172053,doxapram
HOST_INTERACTIONS_OF_HIV_FACTORS,-2.132742914,0.022859106,doxapram
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,-2.1100232,0.024282567,doxapram
S_PHASE,-2.095648,0.023005639,doxapram
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,-2.088509197,0.022012473,doxapram
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2.138545301,0.055856088,bisphenol-a
SARS_COV_1_INFECTION,-1.893868092,0.421520237,bisphenol-a
DNA_REPAIR,-1.846919879,0.281449848,bisphenol-a
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.7531731,0.30632216,bisphenol-a
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.726353975,0.269668226,bisphenol-a
SENSORY_PERCEPTION,1.926597191,0.183207967,bisphenol-a
METABOLISM_OF_RNA,-1.690012652,0.255006653,bisphenol-a
GABA_RECEPTOR_ACTIVATION,1.837094273,0.247008032,bisphenol-a
NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,1.834455443,0.189352137,bisphenol-a
PROTEIN_LOCALIZATION,-1.563726811,0.419338455,bisphenol-a
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,5.038655428,0,CCT-018159
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.8855702,0,CCT-018159
NEURONAL_SYSTEM,-3.027180805,0,CCT-018159
SIGNALING_BY_GPCR,-3.15873159,0,CCT-018159
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.195071791,0,CCT-018159
SARS_COV_INFECTIONS,3.325013864,0,CCT-018159
GPCR_LIGAND_BINDING,-3.341748121,0,CCT-018159
SARS_COV_2_INFECTION,3.358267645,0,CCT-018159
SARS_COV_2_HOST_INTERACTIONS,3.566729703,0,CCT-018159
CELLULAR_RESPONSES_TO_STIMULI,3.785654755,0,CCT-018159
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,2.183877099,0.054630309,flupentixol
UCH_PROTEINASES,2.146015133,0.044169186,flupentixol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.033368115,0.088725821,flupentixol
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,1.999335891,0.088919546,flupentixol
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1.99073965,0.077877249,flupentixol
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1.969920422,0.079233321,flupentixol
EUKARYOTIC_TRANSLATION_INITIATION,1.958630216,0.076050704,flupentixol
SLC_TRANSPORTER_DISORDERS,-1.824058541,0.465452516,flupentixol
PTEN_REGULATION,1.88948625,0.118414101,flupentixol
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.883898964,0.109389768,flupentixol
EUKARYOTIC_TRANSLATION_INITIATION,3.675751163,0,ciprofibrate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.900965922,0,ciprofibrate
SIGNALING_BY_ROBO_RECEPTORS,3.03823241,0,ciprofibrate
TRANSLATION,3.256003662,0,ciprofibrate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.258819989,0,ciprofibrate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.265884796,0,ciprofibrate
RRNA_PROCESSING,3.293332438,0,ciprofibrate
SARS_COV_1_HOST_INTERACTIONS,2.964717569,0,ciprofibrate
SELENOAMINO_ACID_METABOLISM,3.334607089,0,ciprofibrate
INFLUENZA_INFECTION,3.381220044,0,ciprofibrate
GPCR_LIGAND_BINDING,2.433070229,0.001420995,cinacalcet
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.409618492,0.000710498,cinacalcet
SENSORY_PERCEPTION,2.341810554,0.001420995,cinacalcet
SIGNALING_BY_GPCR,2.339458687,0.001065746,cinacalcet
NEUTROPHIL_DEGRANULATION,-2.520737127,0.01819357,cinacalcet
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.496454954,0.010916142,cinacalcet
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.265486453,0.027896807,cinacalcet
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.102776797,0.065496852,cinacalcet
G_ALPHA_Q_SIGNALLING_EVENTS,2.021590144,0.024867416,cinacalcet
HIV_INFECTION,-2.008945133,0.094970435,cinacalcet
TRANSLATION,3.411314093,0,sulfacetamide
RESPIRATORY_ELECTRON_TRANSPORT,2.670118288,0.001599573,sulfacetamide
RRNA_PROCESSING,2.382251788,0.00462099,sulfacetamide
UB_SPECIFIC_PROCESSING_PROTEASES,-2.162937491,0.033199987,sulfacetamide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.18504907,0.011996801,sulfacetamide
RHO_GTPASE_CYCLE,-2.02844567,0.093741141,sulfacetamide
RHOG_GTPASE_CYCLE,-1.923592652,0.165999937,sulfacetamide
DEUBIQUITINATION,-1.903109325,0.152817589,sulfacetamide
RHOA_GTPASE_CYCLE,-1.854460463,0.183966989,sulfacetamide
RAC1_GTPASE_CYCLE,-1.835425134,0.176090129,sulfacetamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.133679888,0,econazole
GPCR_LIGAND_BINDING,-2.554491574,0,econazole
INFLUENZA_INFECTION,3.118830733,0,econazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.183843136,0,econazole
SIGNALING_BY_ROBO_RECEPTORS,3.401171837,0,econazole
TRANSLATION,3.413813404,0,econazole
EUKARYOTIC_TRANSLATION_INITIATION,3.712162712,0,econazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.383275543,0,econazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.760738016,0,econazole
NONSENSE_MEDIATED_DECAY_NMD,3.866871164,0,econazole
TRANSLATION,3.510516709,0,amperozide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.562476959,0,amperozide
SARS_COV_1_INFECTION,2.620819038,0,amperozide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.658011894,0,amperozide
SIGNALING_BY_ROBO_RECEPTORS,2.733621677,0,amperozide
SARS_COV_1_HOST_INTERACTIONS,2.759493918,0,amperozide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.79032064,0,amperozide
INFLUENZA_INFECTION,2.9503985,0,amperozide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.848143945,0,amperozide
CELLULAR_RESPONSE_TO_STARVATION,3.079151003,0,amperozide
TRANSLATION,3.181380904,0,cortisone-acetate
RRNA_PROCESSING,2.304109091,0.001280127,cortisone-acetate
RESPIRATORY_ELECTRON_TRANSPORT,2.052596497,0.020055325,cortisone-acetate
CILIUM_ASSEMBLY,-2.072368393,0.073696178,cortisone-acetate
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.840964054,0.415025842,cortisone-acetate
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.544203641,0.297949589,cortisone-acetate
EXTRACELLULAR_MATRIX_ORGANIZATION,1.507488033,0.289564757,cortisone-acetate
CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE,-1.793149395,0.422460106,cortisone-acetate
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.404932062,0.39022542,cortisone-acetate
COLLAGEN_FORMATION,1.402959746,0.337587812,cortisone-acetate
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.238267139,0,doxazosin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.447860137,0,doxazosin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.523910256,0,doxazosin
SIGNALING_BY_ROBO_RECEPTORS,-2.536028376,0,doxazosin
INFLUENZA_INFECTION,-2.553003209,0,doxazosin
RRNA_PROCESSING,-2.644479179,0,doxazosin
CELLULAR_RESPONSE_TO_STARVATION,-2.679294115,0,doxazosin
SARS_COV_1_INFECTION,-2.79114181,0,doxazosin
EUKARYOTIC_TRANSLATION_INITIATION,-2.818906325,0,doxazosin
SARS_COV_2_HOST_INTERACTIONS,-2.564658995,0,doxazosin
GPCR_LIGAND_BINDING,-2.226266014,0.044702293,aminosalicylic-acid
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.194232069,0.032284989,aminosalicylic-acid
REGULATION_OF_TP53_ACTIVITY,2.016606505,0.277636389,aminosalicylic-acid
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.96025452,0.144040721,aminosalicylic-acid
TCR_SIGNALING,1.850556637,0.395631854,aminosalicylic-acid
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.811955218,0.336402758,aminosalicylic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.821360206,0.290150992,aminosalicylic-acid
DOWNSTREAM_TCR_SIGNALING,1.713021478,0.424089584,aminosalicylic-acid
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.667331906,0.443662949,aminosalicylic-acid
SIGNALING_BY_ALK_IN_CANCER,1.627495807,0.456943223,aminosalicylic-acid
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.418719955,0.009464156,itopride
NEURONAL_SYSTEM,2.158797817,0.054812604,itopride
MUSCLE_CONTRACTION,2.144371631,0.031321488,itopride
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.098227029,0.034801653,itopride
EUKARYOTIC_TRANSLATION_INITIATION,2.089436098,0.029363895,itopride
DISEASES_OF_METABOLISM,2.068465343,0.028537356,itopride
RESPIRATORY_ELECTRON_TRANSPORT,2.042096187,0.03074146,itopride
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.062160872,0.15024347,itopride
MITOTIC_SPINDLE_CHECKPOINT,-2.046460144,0.111203828,itopride
CELL_CYCLE_CHECKPOINTS,-2.00718914,0.110316563,itopride
NEUTROPHIL_DEGRANULATION,-3.659209595,0,vatalanib
INNATE_IMMUNE_SYSTEM,-2.356568067,0.005639098,vatalanib
SIGNALING_BY_FGFR,-2.198839763,0.02443609,vatalanib
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-2.049172942,0.060620301,vatalanib
GPCR_LIGAND_BINDING,2.013026408,0.166233867,vatalanib
NEURONAL_SYSTEM,1.968709745,0.127931133,vatalanib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.854864978,0.162406015,vatalanib
G_ALPHA_S_SIGNALLING_EVENTS,1.934834307,0.11592961,vatalanib
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.781848375,0.197368421,vatalanib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.6872224,0.275510204,vatalanib
EUKARYOTIC_TRANSLATION_ELONGATION,3.049662624,0,quinidine
SELENOAMINO_ACID_METABOLISM,3.028171207,0,quinidine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.823490516,0,quinidine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.6445819,0.000149937,quinidine
EUKARYOTIC_TRANSLATION_INITIATION,2.606561866,0.000239899,quinidine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.52073533,0.000399832,quinidine
CELLULAR_RESPONSE_TO_STARVATION,2.467319834,0.000771105,quinidine
NONSENSE_MEDIATED_DECAY_NMD,2.238557812,0.003073709,quinidine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.091523983,0.099677842,quinidine
KERATINIZATION,-2.091523983,0.099677842,quinidine
ADAPTIVE_IMMUNE_SYSTEM,2.441227631,0.004434262,aspirin
GPCR_LIGAND_BINDING,-2.217275848,0.008822071,aspirin
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,2.123720992,0.026605572,aspirin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.177041928,0.007351726,aspirin
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.946411271,0.062079669,aspirin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.890459557,0.073165324,aspirin
HOST_INTERACTIONS_OF_HIV_FACTORS,1.875650178,0.066513931,aspirin
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.870946167,0.057645407,aspirin
SIGNALING_BY_GPCR,-2.014975521,0.032347594,aspirin
NEDDYLATION,1.7489389,0.112123484,aspirin
EUKARYOTIC_TRANSLATION_INITIATION,4.181613364,0,BRD-K98297262
SARS_COV_1_HOST_INTERACTIONS,2.581449776,0,BRD-K98297262
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.65588048,0,BRD-K98297262
METABOLISM_OF_RNA,2.738074493,0,BRD-K98297262
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.739455302,0,BRD-K98297262
SARS_COV_1_INFECTION,2.851965423,0,BRD-K98297262
CELLULAR_RESPONSE_TO_STARVATION,2.980785345,0,BRD-K98297262
RESPIRATORY_ELECTRON_TRANSPORT,3.143904308,0,BRD-K98297262
INFLUENZA_INFECTION,2.886315207,0,BRD-K98297262
RRNA_PROCESSING,3.305051583,0,BRD-K98297262
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.556680506,0.000533153,candesartan
GPCR_LIGAND_BINDING,-2.520881099,0.000533153,candesartan
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.248162777,0.005864684,candesartan
SIGNALING_BY_GPCR,-2.218752571,0.006264549,candesartan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.198208075,0.006504468,candesartan
G_ALPHA_Q_SIGNALLING_EVENTS,-2.142432816,0.009063603,candesartan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.073699699,0.01401431,candesartan
CIRCADIAN_CLOCK,1.941912105,0.778066726,candesartan
TCR_SIGNALING,1.919101632,0.446270455,candesartan
INFLUENZA_INFECTION,1.910478145,0.308841811,candesartan
NEUTROPHIL_DEGRANULATION,-3.169552274,0,butenafine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.451527916,0.001568787,butenafine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.131808629,0.029414748,butenafine
GPCR_LIGAND_BINDING,2.121787599,0.021963012,butenafine
HOMOLOGY_DIRECTED_REPAIR,2.041188083,0.039415762,butenafine
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.988131878,0.050514927,butenafine
INNATE_IMMUNE_SYSTEM,-1.898786062,0.297153477,butenafine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.853463958,0.264677688,butenafine
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1.891983322,0.097003302,butenafine
SIGNALING_BY_GPCR,1.85570403,0.109366834,butenafine
GPCR_LIGAND_BINDING,-2.166180682,0.012266449,palonosetron
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.114752064,0.188617621,palonosetron
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.087715816,0.11586511,palonosetron
SIGNALING_BY_GPCR,-2.089535928,0.01601453,palonosetron
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.067041707,0.0140837,palonosetron
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.797241454,0.271250102,palonosetron
CELLULAR_RESPONSE_TO_STARVATION,1.779822855,0.22095207,palonosetron
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.963584614,0.034754938,palonosetron
UB_SPECIFIC_PROCESSING_PROTEASES,1.748083365,0.224185515,palonosetron
NEDDYLATION,1.713930359,0.216461174,palonosetron
EUKARYOTIC_TRANSLATION_INITIATION,1.964810001,0.416700416,dyclonine
RAC3_GTPASE_CYCLE,-1.915772158,0.633617631,dyclonine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.803686282,0.594779422,dyclonine
RRNA_PROCESSING,1.818809463,0.665300095,dyclonine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.817673732,0.447637265,dyclonine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.741553637,0.558530428,dyclonine
CELLULAR_RESPONSE_TO_STARVATION,1.735758279,0.590720191,dyclonine
TRANSLATION,1.724281227,0.505343959,dyclonine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-1.610177572,0.805337996,dyclonine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.708608381,0.465631146,dyclonine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.562476335,0,zaleplon
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.542433693,0,zaleplon
ECM_PROTEOGLYCANS,-2.094665565,0.049532989,zaleplon
GASTRULATION,-1.775704068,0.400652909,zaleplon
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.657573889,1,zaleplon
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,-1.659116875,0.654964051,zaleplon
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.64775707,0.581228868,zaleplon
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.541697898,1,zaleplon
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.540316323,1,zaleplon
SIGNALING_BY_NTRKS,1.529131271,1,zaleplon
RESPIRATORY_ELECTRON_TRANSPORT,-3.516998366,0,regorafenib
RRNA_PROCESSING,-2.767352196,0,regorafenib
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,-2.772276965,0,regorafenib
CELLULAR_RESPONSE_TO_HYPOXIA,-2.78333031,0,regorafenib
DNA_REPLICATION_PRE_INITIATION,-2.791057169,0,regorafenib
ORC1_REMOVAL_FROM_CHROMATIN,-2.839064206,0,regorafenib
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,-2.847300107,0,regorafenib
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,-2.811529696,0,regorafenib
PROTEASOME_ASSEMBLY,-2.927655413,0,regorafenib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.938544256,0,regorafenib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.177037821,0.152319423,fulvestrant
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.152121131,0.060089314,fulvestrant
KERATINIZATION,-2.152121131,0.060089314,fulvestrant
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,-2.017075902,0.11493828,fulvestrant
MITOTIC_G2_G2_M_PHASES,-2.000688758,0.102291576,fulvestrant
DEVELOPMENTAL_CELL_LINEAGES,-2.00045345,0.085475884,fulvestrant
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.915720309,0.124969802,fulvestrant
FATTY_ACID_METABOLISM,-1.859079151,0.155114275,fulvestrant
CILIUM_ASSEMBLY,-1.843730074,0.149679841,fulvestrant
REGULATION_OF_INSULIN_SECRETION,-1.840861227,0.137087481,fulvestrant
GPCR_LIGAND_BINDING,-2.610878575,0,SR-27897
G_ALPHA_Q_SIGNALLING_EVENTS,-2.425634775,0,SR-27897
SIGNALING_BY_GPCR,-2.401873464,0,SR-27897
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.38194677,0.000168759,SR-27897
G_ALPHA_I_SIGNALLING_EVENTS,-2.265096873,0.000675037,SR-27897
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.219750509,0.001125062,SR-27897
G_ALPHA_S_SIGNALLING_EVENTS,-2.15403554,0.002410847,SR-27897
GASTRULATION,-2.134958091,0.00236263,SR-27897
SENSORY_PERCEPTION,-2.090907243,0.00382521,SR-27897
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.075540413,0.161949514,SR-27897
NEDDYLATION,2.230712198,0.037252056,CP-945598
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.996430925,0.082970489,CP-945598
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.015053057,0.090917982,CP-945598
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.998448171,0.052421179,CP-945598
GPCR_LIGAND_BINDING,-1.979056325,0.043684316,CP-945598
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.785134351,0.163683277,CP-945598
CDC42_GTPASE_CYCLE,1.718525412,0.180333817,CP-945598
HIV_INFECTION,1.698747209,0.158490566,CP-945598
SIGNALING_BY_GPCR,-1.929875732,0.055492732,CP-945598
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.661301148,0.164247702,CP-945598
EUKARYOTIC_TRANSLATION_ELONGATION,-3.46859261,0,colchicine
VIRAL_INFECTION_PATHWAYS,-2.54351045,0,colchicine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.566829902,0,colchicine
NERVOUS_SYSTEM_DEVELOPMENT,-2.615430576,0,colchicine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.617500154,0,colchicine
SARS_COV_1_INFECTION,-2.650742498,0,colchicine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.652150595,0,colchicine
SARS_COV_1_HOST_INTERACTIONS,-2.663188178,0,colchicine
SIGNALING_BY_ROBO_RECEPTORS,-2.908697507,0,colchicine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.043299925,0,colchicine
METABOLISM_OF_RNA,-2.699422202,0,brequinar
GASTRULATION,-2.480863712,0.00056182,brequinar
RESPIRATORY_ELECTRON_TRANSPORT,2.345862597,0.026172086,brequinar
CIRCADIAN_CLOCK,-2.317760754,0.004494558,brequinar
M_PHASE,-2.311996105,0.003370918,brequinar
NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,-2.267885424,0.004494558,brequinar
SIGNALING_BY_NOTCH4,-2.232018647,0.00580547,brequinar
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,-2.230532976,0.004976117,brequinar
DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,-2.212462888,0.005337287,brequinar
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,-2.197527477,0.005493348,brequinar
FATTY_ACID_METABOLISM,1.736000473,0.379876602,theobromine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.436488367,0.800142383,theobromine
BIOLOGICAL_OXIDATIONS,1.406928672,0.61347888,theobromine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.400721246,0.474845752,theobromine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.742216502,0.93984358,theobromine
INTERFERON_SIGNALING,-1.740495548,0.477761506,theobromine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.381724964,0.412187945,theobromine
P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,1.334562393,0.432637241,theobromine
RHO_GTPASE_CYCLE,1.298484891,0.434144688,theobromine
GPCR_LIGAND_BINDING,-1.694833581,0.492211178,theobromine
INFLUENZA_INFECTION,2.980654779,0,ORE-1001
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.952318268,0,ORE-1001
NONSENSE_MEDIATED_DECAY_NMD,2.806945431,0,ORE-1001
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.721904476,0.000610703,ORE-1001
METABOLISM_OF_RNA,2.614964677,0.001954249,ORE-1001
TRANSLATION,2.514348452,0.001628541,ORE-1001
EUKARYOTIC_TRANSLATION_INITIATION,2.503322489,0.002093838,ORE-1001
GPCR_LIGAND_BINDING,-2.249581143,0.007773636,ORE-1001
CELLULAR_RESPONSE_TO_STARVATION,2.325633953,0.005496324,ORE-1001
SIGNALING_BY_ROBO_RECEPTORS,2.26408869,0.007871279,ORE-1001
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.502623547,0.00064044,BRD-K57044355
GPCR_LIGAND_BINDING,2.491835448,0.00032022,BRD-K57044355
SIGNALING_BY_GPCR,2.283143736,0.003842639,BRD-K57044355
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.194756865,0.007044837,BRD-K57044355
NEUTROPHIL_DEGRANULATION,-2.210650943,0.119657646,BRD-K57044355
TOLL_LIKE_RECEPTOR_CASCADES,-2.188731663,0.07852533,BRD-K57044355
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.12906015,0.082264632,BRD-K57044355
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-2.124917561,0.061698474,BRD-K57044355
MRNA_SPLICING,-1.981480823,0.111181896,BRD-K57044355
INNATE_IMMUNE_SYSTEM,-1.967811999,0.100545661,BRD-K57044355
METABOLISM_OF_RNA,2.678704687,0,cinnarizine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.39582665,0.001218302,cinnarizine
MRNA_SPLICING,2.362142874,0.000812201,cinnarizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.104248983,0.017983903,cinnarizine
GPCR_LIGAND_BINDING,-1.965363632,0.054850905,cinnarizine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.865508423,0.107303955,cinnarizine
M_PHASE,1.60096374,0.209547875,cinnarizine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.814473117,0.132181688,cinnarizine
RHOA_GTPASE_CYCLE,1.482879632,0.293854345,cinnarizine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.805215649,0.117614727,cinnarizine
SENSORY_PERCEPTION,-2.319462851,0.005741993,midostaurin
GPCR_LIGAND_BINDING,-2.247181858,0.009091489,midostaurin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.129514705,0.023286972,midostaurin
RESPIRATORY_ELECTRON_TRANSPORT,1.963002704,0.162243454,midostaurin
SIGNALING_BY_GPCR,-2.071302717,0.032298711,midostaurin
INTERLEUKIN_17_SIGNALING,1.84241756,0.165958953,midostaurin
POTASSIUM_CHANNELS,-1.957510286,0.068329718,midostaurin
EPH_EPHRIN_SIGNALING,-1.825486891,0.17497129,midostaurin
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.5805195,0.49044586,midostaurin
G_ALPHA_Q_SIGNALLING_EVENTS,-1.782901086,0.21163346,midostaurin
EUKARYOTIC_TRANSLATION_ELONGATION,2.534698351,0.001124154,ranitidine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.493847947,0.000562077,ranitidine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.46968704,0.000749436,ranitidine
EUKARYOTIC_TRANSLATION_INITIATION,2.41739336,0.000843115,ranitidine
NONSENSE_MEDIATED_DECAY_NMD,2.412580711,0.000674492,ranitidine
RRNA_PROCESSING,2.40782831,0.000749436,ranitidine
TRANSLATION,2.339610442,0.001445341,ranitidine
SELENOAMINO_ACID_METABOLISM,2.273019486,0.003512981,ranitidine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.231662081,0.005246052,ranitidine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.217565867,0.005733185,ranitidine
EUKARYOTIC_TRANSLATION_ELONGATION,5.641210178,0,sapropterin
SARS_COV_INFECTIONS,3.128669426,0,sapropterin
SARS_COV_2_INFECTION,3.445048268,0,sapropterin
SARS_COV_2_HOST_INTERACTIONS,3.45622133,0,sapropterin
MRNA_SPLICING,3.477559626,0,sapropterin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.52493051,0,sapropterin
INFECTIOUS_DISEASE,3.528251544,0,sapropterin
VIRAL_INFECTION_PATHWAYS,3.862071145,0,sapropterin
CELLULAR_RESPONSES_TO_STIMULI,3.915214885,0,sapropterin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,4.085046802,0,sapropterin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.694304291,0,orphenadrine
METABOLISM_OF_RNA,2.706403287,0,orphenadrine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.145835833,0,orphenadrine
RRNA_PROCESSING,3.259831152,0,orphenadrine
SIGNALING_BY_ROBO_RECEPTORS,3.589674412,0,orphenadrine
CELLULAR_RESPONSE_TO_STARVATION,3.956718604,0,orphenadrine
SELENOAMINO_ACID_METABOLISM,4.163790928,0,orphenadrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,4.045111414,0,orphenadrine
EUKARYOTIC_TRANSLATION_INITIATION,4.330968712,0,orphenadrine
NONSENSE_MEDIATED_DECAY_NMD,4.330987655,0,orphenadrine
EUKARYOTIC_TRANSLATION_ELONGATION,3.158252843,0,BRD-K55591206
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.821765859,0,BRD-K55591206
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.943462984,0,BRD-K55591206
SELENOAMINO_ACID_METABOLISM,2.960497461,0,BRD-K55591206
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.62204691,0,BRD-K55591206
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.014222432,0,BRD-K55591206
NONSENSE_MEDIATED_DECAY_NMD,3.060477503,0,BRD-K55591206
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.065407865,0,BRD-K55591206
CELLULAR_RESPONSE_TO_STARVATION,2.960552625,0,BRD-K55591206
SIGNALING_BY_ROBO_RECEPTORS,2.71999195,0.000102006,BRD-K55591206
GPCR_LIGAND_BINDING,3.571397318,0,acitretin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.264404241,0,acitretin
SIGNALING_BY_GPCR,3.13077932,0,acitretin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.591197974,0.000107568,acitretin
G_ALPHA_I_SIGNALLING_EVENTS,2.465135194,0.000344218,acitretin
G_ALPHA_Q_SIGNALLING_EVENTS,2.186674878,0.00430272,acitretin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.294417965,0.161027514,acitretin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.141640645,0.005655004,acitretin
M_PHASE,-2.200844788,0.138273626,acitretin
PROTEIN_LOCALIZATION,-2.133718034,0.147608554,acitretin
GPCR_LIGAND_BINDING,-3.2468221,0,mephentermine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.925760195,0,mephentermine
TRANSLATION,-2.790152595,0,mephentermine
G_ALPHA_Q_SIGNALLING_EVENTS,-2.762283552,0,mephentermine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.748290449,0,mephentermine
SIGNALING_BY_GPCR,-2.675228566,0,mephentermine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.653037258,0,mephentermine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.602100157,0,mephentermine
EUKARYOTIC_TRANSLATION_INITIATION,-2.574631967,0,mephentermine
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2.643740228,0.001417678,mephentermine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.009507303,0.281863571,brompheniramine
EUKARYOTIC_TRANSLATION_INITIATION,2.001832055,0.30610793,brompheniramine
EUKARYOTIC_TRANSLATION_ELONGATION,1.993779882,0.161875519,brompheniramine
CELLULAR_RESPONSE_TO_STARVATION,1.972570256,0.127618484,brompheniramine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.848943004,0.379988973,brompheniramine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.945514977,0.12328122,brompheniramine
SELENOAMINO_ACID_METABOLISM,1.927006983,0.113268756,brompheniramine
ESR_MEDIATED_SIGNALING,-1.773130435,0.397331046,brompheniramine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.880572728,0.139527582,brompheniramine
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.755405823,0.325987074,brompheniramine
NONSENSE_MEDIATED_DECAY_NMD,2.379442094,0.014637129,quinapril
EUKARYOTIC_TRANSLATION_INITIATION,2.370260524,0.007983888,quinapril
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.291708965,0.023057081,quinapril
SELENOAMINO_ACID_METABOLISM,2.250392439,0.017298425,quinapril
EUKARYOTIC_TRANSLATION_ELONGATION,2.232165423,0.015635115,quinapril
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.200251073,0.016500036,quinapril
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.180594783,0.025692176,quinapril
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.185553577,0.016189551,quinapril
GPCR_LIGAND_BINDING,-2.160644872,0.01932403,quinapril
SARS_COV_1_INFECTION,2.058821154,0.034786942,quinapril
CILIUM_ASSEMBLY,-2.67832276,0.00115304,pramipexole
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.072543582,0.127987421,pramipexole
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-2.065981297,0.090321454,pramipexole
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-2.004398533,0.094837526,pramipexole
SENSORY_PERCEPTION,1.987764874,0.263964687,pramipexole
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-1.878160169,0.173647799,pramipexole
ESR_MEDIATED_SIGNALING,-1.870385724,0.152969951,pramipexole
GPCR_LIGAND_BINDING,1.868347176,0.346508828,pramipexole
NEUTROPHIL_DEGRANULATION,-1.780183551,0.219901168,pramipexole
RESPIRATORY_ELECTRON_TRANSPORT,1.795682991,0.381086142,pramipexole
BIOLOGICAL_OXIDATIONS,-2.237085747,0.067372497,hycanthone
DRUG_ADME,-2.06254942,0.103962732,hycanthone
EUKARYOTIC_TRANSLATION_INITIATION,1.928963585,0.525433826,hycanthone
NONSENSE_MEDIATED_DECAY_NMD,1.897026655,0.32896332,hycanthone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.834166617,0.335700889,hycanthone
INNATE_IMMUNE_SYSTEM,-1.820862224,0.272393974,hycanthone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.765197287,0.300388408,hycanthone
NEUTROPHIL_DEGRANULATION,-1.703069825,0.3556416,hycanthone
PROTEIN_FOLDING,1.748802185,0.656414164,hycanthone
EUKARYOTIC_TRANSLATION_ELONGATION,1.747751116,0.495713692,hycanthone
SELENOAMINO_ACID_METABOLISM,2.56802993,0.002279966,nimesulide
GPCR_LIGAND_BINDING,-2.371137184,0.006405694,nimesulide
NONSENSE_MEDIATED_DECAY_NMD,2.32574301,0.013679799,nimesulide
GASTRULATION,-2.268830394,0.014184037,nimesulide
CELLULAR_RESPONSE_TO_STARVATION,2.259040972,0.01633976,nimesulide
SIGNALING_BY_ALK_IN_CANCER,2.053272255,0.066974015,nimesulide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.006160308,0.096390442,nimesulide
INFLUENZA_INFECTION,1.968579607,0.090286672,nimesulide
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.895871024,0.122548198,nimesulide
PEROXISOMAL_PROTEIN_IMPORT,1.845397651,0.142497904,nimesulide
EUKARYOTIC_TRANSLATION_ELONGATION,2.9034972,0,cerivastatin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.789443247,0,cerivastatin
EUKARYOTIC_TRANSLATION_INITIATION,2.748212858,0,cerivastatin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.712037025,0,cerivastatin
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-2.622412702,0,cerivastatin
DISEASES_OF_DNA_REPAIR,-2.425342167,0.001355626,cerivastatin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.504884964,0.002283757,cerivastatin
TRANSLATION,2.359690146,0.006280331,cerivastatin
RESPIRATORY_ELECTRON_TRANSPORT,2.326506197,0.006035643,cerivastatin
HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,-2.189379282,0.017773761,cerivastatin
EUKARYOTIC_TRANSLATION_ELONGATION,-3.674844783,0,folic-acid
G_ALPHA_Q_SIGNALLING_EVENTS,-2.527970189,0,folic-acid
SIGNALING_BY_GPCR,-2.583582171,0,folic-acid
NERVOUS_SYSTEM_DEVELOPMENT,-2.605579306,0,folic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.637649711,0,folic-acid
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.744120883,0,folic-acid
METABOLISM_OF_RNA,-2.811114452,0,folic-acid
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.822917049,0,folic-acid
INFLUENZA_INFECTION,-2.849249847,0,folic-acid
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.906955046,0,folic-acid
TRANSPORT_OF_SMALL_MOLECULES,-2.552635886,0.002452504,lestaurtinib
GASTRULATION,-2.406259675,0.004905007,lestaurtinib
NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,-2.340581551,0.004905007,lestaurtinib
SIGNALING_BY_WNT,-2.338528021,0.003678756,lestaurtinib
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,-2.327809409,0.003188255,lestaurtinib
REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC,-2.312721745,0.00297804,lestaurtinib
METABOLISM_OF_POLYAMINES,-2.312721745,0.00297804,lestaurtinib
SIGNALING_BY_NOTCH4,-2.300114961,0.002912348,lestaurtinib
ORC1_REMOVAL_FROM_CHROMATIN,-2.298042133,0.002588754,lestaurtinib
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-2.279122787,0.002820379,lestaurtinib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.784846336,0,dicoumarol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.638948439,0.000576131,dicoumarol
COLLAGEN_DEGRADATION,-2.385336042,0.005377221,dicoumarol
S_PHASE,-2.380669881,0.004032916,dicoumarol
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.276845788,0.029790219,dicoumarol
SELENOAMINO_ACID_METABOLISM,2.250648245,0.020311513,dicoumarol
EUKARYOTIC_TRANSLATION_ELONGATION,2.177814575,0.028285662,dicoumarol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.070237796,0.047844896,dicoumarol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.068255596,0.038456464,dicoumarol
CELLULAR_RESPONSE_TO_STARVATION,2.060841781,0.034604799,dicoumarol
CELLULAR_RESPONSE_TO_STARVATION,2.354958553,0.009962212,niacin
RAB_REGULATION_OF_TRAFFICKING,1.954662644,0.07272415,niacin
ECM_PROTEOGLYCANS,-2.037820842,0.316848,niacin
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.01354351,0.196944904,niacin
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.735558383,0.159174014,niacin
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.871439959,0.39063452,niacin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.839795891,0.37218789,niacin
NEUTROPHIL_DEGRANULATION,1.604609143,0.237598763,niacin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.604402265,0.19034467,niacin
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.781568885,0.459646619,niacin
CELL_CYCLE_MITOTIC,-2.052151452,0.299280149,nelarabine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.959023425,0.298175794,nelarabine
MITOTIC_METAPHASE_AND_ANAPHASE,-1.942679123,0.220502841,nelarabine
MITOCHONDRIAL_BIOGENESIS,1.895243632,0.502219323,nelarabine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.825136142,0.379167246,nelarabine
RNA_POLYMERASE_II_TRANSCRIPTION,1.823625352,0.255002834,nelarabine
DNA_REPLICATION,-1.87124858,0.278021319,nelarabine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.860572377,0.242074571,nelarabine
CELL_CYCLE,-1.851150461,0.217557894,nelarabine
S_PHASE,-1.810123635,0.247059944,nelarabine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.112113386,0,avanafil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.654154906,0,avanafil
MRNA_SPLICING,2.668189624,0,avanafil
VIRAL_INFECTION_PATHWAYS,2.802903894,0,avanafil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.914167295,0,avanafil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.929937769,0,avanafil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.080185841,0,avanafil
RRNA_PROCESSING,3.234632836,0,avanafil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.379829528,0,avanafil
TRANSLATION,3.483416083,0,avanafil
CILIUM_ASSEMBLY,2.359857619,0.004809454,rivastigmine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.229552949,0.024047272,rivastigmine
SELENOAMINO_ACID_METABOLISM,2.143609106,0.038876422,rivastigmine
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,2.130567259,0.033064998,rivastigmine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.122429348,0.029097199,rivastigmine
EUKARYOTIC_TRANSLATION_ELONGATION,2.103541613,0.028455938,rivastigmine
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,2.10149304,0.024734336,rivastigmine
SIGNALING_BY_ROBO_RECEPTORS,2.094468381,0.022394022,rivastigmine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.075342182,0.024047272,rivastigmine
SARS_COV_1_HOST_INTERACTIONS,2.02846586,0.028528809,rivastigmine
NEUTROPHIL_DEGRANULATION,-2.182306778,0.093097762,zolmitriptan
ECM_PROTEOGLYCANS,2.059335645,0.216427105,zolmitriptan
GPCR_LIGAND_BINDING,2.015775753,0.164972621,zolmitriptan
MEMBRANE_TRAFFICKING,-1.79362555,0.566195524,zolmitriptan
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.770696586,0.432665881,zolmitriptan
FCERI_MEDIATED_NF_KB_ACTIVATION,-1.713835052,0.435276796,zolmitriptan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.740582755,0.796748802,zolmitriptan
VESICLE_MEDIATED_TRANSPORT,-1.652487566,0.47193404,zolmitriptan
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.702038086,0.76757358,zolmitriptan
INNATE_IMMUNE_SYSTEM,-1.638120214,0.422669808,zolmitriptan
NEUTROPHIL_DEGRANULATION,-2.82533069,0,bisacodyl
GPCR_LIGAND_BINDING,2.500028042,0,bisacodyl
SIGNALING_BY_GPCR,2.481747293,0.000954252,bisacodyl
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.371228104,0.000954252,bisacodyl
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-2.298033607,0.017798467,bisacodyl
DNA_REPAIR,-2.293982564,0.011865644,bisacodyl
PROTEIN_LOCALIZATION,-2.158176221,0.021135679,bisacodyl
G_ALPHA_I_SIGNALLING_EVENTS,2.017246836,0.05248384,bisacodyl
REGULATION_OF_TP53_ACTIVITY,-1.963331417,0.058289978,bisacodyl
DNA_DOUBLE_STRAND_BREAK_REPAIR,-1.954833612,0.049687386,bisacodyl
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.130099936,0.071674391,clomethiazole
G_ALPHA_I_SIGNALLING_EVENTS,-2.113848851,0.043426248,clomethiazole
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.078808548,0.041318178,clomethiazole
SIGNALING_BY_GPCR,-2.062327308,0.035837195,clomethiazole
GPCR_LIGAND_BINDING,-2.042093573,0.036090164,clomethiazole
RESPIRATORY_ELECTRON_TRANSPORT,1.935654245,0.412882967,clomethiazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.813492916,0.196050539,clomethiazole
G_ALPHA_Q_SIGNALLING_EVENTS,-1.799575296,0.18575111,clomethiazole
NEURONAL_SYSTEM,-1.764956,0.205853066,clomethiazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.590382246,1,clomethiazole
GPCR_LIGAND_BINDING,2.391018098,0.008020533,BRD-K81538844
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.178452614,0.025665704,BRD-K81538844
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.156406247,0.018981927,BRD-K81538844
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.114600473,0.161323773,BRD-K81538844
G_ALPHA_Q_SIGNALLING_EVENTS,2.041816879,0.035490857,BRD-K81538844
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.078125141,0.109939164,BRD-K81538844
PI_METABOLISM,-1.990907565,0.152958837,BRD-K81538844
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-1.957814381,0.137125207,BRD-K81538844
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.957361999,0.109939164,BRD-K81538844
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.951503204,0.094603447,BRD-K81538844
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.323322092,0.010098096,ritonavir
METABOLISM_OF_RNA,2.00684768,0.045441431,ritonavir
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.978720284,0.033660319,ritonavir
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-1.901752384,0.103484436,ritonavir
RSV_HOST_INTERACTIONS,-1.845512328,0.114660755,ritonavir
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.487684662,0.440529429,ritonavir
G_ALPHA_S_SIGNALLING_EVENTS,-1.807963456,0.114246817,ritonavir
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.801778024,0.092929023,ritonavir
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.436079837,0.45542412,ritonavir
GPCR_LIGAND_BINDING,-1.78718111,0.087092501,ritonavir
RAC3_GTPASE_CYCLE,-2.351856069,0.016655292,methotrexate
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.271241264,0.023061173,methotrexate
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.260061263,0.016655292,methotrexate
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.079438259,0.119298325,methotrexate
EUKARYOTIC_TRANSLATION_ELONGATION,2.021331015,0.106134372,methotrexate
EUKARYOTIC_TRANSLATION_INITIATION,1.997276555,0.085017197,methotrexate
ADAPTIVE_IMMUNE_SYSTEM,-1.992089482,0.10857969,methotrexate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,1.969415228,0.079600779,methotrexate
SELENOAMINO_ACID_METABOLISM,1.945409085,0.078325521,methotrexate
INFLUENZA_INFECTION,1.888440811,0.10119789,methotrexate
EUKARYOTIC_TRANSLATION_INITIATION,4.096264123,0,BRD-K60174629
SARS_COV_1_INFECTION,2.899131072,0,BRD-K60174629
SIGNALING_BY_ROBO_RECEPTORS,2.920309292,0,BRD-K60174629
SARS_COV_1_HOST_INTERACTIONS,2.970891561,0,BRD-K60174629
METABOLISM_OF_RNA,3.15217859,0,BRD-K60174629
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.195746734,0,BRD-K60174629
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.279018706,0,BRD-K60174629
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.297952471,0,BRD-K60174629
VIRAL_INFECTION_PATHWAYS,2.812711728,0,BRD-K60174629
CELLULAR_RESPONSE_TO_STARVATION,3.347297774,0,BRD-K60174629
CHROMATIN_ORGANIZATION,-2.7786986,0,BRD-K68202742
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.672543189,0,BRD-K68202742
METABOLISM_OF_RNA,-2.661460155,0,BRD-K68202742
HATS_ACETYLATE_HISTONES,-2.656268483,0,BRD-K68202742
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,-2.52254893,0.000604046,BRD-K68202742
SUMOYLATION,-2.509274837,0.000503371,BRD-K68202742
M_PHASE,-2.448846657,0.001150563,BRD-K68202742
MITOTIC_METAPHASE_AND_ANAPHASE,-2.338511903,0.002265171,BRD-K68202742
CELL_CYCLE,-2.312306169,0.002460927,BRD-K68202742
CELL_CYCLE_MITOTIC,-2.309951106,0.002214834,BRD-K68202742
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.087460997,0.211303376,metaraminol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.956135731,0.249398937,metaraminol
APOPTOSIS,1.900222363,0.761305272,metaraminol
REPRODUCTION,-1.772797408,0.459517118,metaraminol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.738800063,0.418543226,metaraminol
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.707196177,0.401476415,metaraminol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.688107061,0.366733263,metaraminol
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.709066013,1,metaraminol
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.637131,0.416366337,metaraminol
ADAPTIVE_IMMUNE_SYSTEM,-1.601707444,0.433019539,metaraminol
GPCR_LIGAND_BINDING,2.034379001,0.223786066,ibandronic-acid
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,-1.950563507,0.551791769,ibandronic-acid
NEUTROPHIL_DEGRANULATION,-1.861037175,0.452513131,ibandronic-acid
SENSORY_PERCEPTION,1.896025781,0.387284938,ibandronic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.869306752,0.305455119,ibandronic-acid
INFLUENZA_INFECTION,-1.823705127,0.362010505,ibandronic-acid
G_ALPHA_S_SIGNALLING_EVENTS,1.833251667,0.30191827,ibandronic-acid
NEURONAL_SYSTEM,1.830267955,0.247515106,ibandronic-acid
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.765137301,0.364204508,ibandronic-acid
SIGNALING_BY_GPCR,1.775145143,0.303686695,ibandronic-acid
MITF_M_DEPENDENT_GENE_EXPRESSION,-3.037633618,0,BRD-K38310698
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-3.015785603,0,BRD-K38310698
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.957391164,0.264026005,BRD-K38310698
INNATE_IMMUNE_SYSTEM,-1.952231079,0.203903804,BRD-K38310698
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.934427472,0.17806405,BRD-K38310698
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.881729978,0.195461112,BRD-K38310698
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.875781856,0.172654879,BRD-K38310698
SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,-1.730283303,0.304576511,BRD-K38310698
ADAPTIVE_IMMUNE_SYSTEM,-1.720195551,0.283128662,BRD-K38310698
ONCOGENIC_MAPK_SIGNALING,-1.701687187,0.278045991,BRD-K38310698
SENSORY_PERCEPTION,2.001302816,0.174633061,mepenzolate
GPCR_LIGAND_BINDING,1.792534337,0.504963069,mepenzolate
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-1.895622963,1,mepenzolate
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.774556513,1,mepenzolate
KEAP1_NFE2L2_PATHWAY,-1.753784309,1,mepenzolate
SIGNALING_BY_ROBO_RECEPTORS,-1.59407184,1,mepenzolate
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.58275985,1,mepenzolate
NEURONAL_SYSTEM,1.719999544,0.563641648,mepenzolate
CELL_CYCLE_CHECKPOINTS,-1.54588879,1,mepenzolate
DEUBIQUITINATION,-1.544004945,1,mepenzolate
NEURONAL_SYSTEM,2.359308793,0.009601059,doxofylline
MUSCLE_CONTRACTION,2.2254553,0.01776196,doxofylline
PLATELET_HOMEOSTASIS,2.214478195,0.012161342,doxofylline
CELL_CYCLE_MITOTIC,-2.181643719,0.123470662,doxofylline
CELL_CYCLE,-2.17436624,0.06963171,doxofylline
COLLAGEN_FORMATION,-2.105292132,0.085663754,doxofylline
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.045852395,0.104088639,doxofylline
M_PHASE,-2.043111259,0.086716604,doxofylline
CELL_CYCLE_CHECKPOINTS,-2.040955753,0.073460258,doxofylline
POTASSIUM_CHANNELS,2.010511149,0.037924185,doxofylline
GPCR_LIGAND_BINDING,-2.22138384,0.01228703,pelitinib
TP53_REGULATES_METABOLIC_GENES,2.076401901,0.146353858,pelitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.114175969,0.013732563,pelitinib
CELL_CYCLE_CHECKPOINTS,2.019034262,0.102905056,pelitinib
RESPIRATORY_ELECTRON_TRANSPORT,1.884437532,0.135682222,pelitinib
G2_M_CHECKPOINTS,1.838638824,0.11662573,pelitinib
SIGNALING_BY_GPCR,-2.000561726,0.027224204,pelitinib
ADAPTIVE_IMMUNE_SYSTEM,1.813121544,0.117083086,pelitinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.9814121,0.024574061,pelitinib
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.710793082,0.175319726,pelitinib
INFLUENZA_INFECTION,2.323121309,0.031372975,lonafarnib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.188371102,0.044291258,lonafarnib
CELLULAR_RESPONSE_TO_STARVATION,2.010024752,0.07443392,lonafarnib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.998807369,0.059977746,lonafarnib
SIGNALING_BY_ROBO_RECEPTORS,1.9875845,0.051673135,lonafarnib
GPCR_LIGAND_BINDING,-2.025608109,0.202264132,lonafarnib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.019305682,0.106390934,lonafarnib
SIGNALING_BY_GPCR,-2.010177056,0.076320999,lonafarnib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.91273487,0.135314705,lonafarnib
GASTRULATION,-1.912604048,0.108251764,lonafarnib
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.706376876,0,oxypurinol
GPCR_LIGAND_BINDING,-2.478328456,0.000737854,oxypurinol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.31596511,0.002213561,oxypurinol
G_ALPHA_S_SIGNALLING_EVENTS,-2.262026963,0.002459513,oxypurinol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.260119318,0.001844634,oxypurinol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.231197235,0.00191842,oxypurinol
SELENOAMINO_ACID_METABOLISM,-2.21245959,0.002336537,oxypurinol
SENSORY_PERCEPTION,-2.199122399,0.002213561,oxypurinol
NONSENSE_MEDIATED_DECAY_NMD,-2.169161828,0.002490257,oxypurinol
RHO_GTPASE_CYCLE,2.255110276,0.034179688,oxypurinol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.08068116,0,neostigmine
INFLUENZA_INFECTION,-2.589081421,0,neostigmine
RRNA_PROCESSING,-2.665433107,0,neostigmine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.687478556,0,neostigmine
SELENOAMINO_ACID_METABOLISM,-2.709803143,0,neostigmine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.750083392,0,neostigmine
VIRAL_INFECTION_PATHWAYS,-2.654178853,0,neostigmine
SIGNALING_BY_ROBO_RECEPTORS,-2.869411341,0,neostigmine
NONSENSE_MEDIATED_DECAY_NMD,-2.921933569,0,neostigmine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.995822598,0,neostigmine
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.048264635,0.348702438,talazoparib
M_PHASE,-2.031389545,0.199421329,talazoparib
COLLAGEN_FORMATION,-1.98515574,0.195622827,talazoparib
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-1.983110989,0.150135772,talazoparib
PEROXISOMAL_PROTEIN_IMPORT,1.940126486,0.227535961,talazoparib
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.840054481,0.197832991,talazoparib
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.914532755,0.204207441,talazoparib
ECM_PROTEOGLYCANS,-1.902804199,0.184417248,talazoparib
MITOTIC_METAPHASE_AND_ANAPHASE,-1.851567947,0.226282161,talazoparib
DEVELOPMENTAL_CELL_LINEAGES,-1.827788612,0.239732926,talazoparib
SYNTHESIS_OF_DNA,-2.681041805,0.001572309,idelalisib
CELL_CYCLE_MITOTIC,-2.640012753,0.000786154,idelalisib
DNA_REPLICATION,-2.60714365,0.001048206,idelalisib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.541160472,0.001965386,idelalisib
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,-2.484121748,0.001310257,idelalisib
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-2.484121748,0.001310257,idelalisib
MITOTIC_G2_G2_M_PHASES,-2.452289268,0.001347693,idelalisib
S_PHASE,-2.446904203,0.001179232,idelalisib
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.410479954,0.001921711,idelalisib
CLEC7A_DECTIN_1_SIGNALING,-2.404447444,0.002044002,idelalisib
CELL_CYCLE_MITOTIC,-1.993191801,0.263019632,vilazodone
RAB_REGULATION_OF_TRAFFICKING,1.888676534,0.191704086,vilazodone
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.835868581,0.131952163,vilazodone
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.908342163,0.288881394,vilazodone
CELL_CYCLE,-1.880963626,0.240642787,vilazodone
NEUTROPHIL_DEGRANULATION,1.749955554,0.146060256,vilazodone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.837721602,0.259993255,vilazodone
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-1.766731597,0.382093791,vilazodone
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.765221687,0.322996911,vilazodone
MITOTIC_PROMETAPHASE,-1.751395623,0.311913299,vilazodone
METABOLISM_OF_RNA,2.994659807,0,guvacine
EUKARYOTIC_TRANSLATION_ELONGATION,3.319535631,0,guvacine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.29611796,0,guvacine
EUKARYOTIC_TRANSLATION_INITIATION,3.164516942,0,guvacine
CELLULAR_RESPONSE_TO_STARVATION,3.144552645,0,guvacine
NONSENSE_MEDIATED_DECAY_NMD,3.10818645,0,guvacine
SELENOAMINO_ACID_METABOLISM,3.04971048,0,guvacine
INFLUENZA_INFECTION,3.04966651,0,guvacine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.036505632,0,guvacine
SIGNALING_BY_ROBO_RECEPTORS,2.797047282,0,guvacine
CELLULAR_RESPONSE_TO_STARVATION,-2.606874145,0,estriol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.570705624,0,estriol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.472176334,0,estriol
EUKARYOTIC_TRANSLATION_INITIATION,-2.450852539,0,estriol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.415249399,0,estriol
SELENOAMINO_ACID_METABOLISM,-2.344340477,0.000173837,estriol
NONSENSE_MEDIATED_DECAY_NMD,-2.308621683,0.000894021,estriol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.300087746,0.000782269,estriol
TRANSLATION,-2.223368778,0.002201941,estriol
SIGNALING_BY_ROBO_RECEPTORS,-2.162102183,0.005215124,estriol
DNA_REPLICATION,-2.287777984,0.007800354,BMS-754807
DNA_REPAIR,-2.231564657,0.007020319,BMS-754807
SYNTHESIS_OF_DNA,-2.200232117,0.00728033,BMS-754807
DNA_REPLICATION_PRE_INITIATION,-2.192598072,0.005850265,BMS-754807
DNA_STRAND_ELONGATION,-2.095665758,0.016068729,BMS-754807
MRNA_SPLICING,-2.04152353,0.021580979,BMS-754807
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.020954031,0.023846796,BMS-754807
CELL_CYCLE_MITOTIC,-2.007509484,0.023206053,BMS-754807
METABOLISM_OF_RNA,-1.995508052,0.023401062,BMS-754807
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.977375821,0.025741168,BMS-754807
GPCR_LIGAND_BINDING,-3.070944068,0,hypericin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.042671203,0,hypericin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.95366034,0,hypericin
SIGNALING_BY_GPCR,-2.636037464,0,hypericin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.600479558,0,hypericin
G_ALPHA_Q_SIGNALLING_EVENTS,-2.512312563,0,hypericin
EUKARYOTIC_TRANSLATION_INITIATION,-2.503791203,0,hypericin
RRNA_PROCESSING,-2.501717034,0,hypericin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.464650881,0,hypericin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.405295556,9.04E-05,hypericin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.17720041,0.125064633,finasteride
EUKARYOTIC_TRANSLATION_ELONGATION,2.15071553,0.083174052,finasteride
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.047784906,0.120207754,finasteride
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.005156362,0.129314402,finasteride
RRNA_PROCESSING,1.988886931,0.116565094,finasteride
EUKARYOTIC_TRANSLATION_INITIATION,1.950535762,0.13457602,finasteride
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.899878576,0.167735783,finasteride
S_PHASE,1.895832224,0.149652582,finasteride
NEUTROPHIL_DEGRANULATION,-1.795332127,0.906134836,finasteride
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1.828998664,0.211274234,finasteride
TRANSLATION,3.760377788,0,entacapone
RRNA_PROCESSING,2.745941193,0.000639595,entacapone
RESPIRATORY_ELECTRON_TRANSPORT,2.711010579,0.000426397,entacapone
DISEASES_OF_METABOLISM,2.121451803,0.016949268,entacapone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.643499055,0.263257308,entacapone
METABOLISM_OF_RNA,1.608584827,0.257756791,entacapone
CILIUM_ASSEMBLY,-1.812101291,1,entacapone
DNA_REPLICATION,1.58435894,0.24999028,entacapone
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.561920286,0.242246612,entacapone
SIGNALING_BY_ALK_IN_CANCER,-1.79027438,0.754274588,entacapone
SIGNALING_BY_NTRKS,2.259132008,0.018058313,crizotinib
SENSORY_PERCEPTION,-2.018130609,0.200849605,crizotinib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.97949773,0.150887017,crizotinib
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,1.705549239,0.441425436,crizotinib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.652364958,0.388922562,crizotinib
BIOLOGICAL_OXIDATIONS,1.650317958,0.295203261,crizotinib
PHASE_II_CONJUGATION_OF_COMPOUNDS,1.645864603,0.238971679,crizotinib
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-1.757495258,0.645183558,crizotinib
COLLAGEN_FORMATION,-1.73309602,0.584312471,crizotinib
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1.490488225,0.438917337,crizotinib
CELL_CYCLE,-2.742521102,0,sertindole
CELL_CYCLE_MITOTIC,-2.734334904,0,sertindole
METABOLISM_OF_RNA,-2.616771268,0,sertindole
M_PHASE,-2.49870496,0,sertindole
CELL_CYCLE_CHECKPOINTS,-2.429263649,0.000259,sertindole
MITOTIC_METAPHASE_AND_ANAPHASE,-2.33918059,0.001510831,sertindole
DNA_REPLICATION,-2.262655131,0.005364993,sertindole
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.250090224,0.02054451,sertindole
NEURONAL_SYSTEM,2.213203086,0.013326169,sertindole
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.185041215,0.011475312,sertindole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.392757327,0,alizapride
SARS_COV_1_HOST_INTERACTIONS,-2.514609195,0,alizapride
SARS_COV_1_INFECTION,-2.517486801,0,alizapride
SARS_COV_2_HOST_INTERACTIONS,-2.520430236,0,alizapride
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.540433492,0,alizapride
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.570664757,0,alizapride
VIRAL_INFECTION_PATHWAYS,-2.57118176,0,alizapride
METABOLISM_OF_RNA,-2.641298048,0,alizapride
NERVOUS_SYSTEM_DEVELOPMENT,-2.777209298,0,alizapride
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.954837713,0,alizapride
RESPIRATORY_ELECTRON_TRANSPORT,2.419133356,0.012192762,sulfasalazine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.282966671,0.012192762,sulfasalazine
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.180962951,0.022353397,sulfasalazine
INFLUENZA_INFECTION,2.095385166,0.022861428,sulfasalazine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.048798924,0.023166247,sulfasalazine
RRNA_PROCESSING,2.023601974,0.025401587,sulfasalazine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.886287476,0.060963809,sulfasalazine
G_ALPHA_I_SIGNALLING_EVENTS,-2.033083059,0.054448359,sulfasalazine
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.845733319,0.065536094,sulfasalazine
NONSENSE_MEDIATED_DECAY_NMD,1.802064999,0.071801819,sulfasalazine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.675775732,0,ziprasidone
NERVOUS_SYSTEM_DEVELOPMENT,-2.682445837,0,ziprasidone
SARS_COV_1_HOST_INTERACTIONS,-2.944367106,0,ziprasidone
METABOLISM_OF_RNA,-2.95493464,0,ziprasidone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.987799544,0,ziprasidone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.085375569,0,ziprasidone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.190651317,0,ziprasidone
INFLUENZA_INFECTION,-3.229583639,0,ziprasidone
TRANSLATION,-3.252563945,0,ziprasidone
RRNA_PROCESSING,-3.292687624,0,ziprasidone
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.089699495,0.185801765,carbidopa
NEUTROPHIL_DEGRANULATION,-2.082316128,0.097324734,carbidopa
GPCR_LIGAND_BINDING,1.976954015,0.265951203,carbidopa
NEURONAL_SYSTEM,1.932771324,0.190021348,carbidopa
TRNA_PROCESSING,-1.713771796,0.566252998,carbidopa
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.670385346,0.522014482,carbidopa
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-1.630094339,0.498656546,carbidopa
SENSORY_PERCEPTION,1.80249106,0.362732262,carbidopa
MITOCHONDRIAL_PROTEIN_IMPORT,-1.584934195,0.521129712,carbidopa
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.766853546,0.35230666,carbidopa
SIGNALING_BY_NUCLEAR_RECEPTORS,-2.124321527,0.191101177,BRD-K33396764
NEUTROPHIL_DEGRANULATION,-2.086496282,0.113990176,BRD-K33396764
INNATE_IMMUNE_SYSTEM,-2.041537992,0.10020705,BRD-K33396764
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.953055477,0.134385477,BRD-K33396764
ECM_PROTEOGLYCANS,1.918450531,0.545702743,BRD-K33396764
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.909213587,0.138799802,BRD-K33396764
ESR_MEDIATED_SIGNALING,-1.906838367,0.116784053,BRD-K33396764
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.847792033,0.145760547,BRD-K33396764
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1.820355697,0.582739269,BRD-K33396764
NCAM1_INTERACTIONS,1.819289158,0.390055569,BRD-K33396764
TRANSLATION,2.786118638,0.001076128,nicorandil
EUKARYOTIC_TRANSLATION_INITIATION,2.711528929,0.000538064,nicorandil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.537276317,0.001076128,nicorandil
EUKARYOTIC_TRANSLATION_ELONGATION,2.500000731,0.001076128,nicorandil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.472760734,0.001076128,nicorandil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.42445602,0.001434838,nicorandil
INFLUENZA_INFECTION,2.41857944,0.001383594,nicorandil
RRNA_PROCESSING,2.370920682,0.001883225,nicorandil
CELLULAR_RESPONSE_TO_STARVATION,2.348605181,0.002032687,nicorandil
SELENOAMINO_ACID_METABOLISM,2.282805527,0.003443611,nicorandil
CELL_CYCLE_MITOTIC,-2.334804762,0.004550334,camptothecin
M_PHASE,-2.27197778,0.005119125,camptothecin
CELL_CYCLE,-2.245130778,0.006067112,camptothecin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.075795844,0.02815519,camptothecin
MITOTIC_PROMETAPHASE,-2.040732758,0.029577169,camptothecin
MITOTIC_PROPHASE,-2.021738878,0.033558711,camptothecin
SIGNALING_BY_WNT,-1.990034819,0.03981542,camptothecin
MITOTIC_SPINDLE_CHECKPOINT,-1.978274639,0.037824649,camptothecin
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.975373134,0.034253901,camptothecin
CELL_CYCLE_CHECKPOINTS,-1.974891896,0.030942269,camptothecin
GPCR_LIGAND_BINDING,-3.276556511,0,bambuterol
SIGNALING_BY_GPCR,-3.124407571,0,bambuterol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.057291999,0,bambuterol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.916520383,0,bambuterol
G_ALPHA_Q_SIGNALLING_EVENTS,-2.824753087,0,bambuterol
G_ALPHA_I_SIGNALLING_EVENTS,-2.545112037,0,bambuterol
G_ALPHA_S_SIGNALLING_EVENTS,-2.529713041,0,bambuterol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.495133635,0,bambuterol
EUKARYOTIC_TRANSLATION_INITIATION,-2.44861105,0,bambuterol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.448350245,0,bambuterol
EUKARYOTIC_TRANSLATION_ELONGATION,-3.585663678,0,ramelteon
METABOLISM_OF_RNA,-2.801965993,0,ramelteon
GPCR_LIGAND_BINDING,-2.859198632,0,ramelteon
SARS_COV_1_HOST_INTERACTIONS,-3.00450486,0,ramelteon
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.027183733,0,ramelteon
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.055460459,0,ramelteon
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.092043563,0,ramelteon
INFLUENZA_INFECTION,-3.1813432,0,ramelteon
TRANSLATION,-3.28560488,0,ramelteon
RRNA_PROCESSING,-3.338169963,0,ramelteon
CELLULAR_SENESCENCE,2.483028905,0.003877248,arbutin
NEDDYLATION,2.227503178,0.025202112,arbutin
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.992760862,0.07108288,arbutin
KERATINIZATION,-2.035025653,0.071301779,arbutin
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.841837704,0.117286751,arbutin
GPCR_LIGAND_BINDING,-1.957512254,0.081204803,arbutin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.922376865,0.076847473,arbutin
SIGNALING_BY_GPCR,-1.92093368,0.059022028,arbutin
RHO_GTPASE_CYCLE,1.628470821,0.252021119,arbutin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.560066396,0.319872958,arbutin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.84322005,0,BRD-K24255045
NONSENSE_MEDIATED_DECAY_NMD,2.754356152,0,BRD-K24255045
EUKARYOTIC_TRANSLATION_ELONGATION,2.730429868,0,BRD-K24255045
SELENOAMINO_ACID_METABOLISM,2.629856843,0,BRD-K24255045
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.568785675,0.000734056,BRD-K24255045
CELLULAR_RESPONSE_TO_STARVATION,2.549398275,0.000611713,BRD-K24255045
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.470416991,0.001310814,BRD-K24255045
SIGNALING_BY_ROBO_RECEPTORS,2.45440585,0.001376354,BRD-K24255045
EUKARYOTIC_TRANSLATION_INITIATION,2.41805119,0.002650757,BRD-K24255045
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.392918685,0.002936223,BRD-K24255045
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.081388832,0.116068532,alvimopan
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.865641341,0.397534723,alvimopan
SIGNALING_BY_ALK_IN_CANCER,1.673299711,1,alvimopan
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.607876179,0.703290415,alvimopan
PROTEIN_LOCALIZATION,1.540090112,0.666857415,alvimopan
GASTRULATION,-1.760371131,0.596463291,alvimopan
RESPIRATORY_ELECTRON_TRANSPORT,1.510489184,0.577968526,alvimopan
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.728374701,0.565834095,alvimopan
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.409311224,0.750329041,alvimopan
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.395625766,0.661707201,alvimopan
EUKARYOTIC_TRANSLATION_INITIATION,5.074416578,0,AR-A014418
SEPARATION_OF_SISTER_CHROMATIDS,3.338348077,0,AR-A014418
MITOTIC_G2_G2_M_PHASES,3.31585659,0,AR-A014418
CELL_CYCLE_CHECKPOINTS,3.3121649,0,AR-A014418
VIRAL_INFECTION_PATHWAYS,3.164175211,0,AR-A014418
HOST_INTERACTIONS_OF_HIV_FACTORS,3.120634268,0,AR-A014418
DNA_REPLICATION_PRE_INITIATION,3.052039352,0,AR-A014418
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.051618896,0,AR-A014418
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,3.013375312,0,AR-A014418
CELLULAR_RESPONSES_TO_STIMULI,3.354075676,0,AR-A014418
EUKARYOTIC_TRANSLATION_INITIATION,3.667916152,0,betamethasone
SIGNALING_BY_ROBO_RECEPTORS,2.767830322,0,betamethasone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.897667896,0,betamethasone
CELLULAR_RESPONSE_TO_STARVATION,2.983338569,0,betamethasone
INFLUENZA_INFECTION,3.183093869,0,betamethasone
METABOLISM_OF_RNA,3.207739354,0,betamethasone
SELENOAMINO_ACID_METABOLISM,3.376774188,0,betamethasone
SARS_COV_1_HOST_INTERACTIONS,2.730733315,0,betamethasone
RRNA_PROCESSING,3.377925309,0,betamethasone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.398443744,0,betamethasone
NEUTROPHIL_DEGRANULATION,-2.621912651,0.000828679,dipivefrine
INNATE_IMMUNE_SYSTEM,-2.252163651,0.027760738,dipivefrine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.184314548,0.028451303,dipivefrine
RRNA_PROCESSING,2.069206912,0.210564247,dipivefrine
TRANSLATION,1.971436304,0.234391254,dipivefrine
HEMOSTASIS,-1.880038437,0.162835373,dipivefrine
EUKARYOTIC_TRANSLATION_INITIATION,1.867422602,0.353156877,dipivefrine
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.719968541,0.327162367,dipivefrine
RESPIRATORY_ELECTRON_TRANSPORT,1.760622949,0.55716408,dipivefrine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.701086704,0.664053141,dipivefrine
NEUTROPHIL_DEGRANULATION,-2.128722379,0.109639153,pirlindole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.103757194,0.195647215,pirlindole
INNATE_IMMUNE_SYSTEM,-2.05732479,0.096586873,pirlindole
RESPIRATORY_ELECTRON_TRANSPORT,1.945329094,0.314911614,pirlindole
TRANSLATION,1.914871789,0.263989736,pirlindole
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.929305598,0.184223611,pirlindole
PROTEIN_FOLDING,1.84536086,0.313571564,pirlindole
RRNA_PROCESSING,1.831216856,0.27712222,pirlindole
ECM_PROTEOGLYCANS,1.757517064,0.358686561,pirlindole
SYNTHESIS_OF_DNA,1.715619833,0.397611807,pirlindole
EUKARYOTIC_TRANSLATION_ELONGATION,4.176262405,0,betahistine
SARS_COV_2_HOST_INTERACTIONS,2.463439128,0,betahistine
SARS_COV_2_INFECTION,2.484281577,0,betahistine
SARS_COV_INFECTIONS,2.67662668,0,betahistine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.954997686,0,betahistine
INFECTIOUS_DISEASE,2.971820013,0,betahistine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.071670215,0,betahistine
METABOLISM_OF_RNA,3.14410807,0,betahistine
SARS_COV_1_HOST_INTERACTIONS,3.148820492,0,betahistine
VIRAL_INFECTION_PATHWAYS,3.171582627,0,betahistine
EUKARYOTIC_TRANSLATION_INITIATION,3.858660909,0,alprostadil
SIGNALING_BY_GPCR,-2.550235543,0,alprostadil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.605284258,0,alprostadil
SIGNALING_BY_ROBO_RECEPTORS,2.939805384,0,alprostadil
CELLULAR_RESPONSE_TO_STARVATION,3.001863405,0,alprostadil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.039356393,0,alprostadil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.269132154,0,alprostadil
RRNA_PROCESSING,3.317512116,0,alprostadil
GPCR_LIGAND_BINDING,-2.743576765,0,alprostadil
NONSENSE_MEDIATED_DECAY_NMD,3.377961088,0,alprostadil
RESPIRATORY_ELECTRON_TRANSPORT,2.397940694,0.010292841,nadolol
TRANSLATION,2.184182032,0.035510303,nadolol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.079892104,0.055924438,nadolol
GPCR_LIGAND_BINDING,1.946210817,0.111420008,nadolol
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.937591003,0.095723425,nadolol
DISEASES_OF_METABOLISM,1.921526506,0.08954772,nadolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.912968013,0.082930894,nadolol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.864582286,0.101513149,nadolol
RHO_GTPASE_CYCLE,-1.870941503,0.904135002,nadolol
EXTRACELLULAR_MATRIX_ORGANIZATION,1.84360349,0.101212941,nadolol
EUKARYOTIC_TRANSLATION_ELONGATION,-3.764479013,0,moracizine
SARS_COV_2_HOST_INTERACTIONS,-2.616649989,0,moracizine
VIRAL_INFECTION_PATHWAYS,-2.617046954,0,moracizine
CELLULAR_RESPONSES_TO_STIMULI,-2.753545871,0,moracizine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.861210282,0,moracizine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.932545775,0,moracizine
SARS_COV_1_HOST_INTERACTIONS,-3.145448169,0,moracizine
SARS_COV_1_INFECTION,-3.169576516,0,moracizine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.171053049,0,moracizine
CELLULAR_RESPONSE_TO_STARVATION,-3.423366392,0,moracizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.330922174,0,iloperidone
GPCR_LIGAND_BINDING,3.265517483,0,iloperidone
SIGNALING_BY_GPCR,2.670243512,0,iloperidone
G_ALPHA_Q_SIGNALLING_EVENTS,2.547910848,0.000386051,iloperidone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.305292334,0.00195599,iloperidone
HIV_LIFE_CYCLE,-2.304372787,0.036192988,iloperidone
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-2.138264193,0.073290801,iloperidone
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.123112503,0.054289483,iloperidone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.103016941,0.050217771,iloperidone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.087649077,0.047050885,iloperidone
SIGNALING_BY_NTRKS,2.349655374,0.01906066,diacerein
CELL_CYCLE,-2.266593624,0.022814278,diacerein
NEURONAL_SYSTEM,2.243052955,0.014692592,diacerein
CELL_CYCLE_MITOTIC,-2.215626535,0.020098293,diacerein
S_PHASE,-2.20427138,0.015209519,diacerein
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.097024266,0.032297229,diacerein
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.091947924,0.02581131,diacerein
CELL_CYCLE_CHECKPOINTS,-2.075063647,0.045900155,diacerein
DNA_REPLICATION,-2.071988725,0.031143301,diacerein
SYNTHESIS_OF_DNA,-2.071988725,0.031143301,diacerein
NEUTROPHIL_DEGRANULATION,-3.043862328,0,benzocaine
GPCR_LIGAND_BINDING,2.489654368,0.001455751,benzocaine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-2.349267161,0.043063303,benzocaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.180135103,0.019652642,benzocaine
SIGNALING_BY_GPCR,1.993299428,0.074000687,benzocaine
CARDIAC_CONDUCTION,1.992923457,0.055500516,benzocaine
SENSORY_PERCEPTION,1.978336435,0.050805718,benzocaine
G_ALPHA_S_SIGNALLING_EVENTS,1.95118264,0.054226733,benzocaine
INNATE_IMMUNE_SYSTEM,-1.945706792,0.327055934,benzocaine
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-1.920514024,0.280333657,benzocaine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.795182734,0,nintedanib
MITOTIC_G2_G2_M_PHASES,-2.490941817,0.001699288,nintedanib
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.484854469,0.005237053,nintedanib
CELL_CYCLE_MITOTIC,-2.422328937,0.002643337,nintedanib
S_PHASE,-2.364987025,0.002548932,nintedanib
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.28899369,0.004304863,nintedanib
KEAP1_NFE2L2_PATHWAY,-2.283310197,0.003776196,nintedanib
CELL_CYCLE_CHECKPOINTS,-2.237595585,0.00534062,nintedanib
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,-2.236643095,0.004673042,nintedanib
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-2.22409102,0.003965006,nintedanib
TRANSLATION,2.631598662,0,liothyronine
RRNA_PROCESSING,2.429171229,0.006740694,liothyronine
METABOLISM_OF_RNA,2.341347552,0.008987592,liothyronine
RESPIRATORY_ELECTRON_TRANSPORT,2.286775739,0.011796214,liothyronine
S_PHASE,2.281208429,0.010111041,liothyronine
PCP_CE_PATHWAY,2.259117516,0.010111041,liothyronine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.250984787,0.009388824,liothyronine
SARS_COV_1_HOST_INTERACTIONS,2.23434212,0.009900394,liothyronine
SYNTHESIS_OF_DNA,2.212977517,0.010485524,liothyronine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.204457154,0.009942524,liothyronine
CELLULAR_RESPONSE_TO_STARVATION,3.203225316,0,domperidone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.613153492,0,domperidone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.634229208,0,domperidone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.735569908,0,domperidone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.742368644,0,domperidone
RRNA_PROCESSING,2.751731111,0,domperidone
NONSENSE_MEDIATED_DECAY_NMD,3.037828436,0,domperidone
SELENOAMINO_ACID_METABOLISM,3.024487586,0,domperidone
EUKARYOTIC_TRANSLATION_INITIATION,3.096204639,0,domperidone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.150653216,0,domperidone
RAB_REGULATION_OF_TRAFFICKING,2.520579088,0,acetazolamide
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.174210522,0.007982316,acetazolamide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.127071588,0.007450162,acetazolamide
MRNA_SPLICING,2.054391177,0.014368169,acetazolamide
EUKARYOTIC_TRANSLATION_ELONGATION,-1.96507767,0.072639952,acetazolamide
RRNA_PROCESSING,-1.95859805,0.040045102,acetazolamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.940375399,0.032905277,acetazolamide
SELENOAMINO_ACID_METABOLISM,-1.925883455,0.030732287,acetazolamide
EUKARYOTIC_TRANSLATION_INITIATION,-1.891894504,0.040417614,acetazolamide
NONSENSE_MEDIATED_DECAY_NMD,-1.870440022,0.041907665,acetazolamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.657215349,0,nortriptyline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.442735723,0,nortriptyline
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.519793697,0,nortriptyline
GPCR_LIGAND_BINDING,-2.545258069,0,nortriptyline
TRANSLATION,2.71852012,0,nortriptyline
EUKARYOTIC_TRANSLATION_INITIATION,3.287414039,0,nortriptyline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.981005976,0,nortriptyline
INFLUENZA_INFECTION,3.544000362,0,nortriptyline
SELENOAMINO_ACID_METABOLISM,3.616409908,0,nortriptyline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.617397847,0,nortriptyline
TRANSLATION,2.934298891,0,terbutaline
RRNA_PROCESSING,2.888371913,0,terbutaline
RESPIRATORY_ELECTRON_TRANSPORT,2.098780674,0.017469023,terbutaline
HATS_ACETYLATE_HISTONES,-1.905863962,0.480947574,terbutaline
SIGNALING_BY_ALK_IN_CANCER,-1.843540947,0.430040825,terbutaline
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.522624152,0.376599634,terbutaline
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-1.777572206,0.503249579,terbutaline
DISEASES_OF_METABOLISM,1.411377118,0.523583181,terbutaline
OPIOID_SIGNALLING,1.326407406,0.651228925,terbutaline
TCR_SIGNALING,-1.656241228,0.954137929,terbutaline
NEUTROPHIL_DEGRANULATION,-2.993500179,0,trimethadione
INNATE_IMMUNE_SYSTEM,-2.142269194,0.128262956,trimethadione
GPCR_LIGAND_BINDING,2.045344451,0.139907223,trimethadione
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.993120491,0.201420345,trimethadione
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-1.937035329,0.203320537,trimethadione
SIGNALING_BY_INSULIN_RECEPTOR,-1.906696117,0.196099808,trimethadione
CARDIAC_CONDUCTION,1.941572116,0.162995361,trimethadione
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.859479715,0.204270633,trimethadione
SIGNALING_BY_GPCR,1.873778552,0.189070024,trimethadione
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-1.781568091,0.258154648,trimethadione
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,5.062568075,0,etodolac
RESPIRATORY_ELECTRON_TRANSPORT,2.525806324,0,etodolac
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.57841657,0,etodolac
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.813709696,0,etodolac
SIGNALING_BY_GPCR,-2.848419478,0,etodolac
SARS_COV_INFECTIONS,2.942135538,0,etodolac
GPCR_LIGAND_BINDING,-3.075296437,0,etodolac
SARS_COV_2_HOST_INTERACTIONS,3.108151934,0,etodolac
NERVOUS_SYSTEM_DEVELOPMENT,3.48393613,0,etodolac
INFECTIOUS_DISEASE,3.502888232,0,etodolac
NEUTROPHIL_DEGRANULATION,-2.847722977,0.004219805,homosalate
INNATE_IMMUNE_SYSTEM,-1.86913286,0.471563203,homosalate
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.763914591,0.570376969,homosalate
TRNA_PROCESSING,-1.647528861,0.746905476,homosalate
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,-1.55962997,0.897552513,homosalate
INTERLEUKIN_17_SIGNALING,-1.545798792,0.803169542,homosalate
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,-1.503210577,0.84456382,homosalate
ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,-1.493574023,0.774334209,homosalate
SIGNALING_BY_NTRKS,-1.473089408,0.757220555,homosalate
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,-1.449563438,0.763573706,homosalate
GPCR_LIGAND_BINDING,3.08408497,0,benzatropine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.040494226,0,benzatropine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.796689822,0,benzatropine
SIGNALING_BY_GPCR,2.7152098,0,benzatropine
G_ALPHA_I_SIGNALLING_EVENTS,2.59767356,0,benzatropine
SENSORY_PERCEPTION,2.332641642,0.000420846,benzatropine
VISUAL_PHOTOTRANSDUCTION,2.223830452,0.002525075,benzatropine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-3.464370869,0.250914156,benzatropine
G_ALPHA_Q_SIGNALLING_EVENTS,2.001998956,0.018306797,benzatropine
ESR_MEDIATED_SIGNALING,-3.31479614,0.625370016,benzatropine
EUKARYOTIC_TRANSLATION_ELONGATION,4.546171787,0,exemestane
METABOLISM_OF_RNA,2.58690506,0,exemestane
SARS_COV_1_INFECTION,2.658317127,0,exemestane
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.973037956,0,exemestane
KEAP1_NFE2L2_PATHWAY,2.98397734,0,exemestane
SARS_COV_1_HOST_INTERACTIONS,3.028810647,0,exemestane
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.066175584,0,exemestane
RESPIRATORY_ELECTRON_TRANSPORT,3.167639656,0,exemestane
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,3.220511402,0,exemestane
CELLULAR_RESPONSES_TO_STIMULI,3.301185761,0,exemestane
EUKARYOTIC_TRANSLATION_ELONGATION,3.892788666,0,trazodone
NERVOUS_SYSTEM_DEVELOPMENT,2.70947341,0,trazodone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.811095513,0,trazodone
SARS_COV_1_INFECTION,2.853480032,0,trazodone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.91671709,0,trazodone
SARS_COV_1_HOST_INTERACTIONS,3.115346137,0,trazodone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.279855277,0,trazodone
INFLUENZA_INFECTION,3.318852257,0,trazodone
TRANSLATION,3.382573069,0,trazodone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.054241707,0,trazodone
ECM_PROTEOGLYCANS,-2.065832014,0.210993583,tiapride
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.053080246,0.120567762,tiapride
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.886677057,0.277308211,tiapride
DISEASES_OF_GLYCOSYLATION,-1.947139571,0.198434441,tiapride
SIGNALING_BY_PDGF,-1.944061562,0.1517862,tiapride
NEUTROPHIL_DEGRANULATION,1.817374445,0.212349712,tiapride
RAB_REGULATION_OF_TRAFFICKING,1.758496921,0.192722875,tiapride
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.833903012,0.282903641,tiapride
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.828053742,0.245262099,tiapride
DISEASES_OF_METABOLISM,-1.811354366,0.239443884,tiapride
EUKARYOTIC_TRANSLATION_ELONGATION,-3.472985575,0,propylthiouracil
SARS_COV_2_INFECTION,-2.572766555,0,propylthiouracil
NERVOUS_SYSTEM_DEVELOPMENT,-2.660525839,0,propylthiouracil
SARS_COV_2_HOST_INTERACTIONS,-2.664735781,0,propylthiouracil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.791086822,0,propylthiouracil
SARS_COV_1_HOST_INTERACTIONS,-2.858616517,0,propylthiouracil
SARS_COV_1_INFECTION,-2.880820427,0,propylthiouracil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.964131498,0,propylthiouracil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.007794581,0,propylthiouracil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.070273621,0,propylthiouracil
CELL_CYCLE,-2.891279663,0,atorvastatin
CELL_CYCLE_MITOTIC,-2.782354705,0,atorvastatin
METABOLISM_OF_RNA,-2.513656223,0,atorvastatin
M_PHASE,-2.425497718,0.000285261,atorvastatin
S_PHASE,-2.399124992,0.000456417,atorvastatin
CELL_CYCLE_CHECKPOINTS,-2.327749811,0.003042782,atorvastatin
DNA_REPLICATION,-2.322124977,0.003097117,atorvastatin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.293674802,0.00342313,atorvastatin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.29194077,0.003169565,atorvastatin
CHROMOSOME_MAINTENANCE,-2.271381572,0.003537234,atorvastatin
METABOLISM_OF_RNA,3.058120414,0,filanesib
MRNA_SPLICING,2.563287504,0.001431953,filanesib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.466724394,0.003341223,filanesib
DISEASES_OF_METABOLISM,-3.317831355,0.026678466,filanesib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.188606669,0.025775148,filanesib
RRNA_PROCESSING,1.950921121,0.114556213,filanesib
BIOLOGICAL_OXIDATIONS,-3.050790475,0.731696165,filanesib
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,1.671303398,0.534357002,filanesib
MUSCLE_CONTRACTION,-2.907089909,1,filanesib
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,-2.899529864,0.996126844,filanesib
EUKARYOTIC_TRANSLATION_ELONGATION,2.913796089,0,demecarium
RRNA_PROCESSING,2.566035954,0,demecarium
INFLUENZA_INFECTION,2.679274707,0,demecarium
SIGNALING_BY_ROBO_RECEPTORS,2.691227401,0,demecarium
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.696067341,0,demecarium
EUKARYOTIC_TRANSLATION_INITIATION,2.685593376,0,demecarium
CELLULAR_RESPONSE_TO_STARVATION,2.78884942,0,demecarium
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.823603189,0,demecarium
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.824575164,0,demecarium
NONSENSE_MEDIATED_DECAY_NMD,2.902862456,0,demecarium
EUKARYOTIC_TRANSLATION_INITIATION,3.107839069,0,alosetron
EUKARYOTIC_TRANSLATION_ELONGATION,2.965694743,0,alosetron
TRANSLATION,2.886960752,0,alosetron
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.703327591,0,alosetron
SELENOAMINO_ACID_METABOLISM,2.596329319,0.000492652,alosetron
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.523410505,0.001026357,alosetron
RRNA_PROCESSING,2.463267336,0.001231629,alosetron
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.446951445,0.001231629,alosetron
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.365177278,0.002189563,alosetron
SIGNALING_BY_ROBO_RECEPTORS,2.357452598,0.002093769,alosetron
EXTRACELLULAR_MATRIX_ORGANIZATION,2.668727827,0,isotretinoin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.488616074,0.002563164,isotretinoin
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.360242551,0.003295496,isotretinoin
KERATINIZATION,2.360242551,0.003295496,isotretinoin
DISEASES_OF_METABOLISM,2.005743268,0.026656902,isotretinoin
RRNA_PROCESSING,1.937795979,0.035640181,isotretinoin
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.936345017,0.030653345,isotretinoin
MUSCLE_CONTRACTION,1.935890617,0.027096302,isotretinoin
TRANSLATION,1.852661869,0.040929249,isotretinoin
COPII_MEDIATED_VESICLE_TRANSPORT,-1.894170612,0.777586424,isotretinoin
EUKARYOTIC_TRANSLATION_INITIATION,3.953837876,0,dexbrompheniramine
SARS_COV_1_HOST_INTERACTIONS,2.900183304,0,dexbrompheniramine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.921135789,0,dexbrompheniramine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.957068002,0,dexbrompheniramine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.056368881,0,dexbrompheniramine
RRNA_PROCESSING,3.062392699,0,dexbrompheniramine
NONSENSE_MEDIATED_DECAY_NMD,3.095848631,0,dexbrompheniramine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.195147335,0,dexbrompheniramine
SIGNALING_BY_ROBO_RECEPTORS,2.972546943,0,dexbrompheniramine
CELLULAR_RESPONSE_TO_STARVATION,3.340273506,0,dexbrompheniramine
RESPIRATORY_ELECTRON_TRANSPORT,3.183628506,0,caffeic-acid
TRANSLATION,3.070768749,0,caffeic-acid
METABOLISM_OF_NUCLEOTIDES,2.462101347,0.000926396,caffeic-acid
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.450707867,0.000926396,caffeic-acid
RRNA_PROCESSING,2.249857431,0.004631982,caffeic-acid
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.911156087,0.031034277,caffeic-acid
SIGNALING_BY_ALK_IN_CANCER,-1.939940952,0.361614804,caffeic-acid
CILIUM_ASSEMBLY,-1.894543487,0.278048358,caffeic-acid
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.876509636,0.21406516,caffeic-acid
DISEASES_OF_METABOLISM,1.655740541,0.111299901,caffeic-acid
GPCR_LIGAND_BINDING,3.803309765,0,lypressin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.586131812,0,lypressin
SIGNALING_BY_GPCR,3.38830859,0,lypressin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.956520226,0,lypressin
G_ALPHA_Q_SIGNALLING_EVENTS,2.803728509,0,lypressin
M_PHASE,-2.802933792,0.001675484,lypressin
MITOTIC_PROMETAPHASE,-2.689292434,0.000837742,lypressin
G_ALPHA_I_SIGNALLING_EVENTS,2.484815567,0.000175599,lypressin
CELL_CYCLE,-2.524866564,0.003350968,lypressin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.515116657,0.002513226,lypressin
EUKARYOTIC_TRANSLATION_INITIATION,2.919394408,0,salbutamol
SELENOAMINO_ACID_METABOLISM,2.895921801,0,salbutamol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.861649624,0,salbutamol
EUKARYOTIC_TRANSLATION_ELONGATION,2.827897589,0,salbutamol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.797544101,0,salbutamol
TRANSLATION,2.703687858,0.000163609,salbutamol
RRNA_PROCESSING,2.677771628,0.000140236,salbutamol
INFLUENZA_INFECTION,2.62417425,0.000122706,salbutamol
CELLULAR_RESPONSE_TO_STARVATION,2.620560837,0.000109072,salbutamol
NONSENSE_MEDIATED_DECAY_NMD,2.510638527,0.000294496,salbutamol
METABOLISM_OF_RNA,-3.235352277,0,razoxane
CELL_CYCLE_MITOTIC,-3.169643913,0,razoxane
CELL_CYCLE_CHECKPOINTS,-3.088225187,0,razoxane
CELL_CYCLE,-3.01944812,0,razoxane
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.891740825,0,razoxane
MITOTIC_METAPHASE_AND_ANAPHASE,-2.874348192,0,razoxane
GPCR_LIGAND_BINDING,2.857137335,0,razoxane
G2_M_CHECKPOINTS,-2.815924796,0,razoxane
TRNA_PROCESSING_IN_THE_NUCLEUS,-2.715411509,0.000515131,razoxane
S_PHASE,-2.66073196,0.000457895,razoxane
GPCR_LIGAND_BINDING,2.427453519,0.00328445,mesalazine
SIGNALING_BY_GPCR,2.161326926,0.03667636,mesalazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.124384366,0.036128951,mesalazine
RAC3_GTPASE_CYCLE,-2.075174747,0.109589916,mesalazine
G_ALPHA_Q_SIGNALLING_EVENTS,1.911755291,0.161485464,mesalazine
SENSORY_PERCEPTION,1.848439462,0.207358284,mesalazine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-1.645140612,0.711943064,mesalazine
SIGNALING_BY_INTERLEUKINS,1.727868585,0.421504432,mesalazine
MUSCLE_CONTRACTION,1.667197089,0.470360627,mesalazine
MAPK_FAMILY_SIGNALING_CASCADES,1.667775886,0.536303783,mesalazine
NONSENSE_MEDIATED_DECAY_NMD,-3.830958934,0,rufinamide
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.497752764,0,rufinamide
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,-2.51844558,0,rufinamide
SARS_COV_2_INFECTION,-2.678858068,0,rufinamide
SARS_COV_INFECTIONS,-2.764176743,0,rufinamide
CELLULAR_RESPONSES_TO_STIMULI,-2.8783592,0,rufinamide
INFECTIOUS_DISEASE,-2.880494731,0,rufinamide
SARS_COV_2_HOST_INTERACTIONS,-2.968219009,0,rufinamide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.988882105,0,rufinamide
METABOLISM_OF_RNA,-3.025959982,0,rufinamide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.931406146,0,furosemide
EUKARYOTIC_TRANSLATION_INITIATION,2.255519035,0.038642394,furosemide
CELLULAR_RESPONSE_TO_STARVATION,2.237822547,0.021302858,furosemide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.23557089,0.02875117,furosemide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.139136209,0.035669902,furosemide
EUKARYOTIC_TRANSLATION_ELONGATION,2.129769907,0.028734088,furosemide
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.116091256,0.05413963,furosemide
SELENOAMINO_ACID_METABOLISM,2.068611244,0.037057065,furosemide
GPCR_LIGAND_BINDING,-2.076814752,0.051197259,furosemide
S_PHASE,-2.051588949,0.053265326,furosemide
REGULATION_OF_TP53_ACTIVITY,2.229236178,0.065807231,ARRY-334543
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.159090944,0.052845201,ARRY-334543
DEUBIQUITINATION,1.944523518,0.155544365,ARRY-334543
GPCR_LIGAND_BINDING,-1.949269571,0.251012277,ARRY-334543
MITF_M_DEPENDENT_GENE_EXPRESSION,1.860675798,0.197421694,ARRY-334543
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.784774276,0.251662806,ARRY-334543
SIGNALING_BY_ALK_IN_CANCER,1.784646601,0.209719005,ARRY-334543
INNATE_IMMUNE_SYSTEM,1.777702813,0.184032344,ARRY-334543
TCR_SIGNALING,1.753503609,0.181717696,ARRY-334543
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.737458308,0.175264377,ARRY-334543
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.186575931,0.028312548,zofenopril-calcium
METABOLISM_OF_RNA,-2.118330273,0.03157938,zofenopril-calcium
S_PHASE,-2.099942237,0.024319752,zofenopril-calcium
MITF_M_DEPENDENT_GENE_EXPRESSION,2.084586112,0.04705199,zofenopril-calcium
APOPTOSIS,-2.05136073,0.035390684,zofenopril-calcium
PROGRAMMED_CELL_DEATH,-1.99593094,0.056407306,zofenopril-calcium
HOST_INTERACTIONS_OF_HIV_FACTORS,-1.932847887,0.083667208,zofenopril-calcium
HIV_INFECTION,-1.909213203,0.08664884,zofenopril-calcium
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.881625089,0.099774506,zofenopril-calcium
SIGNALING_BY_VEGF,-1.881172923,0.08868845,zofenopril-calcium
TRANSLATION,3.376517409,0,sulindac
RRNA_PROCESSING,2.668897528,0,sulindac
RESPIRATORY_ELECTRON_TRANSPORT,2.391638824,0.001258092,sulindac
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.828415496,0.109768563,sulindac
SIGNALING_BY_ALK_IN_CANCER,-1.852601208,0.859007213,sulindac
DEVELOPMENTAL_CELL_LINEAGES,1.597655369,0.318800619,sulindac
UB_SPECIFIC_PROCESSING_PROTEASES,-1.794464432,0.68036412,sulindac
CILIUM_ASSEMBLY,-1.783425618,0.494752679,sulindac
DISEASES_OF_METABOLISM,1.525946427,0.377008361,sulindac
DEUBIQUITINATION,-1.704138135,0.682027021,sulindac
GPCR_LIGAND_BINDING,3.321772732,0,BRD-K59946561
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.124391885,0,BRD-K59946561
SIGNALING_BY_GPCR,2.916017584,0,BRD-K59946561
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.79851184,0,BRD-K59946561
G_ALPHA_Q_SIGNALLING_EVENTS,2.327114171,0.001606054,BRD-K59946561
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,-2.103287573,0.162166121,BRD-K59946561
SENSORY_PERCEPTION,2.099576077,0.011264685,BRD-K59946561
NEUTROPHIL_DEGRANULATION,-1.979747049,0.170076664,BRD-K59946561
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-1.974701125,0.11602129,BRD-K59946561
MEMBRANE_TRAFFICKING,-1.948046115,0.104320279,BRD-K59946561
METABOLISM_OF_RNA,2.945553561,0,amyleine
EUKARYOTIC_TRANSLATION_INITIATION,2.432263398,0.003412079,amyleine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.409470507,0.002843399,amyleine
RESPIRATORY_ELECTRON_TRANSPORT,2.295684576,0.010662747,amyleine
TRANSLATION,2.263297908,0.011259861,amyleine
RRNA_PROCESSING,2.257227035,0.010236238,amyleine
NONSENSE_MEDIATED_DECAY_NMD,2.22980144,0.011211117,amyleine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.220510387,0.010662747,amyleine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.218113887,0.009667558,amyleine
MRNA_SPLICING,2.212771502,0.009212614,amyleine
GPCR_LIGAND_BINDING,2.734719411,0,flupirtine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.631099921,0,flupirtine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.463764807,0.000645743,flupirtine
SIGNALING_BY_GPCR,2.417592487,0.000717492,flupirtine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.245927269,0.046935743,flupirtine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.167574391,0.007964159,flupirtine
MEMBRANE_TRAFFICKING,-2.156935469,0.054758367,flupirtine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.111248761,0.055736194,flupirtine
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-2.108816899,0.045594722,flupirtine
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.057673541,0.055875884,flupirtine
GASTRULATION,2.069242973,0.184868681,stiripentol
GPCR_LIGAND_BINDING,2.033492747,0.120956937,stiripentol
EXTRACELLULAR_MATRIX_ORGANIZATION,1.974223318,0.134866104,stiripentol
INTEGRIN_CELL_SURFACE_INTERACTIONS,1.966618879,0.108016129,stiripentol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.876113067,0.166910009,stiripentol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-1.860487788,0.740145308,stiripentol
G_ALPHA_Q_SIGNALLING_EVENTS,1.856346575,0.160043458,stiripentol
SENSORY_PERCEPTION,1.824479948,0.16555179,stiripentol
RHOA_GTPASE_CYCLE,-1.771332076,0.634410264,stiripentol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.732445972,0.253270093,stiripentol
IRE1ALPHA_ACTIVATES_CHAPERONES,1.826849176,0.865273027,raclopride
GLYCOSAMINOGLYCAN_METABOLISM,1.754479376,0.654396739,raclopride
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.753434204,0.440194804,raclopride
TCR_SIGNALING,-1.768982033,1,raclopride
RESPIRATORY_ELECTRON_TRANSPORT,1.67155238,0.529911705,raclopride
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.742645896,1,raclopride
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.708125374,0.961392285,raclopride
RNA_POLYMERASE_II_TRANSCRIPTION,-1.702050914,0.745034594,raclopride
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.635536828,0.507191485,raclopride
RRNA_PROCESSING,1.635382656,0.422961903,raclopride
PROTEIN_LOCALIZATION,2.591351351,0.00097531,droperidol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.42806972,0.00195062,droperidol
MUSCLE_CONTRACTION,2.191708218,0.014954756,droperidol
CELLULAR_RESPONSE_TO_STARVATION,2.061716785,0.029015479,droperidol
MITOCHONDRIAL_BIOGENESIS,1.958401231,0.042328463,droperidol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.957386715,0.359167627,droperidol
SIGNALING_BY_NTRKS,1.871207318,0.066808749,droperidol
INFLUENZA_INFECTION,1.863792403,0.059633252,droperidol
VISUAL_PHOTOTRANSDUCTION,-1.872013133,0.383381175,droperidol
AUTOPHAGY,1.743752068,0.108625174,droperidol
NEUTROPHIL_DEGRANULATION,-2.385042322,0.026436482,nilutamide
INNATE_IMMUNE_SYSTEM,-2.154068205,0.058821173,nilutamide
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.909850191,0.170515311,nilutamide
CELL_CELL_COMMUNICATION,-1.904205444,0.1315215,nilutamide
FCERI_MEDIATED_NF_KB_ACTIVATION,-1.81291123,0.171044041,nilutamide
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.762982445,0.18527568,nilutamide
SIGNALING_BY_VEGF,-1.705297646,0.210358867,nilutamide
SIGNALING_BY_NTRKS,-1.704667964,0.184890148,nilutamide
RAC3_GTPASE_CYCLE,-1.617164132,0.260399351,nilutamide
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-1.585008152,0.276261241,nilutamide
SIGNALING_BY_GPCR,1.999733944,0.261654563,etidronic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.979047823,0.15299403,etidronic-acid
GPCR_LIGAND_BINDING,1.907148477,0.175015898,etidronic-acid
REGULATION_OF_INSULIN_SECRETION,1.810908854,0.25491761,etidronic-acid
NEUTROPHIL_DEGRANULATION,-1.841134952,1,etidronic-acid
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.680000176,1,etidronic-acid
MHC_CLASS_II_ANTIGEN_PRESENTATION,-1.67229667,1,etidronic-acid
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.637689324,1,etidronic-acid
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.556975415,0.932976654,etidronic-acid
AUTOPHAGY,-1.342308789,1,etidronic-acid
GPCR_LIGAND_BINDING,-2.494946316,0.005623809,levobunolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.367246917,0.009239114,levobunolol
SIGNALING_BY_GPCR,-2.35414926,0.00642721,levobunolol
G_ALPHA_Q_SIGNALLING_EVENTS,-2.333288717,0.005222108,levobunolol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.269278927,0.004659727,levobunolol
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.198909519,0.074739429,levobunolol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.082415893,0.012184919,levobunolol
G_ALPHA_I_SIGNALLING_EVENTS,-2.062638871,0.012395333,levobunolol
G_ALPHA_S_SIGNALLING_EVENTS,-2.052130265,0.012051018,levobunolol
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-2.025842706,0.013836355,levobunolol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.499020519,0.000839344,rotundine
EUKARYOTIC_TRANSLATION_INITIATION,-2.412311983,0.001259015,rotundine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.381686915,0.001119125,rotundine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.362825357,0.000839344,rotundine
SELENOAMINO_ACID_METABOLISM,-2.340957783,0.000671475,rotundine
NONSENSE_MEDIATED_DECAY_NMD,-2.322914867,0.000559562,rotundine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.262712333,0.000839344,rotundine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.24809664,0.000839344,rotundine
CELLULAR_RESPONSE_TO_STARVATION,-2.232838736,0.000839344,rotundine
GPCR_LIGAND_BINDING,-2.22912561,0.000755409,rotundine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.645912399,0.002349378,enoxacin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.532540384,0.002349378,enoxacin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.158140483,0.041505682,enoxacin
SIGNALING_BY_NOTCH4,-2.054112922,0.074592759,enoxacin
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,-2.046723206,0.063198275,enoxacin
SYNTHESIS_OF_DNA,-1.987525593,0.080074642,enoxacin
SIGNALING_BY_HEDGEHOG,-1.966261715,0.076019167,enoxacin
SIGNALING_BY_NOTCH,-1.963425643,0.068131969,enoxacin
PCP_CE_PATHWAY,-1.930890235,0.074919062,enoxacin
NONSENSE_MEDIATED_DECAY_NMD,1.915890774,0.462328856,enoxacin
RAB_REGULATION_OF_TRAFFICKING,1.60843737,0.702191752,dexniguldipine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.563418356,0.434818739,dexniguldipine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.546109453,0.315086043,dexniguldipine
INFLUENZA_INFECTION,1.508181744,0.293705204,dexniguldipine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.460898515,0.301402306,dexniguldipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.798118467,0.580014997,dexniguldipine
GPCR_LIGAND_BINDING,-1.789644453,0.314515174,dexniguldipine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.779529374,0.233276767,dexniguldipine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.770888473,0.187438336,dexniguldipine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.767535836,0.154126051,dexniguldipine
NEUTROPHIL_DEGRANULATION,1.941779273,0.184610457,rotigotine
DEVELOPMENTAL_CELL_LINEAGES,-1.940649571,0.271722057,rotigotine
HCMV_INFECTION,1.77032381,0.254012884,rotigotine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.755781877,0.783087873,rotigotine
GPCR_LIGAND_BINDING,-1.722777557,0.683393554,rotigotine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.707799665,0.573399584,rotigotine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.63697804,0.793088754,rotigotine
INNATE_IMMUNE_SYSTEM,1.26580256,1,rotigotine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.222845697,1,rotigotine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.219325519,1,rotigotine
CELLULAR_RESPONSE_TO_STARVATION,2.114607338,0.066851729,carglumic-acid
NEUTROPHIL_DEGRANULATION,2.023155056,0.065234348,carglumic-acid
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.873861138,0.105309444,carglumic-acid
RAB_REGULATION_OF_TRAFFICKING,1.863631892,0.083834224,carglumic-acid
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.051745496,0.423145105,carglumic-acid
MITOTIC_PROMETAPHASE,-1.980756524,0.367313459,carglumic-acid
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.746119931,0.139094726,carglumic-acid
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.886436022,0.465916716,carglumic-acid
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.661141555,0.188874104,carglumic-acid
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.652847831,0.168977757,carglumic-acid
RESPIRATORY_ELECTRON_TRANSPORT,2.363970425,0.012985339,darifenacin
CELLULAR_RESPONSE_TO_STARVATION,2.209790212,0.025471242,darifenacin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.248019262,0.085036744,darifenacin
DISEASES_OF_GLYCOSYLATION,-2.242071019,0.045019453,darifenacin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.080833491,0.044283336,darifenacin
INFLUENZA_INFECTION,2.055042813,0.037207991,darifenacin
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.132744326,0.086370654,darifenacin
GASTRULATION,-2.075105153,0.096541716,darifenacin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.037575766,0.104645217,darifenacin
ECM_PROTEOGLYCANS,-2.023244791,0.097041932,darifenacin
GPCR_LIGAND_BINDING,3.262946188,0,androstenedione
SIGNALING_BY_GPCR,3.144753594,0,androstenedione
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.901764546,0,androstenedione
G_ALPHA_S_SIGNALLING_EVENTS,2.747424757,0,androstenedione
MYD88_INDEPENDENT_TLR4_CASCADE,-2.592598698,0,androstenedione
G_ALPHA_Q_SIGNALLING_EVENTS,2.510274493,0.000265551,androstenedione
G_ALPHA_I_SIGNALLING_EVENTS,2.293878201,0.003319384,androstenedione
COLLAGEN_DEGRADATION,2.274539398,0.003414223,androstenedione
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.270102355,0.003153414,androstenedione
PROTEIN_LOCALIZATION,-2.22341341,0.039598416,androstenedione
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.229063359,0.018624525,trimebutine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.172961497,0.050494596,trimebutine
FATTY_ACID_METABOLISM,1.907230554,0.133083216,trimebutine
SIGNALING_BY_NTRKS,1.832426932,0.140357861,trimebutine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.815095246,0.116608284,trimebutine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.646483874,0.231761638,trimebutine
GASTRULATION,-1.823161059,0.704110521,trimebutine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.609816273,0.233644488,trimebutine
PROTEIN_LOCALIZATION,1.588320409,0.223496663,trimebutine
INTERLEUKIN_1_SIGNALING,-1.770699966,0.710836044,trimebutine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.638149678,0.010882528,alimemazine
RESPIRATORY_ELECTRON_TRANSPORT,2.207245044,0.051147883,alimemazine
CELL_CYCLE_CHECKPOINTS,2.055091052,0.075452196,alimemazine
MITOTIC_METAPHASE_AND_ANAPHASE,2.002025712,0.075089445,alimemazine
RHO_GTPASES_ACTIVATE_FORMINS,1.964595112,0.068777579,alimemazine
MITOTIC_SPINDLE_CHECKPOINT,1.88713315,0.091413238,alimemazine
CELL_CYCLE_MITOTIC,1.864225479,0.086127438,alimemazine
M_PHASE,1.829000439,0.092501491,alimemazine
COLLAGEN_FORMATION,1.811124621,0.091413238,alimemazine
TRANSLATION,1.791537159,0.091195587,alimemazine
TRANSLATION,4.756751627,0,ramipril
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.044100088,0,ramipril
NONSENSE_MEDIATED_DECAY_NMD,3.191624661,0,ramipril
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.301139856,0,ramipril
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.403880445,0,ramipril
RRNA_PROCESSING,3.445559416,0,ramipril
CELLULAR_RESPONSE_TO_STARVATION,3.397103585,0,ramipril
SELENOAMINO_ACID_METABOLISM,3.487636333,0,ramipril
EUKARYOTIC_TRANSLATION_ELONGATION,4.01368421,0,ramipril
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.026729205,0,ramipril
S_PHASE,-2.728440708,0,clofibrate
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.618756207,0.000702242,clofibrate
HOST_INTERACTIONS_OF_HIV_FACTORS,-2.589042787,0.000468162,clofibrate
HIV_INFECTION,-2.546400965,0.000351121,clofibrate
SYNTHESIS_OF_DNA,-2.507515798,0.000280897,clofibrate
METABOLISM_OF_RNA,-2.453182065,0.000936323,clofibrate
PROTEASOME_ASSEMBLY,-2.452280767,0.001003203,clofibrate
DNA_REPLICATION,-2.426388924,0.001053363,clofibrate
UCH_PROTEINASES,-2.415856411,0.001248431,clofibrate
CELL_CYCLE,-2.343800085,0.002387624,clofibrate
NEUTROPHIL_DEGRANULATION,-1.941341706,0.389814464,carteolol
NEURONAL_SYSTEM,1.917667333,0.59582837,carteolol
SIGNALING_BY_NTRKS,-1.738937605,0.588922283,carteolol
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-1.628872731,0.704578443,carteolol
COLLAGEN_FORMATION,-1.622513544,0.547336473,carteolol
ESR_MEDIATED_SIGNALING,-1.600157179,0.498021583,carteolol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.546249639,0.550556923,carteolol
TRANSLATION,-1.524440394,0.527593715,carteolol
SENSORY_PERCEPTION,1.74687588,1,carteolol
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.502788446,0.51625213,carteolol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.791134068,0.002244941,PD-407824
EUKARYOTIC_TRANSLATION_INITIATION,2.627108565,0.001122471,PD-407824
CELLULAR_RESPONSE_TO_STARVATION,2.406031114,0.00598651,PD-407824
AUTOPHAGY,2.353840088,0.007296059,PD-407824
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,2.328712171,0.006734824,PD-407824
SARS_COV_1_HOST_INTERACTIONS,2.318186503,0.006360667,PD-407824
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,2.293769258,0.00705553,PD-407824
EXTRACELLULAR_MATRIX_ORGANIZATION,2.291178381,0.006454206,PD-407824
SARS_COV_1_INFECTION,2.183312643,0.016213465,PD-407824
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.167417298,0.015714589,PD-407824
GPCR_LIGAND_BINDING,2.865349553,0,ropivacaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.63765232,0,ropivacaine
G_ALPHA_Q_SIGNALLING_EVENTS,2.416221794,0.001586783,ropivacaine
SIGNALING_BY_GPCR,2.362680753,0.002142156,ropivacaine
SENSORY_PERCEPTION,2.24806699,0.005712417,ropivacaine
CARDIAC_CONDUCTION,1.924996391,0.072198607,ropivacaine
RAB_REGULATION_OF_TRAFFICKING,-1.898183748,0.567682495,ropivacaine
GASTRULATION,1.864280527,0.095887005,ropivacaine
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-1.830846568,0.445428774,ropivacaine
RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,-1.817565055,0.322466336,ropivacaine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.375911372,0.008632536,bromfenac
TRANSLATION,1.975823209,0.067827067,bromfenac
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.975568855,0.045218045,bromfenac
DISEASES_OF_METABOLISM,1.839532219,0.067210458,bromfenac
SYNTHESIS_OF_DNA,1.69412297,0.12578838,bromfenac
S_PHASE,1.684543498,0.110373137,bromfenac
DNA_REPLICATION,1.676675885,0.09812903,bromfenac
G_ALPHA_Q_SIGNALLING_EVENTS,1.597711651,0.137812269,bromfenac
SIGNALING_BY_ALK_IN_CANCER,-1.842224342,0.917183563,bromfenac
METABOLISM_OF_STEROIDS,-1.817688706,0.54856865,bromfenac
CELL_CYCLE_MITOTIC,-3.345188996,0,topotecan
RHO_GTPASE_EFFECTORS,-2.60192903,0,topotecan
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.620227363,0,topotecan
GPCR_LIGAND_BINDING,2.63223936,0,topotecan
AURKA_ACTIVATION_BY_TPX2,-2.662879458,0,topotecan
MITOTIC_SPINDLE_CHECKPOINT,-2.688652159,0,topotecan
CHROMATIN_ORGANIZATION,-2.713250095,0,topotecan
SEPARATION_OF_SISTER_CHROMATIDS,-2.725836223,0,topotecan
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,-2.730902902,0,topotecan
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-2.766657055,0,topotecan
RESPIRATORY_ELECTRON_TRANSPORT,2.318764943,0.020368574,diflunisal
GPCR_LIGAND_BINDING,-2.249578412,0.005021252,diflunisal
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.135081231,0.008368754,diflunisal
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1.995731411,0.074684772,diflunisal
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.058354637,0.014226881,diflunisal
SIGNALING_BY_GPCR,-2.040825504,0.012343912,diflunisal
G_ALPHA_S_SIGNALLING_EVENTS,-1.991078338,0.020921884,diflunisal
TOLL_LIKE_RECEPTOR_CASCADES,1.766041056,0.176527643,diflunisal
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.72084311,0.162948594,diflunisal
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.70470397,0.139185257,diflunisal
GPCR_LIGAND_BINDING,-1.888999951,0.557069245,MEK-162
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.791850008,0.99168078,MEK-162
REGULATION_OF_TP53_ACTIVITY,1.774696888,0.54456459,MEK-162
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.762476897,0.393615107,MEK-162
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.786185715,0.651625545,MEK-162
PEROXISOMAL_PROTEIN_IMPORT,1.610284755,0.66924122,MEK-162
NEUTROPHIL_DEGRANULATION,1.537019923,0.769842363,MEK-162
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.709255093,0.774135141,MEK-162
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.696323077,0.633655569,MEK-162
DEUBIQUITINATION,1.47565592,0.858166918,MEK-162
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.008261177,0.155578301,D-serine
VISUAL_PHOTOTRANSDUCTION,1.817297863,0.248038212,D-serine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.780819054,0.201296486,D-serine
CELL_CYCLE_MITOTIC,-1.787230893,1,D-serine
CELL_CYCLE,-1.776248697,1,D-serine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.605951364,0.299147049,D-serine
KERATINIZATION,1.605951364,0.299147049,D-serine
M_PHASE,-1.70501649,1,D-serine
NERVOUS_SYSTEM_DEVELOPMENT,-1.695690817,1,D-serine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.506417939,0.412942113,D-serine
S_PHASE,-2.213175318,0.036617604,epinephrine
SYNTHESIS_OF_DNA,-2.077920411,0.045592507,epinephrine
DNA_REPLICATION,-2.077920411,0.045592507,epinephrine
PROTEIN_FOLDING,-2.054267214,0.042002546,epinephrine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.99928785,0.055787996,epinephrine
MITOTIC_METAPHASE_AND_ANAPHASE,-1.947155105,0.079158644,epinephrine
SEPARATION_OF_SISTER_CHROMATIDS,-1.916648819,0.091851721,epinephrine
CELL_CYCLE_MITOTIC,-1.892125171,0.102448517,epinephrine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.881755573,0.098125605,epinephrine
DNA_REPLICATION_PRE_INITIATION,-1.829677379,0.13031559,epinephrine
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-2.146185322,0.092419286,mazindol
PEROXISOMAL_PROTEIN_IMPORT,2.118020985,0.057817733,mazindol
MUSCLE_CONTRACTION,2.017205997,0.06373091,mazindol
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.988230748,0.213232448,mazindol
CELL_CYCLE_MITOTIC,-1.845656286,0.471746634,mazindol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.819512878,0.430918838,mazindol
BIOLOGICAL_OXIDATIONS,1.646891452,0.38764162,mazindol
SIGNALING_BY_HEDGEHOG,-1.766562653,0.515321028,mazindol
CELL_CYCLE,-1.731674686,0.540040404,mazindol
VISUAL_PHOTOTRANSDUCTION,1.541905889,0.486523084,mazindol
INTERFERON_ALPHA_BETA_SIGNALING,-3.590848036,0,ponatinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.186485269,0.035507641,ponatinib
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.184681755,0.01775382,ponatinib
NONSENSE_MEDIATED_DECAY_NMD,2.175517272,0.013435324,ponatinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.161641973,0.011276075,ponatinib
DEVELOPMENTAL_CELL_LINEAGES,2.060550677,0.026102914,ponatinib
SARS_COV_1_INFECTION,2.055590173,0.023031983,ponatinib
INTERFERON_SIGNALING,-2.141971959,0.122319895,ponatinib
EUKARYOTIC_TRANSLATION_INITIATION,2.016399389,0.029064169,ponatinib
RESPIRATORY_ELECTRON_TRANSPORT,-2.111549519,0.100249945,ponatinib
GPCR_LIGAND_BINDING,2.729426906,0.001038252,tibolone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.515214253,0.00259563,tibolone
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.390564721,0.004153007,tibolone
SENSORY_PERCEPTION,2.278769085,0.008565577,tibolone
G_ALPHA_Q_SIGNALLING_EVENTS,2.216115132,0.011005469,tibolone
SIGNALING_BY_GPCR,2.182197732,0.011939896,tibolone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.117253459,0.019578463,tibolone
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,2.06574798,0.026734984,tibolone
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.030379734,0.03080147,tibolone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.02158498,0.246873618,tibolone
ESR_MEDIATED_SIGNALING,-2.070116698,0.028998077,amlexanox
G_ALPHA_Q_SIGNALLING_EVENTS,-1.930380507,0.077994827,amlexanox
INTERLEUKIN_2_FAMILY_SIGNALING,-1.896808672,0.072661847,amlexanox
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-1.8740954,0.070995291,amlexanox
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.634456751,0.294318845,amlexanox
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.628995057,0.153666472,amlexanox
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.792796931,0.131391285,amlexanox
SIGNALING_BY_ALK_IN_CANCER,-1.774515992,0.134824391,amlexanox
POTASSIUM_CHANNELS,-1.753347961,0.13970502,amlexanox
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.741761392,0.137615872,amlexanox
RRNA_PROCESSING,2.503610869,0.01128448,methylene-blue
RESPIRATORY_ELECTRON_TRANSPORT,2.153617288,0.062064642,methylene-blue
INFLUENZA_INFECTION,2.146678132,0.043525853,methylene-blue
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.040767732,0.057228436,methylene-blue
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.824056745,0.166687896,methylene-blue
CELLULAR_RESPONSE_TO_STARVATION,1.820893262,0.141593361,methylene-blue
PEPTIDE_HORMONE_METABOLISM,-1.901003097,0.604272262,methylene-blue
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.734738066,0.195520894,methylene-blue
CELL_JUNCTION_ORGANIZATION,-1.860234017,0.41543718,methylene-blue
EXTRACELLULAR_MATRIX_ORGANIZATION,1.588628877,0.378836126,methylene-blue
EUKARYOTIC_TRANSLATION_ELONGATION,3.477643779,0,guanfacine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.617505451,0,guanfacine
SIGNALING_BY_ROBO_RECEPTORS,2.663730888,0,guanfacine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.766270098,0,guanfacine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.767553489,0,guanfacine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.879486284,0,guanfacine
RRNA_PROCESSING,2.952051158,0,guanfacine
CELLULAR_RESPONSE_TO_STARVATION,3.078531783,0,guanfacine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.785913674,0,guanfacine
INFLUENZA_INFECTION,3.159119545,0,guanfacine
CELL_CYCLE_CHECKPOINTS,2.601537252,0.007684833,homatropine
MITOTIC_METAPHASE_AND_ANAPHASE,2.50402776,0.005123222,homatropine
HOST_INTERACTIONS_OF_HIV_FACTORS,2.454414101,0.004269352,homatropine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.366072503,0.009606042,homatropine
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,2.337817279,0.009734122,homatropine
TRANSLATION,2.322535488,0.008965639,homatropine
CELL_CYCLE_MITOTIC,2.273993008,0.010612389,homatropine
M_PHASE,2.235376155,0.012487854,homatropine
CELL_CYCLE,2.202133678,0.01394655,homatropine
SEPARATION_OF_SISTER_CHROMATIDS,2.170230922,0.014857345,homatropine
TRANSLATION,2.768955888,0.001230346,tocainide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.52112548,0.001845519,tocainide
RESPIRATORY_ELECTRON_TRANSPORT,2.243671953,0.020505762,tocainide
SYNTHESIS_OF_DNA,2.121236114,0.038448305,tocainide
MUSCLE_CONTRACTION,2.116307727,0.030758644,tocainide
DNA_REPLICATION,2.081748708,0.03280922,tocainide
EUKARYOTIC_TRANSLATION_INITIATION,2.036733368,0.039371064,tocainide
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.001448131,0.043062101,tocainide
DNA_REPLICATION_PRE_INITIATION,1.914748767,0.07341063,tocainide
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-1.914181039,0.593027313,tocainide
SENSORY_PERCEPTION,2.031913368,0.185065132,zopiclone
GLYCOSAMINOGLYCAN_METABOLISM,2.012369775,0.108942282,zopiclone
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-2.002702742,0.439196945,zopiclone
NEUTROPHIL_DEGRANULATION,-1.953326636,0.290251894,zopiclone
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.947732199,0.199442091,zopiclone
L1CAM_INTERACTIONS,1.937454188,0.129150544,zopiclone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.936787203,0.097546646,zopiclone
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.869513424,0.229782749,zopiclone
TRNA_PROCESSING,-1.804207107,0.25333389,zopiclone
GPCR_LIGAND_BINDING,1.848915031,0.167196775,zopiclone
ASPARAGINE_N_LINKED_GLYCOSYLATION,2.094413912,0.185114504,dequalinium
GPCR_LIGAND_BINDING,-2.082697813,0.098313343,dequalinium
RESPIRATORY_ELECTRON_TRANSPORT,1.994782919,0.164122137,dequalinium
TRANSLATION,1.928096459,0.153307888,dequalinium
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.946585014,0.171476762,dequalinium
SIGNALING_BY_NTRKS,1.710515029,0.394561069,dequalinium
SARS_COV_1_INFECTION,1.686026852,0.355343511,dequalinium
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.681002184,0.304707379,dequalinium
GASTRULATION,-1.792570238,0.408495752,dequalinium
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.778345247,0.344096702,dequalinium
MRNA_SPLICING,1.978334471,0.071116432,LY-215490
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.828445065,0.092846453,LY-215490
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.562315521,0.269979048,LY-215490
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.412065146,1,LY-215490
G_ALPHA_I_SIGNALLING_EVENTS,-2.349154016,0.777365514,LY-215490
EUKARYOTIC_TRANSLATION_ELONGATION,-2.35083149,1,LY-215490
SELENOAMINO_ACID_METABOLISM,-2.314774796,0.630607931,LY-215490
NONSENSE_MEDIATED_DECAY_NMD,-2.268384667,0.543338269,LY-215490
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.26185167,0.456215773,LY-215490
EUKARYOTIC_TRANSLATION_INITIATION,-2.253466158,0.396928746,LY-215490
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.868231614,0,ripasudil
SELENOAMINO_ACID_METABOLISM,4.673905507,0,ripasudil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.636483911,0,ripasudil
EUKARYOTIC_TRANSLATION_ELONGATION,4.60980243,0,ripasudil
INFLUENZA_INFECTION,4.488370058,0,ripasudil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,4.466012084,0,ripasudil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,4.414839597,0,ripasudil
NONSENSE_MEDIATED_DECAY_NMD,4.366395724,0,ripasudil
EUKARYOTIC_TRANSLATION_INITIATION,4.340403498,0,ripasudil
CELLULAR_RESPONSE_TO_STARVATION,4.295513008,0,ripasudil
INFLUENZA_INFECTION,2.14740544,0.09200866,relcovaptan
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.074890393,0.134685427,relcovaptan
ESTROGEN_DEPENDENT_GENE_EXPRESSION,2.014075599,0.125011766,relcovaptan
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.886903264,0.173349649,relcovaptan
BIOLOGICAL_OXIDATIONS,1.881363145,0.133012519,relcovaptan
GPCR_LIGAND_BINDING,-1.981171667,0.149693232,relcovaptan
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.739220483,0.255624059,relcovaptan
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.900572347,0.195486277,relcovaptan
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.718173448,0.237355673,relcovaptan
SIGNALING_BY_NTRKS,1.70506666,0.217163296,relcovaptan
TRANSLATION,3.39012822,0,testosterone
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.697573965,0,testosterone
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,2.737057609,0,testosterone
ORC1_REMOVAL_FROM_CHROMATIN,2.741732513,0,testosterone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.745037932,0,testosterone
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.755995715,0,testosterone
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.755995715,0,testosterone
NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,2.760446199,0,testosterone
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,2.77347291,0,testosterone
UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D,2.77347291,0,testosterone
EUKARYOTIC_TRANSLATION_INITIATION,3.131095898,0,piperine
EUKARYOTIC_TRANSLATION_ELONGATION,2.905868728,0,piperine
SELENOAMINO_ACID_METABOLISM,2.855903699,0,piperine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.825379277,0,piperine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.804107137,0,piperine
INFLUENZA_INFECTION,2.591979906,0,piperine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.588576198,0,piperine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.550553488,0,piperine
NONSENSE_MEDIATED_DECAY_NMD,2.525624108,0,piperine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.466327725,0,piperine
EUKARYOTIC_TRANSLATION_INITIATION,3.037365564,0,midazolam
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.020668859,0,midazolam
SELENOAMINO_ACID_METABOLISM,2.993819722,0,midazolam
EUKARYOTIC_TRANSLATION_ELONGATION,2.963776419,0,midazolam
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.948872279,0,midazolam
SIGNALING_BY_ROBO_RECEPTORS,2.848860723,0,midazolam
RRNA_PROCESSING,2.847353646,0,midazolam
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.823258255,0,midazolam
TRANSLATION,2.781437839,0,midazolam
INFLUENZA_INFECTION,2.639014711,0.000148026,midazolam
EUKARYOTIC_TRANSLATION_ELONGATION,3.354457059,0,TG-100115
SELENOAMINO_ACID_METABOLISM,3.271543568,0,TG-100115
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.182805303,0,TG-100115
EUKARYOTIC_TRANSLATION_INITIATION,3.131197026,0,TG-100115
NONSENSE_MEDIATED_DECAY_NMD,3.040342826,0,TG-100115
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.016358587,0,TG-100115
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.892013825,0,TG-100115
CELLULAR_RESPONSE_TO_STARVATION,2.889083169,0,TG-100115
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.876831511,0,TG-100115
RRNA_PROCESSING,2.729081372,0,TG-100115
RESPIRATORY_ELECTRON_TRANSPORT,-2.436419736,0.017446003,veliparib
GPCR_LIGAND_BINDING,2.161514104,0.029360389,veliparib
ISG15_ANTIVIRAL_MECHANISM,-2.19109396,0.062805612,veliparib
SIGNALING_BY_GPCR,2.067057671,0.041593884,veliparib
CELL_CYCLE_CHECKPOINTS,-2.136534491,0.059316412,veliparib
INTERFERON_ALPHA_BETA_SIGNALING,-2.113288636,0.05190186,veliparib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.043865984,0.035069354,veliparib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.045289528,0.060712092,veliparib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.004760625,0.038535511,veliparib
CELL_CYCLE,-2.03641773,0.05233801,veliparib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.213223223,0.07243315,efaproxiral
MRNA_SPLICING,2.166389253,0.043007183,efaproxiral
PEPTIDE_HORMONE_METABOLISM,1.758210141,0.354620631,efaproxiral
L1CAM_INTERACTIONS,1.629607029,0.500241444,efaproxiral
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.561208056,0.58942476,efaproxiral
UB_SPECIFIC_PROCESSING_PROTEASES,1.424653086,0.950685097,efaproxiral
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.28918545,1,efaproxiral
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.270063577,0.832727842,efaproxiral
G_ALPHA_I_SIGNALLING_EVENTS,-2.146226375,0.670065189,efaproxiral
UCH_PROTEINASES,1.348113518,1,efaproxiral
GPCR_LIGAND_BINDING,-3.121127882,0,cefdinir
G_ALPHA_S_SIGNALLING_EVENTS,-2.540517474,0,cefdinir
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.587827477,0,cefdinir
NONSENSE_MEDIATED_DECAY_NMD,-2.605401609,0,cefdinir
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.612033486,0,cefdinir
SIGNALING_BY_ROBO_RECEPTORS,-2.612476253,0,cefdinir
G_ALPHA_Q_SIGNALLING_EVENTS,-2.654074461,0,cefdinir
RRNA_PROCESSING,-2.656681996,0,cefdinir
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.701980767,0,cefdinir
SELENOAMINO_ACID_METABOLISM,-2.708725568,0,cefdinir
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.247536076,0.054471574,bexarotene
SEPARATION_OF_SISTER_CHROMATIDS,-2.202647651,0.04357726,bexarotene
CELL_CYCLE_MITOTIC,-2.192410243,0.033590804,bexarotene
MITOTIC_METAPHASE_AND_ANAPHASE,-2.153646232,0.034725629,bexarotene
M_PHASE,-2.038898758,0.075443131,bexarotene
MITOTIC_PROMETAPHASE,-2.033880403,0.06491196,bexarotene
DNA_REPLICATION,-2.001335517,0.073536626,bexarotene
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.953860031,0.266853354,bexarotene
DNA_REPLICATION_PRE_INITIATION,-1.960519796,0.086643848,bexarotene
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.956194867,0.079286403,bexarotene
METABOLISM_OF_RNA,5.749583178,0,fasudil
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.641372837,0,fasudil
INFECTIOUS_DISEASE,2.683822018,0,fasudil
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.695548461,0,fasudil
RESPIRATORY_ELECTRON_TRANSPORT,2.817600586,0,fasudil
CELL_CYCLE,2.854035433,0,fasudil
MITOTIC_SPINDLE_CHECKPOINT,2.911976384,0,fasudil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.950613191,0,fasudil
SARS_COV_1_INFECTION,2.974363716,0,fasudil
CELL_CYCLE_CHECKPOINTS,3.065707128,0,fasudil
EUKARYOTIC_TRANSLATION_INITIATION,2.5415078,0.001210286,tubocurarine
EUKARYOTIC_TRANSLATION_ELONGATION,2.438812854,0.003025714,tubocurarine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.381225211,0.003227428,tubocurarine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.329399713,0.004236,tubocurarine
RRNA_PROCESSING,2.220365285,0.01089257,tubocurarine
TRANSLATION,2.212022854,0.010085713,tubocurarine
NONSENSE_MEDIATED_DECAY_NMD,2.198907699,0.010546775,tubocurarine
SIGNALING_BY_ROBO_RECEPTORS,2.17742323,0.011648999,tubocurarine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.146285504,0.01371657,tubocurarine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.991281125,0.043812339,tubocurarine
NONSENSE_MEDIATED_DECAY_NMD,4.298464083,0,GW-501516
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.136360343,0,GW-501516
SIGNALING_BY_ROBO_RECEPTORS,3.440761081,0,GW-501516
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.560104147,0,GW-501516
METABOLISM_OF_RNA,3.560200777,0,GW-501516
INFLUENZA_INFECTION,3.738618004,0,GW-501516
RRNA_PROCESSING,3.767166412,0,GW-501516
CELLULAR_RESPONSE_TO_STARVATION,3.644416155,0,GW-501516
SELENOAMINO_ACID_METABOLISM,3.922747798,0,GW-501516
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.984458874,0,GW-501516
EUKARYOTIC_TRANSLATION_INITIATION,2.155706189,0.09298076,benzonatate
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.118484811,0.064870297,benzonatate
COLLAGEN_FORMATION,2.053021071,0.085052168,benzonatate
EUKARYOTIC_TRANSLATION_ELONGATION,2.025771974,0.077033478,benzonatate
EXTRACELLULAR_MATRIX_ORGANIZATION,2.007749683,0.071789796,benzonatate
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-1.956261476,0.396455898,benzonatate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,1.932465268,0.104693452,benzonatate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.925235676,0.095452009,benzonatate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.916933299,0.087169462,benzonatate
INFLUENZA_INFECTION,1.914781787,0.078925529,benzonatate
TCR_SIGNALING,-2.191912625,0.104386383,esmolol
EUKARYOTIC_TRANSLATION_INITIATION,2.138772704,0.08093729,esmolol
RESPIRATORY_ELECTRON_TRANSPORT,2.106909574,0.052857006,esmolol
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.090607608,0.119047392,esmolol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.062383817,0.053407599,esmolol
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.018712215,0.141527606,esmolol
GPCR_LIGAND_BINDING,1.940404189,0.098900413,esmolol
TRANSLATION,1.936084102,0.081267646,esmolol
CILIUM_ASSEMBLY,-1.951376466,0.180330409,esmolol
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.943844902,0.150363307,esmolol
TRANSLATION,3.500387102,0,isradipine
SARS_COV_2_HOST_INTERACTIONS,2.463678393,0.001333387,isradipine
SARS_COV_2_INFECTION,2.42920137,0.00177785,isradipine
SARS_COV_INFECTIONS,2.290156251,0.006000242,isradipine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.281214755,0.005866904,isradipine
VIRAL_INFECTION_PATHWAYS,2.245861757,0.007555861,isradipine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.204619716,0.014411483,isradipine
NEDDYLATION,2.125389476,0.012190969,isradipine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.023603643,0.022667583,isradipine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.995397074,0.025186203,isradipine
RESPIRATORY_ELECTRON_TRANSPORT,2.362445652,0.036578117,oxybutynin
CELLULAR_RESPONSE_TO_STARVATION,2.147525116,0.05943944,oxybutynin
TRANSLATION,2.052058781,0.079862222,oxybutynin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.977849243,0.095103105,oxybutynin
INFLUENZA_INFECTION,1.909393049,0.103881853,oxybutynin
ANTIGEN_PROCESSING_CROSS_PRESENTATION,1.783564789,0.172526786,oxybutynin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.696459237,0.241415573,oxybutynin
SIGNALING_BY_ROBO_RECEPTORS,1.692556884,0.214667825,oxybutynin
G1_S_DNA_DAMAGE_CHECKPOINTS,1.691726229,0.191628691,oxybutynin
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,1.645959292,0.219834484,oxybutynin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.20404619,0.009742095,norfloxacin
GPCR_LIGAND_BINDING,-2.174333143,0.007119223,norfloxacin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.126301584,0.010241689,norfloxacin
SIGNALING_BY_GPCR,-2.114283215,0.008243311,norfloxacin
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.955161246,0.232469874,norfloxacin
G_ALPHA_I_SIGNALLING_EVENTS,-2.075273335,0.009442338,norfloxacin
CELLULAR_RESPONSE_TO_STARVATION,1.836625803,0.237214157,norfloxacin
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.823207507,0.170794193,norfloxacin
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.799354128,0.144700636,norfloxacin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.779341322,0.126197931,norfloxacin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.629348609,0,etizolam
ECM_PROTEOGLYCANS,-2.338243406,0.003271277,etizolam
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.242856591,0.006542554,etizolam
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.161626561,0.011994683,etizolam
COLLAGEN_FORMATION,-2.091150157,0.021226954,etizolam
LEISHMANIA_INFECTION,1.945197082,0.549423644,etizolam
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.895015212,0.376682416,etizolam
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1.805843191,0.424623814,etizolam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.856645413,0.127337492,etizolam
COLLAGEN_DEGRADATION,-1.823392469,0.138535991,etizolam
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.163976204,0,aminoguanidine
GPCR_LIGAND_BINDING,-2.5090046,0,aminoguanidine
SIGNALING_BY_ROBO_RECEPTORS,-2.725341252,0,aminoguanidine
SARS_COV_1_INFECTION,-2.753137021,0,aminoguanidine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.812078658,0,aminoguanidine
INFLUENZA_INFECTION,-2.813293337,0,aminoguanidine
RRNA_PROCESSING,-2.841495346,0,aminoguanidine
TRANSLATION,-2.843291029,0,aminoguanidine
SARS_COV_1_HOST_INTERACTIONS,-2.867648755,0,aminoguanidine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.787908686,0,aminoguanidine
SELENOAMINO_ACID_METABOLISM,-3.492441577,0,levosimendan
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.904160632,0,levosimendan
SARS_COV_1_HOST_INTERACTIONS,-2.926724649,0,levosimendan
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.929254562,0,levosimendan
SIGNALING_BY_ROBO_RECEPTORS,-2.999233264,0,levosimendan
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.146993006,0,levosimendan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.162996002,0,levosimendan
TRANSLATION,-3.199477245,0,levosimendan
RRNA_PROCESSING,-3.182792379,0,levosimendan
CELLULAR_RESPONSE_TO_STARVATION,-3.313554219,0,levosimendan
REGULATION_OF_INSULIN_SECRETION,-1.991036275,0.163781138,dofequidar
ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,-1.967748631,0.10456084,dofequidar
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.934328766,0.099934254,dofequidar
INTEGRATION_OF_ENERGY_METABOLISM,-1.933514565,0.07518202,dofequidar
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.553955576,1,dofequidar
HOST_INTERACTIONS_OF_HIV_FACTORS,1.550020749,0.532041946,dofequidar
NEUTROPHIL_DEGRANULATION,1.47465792,0.508690164,dofequidar
GPCR_LIGAND_BINDING,-1.795063946,0.198573064,dofequidar
REGULATION_OF_BETA_CELL_DEVELOPMENT,-1.766681055,0.209430118,dofequidar
SIGNALING_BY_GPCR,-1.759997196,0.190086583,dofequidar
EUKARYOTIC_TRANSLATION_ELONGATION,3.508836072,0,macitentan
TRANSLATION,2.585062137,0,macitentan
RRNA_PROCESSING,2.63650564,0,macitentan
SIGNALING_BY_ROBO_RECEPTORS,2.867406987,0,macitentan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.042987146,0,macitentan
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.173880213,0,macitentan
EUKARYOTIC_TRANSLATION_INITIATION,3.26082435,0,macitentan
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.643932241,0,macitentan
INFLUENZA_INFECTION,3.352158389,0,macitentan
CELLULAR_RESPONSE_TO_STARVATION,3.353965016,0,macitentan
GPCR_LIGAND_BINDING,-2.793422397,0,ganaxolone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.61106528,0,ganaxolone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.555123728,0.000297187,ganaxolone
SIGNALING_BY_GPCR,-2.458336422,0.000668671,ganaxolone
G_ALPHA_I_SIGNALLING_EVENTS,-2.379087808,0.000891561,ganaxolone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.271505328,0.002228903,ganaxolone
EUKARYOTIC_TRANSLATION_INITIATION,-2.255735196,0.00216522,ganaxolone
RRNA_PROCESSING,-2.154530098,0.005572256,ganaxolone
G_ALPHA_S_SIGNALLING_EVENTS,-2.152785904,0.005151242,ganaxolone
HATS_ACETYLATE_HISTONES,2.169578243,0.098243525,ganaxolone
METABOLISM_OF_RNA,3.724419214,0,tipifarnib-P2
GPCR_LIGAND_BINDING,-2.458150282,0,tipifarnib-P2
SIGNALING_BY_ALK_IN_CANCER,2.561330583,0,tipifarnib-P2
TRANSLATION,2.643662263,0,tipifarnib-P2
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.700166147,0,tipifarnib-P2
SIGNALING_BY_ROBO_RECEPTORS,2.783662041,0,tipifarnib-P2
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.177045121,0,tipifarnib-P2
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.183256012,0,tipifarnib-P2
RRNA_PROCESSING,2.95715776,0,tipifarnib-P2
EUKARYOTIC_TRANSLATION_ELONGATION,3.253075709,0,tipifarnib-P2
EUKARYOTIC_TRANSLATION_ELONGATION,3.635509544,0,PP-1
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.520663902,0,PP-1
SELENOAMINO_ACID_METABOLISM,3.518731577,0,PP-1
EUKARYOTIC_TRANSLATION_INITIATION,3.505206927,0,PP-1
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.435411804,0,PP-1
CELLULAR_RESPONSE_TO_STARVATION,3.301484542,0,PP-1
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.863732134,0,PP-1
TRANSLATION,2.846638218,0,PP-1
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.801025762,0,PP-1
INFLUENZA_INFECTION,2.696374808,0,PP-1
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.035362092,0.132562403,VX-702
MUSCLE_CONTRACTION,1.942073337,0.119306163,VX-702
DNA_REPLICATION_PRE_INITIATION,1.765659251,0.233562329,VX-702
SENSORY_PERCEPTION,1.698671343,0.258733405,VX-702
EXTRACELLULAR_MATRIX_ORGANIZATION,1.658065994,0.254141064,VX-702
GASTRULATION,1.561461507,0.342926312,VX-702
PI_METABOLISM,-1.936636526,1,VX-702
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.812201388,1,VX-702
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,-1.789313111,1,VX-702
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-1.784422408,1,VX-702
GPCR_LIGAND_BINDING,2.548315176,0.002829098,BRD-K73589401
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.350833046,0.004243647,BRD-K73589401
G_ALPHA_S_SIGNALLING_EVENTS,2.173739886,0.022004097,BRD-K73589401
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.144857693,0.020982478,BRD-K73589401
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.156036656,0.118219073,BRD-K73589401
BIOLOGICAL_OXIDATIONS,2.088833272,0.02565049,BRD-K73589401
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,2.043222601,0.030334219,BRD-K73589401
MUSCLE_CONTRACTION,1.963223091,0.049711296,BRD-K73589401
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.963561502,0.22259267,BRD-K73589401
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.94092653,0.050923766,BRD-K73589401
COMPLEMENT_CASCADE,2.186838283,0.054399363,chlordiazepoxide
SYNTHESIS_OF_DNA,2.159355225,0.033703953,chlordiazepoxide
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.172248396,0.059184935,chlordiazepoxide
DNA_REPLICATION,2.078856333,0.046909596,chlordiazepoxide
S_PHASE,2.034462878,0.04819074,chlordiazepoxide
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.056247574,0.078779947,chlordiazepoxide
GPCR_LIGAND_BINDING,2.001399966,0.053926325,chlordiazepoxide
DNA_REPLICATION_PRE_INITIATION,1.881901741,0.114514602,chlordiazepoxide
CARDIAC_CONDUCTION,1.852002371,0.121976212,chlordiazepoxide
SENSORY_PERCEPTION,1.845291888,0.111163916,chlordiazepoxide
PEROXISOMAL_PROTEIN_IMPORT,2.254066631,0.037307484,betrixaban
GASTRULATION,-2.108961135,0.076182458,betrixaban
SIGNALING_BY_HEDGEHOG,-2.082408518,0.054672117,betrixaban
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.058181222,0.046904494,betrixaban
CELL_CYCLE_MITOTIC,-1.924269235,0.116290281,betrixaban
DNA_REPLICATION,-1.91981638,0.079767514,betrixaban
SYNTHESIS_OF_DNA,-1.91981638,0.079767514,betrixaban
S_PHASE,-1.912297332,0.072725439,betrixaban
MITOTIC_METAPHASE_AND_ANAPHASE,-1.892728744,0.074613995,betrixaban
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.777100315,0.580753165,betrixaban
EXTRACELLULAR_MATRIX_ORGANIZATION,-3.595032524,0,linsitinib
ECM_PROTEOGLYCANS,-3.149377047,0,linsitinib
COLLAGEN_FORMATION,-2.92494444,0,linsitinib
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.922931074,0,linsitinib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.84884266,0,linsitinib
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.848679337,0,linsitinib
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.754318745,0,linsitinib
COLLAGEN_DEGRADATION,-2.683226893,0,linsitinib
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.657703071,0,linsitinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.572940352,0.001147617,linsitinib
EUKARYOTIC_TRANSLATION_ELONGATION,-3.375977317,0,trovafloxacin
SELENOAMINO_ACID_METABOLISM,-3.32920154,0,trovafloxacin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.261188654,0,trovafloxacin
NONSENSE_MEDIATED_DECAY_NMD,-3.234156826,0,trovafloxacin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.226812869,0,trovafloxacin
EUKARYOTIC_TRANSLATION_INITIATION,-3.098164429,0,trovafloxacin
CELLULAR_RESPONSE_TO_STARVATION,-3.082838232,0,trovafloxacin
RRNA_PROCESSING,-3.081910885,0,trovafloxacin
TRANSLATION,-2.92605241,0.000190363,trovafloxacin
INFLUENZA_INFECTION,-2.991337045,0.000116333,trovafloxacin
EUKARYOTIC_TRANSLATION_INITIATION,5.709710561,0,calcipotriol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.848488175,0,calcipotriol
KEAP1_NFE2L2_PATHWAY,2.850596071,0,calcipotriol
NERVOUS_SYSTEM_DEVELOPMENT,2.85421426,0,calcipotriol
SARS_COV_INFECTIONS,2.888461238,0,calcipotriol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.317695321,0,calcipotriol
RESPIRATORY_ELECTRON_TRANSPORT,3.443374159,0,calcipotriol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.846752241,0,calcipotriol
METABOLISM_OF_RNA,3.855478553,0,calcipotriol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.891050404,0,calcipotriol
EUKARYOTIC_TRANSLATION_ELONGATION,3.122651935,0,phenolphthalein
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.588753481,0,phenolphthalein
METABOLISM_OF_RNA,2.642304943,0,phenolphthalein
INFLUENZA_INFECTION,2.871427567,0,phenolphthalein
CELLULAR_RESPONSE_TO_STARVATION,2.934342384,0,phenolphthalein
TRANSLATION,2.952841486,0,phenolphthalein
SELENOAMINO_ACID_METABOLISM,2.95377123,0,phenolphthalein
RRNA_PROCESSING,2.913085589,0,phenolphthalein
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.987362113,0,phenolphthalein
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.02010487,0,phenolphthalein
TRANSLATION,-4.313574531,0,ifosfamide
METABOLISM_OF_RNA,-4.072346432,0,ifosfamide
MRNA_SPLICING,-3.300938113,0,ifosfamide
RRNA_PROCESSING,-3.220389404,0,ifosfamide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.117297783,0,ifosfamide
MITOTIC_METAPHASE_AND_ANAPHASE,-2.958464126,0,ifosfamide
SEPARATION_OF_SISTER_CHROMATIDS,-2.795739695,0.000458926,ifosfamide
CELL_CYCLE,-2.775268696,0.00040156,ifosfamide
DNA_REPAIR,-2.455967165,0.000642497,ifosfamide
VIRAL_INFECTION_PATHWAYS,-2.607631014,0.000713885,ifosfamide
EUKARYOTIC_TRANSLATION_ELONGATION,3.260473887,0,pilocarpine
CELLULAR_RESPONSE_TO_STARVATION,3.170173931,0,pilocarpine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.164909438,0,pilocarpine
NONSENSE_MEDIATED_DECAY_NMD,3.10083301,0,pilocarpine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.074488294,0,pilocarpine
EUKARYOTIC_TRANSLATION_INITIATION,3.024150291,0,pilocarpine
SELENOAMINO_ACID_METABOLISM,3.012085222,0,pilocarpine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.927475661,0,pilocarpine
INFLUENZA_INFECTION,2.906894706,0,pilocarpine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.778978079,0,pilocarpine
EUKARYOTIC_TRANSLATION_ELONGATION,4.049083276,0,R-547
CELL_CYCLE_MITOTIC,-2.516746546,0,R-547
CELL_CYCLE,-2.556621508,0,R-547
SIGNALING_BY_ROBO_RECEPTORS,2.88966489,0,R-547
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.962230496,0,R-547
INFLUENZA_INFECTION,2.972520276,0,R-547
NONSENSE_MEDIATED_DECAY_NMD,3.070631279,0,R-547
TRANSLATION,2.766579843,0,R-547
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.492182392,0,R-547
NEUTROPHIL_DEGRANULATION,3.532933256,0,R-547
METABOLISM_OF_RNA,3.373484948,0,dosulepin
MRNA_SPLICING,3.184765292,0,dosulepin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.898359345,0,dosulepin
HOST_INTERACTIONS_OF_HIV_FACTORS,2.543004548,0.001932032,dosulepin
MITOTIC_METAPHASE_AND_ANAPHASE,1.612888551,0.224888537,dosulepin
G_ALPHA_Q_SIGNALLING_EVENTS,-1.857334497,0.334753473,dosulepin
INTERFERON_ALPHA_BETA_SIGNALING,-1.8492875,0.185460153,dosulepin
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.542253997,0.277568612,dosulepin
RESPIRATORY_ELECTRON_TRANSPORT,1.525705698,0.264412393,dosulepin
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.501285605,0.260341326,dosulepin
EUKARYOTIC_TRANSLATION_INITIATION,4.765398583,0,dinoprostone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.692172004,0,dinoprostone
CELL_CYCLE,2.746688589,0,dinoprostone
MITOTIC_G2_G2_M_PHASES,2.766052168,0,dinoprostone
M_PHASE,2.804030089,0,dinoprostone
CELL_CYCLE_MITOTIC,2.872323941,0,dinoprostone
NERVOUS_SYSTEM_DEVELOPMENT,2.955965974,0,dinoprostone
VIRAL_INFECTION_PATHWAYS,3.021199708,0,dinoprostone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.037662897,0,dinoprostone
CELLULAR_RESPONSES_TO_STIMULI,3.216344035,0,dinoprostone
CHOLESTEROL_BIOSYNTHESIS,2.201597935,0.029809914,astemizole
CARDIAC_CONDUCTION,2.082824418,0.057696608,astemizole
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.125059137,0.165145134,astemizole
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1.925019377,0.154178159,astemizole
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.902694502,0.140154678,astemizole
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.88181589,0.132509877,astemizole
SENSORY_PERCEPTION,1.871730402,0.118758852,astemizole
NEUTROPHIL_DEGRANULATION,-1.880172969,0.451502561,astemizole
METABOLISM_OF_RNA,-1.863372563,0.329584519,astemizole
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.852172883,0.118140674,astemizole
SIGNALING_BY_NOTCH,2.077290959,0.103587597,hydrochlorothiazide
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.036639909,0.413280913,hydrochlorothiazide
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.892579945,0.504353454,hydrochlorothiazide
EUKARYOTIC_TRANSLATION_INITIATION,1.781492491,0.46836392,hydrochlorothiazide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.721519432,0.445426666,hydrochlorothiazide
ION_CHANNEL_TRANSPORT,-1.648195963,1,hydrochlorothiazide
DEUBIQUITINATION,-1.631274743,1,hydrochlorothiazide
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-1.628328281,0.952932828,hydrochlorothiazide
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.599726553,0.916378194,hydrochlorothiazide
GPCR_LIGAND_BINDING,1.561015928,0.859962031,hydrochlorothiazide
GPCR_LIGAND_BINDING,2.353469618,0.009924932,OSI-930
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.234697602,0.012819703,OSI-930
INTERFERON_ALPHA_BETA_SIGNALING,-2.741956177,0.107962213,OSI-930
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.143350669,0.019574171,OSI-930
SIGNALING_BY_GPCR,2.089208098,0.023158174,OSI-930
RESPIRATORY_ELECTRON_TRANSPORT,-2.404241477,0.629526145,OSI-930
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.070121916,0.874341868,OSI-930
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-1.901172538,0.807055559,OSI-930
INFLUENZA_INFECTION,-1.885124085,0.657505084,OSI-930
CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,1.777452496,0.261356534,OSI-930
GPCR_LIGAND_BINDING,-2.829904716,0,blonanserin
EUKARYOTIC_TRANSLATION_INITIATION,-2.5827404,0,blonanserin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.594096666,0,blonanserin
RRNA_PROCESSING,-2.601168719,0,blonanserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.605597504,0,blonanserin
SIGNALING_BY_GPCR,-2.551450833,0,blonanserin
SELENOAMINO_ACID_METABOLISM,-2.624920586,0,blonanserin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.739477666,0,blonanserin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.749974707,0,blonanserin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.615030305,0,blonanserin
GPCR_LIGAND_BINDING,-3.164751621,0,talmapimod
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.957295742,0,talmapimod
SIGNALING_BY_GPCR,-2.871496219,0,talmapimod
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2.701075464,0,talmapimod
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.669887188,0,talmapimod
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.655748925,0,talmapimod
EUKARYOTIC_TRANSLATION_INITIATION,-2.609729822,0,talmapimod
EUKARYOTIC_TRANSLATION_ELONGATION,-2.601430833,0,talmapimod
RRNA_PROCESSING,-2.585271823,0,talmapimod
G_ALPHA_Q_SIGNALLING_EVENTS,-2.572252067,0,talmapimod
NEUTROPHIL_DEGRANULATION,2.09933796,0.054389491,pasireotide
RAB_REGULATION_OF_TRAFFICKING,2.067749917,0.03315169,pasireotide
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.030198075,0.026417753,pasireotide
MITOTIC_PROMETAPHASE,-1.960513759,0.375495594,pasireotide
CELL_CYCLE_MITOTIC,-1.944132846,0.213349769,pasireotide
CELL_CYCLE,-1.931709767,0.162335469,pasireotide
MITOTIC_SPINDLE_CHECKPOINT,-1.900543814,0.164421555,pasireotide
MITOTIC_G2_G2_M_PHASES,-1.834916665,0.236903584,pasireotide
M_PHASE,-1.805660095,0.253743992,pasireotide
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.779469343,0.267235825,pasireotide
PHOSPHOLIPID_METABOLISM,-1.988027586,0.331159459,CTS-1027
S_PHASE,-1.971940926,0.188182677,CTS-1027
APOPTOSIS,-1.849516765,0.372160154,CTS-1027
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-1.796002077,0.418680173,CTS-1027
CLEC7A_DECTIN_1_SIGNALING,-1.783928031,0.359124036,CTS-1027
SIGNALING_BY_NUCLEAR_RECEPTORS,1.518958572,1,CTS-1027
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.765296945,0.344475924,CTS-1027
PEROXISOMAL_PROTEIN_IMPORT,1.497854208,0.691975365,CTS-1027
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,-1.755745965,0.316741632,CTS-1027
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.39851224,0.735361706,CTS-1027
NONSENSE_MEDIATED_DECAY_NMD,4.122613605,0,hesperetin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.747500238,0,hesperetin
VIRAL_INFECTION_PATHWAYS,2.812701751,0,hesperetin
CELLULAR_RESPONSES_TO_STIMULI,2.859103783,0,hesperetin
MRNA_SPLICING,2.966845508,0,hesperetin
SARS_COV_1_HOST_INTERACTIONS,2.996200233,0,hesperetin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.01901622,0,hesperetin
SARS_COV_1_INFECTION,3.02154588,0,hesperetin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.164755258,0,hesperetin
TRANSLATION,3.222543728,0,hesperetin
METABOLISM_OF_RNA,3.565139136,0,rilmenidine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.276697806,0.001638089,rilmenidine
MITOTIC_METAPHASE_AND_ANAPHASE,2.233256764,0.012286374,rilmenidine
CELL_CYCLE_MITOTIC,2.087918638,0.023402617,rilmenidine
DNA_REPAIR,2.080098464,0.018429561,rilmenidine
HIV_INFECTION,2.066119936,0.017551963,rilmenidine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.058244126,0.014333278,rilmenidine
GPCR_LIGAND_BINDING,-2.020057468,0.018291993,rilmenidine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.876444151,0.045050038,rilmenidine
CELL_CYCLE_CHECKPOINTS,1.857394071,0.047641043,rilmenidine
GPCR_LIGAND_BINDING,2.884842578,0.000823947,granisetron
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.733998609,0.000823947,granisetron
SIGNALING_BY_GPCR,2.490931083,0.001647893,granisetron
G_ALPHA_Q_SIGNALLING_EVENTS,2.454797351,0.002059866,granisetron
G_ALPHA_S_SIGNALLING_EVENTS,2.419435457,0.001977472,granisetron
CARDIAC_CONDUCTION,2.268986573,0.005218328,granisetron
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-2.279467233,0.050998869,granisetron
MUSCLE_CONTRACTION,2.245315763,0.005179093,granisetron
COPII_MEDIATED_VESICLE_TRANSPORT,-2.257136482,0.034771956,granisetron
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.107459694,0.074952884,granisetron
SPHINGOLIPID_METABOLISM,-1.697212131,1,bufexamac
S_PHASE,-1.674579859,1,bufexamac
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.674028986,1,bufexamac
CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.625117167,1,bufexamac
RAC3_GTPASE_CYCLE,-1.598014115,1,bufexamac
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.553348756,1,bufexamac
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.519794691,1,bufexamac
DNA_REPLICATION,-1.493958824,1,bufexamac
SYNTHESIS_OF_DNA,-1.492743734,0.955104781,bufexamac
DNA_REPLICATION_PRE_INITIATION,-1.472426482,0.899646094,bufexamac
GPCR_LIGAND_BINDING,3.187218792,0,capecitabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.031840946,0,capecitabine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.687073143,0.000171963,capecitabine
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.614338981,0.000257945,capecitabine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.527141436,0.000619067,capecitabine
HATS_ACETYLATE_HISTONES,-2.232345703,0.033845515,capecitabine
G_ALPHA_Q_SIGNALLING_EVENTS,2.237344405,0.003439263,capecitabine
SIGNALING_BY_GPCR,2.228316657,0.003095336,capecitabine
M_PHASE,-2.155376215,0.03747182,capecitabine
CELL_CYCLE,-2.134242761,0.028204596,capecitabine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.629073982,0,staurosporine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.587743257,0,staurosporine
INFLUENZA_INFECTION,-2.572579287,0,staurosporine
SELENOAMINO_ACID_METABOLISM,-2.551633798,0,staurosporine
NONSENSE_MEDIATED_DECAY_NMD,-2.499683928,0.00020577,staurosporine
CELLULAR_RESPONSE_TO_STARVATION,-2.440477015,0.000171475,staurosporine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.43124755,0.000146978,staurosporine
SIGNALING_BY_ROBO_RECEPTORS,-2.357600107,0.000257212,staurosporine
SARS_COV_1_INFECTION,-2.351360603,0.000228633,staurosporine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.317415515,0.000308655,staurosporine
NEDDYLATION,2.398887825,0.007094539,tiludronate
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.154214106,0.028378155,tiludronate
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.005577689,0.039019964,tiludronate
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.772159733,0.140117142,tiludronate
KERATINIZATION,-1.980762738,0.17148437,tiludronate
GPCR_LIGAND_BINDING,-1.931597048,0.139381846,tiludronate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.914342279,0.105924785,tiludronate
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.884049093,0.105450697,tiludronate
KEAP1_NFE2L2_PATHWAY,1.562015286,0.348341858,tiludronate
SIGNALING_BY_GPCR,-1.833646838,0.124671575,tiludronate
NEDDYLATION,2.667920059,0.004170342,naringenin
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.365888411,0.010425856,naringenin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.095068972,0.029192397,naringenin
ADAPTIVE_IMMUNE_SYSTEM,2.064561519,0.028149812,naringenin
CDC42_GTPASE_CYCLE,1.832239224,0.100922287,naringenin
CELLULAR_SENESCENCE,1.831081415,0.084101906,naringenin
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.82716471,0.073874638,naringenin
GPCR_LIGAND_BINDING,-1.938552519,0.242315565,naringenin
CELL_CYCLE_CHECKPOINTS,1.620987683,0.197048681,naringenin
RHO_GTPASE_CYCLE,1.598551458,0.196469466,naringenin
SIGNALING_BY_NOTCH,-2.400889131,0.014549309,ibrutinib
DNA_REPLICATION,-2.285367827,0.022485296,ibrutinib
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.262035554,0.019839967,ibrutinib
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-2.255778319,0.015541307,ibrutinib
SYNTHESIS_OF_DNA,-2.253686412,0.012433046,ibrutinib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.205628576,0.014108421,ibrutinib
DNA_REPLICATION_PRE_INITIATION,-2.140230202,0.02191844,ibrutinib
S_PHASE,-2.018454834,0.050922582,ibrutinib
SEPARATION_OF_SISTER_CHROMATIDS,-1.980263905,0.061136491,ibrutinib
CELL_CYCLE_MITOTIC,-1.980102163,0.055022842,ibrutinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.366705069,0,MDL-29951
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.565963202,0,MDL-29951
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.591387909,0,MDL-29951
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.678902201,0,MDL-29951
SIGNALING_BY_ROBO_RECEPTORS,2.916317337,0,MDL-29951
INFLUENZA_INFECTION,2.999154376,0,MDL-29951
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.049105874,0,MDL-29951
TRANSLATION,2.883342539,0,MDL-29951
CELLULAR_RESPONSE_TO_STARVATION,3.184231287,0,MDL-29951
RRNA_PROCESSING,3.254809402,0,MDL-29951
GPCR_LIGAND_BINDING,3.430878887,0,BRD-K18135438
SIGNALING_BY_GPCR,3.138262896,0,BRD-K18135438
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.129130408,0,BRD-K18135438
NEUTROPHIL_DEGRANULATION,-2.947507758,0,BRD-K18135438
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.706178751,0,BRD-K18135438
G_ALPHA_I_SIGNALLING_EVENTS,2.377730491,0.000308804,BRD-K18135438
G_ALPHA_Q_SIGNALLING_EVENTS,2.291793516,0.001200904,BRD-K18135438
MRNA_SPLICING,-2.421939917,0.019159728,BRD-K18135438
INNATE_IMMUNE_SYSTEM,-2.408188157,0.013445423,BRD-K18135438
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.387009867,0.012100881,BRD-K18135438
NEUTROPHIL_DEGRANULATION,-2.297174308,0.044744929,methoxamine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-2.100001285,0.085187462,methoxamine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.881304686,0.1755378,methoxamine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.772816861,0.23275968,methoxamine
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-1.752523147,0.212366318,methoxamine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.661659358,0.298586355,methoxamine
HOMOLOGY_DIRECTED_REPAIR,1.825283355,1,methoxamine
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.793676244,0.657863967,methoxamine
SIGNALING_BY_INSULIN_RECEPTOR,-1.579686234,0.386969883,methoxamine
KEAP1_NFE2L2_PATHWAY,-1.57234503,0.35064536,methoxamine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.336883573,0.003911677,gimeracil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.238435507,0.007823354,gimeracil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.20838704,0.006258683,gimeracil
NONSENSE_MEDIATED_DECAY_NMD,-2.200757429,0.005476348,gimeracil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.198110422,0.004537545,gimeracil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.194253958,0.003781288,gimeracil
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.20008894,0.070202213,gimeracil
EUKARYOTIC_TRANSLATION_INITIATION,-2.187024923,0.00357639,gimeracil
SELENOAMINO_ACID_METABOLISM,-2.186445073,0.003129342,gimeracil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.174355495,0.003042415,gimeracil
EUKARYOTIC_TRANSLATION_ELONGATION,-3.133954721,0,adenosine
SELENOAMINO_ACID_METABOLISM,-3.081673672,0,adenosine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.062880501,0,adenosine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.043919118,0,adenosine
NONSENSE_MEDIATED_DECAY_NMD,-3.034364099,0,adenosine
EUKARYOTIC_TRANSLATION_INITIATION,-2.962581399,0,adenosine
CELLULAR_RESPONSE_TO_STARVATION,-2.925238554,0,adenosine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.840468396,0,adenosine
TRANSLATION,-2.819604399,0.000345378,adenosine
INFLUENZA_INFECTION,-2.813890029,0.000414454,adenosine
CELL_CYCLE_MITOTIC,-2.204226173,0.043799264,dipraglurant
S_PHASE,-2.136022786,0.042114677,dipraglurant
CELL_CYCLE,-2.044292174,0.069629599,dipraglurant
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.027257061,0.062048957,dipraglurant
DNA_REPLICATION,-1.96418398,0.07880124,dipraglurant
SYNTHESIS_OF_DNA,-1.96418398,0.07880124,dipraglurant
CHROMOSOME_MAINTENANCE,-1.949497169,0.076528384,dipraglurant
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.895597134,0.093962523,dipraglurant
MITOTIC_METAPHASE_AND_ANAPHASE,-1.895712783,0.105707839,dipraglurant
CELL_CYCLE_CHECKPOINTS,-1.886767269,0.091866148,dipraglurant
INFLUENZA_INFECTION,3.091907372,0,imexon
METABOLISM_OF_RNA,2.704628381,0,imexon
RESPIRATORY_ELECTRON_TRANSPORT,2.700898012,0,imexon
CELLULAR_RESPONSE_TO_STARVATION,2.656783775,0,imexon
TRANSLATION,2.564108199,0.000675754,imexon
GPCR_LIGAND_BINDING,-2.351562332,0.001244985,imexon
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.306735008,0.000622492,imexon
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.202391613,0.001867477,imexon
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.295329883,0.009010059,imexon
MITF_M_DEPENDENT_GENE_EXPRESSION,2.262154156,0.008688271,imexon
NEUTROPHIL_DEGRANULATION,-2.340858915,0.028455422,triamcinolone
INNATE_IMMUNE_SYSTEM,-2.312541459,0.017171375,triamcinolone
FCERI_MEDIATED_NF_KB_ACTIVATION,-2.279626535,0.01798906,triamcinolone
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.25146916,0.017416681,triamcinolone
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.037673279,0.32576736,triamcinolone
SIGNALING_BY_NTRKS,-1.924328302,0.135212316,triamcinolone
TCR_SIGNALING,-1.815210779,0.203603451,triamcinolone
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.653650097,0.401740097,triamcinolone
DEVELOPMENTAL_CELL_LINEAGES,1.733476305,1,triamcinolone
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.601692742,0.455164101,triamcinolone
CELLULAR_RESPONSE_TO_STARVATION,3.090980658,0,phenytoin
EUKARYOTIC_TRANSLATION_INITIATION,2.53053049,0.002052641,phenytoin
TRANSLATION,2.346009727,0.004105283,phenytoin
NONSENSE_MEDIATED_DECAY_NMD,2.057223076,0.019500094,phenytoin
INFLUENZA_INFECTION,1.874615272,0.04860655,phenytoin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.823960672,0.051589722,phenytoin
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1.813121171,0.046565638,phenytoin
RAB_REGULATION_OF_TRAFFICKING,1.744909952,0.062810829,phenytoin
SIGNALING_BY_PDGF,-1.868412544,0.849062622,phenytoin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.650803399,0.094330278,phenytoin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.343220725,0.00246083,dimethyl-fumarate
RHO_GTPASE_CYCLE,2.356235177,0.024812111,dimethyl-fumarate
EUKARYOTIC_TRANSLATION_INITIATION,-2.259410308,0.007382489,dimethyl-fumarate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.252768853,0.006015361,dimethyl-fumarate
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.293592832,0.017368478,dimethyl-fumarate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.23382672,0.005536867,dimethyl-fumarate
NONSENSE_MEDIATED_DECAY_NMD,-2.232798941,0.004593549,dimethyl-fumarate
SELENOAMINO_ACID_METABOLISM,-2.22748183,0.00396467,dimethyl-fumarate
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.209982905,0.003867018,dimethyl-fumarate
RRNA_PROCESSING,-2.207491603,0.003383641,dimethyl-fumarate
CELLULAR_RESPONSE_TO_STARVATION,2.303026392,0.01624634,indoramin
NONSENSE_MEDIATED_DECAY_NMD,2.293240033,0.010153962,indoramin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.196069507,0.05547953,indoramin
SELENOAMINO_ACID_METABOLISM,2.163238712,0.025046441,indoramin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.109768983,0.064395883,indoramin
INFLUENZA_INFECTION,2.095430436,0.031731133,indoramin
SEPARATION_OF_SISTER_CHROMATIDS,-2.100596761,0.046232942,indoramin
CELL_CYCLE_MITOTIC,-2.048061,0.05622256,indoramin
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.027303655,0.042646642,indoramin
DNA_REPLICATION,-1.956294958,0.082723942,indoramin
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.876466402,0,carbachol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.585795877,0.000572817,carbachol
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.379085061,0.004964416,carbachol
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.356977647,0.004296129,carbachol
S_PHASE,-2.329768421,0.004582538,carbachol
PCP_CE_PATHWAY,-2.170081008,0.020430481,carbachol
CELLULAR_RESPONSE_TO_STARVATION,2.080066367,0.168349894,carbachol
CELL_CYCLE_MITOTIC,-2.055928964,0.044352419,carbachol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.024581169,0.047687034,carbachol
SELENOAMINO_ACID_METABOLISM,1.989965823,0.154104903,carbachol
METABOLISM_OF_RNA,2.318860653,0.04810193,chlormezanone
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.056981838,0.099327948,chlormezanone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.02729433,0.158335521,chlormezanone
MRNA_SPLICING,1.989073282,0.123595238,chlormezanone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.986757748,0.097867242,chlormezanone
RESPIRATORY_ELECTRON_TRANSPORT,1.897273858,0.143303667,chlormezanone
MITF_M_DEPENDENT_GENE_EXPRESSION,1.823646356,0.169158455,chlormezanone
GPCR_LIGAND_BINDING,-1.929554986,0.113691548,chlormezanone
SIGNALING_BY_GPCR,-1.92632447,0.087642307,chlormezanone
G_ALPHA_Q_SIGNALLING_EVENTS,-1.904944233,0.084574826,chlormezanone
CARDIAC_CONDUCTION,1.822301338,0.769517078,ethosuximide
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.842906644,1,ethosuximide
PROTEIN_LOCALIZATION,-1.714802721,1,ethosuximide
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-1.657431036,1,ethosuximide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.640661819,1,ethosuximide
FATTY_ACID_METABOLISM,-1.598982652,1,ethosuximide
MUSCLE_CONTRACTION,1.553728528,1,ethosuximide
BIOLOGICAL_OXIDATIONS,-1.535463077,1,ethosuximide
DEUBIQUITINATION,-1.499359594,1,ethosuximide
UB_SPECIFIC_PROCESSING_PROTEASES,-1.492632272,1,ethosuximide
EUKARYOTIC_TRANSLATION_INITIATION,2.152427285,0.088869585,doxepin
TRANSLATION,2.124182692,0.055258652,doxepin
EUKARYOTIC_TRANSLATION_ELONGATION,2.049671967,0.090008939,doxepin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.021717262,0.085166686,doxepin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,1.968963632,0.107554985,doxepin
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.952735536,0.100832798,doxepin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.950403935,0.087241937,doxepin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.915076649,0.456247616,doxepin
RHO_GTPASES_ACTIVATE_FORMINS,1.925566622,0.093142161,doxepin
RHO_GTPASE_EFFECTORS,1.829424893,0.169510505,doxepin
MUSCLE_CONTRACTION,3.794366112,0,idarubicin
EXTRACELLULAR_MATRIX_ORGANIZATION,3.694540338,0,idarubicin
GPCR_LIGAND_BINDING,3.103555099,0,idarubicin
INTEGRIN_CELL_SURFACE_INTERACTIONS,3.00326327,0,idarubicin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.860459607,0,idarubicin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.820980599,0,idarubicin
SIGNALING_BY_GPCR,2.774620778,0,idarubicin
TRANSCRIPTION_OF_THE_HIV_GENOME,-2.320593291,0.000967145,idarubicin
METABOLISM_OF_RNA,-2.324938728,0.001934289,idarubicin
SENSORY_PERCEPTION,2.417028473,0.001356776,idarubicin
METABOLISM_OF_RNA,-2.240780256,0.026736917,E-2012
S_PHASE,-2.203316508,0.019495668,E-2012
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-2.160641539,0.023023456,E-2012
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.151728019,0.018938649,E-2012
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.112874742,0.021835149,E-2012
SYNTHESIS_OF_DNA,-2.09851942,0.019495668,E-2012
HIV_INFECTION,-2.095475846,0.017506314,E-2012
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.042925191,0.027154681,E-2012
AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,-2.042535732,0.024137494,E-2012
PROTEASOME_ASSEMBLY,-2.033732295,0.023951821,E-2012
BIOLOGICAL_OXIDATIONS,2.448652935,0.004557696,elacridar
RAB_REGULATION_OF_TRAFFICKING,2.007289301,0.035322146,elacridar
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.632660284,0.185346316,elacridar
G_ALPHA_I_SIGNALLING_EVENTS,-1.859380271,0.345558252,elacridar
FATTY_ACID_METABOLISM,1.55899261,0.216490574,elacridar
G_ALPHA_Q_SIGNALLING_EVENTS,-1.810080199,0.27025612,elacridar
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.797165361,0.202345608,elacridar
INTERFERON_ALPHA_BETA_SIGNALING,-1.788276757,0.164463553,elacridar
MEMBRANE_TRAFFICKING,1.296846557,0.581106277,elacridar
L1CAM_INTERACTIONS,1.260778524,0.567812996,elacridar
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.285668859,0.01147833,BVD-523
NONSENSE_MEDIATED_DECAY_NMD,-2.264337278,0.007788867,BVD-523
EUKARYOTIC_TRANSLATION_ELONGATION,-2.255331987,0.006012458,BVD-523
EUKARYOTIC_TRANSLATION_INITIATION,-2.249008228,0.005534195,BVD-523
SELENOAMINO_ACID_METABOLISM,-2.247601788,0.004427356,BVD-523
TRANSLATION,-2.224977989,0.00423605,BVD-523
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.186162412,0.005856291,BVD-523
RRNA_PROCESSING,-2.157949778,0.006661531,BVD-523
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.148178141,0.006194654,BVD-523
CELLULAR_RESPONSE_TO_STARVATION,-2.090781171,0.009018688,BVD-523
EUKARYOTIC_TRANSLATION_ELONGATION,5.335553397,0,temocapril
GPCR_LIGAND_BINDING,-3.011278629,0,temocapril
SARS_COV_2_INFECTION,3.106258729,0,temocapril
SARS_COV_2_HOST_INTERACTIONS,3.370473496,0,temocapril
NERVOUS_SYSTEM_DEVELOPMENT,3.628970071,0,temocapril
MRNA_SPLICING,3.633349281,0,temocapril
SARS_COV_1_INFECTION,3.766996154,0,temocapril
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.953317702,0,temocapril
VIRAL_INFECTION_PATHWAYS,3.954206245,0,temocapril
CELLULAR_RESPONSES_TO_STIMULI,4.011064608,0,temocapril
CELL_CYCLE_CHECKPOINTS,-2.732411397,0,A-443654
M_PHASE,-2.724738624,0,A-443654
CELL_CYCLE,-2.630089902,0,A-443654
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.629303425,0.00209351,A-443654
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.586172046,0.001046755,A-443654
EUKARYOTIC_TRANSLATION_INITIATION,2.573765938,0.000697837,A-443654
EUKARYOTIC_TRANSLATION_ELONGATION,2.561813599,0.000523378,A-443654
MITOTIC_METAPHASE_AND_ANAPHASE,-2.559175793,0.00048405,A-443654
CELLULAR_RESPONSE_TO_STARVATION,2.551210005,0.000418702,A-443654
CELL_CYCLE_MITOTIC,-2.52221438,0.00038724,A-443654
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.181243789,0.085867517,aminocaproic-acid
REGULATION_OF_TP53_ACTIVITY,2.155250796,0.057714233,aminocaproic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.155446739,0.176041033,aminocaproic-acid
SIGNALING_BY_ALK_IN_CANCER,1.778359963,0.550865927,aminocaproic-acid
COMPLEMENT_CASCADE,-1.897858213,0.569199339,aminocaproic-acid
DEVELOPMENTAL_CELL_LINEAGES,-1.893267503,0.387551074,aminocaproic-acid
DISEASES_OF_GLYCOSYLATION,-1.852233603,0.37164218,aminocaproic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.837623985,0.325323829,aminocaproic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.835136659,0.275797618,aminocaproic-acid
TCR_SIGNALING,1.693474756,0.673567324,aminocaproic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.2468898,0.005687643,torcitabine
GPCR_LIGAND_BINDING,-2.173611318,0.007718944,torcitabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.067109499,0.020854692,torcitabine
REGULATION_OF_TP53_ACTIVITY,1.920751433,0.341435011,torcitabine
BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,1.775728066,0.39757701,torcitabine
SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,1.749404599,0.301715502,torcitabine
RESPIRATORY_ELECTRON_TRANSPORT,1.694654294,0.297323441,torcitabine
SIGNALING_BY_NTRKS,1.49733831,0.631998497,torcitabine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.761729307,0.321351838,torcitabine
SARS_COV_2_HOST_INTERACTIONS,1.471279879,0.593501127,torcitabine
CELL_CYCLE_MITOTIC,-3.181744248,0,SB-939
CELL_CYCLE,-3.151430398,0,SB-939
METABOLISM_OF_RNA,-2.988174288,0,SB-939
DNA_REPLICATION,-2.945975028,0,SB-939
SYNTHESIS_OF_DNA,-2.878041603,0,SB-939
CELL_CYCLE_CHECKPOINTS,-2.754770794,0,SB-939
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.506489152,9.08E-05,SB-939
G2_M_CHECKPOINTS,-2.567218421,9.77E-05,SB-939
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.583489177,0.000115515,SB-939
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.577565974,0.000105889,SB-939
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.277310998,0.017315683,levamisole
GASTRULATION,-2.085629161,0.162838667,levamisole
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.048780258,0.11188235,levamisole
SIGNALING_BY_NOTCH4,-1.907142127,0.245550372,levamisole
CELL_CYCLE_MITOTIC,-1.906269359,0.185547461,levamisole
SIGNALING_BY_HEDGEHOG,-1.887581176,0.169928242,levamisole
CELL_CYCLE,-1.869269495,0.164684911,levamisole
S_PHASE,-1.843558178,0.177081116,levamisole
SIGNALING_BY_NOTCH,-1.836272691,0.164500286,levamisole
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.811634165,0.177608615,levamisole
GPCR_LIGAND_BINDING,-2.393876167,0.002463235,dazoxiben
SIGNALING_BY_ALK_IN_CANCER,2.260550636,0.066973244,dazoxiben
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.070507987,0.061170343,dazoxiben
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.998528159,0.154038462,dazoxiben
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.99849603,0.075265523,dazoxiben
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.826872687,0.289721293,dazoxiben
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.915573143,0.121930147,dazoxiben
SIGNALING_BY_GPCR,-1.888249661,0.121519608,dazoxiben
SIGNALING_BY_MET,-1.872576257,0.114403595,dazoxiben
TCR_SIGNALING,1.72555182,0.38472408,dazoxiben
MRNA_SPLICING,2.454458697,0.000573954,phenprocoumon
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.210305857,0.002582793,phenprocoumon
RAB_REGULATION_OF_TRAFFICKING,1.906702866,0.019131799,phenprocoumon
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.496180691,1,phenprocoumon
EUKARYOTIC_TRANSLATION_ELONGATION,-2.492641839,1,phenprocoumon
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.465004293,0.749592338,phenprocoumon
SELENOAMINO_ACID_METABOLISM,-2.463788152,0.563734512,phenprocoumon
NONSENSE_MEDIATED_DECAY_NMD,-2.452221162,0.466595559,phenprocoumon
EUKARYOTIC_TRANSLATION_INITIATION,-2.425804335,0.412275786,phenprocoumon
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.34990013,0.400027066,phenprocoumon
NONSENSE_MEDIATED_DECAY_NMD,2.713861344,0,butalbital
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.632946473,0,butalbital
CELLULAR_RESPONSE_TO_STARVATION,2.609048309,0,butalbital
EUKARYOTIC_TRANSLATION_ELONGATION,2.582860796,0.000283435,butalbital
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.432627948,0.001360487,butalbital
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.429441415,0.001133739,butalbital
SIGNALING_BY_ROBO_RECEPTORS,2.428971238,0.000971776,butalbital
SELENOAMINO_ACID_METABOLISM,2.425629513,0.000850304,butalbital
INFLUENZA_INFECTION,2.347573373,0.00125971,butalbital
EUKARYOTIC_TRANSLATION_INITIATION,2.299767028,0.001927356,butalbital
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.293411188,0.035328177,neomycin
BIOLOGICAL_OXIDATIONS,-1.889941709,0.274596282,neomycin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.820229157,0.280841161,neomycin
NEUTROPHIL_DEGRANULATION,-1.756812562,0.289583993,neomycin
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.673449684,0.35927685,neomycin
DEUBIQUITINATION,-1.663436636,0.315098787,neomycin
RAB_REGULATION_OF_TRAFFICKING,-1.653494969,0.28491945,neomycin
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.565147611,0.38660266,neomycin
PHASE_II_CONJUGATION_OF_COMPOUNDS,-1.558665696,0.355303917,neomycin
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.501505358,0.421261742,neomycin
INTERFERON_ALPHA_BETA_SIGNALING,-2.685478148,0.000876408,amuvatinib
SELENOAMINO_ACID_METABOLISM,2.100704255,0.10410728,amuvatinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.051462495,0.084847433,amuvatinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.001996707,0.088838212,amuvatinib
CELLULAR_RESPONSE_TO_STARVATION,1.979809813,0.081463947,amuvatinib
NONSENSE_MEDIATED_DECAY_NMD,1.968121325,0.073083311,amuvatinib
NEUTROPHIL_DEGRANULATION,1.942184781,0.079295045,amuvatinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.921558501,0.081947302,amuvatinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.891837704,0.090182931,amuvatinib
INFLUENZA_INFECTION,1.884186785,0.084095547,amuvatinib
GPCR_LIGAND_BINDING,-2.976788093,0,tesaglitazar
EUKARYOTIC_TRANSLATION_ELONGATION,-2.861280008,0,tesaglitazar
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.777893071,0,tesaglitazar
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.76456958,0,tesaglitazar
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.74534395,0,tesaglitazar
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.739466125,0,tesaglitazar
EUKARYOTIC_TRANSLATION_INITIATION,-2.691838822,0,tesaglitazar
SELENOAMINO_ACID_METABOLISM,-2.682060211,0,tesaglitazar
NONSENSE_MEDIATED_DECAY_NMD,-2.458455196,0,tesaglitazar
SIGNALING_BY_GPCR,-2.652225418,0,tesaglitazar
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.558807089,0,sasapyrine
GPCR_LIGAND_BINDING,-2.31761142,0.007815541,sasapyrine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.055412787,0.071642459,sasapyrine
SIGNALING_BY_GPCR,-1.974930052,0.102578976,sasapyrine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.858772935,0.792953248,sasapyrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.891679185,0.157287763,sasapyrine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.866521243,0.159892943,sasapyrine
REGULATION_OF_TP53_ACTIVITY,1.778835595,0.630335882,sasapyrine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.73674876,0.550661977,sasapyrine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.697076156,0.514696867,sasapyrine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.567712711,0.090150845,seocalcitol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.885243692,0.498150862,seocalcitol
MRNA_SPLICING,1.75912016,0.430221199,seocalcitol
SELENOAMINO_ACID_METABOLISM,-2.517066354,0.133119939,seocalcitol
NONSENSE_MEDIATED_DECAY_NMD,-2.511156175,0.099418689,seocalcitol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.485670844,0.105105775,seocalcitol
EUKARYOTIC_TRANSLATION_INITIATION,-2.457968339,0.115595289,seocalcitol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.434557722,0.125115892,seocalcitol
CELLULAR_RESPONSE_TO_STARVATION,-2.402924415,0.140100912,seocalcitol
TRANSLATION,-2.331397423,0.179669791,seocalcitol
CELLULAR_RESPONSE_TO_STARVATION,3.252168849,0,bazedoxifene
NONSENSE_MEDIATED_DECAY_NMD,3.156632796,0,bazedoxifene
SELENOAMINO_ACID_METABOLISM,3.122728022,0,bazedoxifene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.055487652,0,bazedoxifene
INFLUENZA_INFECTION,2.833318942,0.001143001,bazedoxifene
EUKARYOTIC_TRANSLATION_INITIATION,2.605259703,0.001905001,bazedoxifene
CELLULAR_RESPONSES_TO_STIMULI,2.388854231,0.003673931,bazedoxifene
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.227296466,0.005795828,bazedoxifene
NEUTROPHIL_DEGRANULATION,2.328484927,0.00464344,bazedoxifene
RAB_REGULATION_OF_TRAFFICKING,2.17248135,0.012700008,bazedoxifene
NEUTROPHIL_DEGRANULATION,2.307407577,0.024566591,temazepam
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,2.254065216,0.016377728,temazepam
INNATE_IMMUNE_SYSTEM,1.793750605,0.238690215,temazepam
ECM_PROTEOGLYCANS,-1.923875576,0.782550459,temazepam
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.914989758,0.423540072,temazepam
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.905947366,0.30523565,temazepam
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.87705185,0.293456422,temazepam
GASTRULATION,-1.873288483,0.243573952,temazepam
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.825818516,0.301821381,temazepam
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.581879406,0.539782605,temazepam
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.702229973,0,amantadine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.607503716,0,amantadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.331373917,0.017338262,amantadine
EUKARYOTIC_TRANSLATION_ELONGATION,2.325540248,0.009288355,amantadine
NONSENSE_MEDIATED_DECAY_NMD,2.258260707,0.011558842,amantadine
EUKARYOTIC_TRANSLATION_INITIATION,2.175838263,0.019505545,amantadine
SELENOAMINO_ACID_METABOLISM,2.116413339,0.026750462,amantadine
CELLULAR_RESPONSE_TO_STARVATION,2.082622575,0.030754775,amantadine
ECM_PROTEOGLYCANS,-2.083612621,0.048074609,amantadine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.056952636,0.042193141,amantadine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.398417973,0.000792047,levalbuterol
GPCR_LIGAND_BINDING,-2.370815114,0.000396024,levalbuterol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.340695434,0.000792047,levalbuterol
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.488374257,0.01351801,levalbuterol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.398142819,0.009462607,levalbuterol
NONSENSE_MEDIATED_DECAY_NMD,-2.187004088,0.004158247,levalbuterol
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.174069703,0.023431218,levalbuterol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.169559486,0.004435463,levalbuterol
SIGNALING_BY_GPCR,-2.160366429,0.004488267,levalbuterol
SELENOAMINO_ACID_METABOLISM,-2.158383634,0.003847086,levalbuterol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.419023039,0,glasdegib
GPCR_LIGAND_BINDING,-2.417873087,0,glasdegib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.305570047,0.001236683,glasdegib
G_ALPHA_Q_SIGNALLING_EVENTS,-2.225996296,0.003524546,glasdegib
RHO_GTPASE_CYCLE,2.196518942,0.09581678,glasdegib
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.172404709,0.055893121,glasdegib
SIGNALING_BY_GPCR,-2.115321055,0.009497724,glasdegib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.088110292,0.010882808,glasdegib
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.908474248,0.161823894,glasdegib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.990157054,0.026712348,glasdegib
GPCR_LIGAND_BINDING,-2.140856678,0.04240623,acrivastine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.079350139,0.039847233,acrivastine
REGULATION_OF_TP53_ACTIVITY,2.080187189,0.236082673,acrivastine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.045499845,0.040456518,acrivastine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.934998467,0.267935098,acrivastine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.884736272,0.247949263,acrivastine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.685389684,0.553201661,acrivastine
SIGNALING_BY_NTRKS,1.600712512,0.694382847,acrivastine
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.562459581,0.704500676,acrivastine
DEUBIQUITINATION,1.527018548,0.714672038,acrivastine
ISG15_ANTIVIRAL_MECHANISM,2.405333392,0.00720865,foretinib
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.167272819,0.013516219,foretinib
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-2.030103992,0.083280754,foretinib
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-1.97189095,0.068308933,foretinib
RSV_HOST_INTERACTIONS,-1.903066007,0.066905325,foretinib
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,-1.903066007,0.066905325,foretinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.895300908,0.057080067,foretinib
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.885900229,0.053493068,foretinib
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.646787939,0.188025631,foretinib
GPCR_LIGAND_BINDING,-1.862356345,0.057080067,foretinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.087825886,0.103287003,urea
MRNA_SPLICING,2.004225025,0.078387458,urea
RAB_REGULATION_OF_TRAFFICKING,1.587728503,0.34736403,urea
EUKARYOTIC_TRANSLATION_ELONGATION,-2.304181882,1,urea
SELENOAMINO_ACID_METABOLISM,-2.25581774,0.852780378,urea
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.259811947,1,urea
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.252159041,0.642201661,urea
NONSENSE_MEDIATED_DECAY_NMD,-2.229359633,0.525558811,urea
EUKARYOTIC_TRANSLATION_INITIATION,-2.207704066,0.448906889,urea
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.20263251,0.387631563,urea
METABOLISM_OF_RNA,3.461321571,0,EX-527
CELLULAR_RESPONSE_TO_STARVATION,2.777190334,0,EX-527
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.740700354,0,EX-527
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.700649629,0,EX-527
RESPIRATORY_ELECTRON_TRANSPORT,2.537541368,0.000589971,EX-527
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.515132398,0.000491642,EX-527
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.42179672,0.000618088,EX-527
GPCR_LIGAND_BINDING,-2.40852774,0.000309044,EX-527
SIGNALING_BY_GPCR,-2.315823512,0.000618088,EX-527
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.245980811,0.001854265,EX-527
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.250872122,0,BRD-K40331046
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.176125878,0,BRD-K40331046
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.151356368,0,BRD-K40331046
EUKARYOTIC_TRANSLATION_ELONGATION,3.126207483,0,BRD-K40331046
SELENOAMINO_ACID_METABOLISM,3.065149219,0,BRD-K40331046
NEUTROPHIL_DEGRANULATION,2.994630239,0,BRD-K40331046
CELLULAR_RESPONSE_TO_STARVATION,2.96177637,0,BRD-K40331046
LEISHMANIA_INFECTION,2.729607413,0.000258986,BRD-K40331046
EUKARYOTIC_TRANSLATION_INITIATION,2.719056358,0.00023021,BRD-K40331046
NONSENSE_MEDIATED_DECAY_NMD,2.701606851,0.000207189,BRD-K40331046
CELLULAR_RESPONSE_TO_STARVATION,2.469190393,0.012476104,BRD-K63750851
INFLUENZA_INFECTION,2.246316865,0.027031559,BRD-K63750851
RESPIRATORY_ELECTRON_TRANSPORT,2.143853885,0.033269611,BRD-K63750851
NEUTROPHIL_DEGRANULATION,2.027693451,0.045225878,BRD-K63750851
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.039589244,0.093044413,BRD-K63750851
SENSORY_PERCEPTION,-2.010089682,0.061234357,BRD-K63750851
GPCR_LIGAND_BINDING,-1.96802152,0.062294693,BRD-K63750851
SARS_COV_2_HOST_INTERACTIONS,1.848870399,0.102719925,BRD-K63750851
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.941099127,0.06421655,BRD-K63750851
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.790873439,0.123721367,BRD-K63750851
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,3.052170194,0,carfilzomib
MRNA_SPLICING,2.942942669,0,carfilzomib
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.550217779,0,carfilzomib
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.725111293,0.00044473,carfilzomib
METABOLISM_OF_RNA,2.691308493,0.000333547,carfilzomib
UNFOLDED_PROTEIN_RESPONSE_UPR,2.675891093,0.000266838,carfilzomib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.455367388,0.000457606,carfilzomib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.590938056,0.00044473,carfilzomib
KEAP1_NFE2L2_PATHWAY,2.580243453,0.000381197,carfilzomib
SIGNALING_BY_ALK_IN_CANCER,2.506226175,0.000667095,carfilzomib
METABOLISM_OF_RNA,5.180459241,0,MRE-269
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,2.68639162,0,MRE-269
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.72705909,0,MRE-269
DNA_REPLICATION,2.733153825,0,MRE-269
INFECTIOUS_DISEASE,2.792453903,0,MRE-269
TRNA_PROCESSING,2.834958428,0,MRE-269
CELLULAR_RESPONSE_TO_STARVATION,2.836823643,0,MRE-269
FCERI_MEDIATED_NF_KB_ACTIVATION,2.844243729,0,MRE-269
MRNA_SPLICING,2.950175887,0,MRE-269
HIV_INFECTION,2.952169155,0,MRE-269
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.831152454,0,dexketoprofen
GPCR_LIGAND_BINDING,2.792926753,0,dexketoprofen
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.597855087,0.001691024,dexketoprofen
G2_M_CHECKPOINTS,-2.493397024,0.001691024,dexketoprofen
G_ALPHA_Q_SIGNALLING_EVENTS,2.460089552,0.000461609,dexketoprofen
SIGNALING_BY_GPCR,2.40424602,0.000577012,dexketoprofen
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.180160778,0.005170026,dexketoprofen
NEUTROPHIL_DEGRANULATION,-2.215893896,0.033256805,dexketoprofen
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-2.163478376,0.040584576,dexketoprofen
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.132777642,0.04159919,dexketoprofen
S_PHASE,-1.937458523,0.587947307,oxetacaine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.783041086,0.743183394,oxetacaine
VISUAL_PHOTOTRANSDUCTION,1.810105514,1,oxetacaine
SYNTHESIS_OF_DNA,-1.674777994,0.894919795,oxetacaine
RAC3_GTPASE_CYCLE,-1.660317122,0.715810847,oxetacaine
DEUBIQUITINATION,-1.624136155,0.690238139,oxetacaine
RHOG_GTPASE_CYCLE,-1.621384841,0.580947934,oxetacaine
NEURONAL_SYSTEM,1.73710961,0.949156852,oxetacaine
DNA_REPLICATION_PRE_INITIATION,-1.610839848,0.527309884,oxetacaine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.540052935,0.665002901,oxetacaine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.215540933,0.069281835,allopurinol
REGULATION_OF_TP53_ACTIVITY,2.015386899,0.129284852,allopurinol
SYNTHESIS_OF_DNA,-1.976599518,0.148788374,allopurinol
DNA_REPLICATION,-1.976599518,0.148788374,allopurinol
S_PHASE,-1.899832753,0.19275867,allopurinol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.811305227,0.33032589,allopurinol
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.868924897,0.188539298,allopurinol
SIGNALING_BY_NTRKS,1.705590954,0.44043452,allopurinol
GPCR_LIGAND_BINDING,-1.791366943,0.259735645,allopurinol
MITOCHONDRIAL_BIOGENESIS,1.695289427,0.369668075,allopurinol
METABOLISM_OF_RNA,-5.194571065,0,mocetinostat
G2_M_DNA_DAMAGE_CHECKPOINT,-2.740933952,0,mocetinostat
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.810222725,0,mocetinostat
HIV_LIFE_CYCLE,-2.829182406,0,mocetinostat
G2_M_CHECKPOINTS,-2.870546279,0,mocetinostat
SEPARATION_OF_SISTER_CHROMATIDS,-2.876758788,0,mocetinostat
TRANSLATION,-2.887435221,0,mocetinostat
HIV_INFECTION,-2.914128242,0,mocetinostat
RRNA_PROCESSING,-3.004926059,0,mocetinostat
TRNA_PROCESSING,-3.037875339,0,mocetinostat
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.452819456,0.023219432,azelaic-acid
NEDDYLATION,2.321513194,0.019349527,azelaic-acid
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.104848675,0.039989022,azelaic-acid
G_ALPHA_Q_SIGNALLING_EVENTS,-2.074750223,0.049176922,azelaic-acid
DNA_REPLICATION,1.77049054,0.178983121,azelaic-acid
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.739424885,0.157118156,azelaic-acid
ADAPTIVE_IMMUNE_SYSTEM,1.705384718,0.155441197,azelaic-acid
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.677354252,0.158113274,azelaic-acid
RSV_HOST_INTERACTIONS,1.657022134,0.150442569,azelaic-acid
GPCR_LIGAND_BINDING,-1.890561837,0.163532781,azelaic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,5.268294581,0,tariquidar
SARS_COV_INFECTIONS,2.940878715,0,tariquidar
SARS_COV_2_INFECTION,3.236929267,0,tariquidar
MRNA_SPLICING,3.249807052,0,tariquidar
SARS_COV_2_HOST_INTERACTIONS,3.392816042,0,tariquidar
INFECTIOUS_DISEASE,3.458985105,0,tariquidar
SARS_COV_1_INFECTION,3.68909528,0,tariquidar
CELLULAR_RESPONSES_TO_STIMULI,3.718924982,0,tariquidar
VIRAL_INFECTION_PATHWAYS,3.8387543,0,tariquidar
SARS_COV_1_HOST_INTERACTIONS,3.857816343,0,tariquidar
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,2.211993498,0.030180002,PCI-24781
HIV_LIFE_CYCLE,2.120944311,0.037365717,PCI-24781
TRNA_PROCESSING_IN_THE_NUCLEUS,2.024471482,0.045988575,PCI-24781
FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX,1.891189299,0.063593576,PCI-24781
VIRAL_MESSENGER_RNA_SYNTHESIS,1.880953513,0.052886861,PCI-24781
GENE_SILENCING_BY_RNA,1.864824395,0.048144289,PCI-24781
TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS,1.834323837,0.047015105,PCI-24781
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.01176804,0.292303046,PCI-24781
TRNA_PROCESSING,1.740243049,0.067725362,PCI-24781
G_ALPHA_Q_SIGNALLING_EVENTS,-1.959660267,0.249261659,PCI-24781
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.120227059,0.12668083,dimenhydrinate
ADIPOGENESIS,1.819775303,1,dimenhydrinate
RRNA_PROCESSING,1.777097192,0.902136458,dimenhydrinate
DEATH_RECEPTOR_SIGNALING,1.775708914,0.607765627,dimenhydrinate
EUKARYOTIC_TRANSLATION_INITIATION,1.723233255,0.640807251,dimenhydrinate
HEMOSTASIS,-1.610152063,1,dimenhydrinate
DEVELOPMENTAL_CELL_LINEAGES,-1.607802057,1,dimenhydrinate
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.585073074,0.859334922,dimenhydrinate
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.578177413,0.71160712,dimenhydrinate
ECM_PROTEOGLYCANS,-1.506280579,0.833234016,dimenhydrinate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.444202071,0.003811112,armodafinil
MRNA_SPLICING,2.344736191,0.003811112,armodafinil
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.769097164,0.260425971,armodafinil
CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,-2.65718074,0.597828236,armodafinil
G_ALPHA_I_SIGNALLING_EVENTS,-2.416828084,1,armodafinil
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.299463141,0.795997225,armodafinil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.217251837,0.655950425,armodafinil
EUKARYOTIC_TRANSLATION_ELONGATION,-2.189799158,0.539207856,armodafinil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.180431282,0.455013713,armodafinil
SELENOAMINO_ACID_METABOLISM,-2.149926045,0.401161725,armodafinil
MUSCLE_CONTRACTION,1.828480271,0.424312176,lacosamide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.82348931,0.220330228,lacosamide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.764900752,0.198408671,lacosamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.743435798,0.1634828,lacosamide
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.876872068,1,lacosamide
MITOTIC_METAPHASE_AND_ANAPHASE,-1.862372238,0.597778963,lacosamide
ECM_PROTEOGLYCANS,-1.807986586,0.602064116,lacosamide
CHROMATIN_ORGANIZATION,-1.794119253,0.501898645,lacosamide
CELL_CYCLE,-1.785783776,0.428729643,lacosamide
M_PHASE,-1.755496197,0.446548741,lacosamide
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.253600475,0.020750802,suvorexant
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.196226077,0.020232032,suvorexant
CELL_CYCLE_MITOTIC,-1.916082107,0.237942527,suvorexant
HOMOLOGY_DIRECTED_REPAIR,-1.901217865,0.203357857,suvorexant
CELL_CYCLE,-1.896661459,0.169741558,suvorexant
RHO_GTPASES_ACTIVATE_FORMINS,-1.89598001,0.142315915,suvorexant
DNA_REPAIR,-1.86094459,0.157854313,suvorexant
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.847732763,0.152777778,suvorexant
M_PHASE,-1.781168649,0.2179987,suvorexant
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.607466983,1,suvorexant
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-3.445128769,0.303868079,trichlormethiazide
GPCR_LIGAND_BINDING,1.970904744,0.197730798,trichlormethiazide
SIGNALING_BY_GPCR,1.948565383,0.11659506,trichlormethiazide
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-3.280175529,0.832334304,trichlormethiazide
ESR_MEDIATED_SIGNALING,-3.269134039,0.60920412,trichlormethiazide
VISUAL_PHOTOTRANSDUCTION,1.847538435,0.171486893,trichlormethiazide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.830579388,0.143940809,trichlormethiazide
SIGNALING_BY_NUCLEAR_RECEPTORS,-3.045859109,1,trichlormethiazide
MHC_CLASS_II_ANTIGEN_PRESENTATION,-2.07480602,1,trichlormethiazide
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.865742365,1,trichlormethiazide
GPCR_LIGAND_BINDING,3.619122896,0,everolimus
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.438246033,0,everolimus
SIGNALING_BY_GPCR,3.130043483,0,everolimus
METABOLISM_OF_RNA,-3.033962958,0,everolimus
DNA_REPAIR,-2.875984179,0,everolimus
DNA_REPLICATION,-2.731849465,0,everolimus
G_ALPHA_I_SIGNALLING_EVENTS,2.671373283,0,everolimus
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.546707202,0.000119641,everolimus
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-2.598220319,0.000153824,everolimus
RRNA_PROCESSING,-2.581074182,0.000134596,everolimus
GPCR_LIGAND_BINDING,2.344560183,0.008344798,bretylium
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.206785245,0.013351677,bretylium
SENSORY_PERCEPTION,2.175366705,0.013073517,bretylium
SIGNALING_BY_GPCR,2.101065711,0.021696475,bretylium
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.072591794,0.021529579,bretylium
VISUAL_PHOTOTRANSDUCTION,1.994556852,0.036299871,bretylium
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.85724401,0.102402593,bretylium
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.823131282,0.114219423,bretylium
G_ALPHA_I_SIGNALLING_EVENTS,1.766670649,0.148908285,bretylium
NEUTROPHIL_DEGRANULATION,-2.6270152,1,bretylium
MRNA_SPLICING,1.928230153,0.249983091,tirofiban
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.778651903,0.291646939,tirofiban
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.65256733,0.386337504,tirofiban
DNA_REPLICATION,1.610908465,0.369293203,tirofiban
SYNTHESIS_OF_DNA,1.545185096,0.429516402,tirofiban
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.453071682,0.576981175,tirofiban
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.161254444,1,tirofiban
G_ALPHA_I_SIGNALLING_EVENTS,-2.090307482,1,tirofiban
GPCR_LIGAND_BINDING,-2.073047379,0.809026049,tirofiban
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.068425285,0.61016168,tirofiban
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.905130666,0.117963166,SN-38
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.453682886,1,SN-38
G_ALPHA_I_SIGNALLING_EVENTS,-2.191949459,1,SN-38
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.139121454,1,SN-38
GPCR_LIGAND_BINDING,-2.093133712,0.906538761,SN-38
EUKARYOTIC_TRANSLATION_ELONGATION,-2.025523974,0.772258958,SN-38
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,1.39030474,0.839620181,SN-38
NONSENSE_MEDIATED_DECAY_NMD,-2.012946874,0.651553889,SN-38
SELENOAMINO_ACID_METABOLISM,-1.959772027,0.517807736,SN-38
SIGNALING_BY_GPCR,-1.960263271,0.591637328,SN-38
EUKARYOTIC_TRANSLATION_INITIATION,2.946329558,0,pheniramine
TRANSLATION,2.811653245,0,pheniramine
RRNA_PROCESSING,2.802229765,0,pheniramine
EUKARYOTIC_TRANSLATION_ELONGATION,2.797400943,0,pheniramine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.673929341,0,pheniramine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.665682457,0,pheniramine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.582256256,0,pheniramine
SELENOAMINO_ACID_METABOLISM,2.576938243,0,pheniramine
METABOLISM_OF_RNA,2.553848,0,pheniramine
CELLULAR_RESPONSE_TO_STARVATION,2.514578794,0.000442203,pheniramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.324624283,0.000908705,metoprolol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.316768768,0.000454352,metoprolol
VISUAL_PHOTOTRANSDUCTION,-2.251639727,0.000302902,metoprolol
GPCR_LIGAND_BINDING,-2.231632865,0.000681529,metoprolol
SIGNALING_BY_GPCR,-2.125565691,0.00381656,metoprolol
G_ALPHA_I_SIGNALLING_EVENTS,-2.071540547,0.005149327,metoprolol
G_ALPHA_Q_SIGNALLING_EVENTS,-1.981634859,0.01414983,metoprolol
INTERFERON_ALPHA_BETA_SIGNALING,1.831377414,0.25295683,metoprolol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.757872757,0.191861325,metoprolol
NEURONAL_SYSTEM,-1.899193151,0.032486192,metoprolol
EUKARYOTIC_TRANSLATION_INITIATION,2.274615369,0.022752776,carbenoxolone
NONSENSE_MEDIATED_DECAY_NMD,2.249818205,0.015358124,carbenoxolone
TRANSLATION,2.24841988,0.010238749,carbenoxolone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.242000219,0.008816701,carbenoxolone
EUKARYOTIC_TRANSLATION_ELONGATION,2.234220243,0.007735944,carbenoxolone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.22935261,0.006825833,carbenoxolone
SIGNALING_BY_ROBO_RECEPTORS,2.197125292,0.008613551,carbenoxolone
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.188552782,0.008958905,carbenoxolone
SELENOAMINO_ACID_METABOLISM,2.155736024,0.011123579,carbenoxolone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.150699994,0.010238749,carbenoxolone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.182243549,0.042509018,clodronic-acid
GPCR_LIGAND_BINDING,2.143339237,0.032261308,clodronic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.004085648,0.069077155,clodronic-acid
NEURONAL_SYSTEM,1.986937249,0.059398762,clodronic-acid
HOMOLOGY_DIRECTED_REPAIR,1.770709835,0.272057717,clodronic-acid
SIGNALING_BY_GPCR,1.768061678,0.229877637,clodronic-acid
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.918401081,1,clodronic-acid
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.814232288,1,clodronic-acid
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.731778782,0.250282689,clodronic-acid
SENSORY_PERCEPTION,1.702539321,0.266725112,clodronic-acid
CELL_CYCLE_MITOTIC,-3.373157879,0,azacitidine
CELL_CYCLE,-3.362925059,0,azacitidine
M_PHASE,-3.088377015,0,azacitidine
GPCR_LIGAND_BINDING,2.927775901,0,azacitidine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.836021368,0,azacitidine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.821914779,0,azacitidine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.663375038,0.000166513,azacitidine
MITOTIC_PROMETAPHASE,-2.662693936,0.000761763,azacitidine
CELL_CYCLE_CHECKPOINTS,-2.652721036,0.000634803,azacitidine
SYNTHESIS_OF_DNA,-2.630584548,0.000544117,azacitidine
BIOLOGICAL_OXIDATIONS,-2.514359513,0.006686014,antazoline
RAC3_GTPASE_CYCLE,-2.151752659,0.081903677,antazoline
SPHINGOLIPID_METABOLISM,-1.714512903,0.670087228,antazoline
G_ALPHA_I_SIGNALLING_EVENTS,1.722465318,1,antazoline
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.655355479,0.690888162,antazoline
PHASE_II_CONJUGATION_OF_COMPOUNDS,-1.646294572,0.577894518,antazoline
NEUTROPHIL_DEGRANULATION,-1.644272851,0.486778998,antazoline
CARDIAC_CONDUCTION,1.682054159,1,antazoline
DEUBIQUITINATION,-1.622067081,0.470249685,antazoline
CILIUM_ASSEMBLY,1.637831637,1,antazoline
SIGNALING_BY_NOTCH,2.306746179,0.024417333,baclofen
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.912289207,0.345330857,baclofen
SENSORY_PERCEPTION,1.849460934,0.366647577,baclofen
APOPTOSIS,1.807611657,0.366550683,baclofen
CARDIAC_CONDUCTION,1.799714323,0.308356038,baclofen
NEUTROPHIL_DEGRANULATION,-3.156883007,1,baclofen
VESICLE_MEDIATED_TRANSPORT,-3.007753049,1,baclofen
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.788915755,0.274404318,baclofen
INNATE_IMMUNE_SYSTEM,-2.403919426,0.917294195,baclofen
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.770361625,0.262112599,baclofen
SENSORY_PERCEPTION,2.200443854,0.034275177,phenindione
TRNA_PROCESSING,-2.03837108,0.224885596,phenindione
NEUTROPHIL_DEGRANULATION,-1.955890758,0.166485073,phenindione
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.910955781,0.149923731,phenindione
ISG15_ANTIVIRAL_MECHANISM,-1.835344793,0.178252343,phenindione
HOST_INTERACTIONS_OF_HIV_FACTORS,-1.813752217,0.163521464,phenindione
TRNA_PROCESSING_IN_THE_NUCLEUS,-1.762767465,0.189147963,phenindione
SIGNALING_BY_ROBO_RECEPTORS,-1.753576546,0.172337577,phenindione
NEURONAL_SYSTEM,1.885645153,0.327208375,phenindione
INFLUENZA_INFECTION,-1.649153422,0.269557638,phenindione
EUKARYOTIC_TRANSLATION_ELONGATION,-3.134460128,0,brexpiprazole
SELENOAMINO_ACID_METABOLISM,-3.120763708,0,brexpiprazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.106814958,0,brexpiprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.095981134,0,brexpiprazole
NONSENSE_MEDIATED_DECAY_NMD,-3.086342765,0,brexpiprazole
EUKARYOTIC_TRANSLATION_INITIATION,-3.086138225,0,brexpiprazole
RRNA_PROCESSING,-3.061959794,0,brexpiprazole
TRANSLATION,-3.047185316,0,brexpiprazole
CELLULAR_RESPONSE_TO_STARVATION,-3.01990264,0,brexpiprazole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.921420396,0,brexpiprazole
CELL_CYCLE_MITOTIC,-2.443803118,0.005252938,dacomitinib
CELL_CYCLE,-2.368728701,0.005252938,dacomitinib
MITOTIC_G2_G2_M_PHASES,-2.288081708,0.007441662,dacomitinib
RESPIRATORY_ELECTRON_TRANSPORT,-2.275119183,0.006237864,dacomitinib
RAB_REGULATION_OF_TRAFFICKING,2.277293807,0.019998842,dacomitinib
S_PHASE,-2.254848934,0.007354113,dacomitinib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.244557442,0.006566172,dacomitinib
DNA_REPLICATION,-2.23661908,0.006566172,dacomitinib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.230856207,0.006237864,dacomitinib
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.175886479,0.02346018,dacomitinib
GPCR_LIGAND_BINDING,2.777711782,0,oxyphenbutazone
SIGNALING_BY_GPCR,2.775802922,0,oxyphenbutazone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.42698802,0.000412938,oxyphenbutazone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.347947449,0.001083962,oxyphenbutazone
G_ALPHA_I_SIGNALLING_EVENTS,2.219172908,0.003097034,oxyphenbutazone
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.114743648,0.007329648,oxyphenbutazone
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-3.032411909,0.440489843,oxyphenbutazone
NEUTROPHIL_DEGRANULATION,-3.024830786,0.236832405,oxyphenbutazone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.997252473,0.20212156,oxyphenbutazone
G_ALPHA_Q_SIGNALLING_EVENTS,1.978728442,0.021236806,oxyphenbutazone
SENSORY_PERCEPTION,2.065253092,0.14417861,oxacillin
NEUTROPHIL_DEGRANULATION,-2.019370969,0.766917293,oxacillin
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-1.989180622,0.462116831,oxacillin
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-1.934770601,0.414266435,oxacillin
GASTRULATION,-1.806773662,0.587478311,oxacillin
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.774655871,0.554540197,oxacillin
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.769373067,0.47686524,oxacillin
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.706140457,0.535999339,oxacillin
TRNA_PROCESSING,-1.700490632,0.480552342,oxacillin
BIOLOGICAL_OXIDATIONS,-1.685078283,0.453595527,oxacillin
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.31171137,0.029741379,pimavanserin
GPCR_LIGAND_BINDING,-2.092974444,0.13159306,pimavanserin
CELLULAR_RESPONSE_TO_STARVATION,1.995029854,0.190086207,pimavanserin
SIGNALING_BY_ALK_IN_CANCER,1.930508217,0.193103448,pimavanserin
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.962360628,0.190485016,pimavanserin
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.901760081,0.176831897,pimavanserin
REGULATION_OF_TP53_ACTIVITY,1.825285582,0.229913793,pimavanserin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.823313873,0.340896425,pimavanserin
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.656290355,0.494396552,pimavanserin
PCP_CE_PATHWAY,-1.716391304,0.513172319,pimavanserin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.060534846,0.077174239,ARN-509
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.049554738,0.043356314,ARN-509
GPCR_LIGAND_BINDING,-2.043111811,0.030927504,ARN-509
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.658979806,1,ARN-509
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.636714695,0.656314395,ARN-509
PEROXISOMAL_PROTEIN_IMPORT,1.602062344,0.532577765,ARN-509
SIGNALING_BY_ALK_IN_CANCER,1.592716759,0.421916397,ARN-509
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.581491893,0.354371504,ARN-509
INNATE_IMMUNE_SYSTEM,1.484663424,0.486654892,ARN-509
FCERI_MEDIATED_NF_KB_ACTIVATION,1.472486759,0.440640902,ARN-509
NEUTROPHIL_DEGRANULATION,-2.064438295,0.291863383,dyphylline
HEMOSTASIS,-1.811290973,0.600803879,dyphylline
BIOLOGICAL_OXIDATIONS,-1.802754641,0.419165497,dyphylline
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.63034358,0.71413381,dyphylline
TRANSLATION,1.707534003,1,dyphylline
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.544172533,0.844333858,dyphylline
INNATE_IMMUNE_SYSTEM,-1.536435788,0.727588505,dyphylline
RAC3_GTPASE_CYCLE,-1.503547306,0.714577371,dyphylline
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.491658016,0.656045752,dyphylline
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.460422579,0.666639886,dyphylline
EUKARYOTIC_TRANSLATION_ELONGATION,-2.530735473,0,AZD-9291
SELENOAMINO_ACID_METABOLISM,-2.511214038,0,AZD-9291
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.46360101,0,AZD-9291
EUKARYOTIC_TRANSLATION_INITIATION,-2.432587145,0,AZD-9291
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.413389247,0,AZD-9291
NONSENSE_MEDIATED_DECAY_NMD,-2.369915631,0,AZD-9291
RRNA_PROCESSING,-2.344125907,0.000278226,AZD-9291
CELLULAR_RESPONSE_TO_STARVATION,-2.272470269,0.000608619,AZD-9291
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.181012226,0.002055781,AZD-9291
TRANSLATION,-2.128334961,0.004426322,AZD-9291
EUKARYOTIC_TRANSLATION_ELONGATION,-2.341082369,0,amfepramone
NONSENSE_MEDIATED_DECAY_NMD,-2.298694727,0,amfepramone
SELENOAMINO_ACID_METABOLISM,-2.274033719,0.000257183,amfepramone
EUKARYOTIC_TRANSLATION_INITIATION,-2.262281021,0.000385775,amfepramone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.250625502,0.00030862,amfepramone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.241721529,0.000257183,amfepramone
RRNA_PROCESSING,-2.204747787,0.000220443,amfepramone
CELLULAR_RESPONSE_TO_STARVATION,-2.162398182,0.000289331,amfepramone
TRANSLATION,-2.149101251,0.000342911,amfepramone
SIGNALING_BY_ROBO_RECEPTORS,-2.066726207,0.00108017,amfepramone
EUKARYOTIC_TRANSLATION_INITIATION,2.129987833,0.10116405,tiratricol
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.147094613,0.154121459,tiratricol
CELLULAR_RESPONSE_TO_STARVATION,1.919326226,0.295154454,tiratricol
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.894938321,0.368820069,tiratricol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.891980881,0.250550393,tiratricol
TRANSLATION,1.840808488,0.353518329,tiratricol
RAC3_GTPASE_CYCLE,-1.867362611,0.215728834,tiratricol
CELL_CELL_COMMUNICATION,-1.841585154,0.199286464,tiratricol
NONSENSE_MEDIATED_DECAY_NMD,1.760403214,0.483864316,tiratricol
RRNA_PROCESSING,1.738900519,0.448679237,tiratricol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.978635377,0.349740933,almitrine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.988541456,0.361296361,almitrine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.929113799,0.293968167,almitrine
DNA_REPLICATION,-1.83454949,0.315067496,almitrine
SYNTHESIS_OF_DNA,-1.83454949,0.315067496,almitrine
MITOTIC_METAPHASE_AND_ANAPHASE,-1.81166567,0.304399296,almitrine
REGULATION_OF_TP53_ACTIVITY,1.709930904,0.886010363,almitrine
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,-1.79687482,0.278953664,almitrine
CELL_CYCLE_MITOTIC,-1.787697936,0.25793336,almitrine
S_PHASE,-1.784890133,0.229840434,almitrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,5.436253411,0,hypoxanthine
GPCR_LIGAND_BINDING,-2.620666178,0,hypoxanthine
SARS_COV_INFECTIONS,2.998565875,0,hypoxanthine
SARS_COV_2_INFECTION,3.112694631,0,hypoxanthine
INFECTIOUS_DISEASE,3.2006818,0,hypoxanthine
SARS_COV_2_HOST_INTERACTIONS,3.406088266,0,hypoxanthine
NERVOUS_SYSTEM_DEVELOPMENT,3.459794051,0,hypoxanthine
VIRAL_INFECTION_PATHWAYS,3.641479373,0,hypoxanthine
SARS_COV_1_INFECTION,3.706955083,0,hypoxanthine
MRNA_SPLICING,3.726943038,0,hypoxanthine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.963908797,0.106744852,ciprofloxacin
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.766362504,0.187340798,ciprofloxacin
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.692275114,0.197967523,ciprofloxacin
ADAPTIVE_IMMUNE_SYSTEM,-2.071153993,1,ciprofloxacin
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.023682262,0.747952971,ciprofloxacin
SIGNALING_BY_INTERLEUKINS,-1.977104073,0.591582686,ciprofloxacin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.965517671,0.460636241,ciprofloxacin
SIGNALING_BY_GPCR,-1.915780982,0.426245713,ciprofloxacin
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.91169125,0.360672254,ciprofloxacin
GPCR_LIGAND_BINDING,-1.880887323,0.34039046,ciprofloxacin
EUKARYOTIC_TRANSLATION_ELONGATION,-4.086786644,0,sitagliptin
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-2.3559968,0,sitagliptin
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,-2.373979247,0,sitagliptin
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.503158724,0,sitagliptin
SARS_COV_INFECTIONS,-2.892892792,0,sitagliptin
INFECTIOUS_DISEASE,-3.006859278,0,sitagliptin
METABOLISM_OF_RNA,-3.006911123,0,sitagliptin
SARS_COV_2_INFECTION,-3.016008942,0,sitagliptin
CELLULAR_RESPONSES_TO_STIMULI,-3.0681319,0,sitagliptin
SARS_COV_2_HOST_INTERACTIONS,-3.118845513,0,sitagliptin
SENSORY_PERCEPTION,1.964911883,0.368565055,acetohexamide
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.934176778,0.226915053,acetohexamide
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-1.960715863,1,acetohexamide
RRNA_PROCESSING,1.793949194,0.458108638,acetohexamide
BIOLOGICAL_OXIDATIONS,-1.824123172,1,acetohexamide
GPCR_LIGAND_BINDING,1.707631922,0.609232535,acetohexamide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.716964437,1,acetohexamide
DEVELOPMENTAL_CELL_LINEAGES,-1.677755119,1,acetohexamide
IRON_UPTAKE_AND_TRANSPORT,-1.636435239,0.95066276,acetohexamide
EUKARYOTIC_TRANSLATION_INITIATION,1.577398595,1,acetohexamide
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.536435612,0.003351096,KPT-330
RHO_GTPASE_CYCLE,2.431702617,0.005026644,KPT-330
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.15228088,0.018989544,KPT-330
GPCR_LIGAND_BINDING,-2.096695043,0.04585072,KPT-330
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.043158714,0.041426528,KPT-330
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.848773324,0.099695105,KPT-330
HIV_LIFE_CYCLE,1.781769153,0.128011866,KPT-330
SIGNALING_BY_GPCR,-1.974397583,0.060598028,KPT-330
RAC1_GTPASE_CYCLE,1.765182155,0.103405247,KPT-330
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.766723716,0.120639455,KPT-330
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.29344517,0.015770926,tamsulosin
GASTRULATION,-2.086143773,0.071494863,tamsulosin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.975364967,0.133527171,tamsulosin
SIGNALING_BY_HEDGEHOG,-1.967777881,0.109345085,tamsulosin
NONSENSE_MEDIATED_DECAY_NMD,1.933455224,0.396748565,tamsulosin
SIGNALING_BY_NOTCH4,-1.930424396,0.12091043,tamsulosin
CELLULAR_RESPONSE_TO_STARVATION,1.869918853,0.301834793,tamsulosin
PEROXISOMAL_PROTEIN_IMPORT,1.8358916,0.246206026,tamsulosin
S_PHASE,-1.828413384,0.225349005,tamsulosin
HEMOSTASIS,1.739668852,0.316004384,tamsulosin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.389952688,0,SU-11652
SELENOAMINO_ACID_METABOLISM,-2.316584237,0,SU-11652
NONSENSE_MEDIATED_DECAY_NMD,-2.310641888,0,SU-11652
EUKARYOTIC_TRANSLATION_INITIATION,-2.288906813,0,SU-11652
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.275807552,0,SU-11652
CELLULAR_RESPONSE_TO_STARVATION,-2.214610843,0.000307245,SU-11652
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.213026733,0.000263353,SU-11652
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.397125234,0.011167679,SU-11652
RRNA_PROCESSING,-2.190943208,0.000691301,SU-11652
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.173470303,0.000716905,SU-11652
GPCR_LIGAND_BINDING,3.476157079,0,HO-013
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.357950729,0,HO-013
SIGNALING_BY_GPCR,2.745077301,0,HO-013
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.438647032,0.001053557,HO-013
G_ALPHA_I_SIGNALLING_EVENTS,2.270983364,0.003853008,HO-013
G_ALPHA_Q_SIGNALLING_EVENTS,2.106695832,0.012542343,HO-013
G_ALPHA_S_SIGNALLING_EVENTS,1.984897871,0.026833447,HO-013
KERATINIZATION,1.967002052,0.026940953,HO-013
OPIOID_SIGNALLING,1.936577523,0.029232021,HO-013
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.901839553,0.03244955,HO-013
EUKARYOTIC_TRANSLATION_ELONGATION,-3.859282666,0,cariporide
SARS_COV_INFECTIONS,-2.601908694,0,cariporide
SARS_COV_2_INFECTION,-2.680522025,0,cariporide
CELLULAR_RESPONSES_TO_STIMULI,-2.739347899,0,cariporide
INFECTIOUS_DISEASE,-2.849956846,0,cariporide
SARS_COV_1_INFECTION,-2.961052345,0,cariporide
METABOLISM_OF_RNA,-2.962007583,0,cariporide
VIRAL_INFECTION_PATHWAYS,-2.970456642,0,cariporide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.050698178,0,cariporide
SARS_COV_1_HOST_INTERACTIONS,-3.079866884,0,cariporide
EUKARYOTIC_TRANSLATION_INITIATION,2.775681438,0,ivacaftor
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.768131685,0,ivacaftor
NEUTROPHIL_DEGRANULATION,2.659349206,0,ivacaftor
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.643512415,0,ivacaftor
INFLUENZA_INFECTION,2.630897458,0.000280803,ivacaftor
CELLULAR_RESPONSE_TO_STARVATION,2.601485499,0.000234002,ivacaftor
TRANSLATION,2.319821835,0.002206309,ivacaftor
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.227567165,0.015013293,ivacaftor
SIGNALING_BY_ROBO_RECEPTORS,2.286071426,0.002808029,ivacaftor
GPCR_LIGAND_BINDING,-2.088388329,0.047385706,ivacaftor
RAB_REGULATION_OF_TRAFFICKING,2.041409741,0.177670779,clonazepam
MRNA_SPLICING,1.977502803,0.13650316,clonazepam
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.946365014,0.104002407,clonazepam
L1CAM_INTERACTIONS,1.834308973,0.162503762,clonazepam
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.500302728,0.780884743,clonazepam
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.375543246,1,clonazepam
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.451895104,0.821185676,clonazepam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.139327298,0.984381182,clonazepam
G_ALPHA_I_SIGNALLING_EVENTS,-2.123656923,0.667859902,clonazepam
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.369421171,1,clonazepam
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.981414096,0.098461538,lesinurad
MRNA_SPLICING,1.820414019,0.162461538,lesinurad
CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,-2.576684376,1,lesinurad
DNA_REPLICATION,1.3996374,1,lesinurad
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.372033042,1,lesinurad
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.339492643,0.841736434,lesinurad
GPCR_LIGAND_BINDING,-2.248067955,0.696939535,lesinurad
G_ALPHA_I_SIGNALLING_EVENTS,-2.23084598,0.566303256,lesinurad
EUKARYOTIC_TRANSLATION_ELONGATION,-2.028242576,0.586936434,lesinurad
NONSENSE_MEDIATED_DECAY_NMD,-2.017360573,0.509209302,lesinurad
GPCR_LIGAND_BINDING,2.968397517,0,dichloroacetic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.588576601,0.000977269,dichloroacetic-acid
SIGNALING_BY_GPCR,2.534053195,0.001303026,dichloroacetic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.449514452,0.001954539,dichloroacetic-acid
DEVELOPMENTAL_CELL_LINEAGES,2.371104944,0.003322716,dichloroacetic-acid
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.343613437,0.003583321,dichloroacetic-acid
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.096933368,0.143294808,dichloroacetic-acid
CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE,2.056378953,0.019126559,dichloroacetic-acid
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.075499796,0.088802416,dichloroacetic-acid
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-2.055825654,0.06996554,dichloroacetic-acid
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.998174377,0.330530848,BRD-K85767870
RAC3_GTPASE_CYCLE,-1.928140734,0.25185817,BRD-K85767870
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.764643257,0.450563882,BRD-K85767870
HEMOSTASIS,-1.636878545,0.653933634,BRD-K85767870
BIOLOGICAL_OXIDATIONS,-1.621569871,0.565809675,BRD-K85767870
UB_SPECIFIC_PROCESSING_PROTEASES,-1.601313818,0.515860444,BRD-K85767870
DEUBIQUITINATION,-1.577125463,0.493608824,BRD-K85767870
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.559362015,0.470848057,BRD-K85767870
INNATE_IMMUNE_SYSTEM,-1.553050088,0.433081064,BRD-K85767870
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.495810967,0.508573982,BRD-K85767870
NEUTROPHIL_DEGRANULATION,2.523149391,0.001263743,vortioxetine
GPCR_LIGAND_BINDING,-2.231582409,0.010583259,vortioxetine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.193171683,0.014533047,vortioxetine
CELLULAR_RESPONSE_TO_STARVATION,2.128883289,0.01305868,vortioxetine
SIGNALING_BY_ROBO_RECEPTORS,2.062765994,0.014533047,vortioxetine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.03438001,0.047143609,vortioxetine
TRANSLATION,1.869735232,0.037912296,vortioxetine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.902986064,0.121867833,vortioxetine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.649112339,0.120266229,vortioxetine
SIGNALING_BY_GPCR,-1.826953359,0.186890736,vortioxetine
NEUTROPHIL_DEGRANULATION,2.738457924,0,equol
TRANSLATION,2.610203895,0.000717703,equol
CELLULAR_RESPONSE_TO_STARVATION,2.373248371,0.000956938,equol
SIGNALING_BY_ROBO_RECEPTORS,2.238455269,0.005741627,equol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.149389651,0.009473684,equol
GPCR_LIGAND_BINDING,-2.047777917,0.217557119,equol
MITF_M_DEPENDENT_GENE_EXPRESSION,1.651185445,0.128947368,equol
RRNA_PROCESSING,1.6417699,0.114217362,equol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.632657066,0.104784689,equol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.900637797,0.363066101,equol
GPCR_LIGAND_BINDING,2.390819109,0.008231525,monobenzone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.055624264,0.049732128,monobenzone
SIGNALING_BY_GPCR,2.013082731,0.048703188,monobenzone
SENSORY_PERCEPTION,1.936500481,0.0709969,monobenzone
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.858494949,0.10303125,monobenzone
VISUAL_PHOTOTRANSDUCTION,1.785410407,0.151368592,monobenzone
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.78227743,0.132586344,monobenzone
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,-1.711257117,1,monobenzone
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,-1.606427009,1,monobenzone
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.526664791,1,monobenzone
MRNA_SPLICING,2.344887077,0.022730225,AMD-11070
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.03193729,0.106832056,AMD-11070
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.791764062,0.304585011,AMD-11070
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.659819327,0.483017275,AMD-11070
L1CAM_INTERACTIONS,1.633497406,0.44005715,AMD-11070
SIGNALING_BY_VEGF,1.549417954,0.539464,AMD-11070
DOWNSTREAM_TCR_SIGNALING,1.515477741,0.540329913,AMD-11070
ABC_TRANSPORTER_DISORDERS,1.475342161,0.569960384,AMD-11070
SYNTHESIS_OF_DNA,1.413034084,0.67433,AMD-11070
TCR_SIGNALING,1.389671401,0.67372386,AMD-11070
GPCR_LIGAND_BINDING,-3.233472544,0,atrasentan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.516630751,0,atrasentan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.558577403,0,atrasentan
RRNA_PROCESSING,-2.577168546,0,atrasentan
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.621429462,0,atrasentan
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.622330944,0,atrasentan
CELLULAR_RESPONSE_TO_STARVATION,-2.653766113,0,atrasentan
NONSENSE_MEDIATED_DECAY_NMD,-2.498273387,0,atrasentan
SELENOAMINO_ACID_METABOLISM,-2.672355522,0,atrasentan
G_ALPHA_S_SIGNALLING_EVENTS,-2.690887836,0,atrasentan
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.830303946,0.404662844,EMD-1214063
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,-1.788399002,1,EMD-1214063
SIGNALING_BY_NTRKS,1.545665368,0.829608301,EMD-1214063
SIGNALING_BY_ALK_IN_CANCER,1.534017913,0.585062662,EMD-1214063
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,-1.721929466,1,EMD-1214063
CELL_CYCLE_MITOTIC,-1.718783953,1,EMD-1214063
GASTRULATION,-1.711990878,0.79958401,EMD-1214063
MITOTIC_METAPHASE_AND_ANAPHASE,-1.707341543,0.662712862,EMD-1214063
FATTY_ACID_METABOLISM,1.362405767,0.990385103,EMD-1214063
PROTEIN_LOCALIZATION,1.342302083,0.869283069,EMD-1214063
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.162388077,0.06014905,rupatadine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.878020283,0.153768135,rupatadine
GASTRULATION,-1.951194769,0.401576944,rupatadine
BIOLOGICAL_OXIDATIONS,1.578766882,0.556540401,rupatadine
SIGNALING_BY_NTRKS,1.520027619,0.555408564,rupatadine
MUSCLE_CONTRACTION,1.374837002,0.880698505,rupatadine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.646786796,1,rupatadine
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,-1.644209515,1,rupatadine
FORMATION_OF_PARAXIAL_MESODERM,-1.64407345,1,rupatadine
FATTY_ACID_METABOLISM,1.354868701,0.798753509,rupatadine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.116965608,0.036335891,phenylephrine
REGULATION_OF_TP53_ACTIVITY,2.048862151,0.146348812,phenylephrine
SIGNALING_BY_ALK_IN_CANCER,1.860757308,0.232139495,phenylephrine
GPCR_LIGAND_BINDING,-1.955953288,0.10295169,phenylephrine
DEUBIQUITINATION,1.751540901,0.280081347,phenylephrine
INNATE_IMMUNE_SYSTEM,1.743134457,0.220784845,phenylephrine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.731260927,0.191262758,phenylephrine
SIGNALING_BY_NTRKS,1.654952474,0.240129803,phenylephrine
TRANSCRIPTIONAL_REGULATION_BY_TP53,1.58758933,0.30098832,phenylephrine
NEUTROPHIL_DEGRANULATION,1.534521026,0.356409822,phenylephrine
DISEASES_OF_METABOLISM,-2.323042588,0.094373483,roflumilast
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.728105277,0.482629472,roflumilast
CELLULAR_SENESCENCE,1.643630803,0.396616299,roflumilast
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.604344249,0.325735073,roflumilast
MEMBRANE_TRAFFICKING,1.502204367,0.442609454,roflumilast
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.984278343,0.620855179,roflumilast
INTERFERON_ALPHA_BETA_SIGNALING,-1.972035495,0.427884709,roflumilast
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.441126132,0.479762366,roflumilast
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.434692432,0.415332128,roflumilast
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.878154031,0.429923643,roflumilast
GPCR_LIGAND_BINDING,2.338365693,0.004609645,chloropyramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.292020747,0.004993783,chloropyramine
SIGNALING_BY_GPCR,2.247663158,0.00537792,chloropyramine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.931802184,0.225432759,chloropyramine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.912264994,0.152361451,chloropyramine
G_ALPHA_I_SIGNALLING_EVENTS,2.015041503,0.039758192,chloropyramine
NEURONAL_SYSTEM,1.79707592,0.191761249,chloropyramine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-2.708765746,0.804302625,chloropyramine
SENSORY_PERCEPTION,1.71247337,0.285413878,chloropyramine
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.693948621,0.277566506,chloropyramine
GPCR_LIGAND_BINDING,-3.301507069,0,filgotinib
SIGNALING_BY_GPCR,-3.075479853,0,filgotinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-3.018783594,0,filgotinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.713296398,0,filgotinib
G_ALPHA_Q_SIGNALLING_EVENTS,-2.544424439,0.000312449,filgotinib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.542729669,0.000260374,filgotinib
G_ALPHA_S_SIGNALLING_EVENTS,-2.541364898,0.000223178,filgotinib
EUKARYOTIC_TRANSLATION_INITIATION,-2.538061171,0.00019528,filgotinib
G_ALPHA_I_SIGNALLING_EVENTS,-2.501692202,0.000173583,filgotinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.499254813,0.000156224,filgotinib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.816858103,0.003034225,histamine
SELENOAMINO_ACID_METABOLISM,-2.786119651,0.004045634,histamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.73223819,0.010114084,histamine
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.120400215,0.021279391,histamine
NONSENSE_MEDIATED_DECAY_NMD,-2.730441966,0.007838415,histamine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.725644119,0.006675295,histamine
RAB_REGULATION_OF_TRAFFICKING,2.060715704,0.013004072,histamine
CELLULAR_RESPONSE_TO_STARVATION,-2.660682856,0.026802323,histamine
EUKARYOTIC_TRANSLATION_INITIATION,-2.65837742,0.023984828,histamine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.645532369,0.027687305,histamine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.5208668,0.00985409,clorgiline
NEUTROPHIL_DEGRANULATION,-2.517573808,0.004927045,clorgiline
INNATE_IMMUNE_SYSTEM,-2.140696036,0.066058902,clorgiline
BIOLOGICAL_OXIDATIONS,-1.88246762,0.257574972,clorgiline
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.861506016,0.895387967,clorgiline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.819276062,0.291462093,clorgiline
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.734911617,1,clorgiline
MITOTIC_G2_G2_M_PHASES,1.722297601,0.754010919,clorgiline
HEMOSTASIS,-1.501733592,1,clorgiline
SENSORY_PERCEPTION,1.581571211,1,clorgiline
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.172252957,0.053893103,felbinac
SIGNALING_BY_NTRKS,1.859134145,0.322502425,felbinac
DEVELOPMENTAL_CELL_LINEAGES,-1.833672304,0.617128861,felbinac
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1.584877865,0.701826705,felbinac
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.58168341,0.473771419,felbinac
ADIPOGENESIS,1.514690871,0.502758244,felbinac
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.498004742,0.441060459,felbinac
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.691124602,1,felbinac
COLLAGEN_DEGRADATION,-1.675657932,1,felbinac
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.674158649,0.839464328,felbinac
GPCR_LIGAND_BINDING,-3.218010564,0,atracurium
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.474454918,0,atracurium
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.491022023,0,atracurium
SIGNALING_BY_ROBO_RECEPTORS,-2.545386576,0,atracurium
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.576801289,0,atracurium
NONSENSE_MEDIATED_DECAY_NMD,-2.596848787,0,atracurium
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.654471358,0,atracurium
TRANSLATION,-2.656611083,0,atracurium
G_ALPHA_Q_SIGNALLING_EVENTS,-2.460900762,0,atracurium
CELLULAR_RESPONSE_TO_STARVATION,-2.71995947,0,atracurium
EUKARYOTIC_TRANSLATION_ELONGATION,4.292561503,0,PIK-93
SIGNALING_BY_GPCR,-2.53191027,0,PIK-93
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.835779741,0,PIK-93
METABOLISM_OF_RNA,2.880662778,0,PIK-93
SARS_COV_1_INFECTION,2.941658549,0,PIK-93
GPCR_LIGAND_BINDING,-2.957355415,0,PIK-93
SARS_COV_1_HOST_INTERACTIONS,3.021629448,0,PIK-93
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.076581256,0,PIK-93
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.178036224,0,PIK-93
RRNA_PROCESSING,3.202746292,0,PIK-93
GPCR_LIGAND_BINDING,2.390416881,0.00622246,pralidoxime
SIGNALING_BY_GPCR,2.345069307,0.003456922,pralidoxime
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.203826523,0.006452921,pralidoxime
VISUAL_PHOTOTRANSDUCTION,2.139752682,0.008987998,pralidoxime
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.041570156,0.018114272,pralidoxime
SENSORY_PERCEPTION,2.013504141,0.021087225,pralidoxime
G_ALPHA_I_SIGNALLING_EVENTS,1.857322073,0.068545828,pralidoxime
POTASSIUM_CHANNELS,1.771749543,0.1143377,pralidoxime
VOLTAGE_GATED_POTASSIUM_CHANNELS,1.738075112,0.126907453,pralidoxime
NEUTROPHIL_DEGRANULATION,-2.447416094,1,pralidoxime
GPCR_LIGAND_BINDING,-2.424695342,0.000882744,sobetirome
PEROXISOMAL_PROTEIN_IMPORT,2.511512758,0.006844225,sobetirome
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.178871575,0.023392722,sobetirome
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.124749462,0.027070823,sobetirome
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.123370265,0.062966874,sobetirome
SIGNALING_BY_ALK_IN_CANCER,1.976526974,0.09946941,sobetirome
SIGNALING_BY_GPCR,-2.000301115,0.06377827,sobetirome
REGULATION_OF_TP53_ACTIVITY,1.877170311,0.131409128,sobetirome
NEUTROPHIL_DEGRANULATION,1.799105543,0.163440103,sobetirome
GASTRULATION,-1.830652399,0.195969216,sobetirome
PEROXISOMAL_PROTEIN_IMPORT,2.468790681,0.007427272,clenbuterol
GPCR_LIGAND_BINDING,-2.273570133,0.017323231,clenbuterol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.197080233,0.021172837,clenbuterol
S_PHASE,-2.033333906,0.072821728,clenbuterol
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.016733708,0.061112508,clenbuterol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.954991299,0.246161021,clenbuterol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.960579951,0.082766546,clenbuterol
SYNTHESIS_OF_DNA,-1.943133298,0.081643744,clenbuterol
CELL_CYCLE_MITOTIC,-1.919402445,0.086478667,clenbuterol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.886519158,0.094676267,clenbuterol
EUKARYOTIC_TRANSLATION_ELONGATION,-3.953021562,0,VP-20629
SARS_COV_2_INFECTION,-2.70087076,0,VP-20629
SARS_COV_INFECTIONS,-2.76516303,0,VP-20629
CELLULAR_RESPONSES_TO_STIMULI,-2.788127511,0,VP-20629
METABOLISM_OF_RNA,-2.809472071,0,VP-20629
INFECTIOUS_DISEASE,-2.858695355,0,VP-20629
VIRAL_INFECTION_PATHWAYS,-2.976852834,0,VP-20629
SARS_COV_1_INFECTION,-3.042605562,0,VP-20629
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.135881644,0,VP-20629
SARS_COV_1_HOST_INTERACTIONS,-3.157738612,0,VP-20629
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.452640282,0.002982252,PH-797804
GASTRULATION,-2.093063823,0.08810913,PH-797804
PROTEIN_LOCALIZATION,1.90732668,0.107361071,PH-797804
SIGNALING_BY_NTRKS,1.825913419,0.118627356,PH-797804
PLATELET_HOMEOSTASIS,1.734635412,0.15209485,PH-797804
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.890325152,0.35243652,PH-797804
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,-1.804066325,0.471917841,PH-797804
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.770802411,0.462572933,PH-797804
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,-1.769141054,0.375865539,PH-797804
HEDGEHOG_ON_STATE,-1.751387088,0.359612075,PH-797804
GPCR_LIGAND_BINDING,2.764402889,0,ribavirin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.63979719,0,ribavirin
SIGNALING_BY_GPCR,2.518486791,0.000469201,ribavirin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.378005855,0.001055703,ribavirin
G_ALPHA_I_SIGNALLING_EVENTS,1.932581221,0.054052013,ribavirin
VISUAL_PHOTOTRANSDUCTION,1.860757251,0.081875662,ribavirin
SENSORY_PERCEPTION,1.859084077,0.07118457,ribavirin
G_ALPHA_S_SIGNALLING_EVENTS,1.847664818,0.067828942,ribavirin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.73297572,0.132705824,ribavirin
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.728197729,0.123728435,ribavirin
GPCR_LIGAND_BINDING,2.815883624,0,benserazide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.647168072,0,benserazide
SIGNALING_BY_GPCR,2.444508877,0.000760812,benserazide
NEURONAL_SYSTEM,2.287967908,0.002662843,benserazide
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.266660628,0.002434599,benserazide
SENSORY_PERCEPTION,2.207564034,0.004184468,benserazide
NEUTROPHIL_DEGRANULATION,-3.044288991,0.059054353,benserazide
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-3.019308418,0.040599868,benserazide
G_ALPHA_I_SIGNALLING_EVENTS,2.136869351,0.008042873,benserazide
POTASSIUM_CHANNELS,2.034001783,0.015881957,benserazide
GPCR_LIGAND_BINDING,-2.36247532,0.003864776,erteberel
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.254527777,0.048272316,erteberel
SIGNALING_BY_ALK_IN_CANCER,2.219003263,0.032986082,erteberel
REGULATION_OF_TP53_ACTIVITY,2.108162839,0.047735957,erteberel
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.052788492,0.069179493,erteberel
G_ALPHA_Q_SIGNALLING_EVENTS,-2.047518122,0.049726786,erteberel
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.749475337,0.375719523,erteberel
PEROXISOMAL_PROTEIN_IMPORT,1.738310423,0.317953652,erteberel
SIGNALING_BY_GPCR,-1.835695574,0.221065194,erteberel
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.772668574,0.277027152,erteberel
CELLULAR_RESPONSE_TO_STARVATION,2.087488104,0.121888924,acemetacin
RRNA_PROCESSING,1.858628586,0.377462474,acemetacin
CARDIAC_CONDUCTION,1.809273897,0.368943355,acemetacin
DISEASES_OF_METABOLISM,-3.381405657,1,acemetacin
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.827783613,1,acemetacin
BIOLOGICAL_OXIDATIONS,-1.821016415,1,acemetacin
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.810739877,1,acemetacin
CELL_CELL_COMMUNICATION,-1.598859466,1,acemetacin
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.571458374,0.880301014,acemetacin
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.630904989,0.915149904,acemetacin
GPCR_LIGAND_BINDING,2.168470979,0.071536439,hexamethonium
BIOLOGICAL_OXIDATIONS,-1.718427055,1,hexamethonium
RAC3_GTPASE_CYCLE,-1.709460915,1,hexamethonium
SIGNALING_BY_GPCR,1.726170202,0.984703386,hexamethonium
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.686866987,0.833155309,hexamethonium
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.64082158,1,hexamethonium
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.677737143,0.664728654,hexamethonium
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,-1.590577082,1,hexamethonium
RHOG_GTPASE_CYCLE,-1.536249184,1,hexamethonium
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.504356137,1,hexamethonium
GPCR_LIGAND_BINDING,-2.465580124,0.006617153,tranexamic-acid
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.271834276,0.016542882,tranexamic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.229847786,0.01838098,tranexamic-acid
SIGNALING_BY_GPCR,-2.217667845,0.014612879,tranexamic-acid
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.051642259,0.0374972,tranexamic-acid
COLLAGEN_FORMATION,1.945293784,0.360672317,tranexamic-acid
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.826528072,0.4209401,tranexamic-acid
ADIPOGENESIS,1.819740017,0.29526542,tranexamic-acid
G_ALPHA_I_SIGNALLING_EVENTS,-1.711148427,0.241526081,tranexamic-acid
G_ALPHA_Q_SIGNALLING_EVENTS,-1.670207232,0.260274681,tranexamic-acid
CELLULAR_RESPONSE_TO_STARVATION,2.878318466,0.001443803,resatorvid
GPCR_LIGAND_BINDING,-2.106781571,0.062624289,resatorvid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.099953462,0.033127341,resatorvid
SIGNALING_BY_ALK_IN_CANCER,1.979161542,0.083018658,resatorvid
NEUTROPHIL_DEGRANULATION,1.964162153,0.062083518,resatorvid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.867892566,0.081935806,resatorvid
SIGNALING_BY_GPCR,-1.97604173,0.077750929,resatorvid
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.975736715,0.058540096,resatorvid
INFLUENZA_INFECTION,1.807092808,0.100199911,resatorvid
EUKARYOTIC_TRANSLATION_INITIATION,1.782764856,0.097456686,resatorvid
METABOLISM_OF_RNA,-2.648518855,0,pitavastatin
S_PHASE,-2.460087255,0,pitavastatin
SYNTHESIS_OF_DNA,-2.44650115,0,pitavastatin
DNA_REPAIR,-2.429739386,0,pitavastatin
DNA_REPLICATION,-2.41772938,0.000176008,pitavastatin
CELL_CYCLE,-2.390678721,0.000146673,pitavastatin
SIGNALING_BY_NTRKS,2.440454757,0.005248098,pitavastatin
RRNA_PROCESSING,-2.34457399,0.00050288,pitavastatin
CELL_CYCLE_MITOTIC,-2.330937011,0.000770036,pitavastatin
DNA_STRAND_ELONGATION,-2.307995352,0.001075605,pitavastatin
RAB_REGULATION_OF_TRAFFICKING,1.832741521,0.149098686,asymmetrical-dimethylarginine
MRNA_SPLICING,1.642228278,0.242590895,asymmetrical-dimethylarginine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.537612218,1,asymmetrical-dimethylarginine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.532304051,0.72541138,asymmetrical-dimethylarginine
NONSENSE_MEDIATED_DECAY_NMD,-2.509268308,0.548746568,asymmetrical-dimethylarginine
SELENOAMINO_ACID_METABOLISM,-2.489405188,0.449557665,asymmetrical-dimethylarginine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.465825267,0.393005186,asymmetrical-dimethylarginine
EUKARYOTIC_TRANSLATION_INITIATION,-2.445841967,0.351849193,asymmetrical-dimethylarginine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.395735364,0.339653259,asymmetrical-dimethylarginine
SARS_COV_1_INFECTION,-2.392423438,0.299293879,asymmetrical-dimethylarginine
NEUTROPHIL_DEGRANULATION,-3.230656933,0,H-8
SARS_COV_1_INFECTION,2.535169192,0,H-8
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.580449372,0,H-8
NONSENSE_MEDIATED_DECAY_NMD,2.615186579,0,H-8
RRNA_PROCESSING,2.629647077,0,H-8
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.632730062,0,H-8
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.635894419,0,H-8
CELLULAR_RESPONSE_TO_STARVATION,2.650722304,0,H-8
TRANSLATION,2.627176361,0,H-8
SARS_COV_1_HOST_INTERACTIONS,2.701293919,0,H-8
HOST_INTERACTIONS_OF_HIV_FACTORS,1.879988959,0.740479549,baricitinib
SIGNALING_BY_INTERLEUKINS,1.858505536,0.435743734,baricitinib
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.67314797,0.829716828,baricitinib
DNA_REPLICATION,1.624841593,0.796015515,baricitinib
ABC_TRANSPORTER_DISORDERS,1.540916923,0.960345015,baricitinib
DEVELOPMENTAL_CELL_LINEAGES,1.539889649,0.806932841,baricitinib
L1CAM_INTERACTIONS,1.539677542,0.693284149,baricitinib
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,1.538842408,0.609471629,baricitinib
INTERLEUKIN_1_FAMILY_SIGNALING,1.505818259,0.640483165,baricitinib
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,1.484917447,0.635103613,baricitinib
METABOLISM_OF_RNA,-3.419368111,0,plerixafor
CELL_CYCLE_MITOTIC,-2.928451651,0,plerixafor
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.814202001,0,plerixafor
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.77153262,0,plerixafor
GPCR_LIGAND_BINDING,2.741008704,0.000478081,plerixafor
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.592716008,0.000478081,plerixafor
MRNA_SPLICING,-2.680037482,0.001116878,plerixafor
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.650314085,0.001163414,plerixafor
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.579591911,0.001221585,plerixafor
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.579089169,0.001085853,plerixafor
INFLUENZA_INFECTION,2.350304466,0.029016238,lomustine
NONSENSE_MEDIATED_DECAY_NMD,2.130767275,0.076893031,lomustine
CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE,-2.028237534,0.095624457,lomustine
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.873084088,0.236965943,lomustine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,-1.965161511,0.08705123,lomustine
CHROMOSOME_MAINTENANCE,1.720781779,0.435243569,lomustine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.704505148,0.386496289,lomustine
CELLULAR_RESPONSE_TO_STARVATION,1.680862105,0.364153786,lomustine
REGULATION_OF_INSULIN_SECRETION,-1.841223573,0.201800578,lomustine
TRANSLATION,1.617911413,0.440632299,lomustine
CILIUM_ASSEMBLY,1.919409527,0.308225844,apixaban
SIGNALING_BY_ALK_IN_CANCER,1.792079672,0.346869084,apixaban
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.772507301,0.257314908,apixaban
G_ALPHA_Q_SIGNALLING_EVENTS,-1.864248743,0.90709784,apixaban
GPCR_LIGAND_BINDING,-1.811597262,0.683154843,apixaban
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.807659512,0.469164869,apixaban
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,-1.797182317,0.381475312,apixaban
DNA_REPLICATION,-1.756915482,0.334970674,apixaban
SYNTHESIS_OF_DNA,-1.756915482,0.334970674,apixaban
S_PHASE,-1.740006608,0.321830724,apixaban
CELLULAR_RESPONSE_TO_STARVATION,2.524482688,0.004846145,pilaralisib
SELENOAMINO_ACID_METABOLISM,2.509367014,0.003028841,pilaralisib
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.370340449,0.011147763,pilaralisib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.352237558,0.006865372,pilaralisib
EUKARYOTIC_TRANSLATION_ELONGATION,2.246971002,0.010903827,pilaralisib
GPCR_LIGAND_BINDING,-2.251969082,0.017150405,pilaralisib
EUKARYOTIC_TRANSLATION_INITIATION,2.150613936,0.022292268,pilaralisib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.081485519,0.033721093,pilaralisib
REGULATION_OF_TP53_ACTIVITY,1.947829734,0.082211391,pilaralisib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.968002934,0.148636842,pilaralisib
NEUTROPHIL_DEGRANULATION,2.08309993,0.070286934,epinastine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.050037186,0.063526775,epinastine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.962166397,0.087576197,epinastine
GPCR_LIGAND_BINDING,-1.948265529,0.0644343,epinastine
INNATE_IMMUNE_SYSTEM,1.707212748,0.303675599,epinastine
PROTEIN_LOCALIZATION,1.674921153,0.238494981,epinastine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.868036872,0.115709483,epinastine
OPIOID_SIGNALLING,1.565767207,0.324401233,epinastine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.785476537,0.190943334,epinastine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.507817667,0.373421864,epinastine
GPCR_LIGAND_BINDING,2.278528957,0.014411169,trifluridine
M_PHASE,-2.320254987,0.053880693,trifluridine
MEMBRANE_TRAFFICKING,-2.197161181,0.047594612,trifluridine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.167914236,0.021256474,trifluridine
NEUTROPHIL_DEGRANULATION,-2.16834218,0.040111182,trifluridine
TRANSLATION,-2.143141206,0.033675433,trifluridine
CELL_CYCLE,-2.11308156,0.031969211,trifluridine
CELL_CYCLE_MITOTIC,-2.105113576,0.028437032,trifluridine
METABOLISM_OF_RNA,-2.056128239,0.031045542,trifluridine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.026099903,0.035246953,trifluridine
METABOLISM_OF_RNA,-3.592997733,0,NVP-TAE226
RRNA_PROCESSING,-2.720094228,0,NVP-TAE226
CELL_CYCLE,-2.777142316,0,NVP-TAE226
SIGNALING_BY_GPCR,2.871113817,0,NVP-TAE226
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.634627306,0,NVP-TAE226
CELL_CYCLE_CHECKPOINTS,-3.038225729,0,NVP-TAE226
RESPIRATORY_ELECTRON_TRANSPORT,-3.192362688,0,NVP-TAE226
GPCR_LIGAND_BINDING,2.924756244,0,NVP-TAE226
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.674602273,0.000203102,NVP-TAE226
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.498284105,0.000931582,NVP-TAE226
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.213566287,0.04398092,resiquimod
GPCR_LIGAND_BINDING,-2.069964875,0.052959556,resiquimod
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.008465318,0.048484101,resiquimod
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.982760312,0.0430141,resiquimod
SIGNALING_BY_NTRKS,1.795120808,0.37383782,resiquimod
ADAPTIVE_IMMUNE_SYSTEM,1.739516058,0.3298569,resiquimod
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.731638566,0.259075107,resiquimod
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.668925452,0.291923357,resiquimod
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.828690473,0.141349802,resiquimod
NEDDYLATION,1.589409581,0.371547147,resiquimod
DISEASES_OF_METABOLISM,-3.53071141,0.869722667,lomefloxacin
GPCR_LIGAND_BINDING,1.877622043,0.678094049,lomefloxacin
INTERFERON_ALPHA_BETA_SIGNALING,-1.910569777,1,lomefloxacin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.794002729,1,lomefloxacin
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.669274437,1,lomefloxacin
NEURONAL_SYSTEM,1.660761151,1,lomefloxacin
CDC42_GTPASE_CYCLE,1.653010227,0.798787419,lomefloxacin
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.685991273,1,lomefloxacin
BIOLOGICAL_OXIDATIONS,-1.676622782,1,lomefloxacin
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.649400309,1,lomefloxacin
EUKARYOTIC_TRANSLATION_ELONGATION,-4.05484491,0,sufentanil
SARS_COV_INFECTIONS,-2.741025959,0,sufentanil
INFECTIOUS_DISEASE,-2.793443978,0,sufentanil
CELLULAR_RESPONSES_TO_STIMULI,-2.830202812,0,sufentanil
METABOLISM_OF_RNA,-2.849546326,0,sufentanil
VIRAL_INFECTION_PATHWAYS,-2.923420116,0,sufentanil
SARS_COV_2_INFECTION,-2.969903467,0,sufentanil
SARS_COV_1_INFECTION,-3.264587293,0,sufentanil
NERVOUS_SYSTEM_DEVELOPMENT,-3.310628409,0,sufentanil
SARS_COV_1_HOST_INTERACTIONS,-3.320805217,0,sufentanil
EUKARYOTIC_TRANSLATION_ELONGATION,-3.242148675,0,tipiracil
SARS_COV_1_INFECTION,-2.612778229,0,tipiracil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.63904501,0,tipiracil
TRANSLATION,-2.663073038,0,tipiracil
SARS_COV_1_HOST_INTERACTIONS,-2.710571779,0,tipiracil
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.716385291,0,tipiracil
INFLUENZA_INFECTION,-2.730131098,0,tipiracil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.738616588,0,tipiracil
SIGNALING_BY_ROBO_RECEPTORS,-2.820137499,0,tipiracil
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.891087218,0,tipiracil
G2_M_CHECKPOINTS,-2.844650791,0,vinblastine
DNA_REPLICATION,-2.808837916,0,vinblastine
SYNTHESIS_OF_DNA,-2.755380792,0,vinblastine
DNA_STRAND_ELONGATION,-2.750774887,0,vinblastine
DNA_REPAIR,-2.727306422,0,vinblastine
CELL_CYCLE_CHECKPOINTS,-2.535380472,0.000665037,vinblastine
TELOMERE_MAINTENANCE,-2.482698802,0.001520085,vinblastine
DNA_REPLICATION_PRE_INITIATION,-2.473356243,0.001330074,vinblastine
BASE_EXCISION_REPAIR,-2.459553039,0.001182288,vinblastine
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.409468545,0.001596089,vinblastine
RHO_GTPASE_CYCLE,2.726622995,0.002292776,ciclesonide
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.456645678,0.004585552,ciclesonide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.254941891,0.008603793,ciclesonide
EUKARYOTIC_TRANSLATION_INITIATION,-2.194938437,0.008173604,ciclesonide
NONSENSE_MEDIATED_DECAY_NMD,-2.185268615,0.006596241,ciclesonide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.173662712,0.00580756,ciclesonide
SELENOAMINO_ACID_METABOLISM,-2.138636647,0.007399262,ciclesonide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.137356668,0.006166052,ciclesonide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.130948455,0.00553101,ciclesonide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.124167481,0.005162276,ciclesonide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,5.657770295,0,nitisinone
GPCR_LIGAND_BINDING,-2.592733166,0,nitisinone
HOST_INTERACTIONS_OF_HIV_FACTORS,2.926990383,0,nitisinone
RESPIRATORY_ELECTRON_TRANSPORT,3.080994273,0,nitisinone
SARS_COV_2_INFECTION,3.344839647,0,nitisinone
NERVOUS_SYSTEM_DEVELOPMENT,3.415737169,0,nitisinone
MRNA_SPLICING,3.566848079,0,nitisinone
SARS_COV_2_HOST_INTERACTIONS,3.625732752,0,nitisinone
INFECTIOUS_DISEASE,3.663118173,0,nitisinone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.692316494,0,nitisinone
GPCR_LIGAND_BINDING,2.685441019,0,sparfloxacin
NEUTROPHIL_DEGRANULATION,-3.003219789,0.007163237,sparfloxacin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.411417334,0.001194808,sparfloxacin
SIGNALING_BY_GPCR,2.325896113,0.003451669,sparfloxacin
G_ALPHA_S_SIGNALLING_EVENTS,2.076186009,0.023697034,sparfloxacin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.04854763,0.023896169,sparfloxacin
G_ALPHA_I_SIGNALLING_EVENTS,1.885986064,0.08403486,sparfloxacin
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.848279644,0.095243301,sparfloxacin
ECM_PROTEOGLYCANS,1.822069975,0.102653958,sparfloxacin
INNATE_IMMUNE_SYSTEM,-1.785023105,1,sparfloxacin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.006473865,0.290435104,goserelin-acetate
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.885749502,0.405710892,goserelin-acetate
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.881444395,0.28012183,goserelin-acetate
GASTRULATION,-1.829159458,0.319628323,goserelin-acetate
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.7876603,0.352115136,goserelin-acetate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.782508139,0.306237701,goserelin-acetate
S_PHASE,-1.749786166,0.332210992,goserelin-acetate
PROTEIN_LOCALIZATION,1.5066588,1,goserelin-acetate
MITOTIC_G2_G2_M_PHASES,-1.725722233,0.347823483,goserelin-acetate
HCMV_INFECTION,1.430909353,1,goserelin-acetate
MRNA_SPLICING,1.782298341,0.339859748,ixabepilone
RAB_REGULATION_OF_TRAFFICKING,1.626249696,0.374137447,ixabepilone
SEMAPHORIN_INTERACTIONS,1.536619903,0.384104722,ixabepilone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.431739669,1,ixabepilone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.406513874,0.871891171,ixabepilone
G_ALPHA_I_SIGNALLING_EVENTS,-2.376977319,0.609093981,ixabepilone
SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,-2.250680834,0.543475593,ixabepilone
INSULIN_RECEPTOR_SIGNALLING_CASCADE,-2.200573825,0.464490798,ixabepilone
GPCR_LIGAND_BINDING,-2.17659703,0.399050413,ixabepilone
IRS_MEDIATED_SIGNALLING,-2.1720169,0.343430248,ixabepilone
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.569904146,0,varenicline
GPCR_LIGAND_BINDING,-2.503088078,0,varenicline
COLLAGEN_FORMATION,-2.362083438,0.00318019,varenicline
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.353017229,0.002385142,varenicline
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,2.146917946,0.115590439,varenicline
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.153084595,0.018317892,varenicline
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.062929769,0.032119914,varenicline
SIGNALING_BY_GPCR,-2.047771135,0.03162017,varenicline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.013953252,0.036134904,varenicline
CELLULAR_RESPONSE_TO_STARVATION,1.974685609,0.200142704,varenicline
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.727753936,0.042256167,pentoxyverine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.600637697,0.040782115,pentoxyverine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.513090033,0.059617228,pentoxyverine
ONCOGENIC_MAPK_SIGNALING,-2.489059041,0.051837507,pentoxyverine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-2.233186633,0.181603249,pentoxyverine
NEUTROPHIL_DEGRANULATION,-2.151685697,0.204401925,pentoxyverine
TOLL_LIKE_RECEPTOR_CASCADES,-2.143388436,0.180536316,pentoxyverine
MAPK1_MAPK3_SIGNALING,-2.140512248,0.158951978,pentoxyverine
INNATE_IMMUNE_SYSTEM,-2.118005913,0.152427931,pentoxyverine
MAPK_FAMILY_SIGNALING_CASCADES,-2.06544313,0.158706302,pentoxyverine
MITF_M_DEPENDENT_GENE_EXPRESSION,2.515596514,0.009530466,pomalidomide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.504847665,0.004765233,pomalidomide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.417388542,0.005294703,pomalidomide
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.324515861,0.0053824,pomalidomide
METABOLISM_OF_RNA,2.275114399,0.00873626,pomalidomide
GPCR_LIGAND_BINDING,-2.233596921,0.0053824,pomalidomide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.120851135,0.01025219,pomalidomide
MRNA_SPLICING,2.055908013,0.02604994,pomalidomide
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.937626281,0.039710274,pomalidomide
MEMBRANE_TRAFFICKING,1.784004661,0.078512884,pomalidomide
MRNA_SPLICING,2.260738068,0.056396614,lacidipine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.195280404,0.061523579,lacidipine
HOST_INTERACTIONS_OF_HIV_FACTORS,1.785357869,0.552003225,lacidipine
DNA_REPLICATION,1.747509582,0.480652963,lacidipine
INTERLEUKIN_1_FAMILY_SIGNALING,1.658632598,0.557813785,lacidipine
DNA_REPLICATION_PRE_INITIATION,1.65649979,0.469971786,lacidipine
SYNTHESIS_OF_DNA,1.582502407,0.566163413,lacidipine
C_TYPE_LECTIN_RECEPTORS_CLRS,1.499803824,0.729951632,lacidipine
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,1.488417607,0.684164987,lacidipine
G1_S_DNA_DAMAGE_CHECKPOINTS,1.478383277,0.653175333,lacidipine
RESPIRATORY_ELECTRON_TRANSPORT,2.089831066,0.183859402,travoprost
CELLULAR_SENESCENCE,2.038861026,0.115911362,travoprost
ADAPTIVE_IMMUNE_SYSTEM,1.945731151,0.137228394,travoprost
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.918841508,0.11391289,travoprost
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.8220782,0.145488744,travoprost
MITOTIC_PROMETAPHASE,1.773029542,0.159211583,travoprost
KERATINIZATION,-1.935588803,0.244942919,travoprost
MYD88_INDEPENDENT_TLR4_CASCADE,1.710067231,0.181004442,travoprost
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.694855987,0.170869335,travoprost
GPCR_LIGAND_BINDING,-1.909769277,0.154879292,travoprost
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.985759472,0,moxisylyte
COLLAGEN_FORMATION,-2.534556144,0,moxisylyte
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.455681412,0.001331868,moxisylyte
ECM_PROTEOGLYCANS,-2.364897193,0.002996704,moxisylyte
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.309380365,0.00495455,moxisylyte
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.159107704,0.090293321,moxisylyte
SELENOAMINO_ACID_METABOLISM,2.118485611,0.059989398,moxisylyte
REGULATION_OF_TP53_ACTIVITY,2.090557206,0.051537284,moxisylyte
CELLULAR_RESPONSE_TO_STARVATION,2.071528849,0.042982094,moxisylyte
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.069733441,0.03562257,moxisylyte
EUKARYOTIC_TRANSLATION_ELONGATION,-3.989139662,0,vernakalant
SARS_COV_1_INFECTION,-3.231467024,0,vernakalant
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.250165982,0,vernakalant
NERVOUS_SYSTEM_DEVELOPMENT,-3.264454392,0,vernakalant
SARS_COV_1_HOST_INTERACTIONS,-3.358078659,0,vernakalant
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.358682302,0,vernakalant
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.480911771,0,vernakalant
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.511162825,0,vernakalant
TRANSLATION,-3.565953814,0,vernakalant
SIGNALING_BY_ROBO_RECEPTORS,-3.612297081,0,vernakalant
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.804117058,0,otamixaban
COLLAGEN_FORMATION,-2.440682868,0.001081901,otamixaban
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.388813828,0.002163801,otamixaban
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.383326481,0.001622851,otamixaban
GPCR_LIGAND_BINDING,-2.355649597,0.002163801,otamixaban
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.339138821,0.002163801,otamixaban
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.336137167,0.001854687,otamixaban
ECM_PROTEOGLYCANS,-2.332765257,0.001622851,otamixaban
DEVELOPMENTAL_CELL_LINEAGES,-2.245829975,0.004568025,otamixaban
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.208315441,0.006599594,otamixaban
DEUBIQUITINATION,-1.504832532,1,BRD-K08111712
SIGNALING_BY_NTRKS,-1.493921084,1,BRD-K08111712
GPCR_LIGAND_BINDING,-1.481222432,0.845494246,BRD-K08111712
RAC1_GTPASE_CYCLE,-1.375027677,1,BRD-K08111712
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.462152202,1,BRD-K08111712
SIGNALING_BY_NOTCH,1.435434776,1,BRD-K08111712
NEUTROPHIL_DEGRANULATION,-1.253680891,1,BRD-K08111712
VESICLE_MEDIATED_TRANSPORT,-1.192951395,1,BRD-K08111712
MEMBRANE_TRAFFICKING,-1.192951395,1,BRD-K08111712
TRANSLATION,1.382893067,1,BRD-K08111712
EUKARYOTIC_TRANSLATION_ELONGATION,-3.603515402,0,dalfampridine
CELLULAR_RESPONSES_TO_STIMULI,-2.669767062,0,dalfampridine
INFECTIOUS_DISEASE,-2.721698076,0,dalfampridine
SARS_COV_2_HOST_INTERACTIONS,-2.764761416,0,dalfampridine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.793716631,0,dalfampridine
SARS_COV_1_INFECTION,-2.817114574,0,dalfampridine
VIRAL_INFECTION_PATHWAYS,-2.853633036,0,dalfampridine
SARS_COV_1_HOST_INTERACTIONS,-2.90359527,0,dalfampridine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.984452304,0,dalfampridine
NERVOUS_SYSTEM_DEVELOPMENT,-3.012096167,0,dalfampridine
NEUTROPHIL_DEGRANULATION,2.497589463,0.001598402,telcagepant
INNATE_IMMUNE_SYSTEM,1.917910851,0.096703297,telcagepant
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.593112353,0.462470862,telcagepant
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.81042429,0.922127173,telcagepant
PROTEIN_LOCALIZATION,1.462935438,0.668531469,telcagepant
HEMOSTASIS,1.427832034,0.625294705,telcagepant
MYD88_INDEPENDENT_TLR4_CASCADE,1.414422482,0.558641359,telcagepant
GPCR_LIGAND_BINDING,-1.693898086,1,telcagepant
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.693151958,0.800778441,telcagepant
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.372304821,0.578393036,telcagepant
EUKARYOTIC_TRANSLATION_ELONGATION,3.731353075,0,metharbital
METABOLISM_OF_RNA,2.931351023,0,metharbital
RRNA_PROCESSING,2.966937104,0,metharbital
SIGNALING_BY_ROBO_RECEPTORS,3.304480565,0,metharbital
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.309608999,0,metharbital
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.872358984,0,metharbital
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.385126001,0,metharbital
CELLULAR_RESPONSE_TO_STARVATION,3.333522449,0,metharbital
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.484666719,0,metharbital
SELENOAMINO_ACID_METABOLISM,3.50387022,0,metharbital
GPCR_LIGAND_BINDING,2.412529473,0.00324078,dorzolamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.378233556,0.002025487,dorzolamide
SIGNALING_BY_GPCR,2.241603718,0.008372015,dorzolamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.22883877,0.006684108,dorzolamide
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-3.095720907,0.055391516,dorzolamide
SENSORY_PERCEPTION,1.953163625,0.060440544,dorzolamide
G_ALPHA_I_SIGNALLING_EVENTS,1.91869613,0.066706051,dorzolamide
ESR_MEDIATED_SIGNALING,-2.855703629,0.805307419,dorzolamide
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.81844482,0.75701738,dorzolamide
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1.723493546,0.234956536,dorzolamide
MRNA_SPLICING,2.37231441,0.033637363,perampanel
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.366633051,0.016818682,perampanel
DNA_REPLICATION,1.904358265,0.168186817,perampanel
SYNTHESIS_OF_DNA,1.728124833,0.286968756,perampanel
SIGNALING_BY_NTRKS,1.708826972,0.246393687,perampanel
L1CAM_INTERACTIONS,1.665269477,0.248776333,perampanel
DNA_REPLICATION_PRE_INITIATION,1.603162103,0.294927596,perampanel
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1.563330178,0.320080536,perampanel
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.558320742,0.264894236,perampanel
RESPIRATORY_ELECTRON_TRANSPORT,1.560182512,0.292458187,perampanel
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.821500032,0,isoniazid
INFECTIOUS_DISEASE,-2.797886033,0,isoniazid
SARS_COV_INFECTIONS,-2.830598703,0,isoniazid
CELLULAR_RESPONSES_TO_STIMULI,-2.917422844,0,isoniazid
SARS_COV_2_INFECTION,-2.937798059,0,isoniazid
METABOLISM_OF_RNA,-2.937926082,0,isoniazid
NERVOUS_SYSTEM_DEVELOPMENT,-2.963458765,0,isoniazid
VIRAL_INFECTION_PATHWAYS,-2.98829269,0,isoniazid
SARS_COV_2_HOST_INTERACTIONS,-3.120141072,0,isoniazid
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.155944222,0,isoniazid
CELLULAR_RESPONSE_TO_STARVATION,2.584265425,0.001930884,rasagiline
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.178365793,0.051400869,rasagiline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.002427759,0.088820675,rasagiline
SIGNALING_BY_ROBO_RECEPTORS,2.001941844,0.059213784,rasagiline
RAB_REGULATION_OF_TRAFFICKING,1.9871151,0.047548025,rasagiline
EUKARYOTIC_TRANSLATION_INITIATION,1.964936023,0.043058719,rasagiline
ECM_PROTEOGLYCANS,-1.999978628,0.198548456,rasagiline
INFLUENZA_INFECTION,1.882477504,0.05889197,rasagiline
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.944134917,0.206611338,rasagiline
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.937403616,0.165793,rasagiline
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.366945195,0.017687636,adapalene
MRNA_SPLICING,2.356336194,0.010317788,adapalene
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.549645933,0.380848259,adapalene
TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,1.691937019,0.30560305,adapalene
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.528269937,0.245337134,adapalene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.430686287,0.392362276,adapalene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.403064155,0.339884929,adapalene
EUKARYOTIC_TRANSLATION_INITIATION,-2.393297195,0.287496151,adapalene
SELENOAMINO_ACID_METABOLISM,-2.374401158,0.258327308,adapalene
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.342020157,0.246349356,adapalene
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.115704336,0.085746255,diminazene-aceturate
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.105916357,0.047270372,diminazene-aceturate
PROTEIN_LOCALIZATION,2.080366684,0.086359036,diminazene-aceturate
ECM_PROTEOGLYCANS,-1.997281108,0.09490718,diminazene-aceturate
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-1.980200801,0.085746255,diminazene-aceturate
SIGNALING_BY_NTRKS,1.936124999,0.101318869,diminazene-aceturate
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.95197655,0.093441432,diminazene-aceturate
GASTRULATION,-1.917669701,0.104984197,diminazene-aceturate
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.867167114,0.137570915,diminazene-aceturate
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.714885912,0.258850444,diminazene-aceturate
VISUAL_PHOTOTRANSDUCTION,2.224801872,0.06400621,thonzonium
NEUTROPHIL_DEGRANULATION,2.146041171,0.066629416,thonzonium
HATS_ACETYLATE_HISTONES,-1.948907342,0.133059726,thonzonium
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,2.110721217,0.061557885,thonzonium
SENSORY_PERCEPTION,2.021895078,0.087615058,thonzonium
DISEASES_OF_METABOLISM,2.009775545,0.079745442,thonzonium
DISEASES_OF_GLYCOSYLATION,1.972079648,0.084816973,thonzonium
CHROMATIN_ORGANIZATION,-1.746950402,0.212261943,thonzonium
SIGNALING_BY_FGFR,1.859117538,0.159340987,thonzonium
GASTRULATION,1.808451661,0.198314324,thonzonium
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.518619024,1,nepafenac
G_ALPHA_I_SIGNALLING_EVENTS,-2.286734534,1,nepafenac
MRNA_SPLICING,1.3889838,1,nepafenac
NONSENSE_MEDIATED_DECAY_NMD,-2.158643841,0.754148928,nepafenac
EUKARYOTIC_TRANSLATION_ELONGATION,-2.171017942,0.997414593,nepafenac
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.130421618,0.61995963,nepafenac
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,-2.128581876,0.517309468,nepafenac
SELENOAMINO_ACID_METABOLISM,-2.128558926,0.443408115,nepafenac
GPCR_LIGAND_BINDING,-2.107344854,0.395718913,nepafenac
EUKARYOTIC_TRANSLATION_INITIATION,-2.103461529,0.353892213,nepafenac
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.223392843,0.023429373,umeclidinium
HIV_INFECTION,-2.190972794,0.018104516,umeclidinium
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.10514572,0.035854041,umeclidinium
HOST_INTERACTIONS_OF_HIV_FACTORS,-2.095533903,0.030617931,umeclidinium
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.079976262,0.029606208,umeclidinium
SEPARATION_OF_SISTER_CHROMATIDS,-2.058004788,0.030529184,umeclidinium
S_PHASE,-2.053798623,0.027841398,umeclidinium
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.048726716,0.025026831,umeclidinium
CLEC7A_DECTIN_1_SIGNALING,-1.996947423,0.038693965,umeclidinium
APOPTOSIS,-1.962023586,0.046858747,umeclidinium
MRNA_SPLICING,1.868139849,0.368641254,lenvatinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.704592724,0.548910878,lenvatinib
PEPTIDE_HORMONE_METABOLISM,1.597945195,0.596847744,lenvatinib
SYNTHESIS_OF_DNA,1.536712436,0.618790676,lenvatinib
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.491779243,0.621423828,lenvatinib
L1CAM_INTERACTIONS,1.481840782,0.544184708,lenvatinib
TCR_SIGNALING,1.450895281,0.543991803,lenvatinib
MYD88_INDEPENDENT_TLR4_CASCADE,1.434897571,0.517009231,lenvatinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.304723477,1,lenvatinib
SIGNALING_BY_VEGF,1.423327796,0.491521672,lenvatinib
ASPARAGINE_N_LINKED_GLYCOSYLATION,2.110285019,0.137072789,hexachlorophene
SIGNALING_BY_ALK_IN_CANCER,2.068871565,0.085207409,hexachlorophene
IRE1ALPHA_ACTIVATES_CHAPERONES,1.987656556,0.095703974,hexachlorophene
CELLULAR_RESPONSE_TO_STARVATION,1.870292977,0.141703626,hexachlorophene
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.820742549,0.157078007,hexachlorophene
GPCR_LIGAND_BINDING,-1.927442299,0.453759904,hexachlorophene
MEMBRANE_TRAFFICKING,1.756921405,0.190481781,hexachlorophene
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.753126147,0.16618091,hexachlorophene
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.900808456,0.279204664,hexachlorophene
NEUTROPHIL_DEGRANULATION,1.716627125,0.177824159,hexachlorophene
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.013920475,0.140497987,retigabine
NEUTROPHIL_DEGRANULATION,1.826874319,0.280463999,retigabine
GPCR_LIGAND_BINDING,-1.850401821,0.356611211,retigabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.810255565,0.339862029,retigabine
PROTEIN_LOCALIZATION,1.47853882,0.861175764,retigabine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.772760786,0.353684169,retigabine
REGULATION_OF_TP53_ACTIVITY,1.410914098,0.807643216,retigabine
GASTRULATION,-1.696472977,0.524916091,retigabine
INNATE_IMMUNE_SYSTEM,1.32372218,0.914417374,retigabine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.641821187,0.643949109,retigabine
MITOTIC_METAPHASE_AND_ANAPHASE,-1.906969021,0.632382892,tanaproget
PARASITE_INFECTION,1.742241828,0.583915749,tanaproget
PLATELET_HOMEOSTASIS,1.651846758,0.455672571,tanaproget
CELL_CYCLE_MITOTIC,-1.765011851,0.999490835,tanaproget
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.464777489,0.805840115,tanaproget
SEPARATION_OF_SISTER_CHROMATIDS,-1.712216213,1,tanaproget
M_PHASE,-1.694917295,0.876272912,tanaproget
SARS_COV_1_INFECTION,1.407971565,0.796062709,tanaproget
CELL_CYCLE_CHECKPOINTS,-1.671461642,0.83503055,tanaproget
GLYCOSAMINOGLYCAN_METABOLISM,1.343162622,0.863685974,tanaproget
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.204816073,0.134400915,mitiglinide
MRNA_SPLICING,2.14854611,0.088704604,mitiglinide
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.038251976,0.114688781,mitiglinide
MITOTIC_G2_G2_M_PHASES,1.963356029,0.12633686,mitiglinide
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.880712572,0.132608903,mitiglinide
DNA_REPLICATION,1.883317676,0.158055476,mitiglinide
INTERLEUKIN_1_FAMILY_SIGNALING,1.810873336,0.155137056,mitiglinide
SYNTHESIS_OF_DNA,1.778131257,0.161953103,mitiglinide
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.679791775,0.237740285,mitiglinide
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1.671490013,0.222030312,mitiglinide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.380878803,0.003187413,ampalex
SELENOAMINO_ACID_METABOLISM,-2.354537355,0.001593707,ampalex
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.276200389,0.003718649,ampalex
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.26830677,0.002788987,ampalex
NONSENSE_MEDIATED_DECAY_NMD,-2.259289364,0.002231189,ampalex
EUKARYOTIC_TRANSLATION_INITIATION,-2.226223875,0.003718649,ampalex
TRANSLATION,-2.195656644,0.004098103,ampalex
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.132448877,0.129136001,ampalex
CELLULAR_RESPONSE_TO_STARVATION,-2.126746183,0.006374827,ampalex
MRNA_SPLICING,2.086682549,0.082379863,ampalex
CELLULAR_RESPONSE_TO_STARVATION,2.771654661,0,BRD-K75516118
EUKARYOTIC_TRANSLATION_ELONGATION,3.273341327,0,BRD-K75516118
NONSENSE_MEDIATED_DECAY_NMD,3.231056571,0,BRD-K75516118
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.210368267,0,BRD-K75516118
METABOLISM_OF_RNA,3.164592402,0,BRD-K75516118
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.068213642,0,BRD-K75516118
SIGNALING_BY_ROBO_RECEPTORS,3.039525623,0,BRD-K75516118
SELENOAMINO_ACID_METABOLISM,3.019675164,0,BRD-K75516118
EUKARYOTIC_TRANSLATION_INITIATION,2.901449565,0,BRD-K75516118
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.895639739,0,BRD-K75516118
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.352683136,0.01771868,amsacrine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.19133838,0.024161837,amsacrine
BIOLOGICAL_OXIDATIONS,2.189256366,0.016107891,amsacrine
CELL_CYCLE,-2.067822877,0.198483135,amsacrine
CELL_CYCLE_MITOTIC,-2.044813703,0.118877599,amsacrine
M_PHASE,-2.037800196,0.083497361,amsacrine
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,-1.947501783,0.143820667,amsacrine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.863072776,0.097452742,amsacrine
MITOTIC_G2_G2_M_PHASES,-1.941738192,0.121849539,amsacrine
SIGNALING_BY_NOTCH,-1.916670033,0.124715339,amsacrine
CELLULAR_RESPONSE_TO_STARVATION,2.760150645,0.000820637,romidepsin
CELL_CYCLE,-2.568002736,0.001060517,romidepsin
CELL_CYCLE_MITOTIC,-2.560464477,0.000530259,romidepsin
MITOTIC_SPINDLE_CHECKPOINT,-2.405432111,0.000707012,romidepsin
M_PHASE,-2.394764933,0.000795388,romidepsin
CHROMATIN_ORGANIZATION,-2.342147497,0.000848414,romidepsin
AUTOPHAGY,2.434741736,0.004103183,romidepsin
METABOLISM_OF_STEROIDS,2.362923911,0.004103183,romidepsin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.259724757,0.003711811,romidepsin
MITOTIC_PROMETAPHASE,-2.25241211,0.003333055,romidepsin
MRNA_SPLICING,2.06246622,0.099716933,butorphanol-(+)-tartrate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.047661536,0.057900154,butorphanol-(+)-tartrate
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.761768933,0.219806142,butorphanol-(+)-tartrate
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.658523692,0.29110911,butorphanol-(+)-tartrate
PEPTIDE_HORMONE_METABOLISM,1.632989377,0.26762738,butorphanol-(+)-tartrate
SYNTHESIS_OF_DNA,1.569946373,0.300223023,butorphanol-(+)-tartrate
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.528679447,0.318450849,butorphanol-(+)-tartrate
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.520553356,0.285479928,butorphanol-(+)-tartrate
L1CAM_INTERACTIONS,1.507817322,0.269843312,butorphanol-(+)-tartrate
DOWNSTREAM_TCR_SIGNALING,1.386561764,0.439076171,butorphanol-(+)-tartrate
INFLUENZA_INFECTION,3.106756335,0,alpelisib
EUKARYOTIC_TRANSLATION_INITIATION,3.07908209,0,alpelisib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.007306007,0,alpelisib
NONSENSE_MEDIATED_DECAY_NMD,2.923586784,0,alpelisib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.710237859,0,alpelisib
GPCR_LIGAND_BINDING,-2.756789117,0,alpelisib
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.572348314,0.000211036,alpelisib
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.590346988,0.000263795,alpelisib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.57645271,0.000234484,alpelisib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.82160004,0.000351727,alpelisib
GPCR_LIGAND_BINDING,-1.929566123,0.35807642,desvenlafaxine
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.66467526,1,desvenlafaxine
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.491266799,1,desvenlafaxine
PROTEIN_LOCALIZATION,1.451207844,1,desvenlafaxine
PHOSPHOLIPID_METABOLISM,-1.751818911,0.833743369,desvenlafaxine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.740220942,0.612413828,desvenlafaxine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.705030692,0.612487507,desvenlafaxine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.694627299,0.531898209,desvenlafaxine
SARS_COV_2_HOST_INTERACTIONS,1.343336481,1,desvenlafaxine
TRNA_PROCESSING,1.313023443,1,desvenlafaxine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.627762857,0,NVP-BGJ398
GPCR_LIGAND_BINDING,2.60106084,0,NVP-BGJ398
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.381798882,0.001431961,NVP-BGJ398
INTERFERON_ALPHA_BETA_SIGNALING,-2.642740201,0.006570929,NVP-BGJ398
SIGNALING_BY_GPCR,2.351624662,0.001503559,NVP-BGJ398
SIGNALING_BY_FGFR1,2.111824992,0.015121504,NVP-BGJ398
KERATINIZATION,-2.03932141,0.170022786,NVP-BGJ398
G_ALPHA_S_SIGNALLING_EVENTS,2.048150657,0.026634467,NVP-BGJ398
PROTEIN_LOCALIZATION,-2.006705852,0.141274972,NVP-BGJ398
G_ALPHA_I_SIGNALLING_EVENTS,2.011008776,0.03289418,NVP-BGJ398
GASTRULATION,-1.869548362,0.781877585,VX-661
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.489441368,1,VX-661
TRANS_GOLGI_NETWORK_VESICLE_BUDDING,1.377008135,1,VX-661
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.370466667,1,VX-661
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.635101137,1,VX-661
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.619577405,1,VX-661
CELL_CYCLE_MITOTIC,-1.602481281,1,VX-661
NEUTROPHIL_DEGRANULATION,1.333749036,0.997218185,VX-661
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.598476111,1,VX-661
PROTEIN_LOCALIZATION,1.292032478,0.964154495,VX-661
MRNA_SPLICING,2.839802416,0.002482416,ambrisentan
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.567558537,0.001241208,ambrisentan
L1CAM_INTERACTIONS,1.46162574,0.807612743,ambrisentan
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.416480726,0.739139429,ambrisentan
TCR_SIGNALING,1.404137566,0.623582954,ambrisentan
SYNTHESIS_OF_DNA,1.385878412,0.568059578,ambrisentan
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.288893162,1,ambrisentan
DOWNSTREAM_TCR_SIGNALING,1.285866581,0.759619363,ambrisentan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.124194153,1,ambrisentan
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.234491218,0.819507654,ambrisentan
PEROXISOMAL_PROTEIN_IMPORT,1.982370657,0.218900431,eflornithine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.029810958,0.312815524,eflornithine
GASTRULATION,-1.970386002,0.271460251,eflornithine
INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,1.805155086,0.34806778,eflornithine
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-1.769002877,0.871995365,eflornithine
SIGNALING_BY_NTRKS,1.598737748,0.66313954,eflornithine
M_PHASE,-1.766322928,0.667781615,eflornithine
ION_CHANNEL_TRANSPORT,1.568031789,0.576625583,eflornithine
CELL_CYCLE,-1.746784833,0.606331921,eflornithine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.552133902,0.49671083,eflornithine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.778877723,0.986618689,BRD-K44408410
RAB_REGULATION_OF_TRAFFICKING,1.700322439,0.776846958,BRD-K44408410
RESPIRATORY_ELECTRON_TRANSPORT,1.65871498,0.654672214,BRD-K44408410
EUKARYOTIC_TRANSLATION_ELONGATION,-2.389455987,0.910488888,BRD-K44408410
DNA_REPLICATION,1.543277223,0.90363207,BRD-K44408410
SELENOAMINO_ACID_METABOLISM,-2.357810085,0.540298344,BRD-K44408410
SYNTHESIS_OF_DNA,1.475030758,0.989384909,BRD-K44408410
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.294228185,0.451622472,BRD-K44408410
NONSENSE_MEDIATED_DECAY_NMD,-2.286382118,0.346397933,BRD-K44408410
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.454792874,0.910547622,BRD-K44408410
TRANSLATION,-2.823732509,0,BRD-K22081896
RESPIRATORY_ELECTRON_TRANSPORT,-2.494033058,0.003545666,BRD-K22081896
METABOLISM_OF_RNA,-2.032424642,0.06618576,BRD-K22081896
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.002407486,0.055548763,BRD-K22081896
INTERLEUKIN_1_FAMILY_SIGNALING,-1.983724399,0.048221054,BRD-K22081896
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.951405122,0.050033283,BRD-K22081896
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.866149554,0.069900267,BRD-K22081896
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.699004192,0.148327016,BRD-K22081896
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.804989877,0.907458977,BRD-K22081896
APOPTOSIS,-1.511365955,0.341171836,BRD-K22081896
RRNA_PROCESSING,-3.409639698,0,dioxane
CELLULAR_RESPONSE_TO_STARVATION,-2.902757094,0,dioxane
TRANSLATION,-2.896254616,0,dioxane
INFLUENZA_INFECTION,-2.850675922,0,dioxane
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,-2.270539805,0.011188066,dioxane
METABOLISM_OF_RNA,-2.143194136,0.019090748,dioxane
SARS_COV_1_INFECTION,-2.069075423,0.02473552,dioxane
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.05884814,0.024640384,dioxane
CELLULAR_RESPONSE_TO_HEAT_STRESS,-2.000532011,0.031669922,dioxane
SARS_COV_1_HOST_INTERACTIONS,-1.958578946,0.034363346,dioxane
RRNA_PROCESSING,-3.114927278,0,glycerol
TRANSLATION,-2.845040526,0,glycerol
S_PHASE,-2.447260766,0.004320416,glycerol
METABOLISM_OF_RNA,-2.311294444,0.005940572,glycerol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.301540944,0.006048583,glycerol
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.843980313,0.068046555,glycerol
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.820145099,0.064806243,glycerol
TRANSCRIPTIONAL_REGULATION_BY_TP53,-1.807578686,0.060485826,glycerol
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,-1.784588643,0.061685942,glycerol
ASPARAGINE_N_LINKED_GLYCOSYLATION,-1.662470457,0.116219195,glycerol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.423366619,0,benzoic-acid
TRANSLATION,-3.397282006,0,benzoic-acid
RRNA_PROCESSING,-3.347121608,0,benzoic-acid
CELLULAR_RESPONSE_TO_STARVATION,-3.011955915,0,benzoic-acid
DNA_REPLICATION,-2.575986455,0.000456922,benzoic-acid
INFLUENZA_INFECTION,-2.53713528,0.000380768,benzoic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.481328891,0.000979118,benzoic-acid
S_PHASE,-2.449851883,0.00142788,benzoic-acid
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.285021931,0.003553835,benzoic-acid
GPCR_LIGAND_BINDING,2.162581858,0.039771851,benzoic-acid
S_PHASE,-2.068632031,0.140976701,triptorelin
RHO_GTPASES_ACTIVATE_FORMINS,-2.036645702,0.10741082,triptorelin
SYNTHESIS_OF_DNA,-1.939024302,0.137340398,triptorelin
DNA_REPLICATION,-1.939024302,0.137340398,triptorelin
CELL_CYCLE_MITOTIC,-1.880009361,0.185059892,triptorelin
PEROXISOMAL_PROTEIN_IMPORT,1.756496806,0.541007905,triptorelin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.859814827,0.18312053,triptorelin
MITOTIC_METAPHASE_AND_ANAPHASE,-1.854778901,0.163513793,triptorelin
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.8544029,0.143634,triptorelin
SIGNALING_BY_ALK_IN_CANCER,1.72303813,0.328866107,triptorelin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.102612205,0.12872547,KX-2391
MRNA_SPLICING,1.749901997,0.40278615,KX-2391
EUKARYOTIC_TRANSLATION_ELONGATION,-2.549889906,0.404029111,KX-2391
NONSENSE_MEDIATED_DECAY_NMD,-2.523743789,0.272262415,KX-2391
SELENOAMINO_ACID_METABOLISM,-2.513721015,0.206171234,KX-2391
EUKARYOTIC_TRANSLATION_INITIATION,-2.466380284,0.241918665,KX-2391
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.450401566,0.220137672,KX-2391
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.450383514,0.18344806,KX-2391
TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,1.484571984,1,KX-2391
PCP_CE_PATHWAY,1.469338667,0.968555355,KX-2391
GPCR_LIGAND_BINDING,-2.105823593,0.015164778,berberine
GLUCAGON_TYPE_LIGAND_RECEPTORS,-2.002524554,0.03548558,berberine
MRNA_SPLICING_MINOR_PATHWAY,1.754857857,1,berberine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.943863828,0.04367456,berberine
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.712751368,0.89958493,berberine
HOST_INTERACTIONS_OF_HIV_FACTORS,1.69508321,0.654799915,berberine
HIV_INFECTION,1.620232896,0.748124202,berberine
M_PHASE,1.582161168,0.619612069,berberine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.582768232,0.743534483,berberine
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.575237494,0.542898194,berberine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.086983458,0.161899788,gestrinone
GASTRULATION,-2.104588373,0.228145364,gestrinone
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.011053473,0.257043777,gestrinone
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.949285401,0.291688073,gestrinone
CLEC7A_DECTIN_1_SIGNALING,-1.943330147,0.230933807,gestrinone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.699199623,0.661408252,gestrinone
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.688237412,0.464747627,gestrinone
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.863247536,0.343941811,gestrinone
NEURONAL_SYSTEM,1.668171426,0.381654941,gestrinone
PROTEIN_LOCALIZATION,1.665052758,0.30913336,gestrinone
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.192281493,0.076659968,oxandrolone
PEROXISOMAL_PROTEIN_IMPORT,1.998399886,0.131493139,oxandrolone
GASTRULATION,-1.973628158,0.369725847,oxandrolone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.969597117,0.193133107,oxandrolone
SIGNALING_BY_NTRKS,1.874708492,0.192004827,oxandrolone
M_PHASE,-1.794225205,0.533832232,oxandrolone
DNA_REPLICATION,-1.79279164,0.404022784,oxandrolone
CELL_CYCLE,-1.777142495,0.366612366,oxandrolone
HOMOLOGY_DIRECTED_REPAIR,-1.772826524,0.316212895,oxandrolone
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.658806727,0.510267911,oxandrolone
GPCR_LIGAND_BINDING,-2.24770078,0.007197532,indacaterol
SIGNALING_BY_ALK_IN_CANCER,2.131445362,0.10607727,indacaterol
NEUTROPHIL_DEGRANULATION,2.093424769,0.065721787,indacaterol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.022933028,0.061179024,indacaterol
PROTEIN_LOCALIZATION,1.935028174,0.111458001,indacaterol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.926455295,0.103964355,indacaterol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.74523653,0.250203995,indacaterol
INNATE_IMMUNE_SYSTEM,1.717346307,0.234292404,indacaterol
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.590841697,0.382416244,indacaterol
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.543528215,0.409155183,indacaterol
HOST_INTERACTIONS_OF_HIV_FACTORS,2.200096062,0.025381252,bopindolol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.087614787,0.033539512,bopindolol
MRNA_SPLICING,2.058962779,0.027194199,bopindolol
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.949316252,0.036258931,bopindolol
C_TYPE_LECTIN_RECEPTORS_CLRS,1.698748052,0.126543671,bopindolol
REGULATION_OF_RAS_BY_GAPS,1.636047022,0.148359461,bopindolol
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,1.585422717,0.162129222,bopindolol
STABILIZATION_OF_P53,1.566443956,0.15523355,bopindolol
REGULATION_OF_APOPTOSIS,1.566267242,0.137985378,bopindolol
PCP_CE_PATHWAY,1.562208439,0.126362376,bopindolol
NONSENSE_MEDIATED_DECAY_NMD,-3.228534893,0,cobimetinib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.607121885,0,cobimetinib
SARS_COV_2_HOST_INTERACTIONS,-2.623245553,0,cobimetinib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.649685362,0,cobimetinib
SIGNALING_BY_ROBO_RECEPTORS,-2.675040952,0,cobimetinib
SARS_COV_1_HOST_INTERACTIONS,-2.706644418,0,cobimetinib
SARS_COV_1_INFECTION,-2.790693773,0,cobimetinib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.796824828,0,cobimetinib
INFLUENZA_INFECTION,-2.834246118,0,cobimetinib
TRANSLATION,-2.796550782,0,cobimetinib
PEROXISOMAL_PROTEIN_IMPORT,2.276415987,0.03540196,clinofibrate
INNATE_IMMUNE_SYSTEM,2.160531909,0.04425245,clinofibrate
NEUTROPHIL_DEGRANULATION,2.13354453,0.033189337,clinofibrate
GPCR_LIGAND_BINDING,-2.039810186,0.115993624,clinofibrate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.008969353,0.075315304,clinofibrate
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.991168606,0.058802323,clinofibrate
PROTEIN_LOCALIZATION,1.777908575,0.171478243,clinofibrate
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.567461541,0.451817511,clinofibrate
SIGNALING_BY_NTRKS,1.475827054,0.595564219,clinofibrate
MYD88_INDEPENDENT_TLR4_CASCADE,1.463052326,0.543356864,clinofibrate
MRNA_SPLICING,2.425559401,0.007814866,rilpivirine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.256662119,0.0117223,rilpivirine
TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,1.810471101,0.158902284,rilpivirine
DNA_REPLICATION_PRE_INITIATION,1.596357644,0.355576422,rilpivirine
NUCLEOTIDE_EXCISION_REPAIR,1.509979909,0.438674502,rilpivirine
REGULATION_OF_RAS_BY_GAPS,1.496176982,0.392045799,rilpivirine
UCH_PROTEINASES,1.494299069,0.338644212,rilpivirine
REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,1.442955819,0.372834252,rilpivirine
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.435690352,0.343854122,rilpivirine
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.392686081,0.38084449,rilpivirine
SARS_COV_1_HOST_INTERACTIONS,-2.408747481,0,rimonabant
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.295018617,0.000976065,rimonabant
SARS_COV_1_INFECTION,-2.147796459,0.009109942,rimonabant
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1.908476973,0.104456825,rimonabant
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-1.987066156,0.050999406,rimonabant
NONSENSE_MEDIATED_DECAY_NMD,-1.932944628,0.07261925,rimonabant
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.922182341,0.067511175,rimonabant
GPCR_LIGAND_BINDING,-1.920718326,0.058563911,rimonabant
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.895500742,0.066616449,rimonabant
EUKARYOTIC_TRANSLATION_ELONGATION,-1.865518715,0.078844377,rimonabant
RAB_REGULATION_OF_TRAFFICKING,2.249362718,0.010671937,miglustat
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,2.184950345,0.008893281,miglustat
MRNA_SPLICING,1.86823144,0.042687747,miglustat
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.84052832,0.038241107,miglustat
EUKARYOTIC_TRANSLATION_ELONGATION,-2.518555014,1,miglustat
NUCLEOTIDE_EXCISION_REPAIR,1.455321496,0.223162055,miglustat
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.488585681,0.803379817,miglustat
NONSENSE_MEDIATED_DECAY_NMD,-2.470356157,0.584096232,miglustat
SELENOAMINO_ACID_METABOLISM,-2.451841053,0.477919417,miglustat
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.444087954,0.393621461,miglustat
METABOLISM_OF_RNA,2.264295967,0.061661187,milnacipran
GPCR_LIGAND_BINDING,-2.093008119,0.03674023,milnacipran
UB_SPECIFIC_PROCESSING_PROTEASES,1.698379087,0.905298335,milnacipran
DEATH_RECEPTOR_SIGNALING,1.619767013,0.966025261,milnacipran
HIV_INFECTION,1.605640224,0.786180133,milnacipran
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.869610247,0.230938591,milnacipran
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.863839264,0.162925426,milnacipran
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.505197221,1,milnacipran
SIGNALING_BY_GPCR,-1.82336898,0.176812358,milnacipran
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,1.484109657,0.965091001,milnacipran
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.167205366,0.080885483,TG-100801
GPCR_LIGAND_BINDING,-2.103496876,0.066745692,TG-100801
MRNA_SPLICING,1.919467801,0.146604938,TG-100801
G_ALPHA_Q_SIGNALLING_EVENTS,-2.022549251,0.085286162,TG-100801
MITOCHONDRIAL_BIOGENESIS,1.806115294,0.155030509,TG-100801
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.975842679,0.092084334,TG-100801
EUKARYOTIC_TRANSLATION_ELONGATION,-1.944633503,0.096873955,TG-100801
MITOCHONDRIAL_TRANSLATION,1.690876294,0.203730311,TG-100801
REGULATION_OF_INSULIN_SECRETION,-1.923382932,0.092146135,TG-100801
NONSENSE_MEDIATED_DECAY_NMD,-1.900673987,0.091466318,TG-100801
UCH_PROTEINASES,1.979133077,0.266127771,dronedarone
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1.927890333,0.180704042,dronedarone
PCP_CE_PATHWAY,1.905894603,0.137992177,dronedarone
REGULATION_OF_RAS_BY_GAPS,1.890719361,0.112529335,dronedarone
STABILIZATION_OF_P53,1.851578032,0.11367927,dronedarone
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,1.828128442,0.106232073,dronedarone
METABOLISM_OF_POLYAMINES,1.826246334,0.092933507,dronedarone
ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,1.785463754,0.104315515,dronedarone
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,1.780247594,0.09601043,dronedarone
REGULATION_OF_APOPTOSIS,1.766387252,0.094623207,dronedarone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.425334899,1,dexloxiglumide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.267500405,1,dexloxiglumide
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,-2.212121902,1,dexloxiglumide
G_ALPHA_I_SIGNALLING_EVENTS,-2.196301363,1,dexloxiglumide
GPCR_LIGAND_BINDING,-2.159993546,0.909343703,dexloxiglumide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.001917723,0.848996662,dexloxiglumide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.98836684,0.737022111,dexloxiglumide
SELENOAMINO_ACID_METABOLISM,-1.963226192,0.658601746,dexloxiglumide
NONSENSE_MEDIATED_DECAY_NMD,-1.903539903,0.618988224,dexloxiglumide
SIGNALING_BY_GPCR,-1.894699304,0.562675813,dexloxiglumide
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.165778838,0.119513769,nafamostat
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,2.092063802,0.115595285,nafamostat
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1.909545194,0.357235145,nafamostat
GASTRULATION,1.870916123,0.351194149,nafamostat
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1.847928166,0.334638553,nafamostat
CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.551149722,1,nafamostat
MHC_CLASS_II_ANTIGEN_PRESENTATION,-1.531226834,1,nafamostat
APOPTOSIS,1.796996826,0.404256956,nafamostat
NUCLEOTIDE_EXCISION_REPAIR,-1.404169587,1,nafamostat
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,1.66386249,0.818263474,nafamostat
